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ABSTRACT 
 
Aims of study 
The overall aim of this study was to investigate factors affecting service delivery 
within a national pharmacy chain, from the perspective of pharmacists and consumers, 
using asthma services as an example. Data were collected to explore the current 
environment and opportunities available to pharmacy, the factors affecting service 
delivery, and to identify recommendations for future service models. The impact of 
the design and route of service implementation were studied through two different 
types of asthma services.  
 
Methods 
The brief intervention in asthma was designed centrally and implemented nationally, 
whilst the asthma service was designed and implemented locally by a group of 
pharmacists. A triangulation of qualitative and quantitative methods were used 
throughout this study, including an omnibus survey, audits, mystery customer 
research, customer and pharmacist interviews, and a review of the dispensing data.  
 
Results 
A total of 81 facilitators, 45 barriers and 23 motivators were identified. In addition to 
extending those factors that had been previously recognised within the literature, new 
factors were also identified. Firstly, the route and design of service implementation to 
promote local ownership and responsibility for delivery of services was found to be a 
key factor, as was having flexibility in the length and content of service delivery. 
Clear and visible benefits to the pharmacists delivering the service, the customers 
accessing the service, and the pharmacy organisation were also found to play an 
important role in the delivery of services.  
 
Conclusions 
This is the first large scale study of its kind to look at all the factors involved from the 
perspective of both customers and pharmacists, and many of the facilitators and 
barriers identified extend beyond those provided within the current literature. The 
motivators identified within the previous studies have been from the perspective of 
pharmacists only. This study has looked at the perspective of not only pharmacists, but 
also the motivators to customers and the service provider. Based on all the factors 
identified throughout this study, a number of recommendations have been made for 
future service delivery.  
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CHAPTER I 
Introduction to the thesis  
 
1.0 Introduction to the chapter 
This chapter of my thesis provides an introduction to my research study, including the 
origins and development of my PhD. Despite a number of opportunities that have been 
made available to community pharmacy, the implementation and delivery of both 
private and National Health Services (NHS) is proving problematic and slower than 
expected. Although a number of papers have looked at the factors affecting service 
delivery [1-32], there is still a need for more research, and in particular, studies that 
investigate factors affecting service delivery on a large scale which include business 
and organisational elements [33]. My research should help to identify factors affecting 
service delivery within community pharmacy in the United Kingdom (UK), and help 
to address some of the issues identified within the literature. This chapter commences 
with an overview of the community pharmacy environment and the issues that my 
research is trying to address. I then present the aims and objectives of this study, and a 
detailed breakdown of the rationale and structure of the remainder of this thesis.  
 
 
1.1 Origins and development of the thesis  
The current Government for England have committed to providing a health service 
that is based around the needs of the patient. It has focused on prevention programmes 
that help to keep people healthy, making general healthcare more accessible, and 
introducing programmes that reduce health inequalities. The Government has 
recognised that health and social care will need to work together, along with new 
providers from the public and private sector, to deliver the vision for health outlined in 
The NHS Plan [34]. A number of opportunities exist for community pharmacy to get 
more involved in delivering NHS services that promote self care and improve the 
management of long term conditions. A number of legislative changes have occurred 
to help community pharmacists extend their role, such as the extension of pharmacist 
prescribing responsibilities [35] and supervision requirements [36]. The new 
community pharmacy contract [37] should also help as a vehicle for funding and 
remuneration for elements of these extended roles. This changing environment in 
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health services policy should help to facilitate the extended role of the community 
pharmacist in the delivery of NHS services.  
 
Community pharmacies within the UK are operated and run as private businesses, 
independently of the NHS. They are able to sell products and services directly to 
consumers, and are responsible to their shareholders or owners for the income 
generated. Company directors and boards are responsible for the strategy and direction 
that the companies take. Community pharmacies are able to supply Prescription Only 
Medicines (POM) and advice to consumers based on a contract with the NHS, where 
the bulk of the remuneration has traditionally been based on the volume of 
prescriptions dispensed, rather than the services provided. Within the UK, community 
pharmacies are currently made up of a number of large multiples (>50 stores), small 
chains of pharmacies and independent contractors, with multiples accounting for 
approximately 40% of the market [38]. At the time of the study, Boots The Chemistsa 
(BTC) had 1412 stores of which approximately 90% had pharmacies and NHS 
contracts. These stores were located in a variety of settings ranging from health 
centres, high street locations, edge of town shopping centres, and local communities. 
Community pharmacists are employed directly by a pharmacy company, or own and 
operate an independent pharmacy themselves. All pharmacists are members of the 
Royal Pharmaceutical Society of Great Britain (RPSGB), who act as a professional 
and regulatory body.   
 
Despite the changes in health services policy, and the opportunities this has presented 
for community pharmacy, the implementation and delivery of services has been 
slower than expected. The structure of community pharmacy within the UK may help 
to explain some of the issues around the slow development of non-supply services on 
behalf of the NHS. The implementation and delivery of private services, outside of the 
NHS, has also proved problematic within the past, with issues experienced around 
sustainability and scalability. Problems with the implementation and delivery of 
services within community pharmacy have been experienced not only within the UK, 
but also at an international level. A number of studies have identified some of the 
barriers [1-5, 7, 8, 12, 14-16, 18-21, 23-32], facilitators [1-6, 9-14, 16-20, 22-28, 30-
32] and motivators [14, 16, 22, 28] affecting service delivery within community 
pharmacy, which include: customer need and demand, public attitudes towards the 
pharmacist, pharmacist characteristics and attitude, training, communication, 
                                                 
a Throughout the remainder of this study Boots The Chemists will be referred to as Boots  
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awareness of the service, recruitment to the service, operational aspects of service 
delivery, pharmacists confidence in service delivery, support for the service, time 
available, staff resource, remuneration, pharmacy environment, healthcare 
professional relationships, evidence of the value of the service, and the external 
environment. These factors are explored in more detail within the next chapter of this 
thesis. 
 
I have been involved in pharmacy service development for the last six years as part of 
my role as Service Development Manager within Boots. Over this period of time I 
have observed the market changes within the pharmacy environment, and experienced 
first hand some of the issues in developing and implementing private and NHS 
pharmacy services that are both sustainable and scaleable. My personal and business 
interest in the factors affecting pharmacy service delivery led to the development of 
me further investigating these issues as part of a PhD. This large scale study uses a 
triangulation of data to investigate the factors affecting service delivery within 
community pharmacy, and includes the collection of data from the pharmacists 
delivering the service, the views of customers accessing the service, and the 
operational delivery of the service. Remuneration, which is often quoted as a factor in 
other studies [3-8, 11-16, 20, 22, 23, 25-30, 32], has been excluded from this study 
due to the fact that it is being funded by the company itself. Although previous 
literature has investigated some of the factors affecting service delivery, this is the first 
large scale study within the UK that has investigated the barriers, facilitators and 
motivators relating to the market opportunity, the role of the pharmacist within 
services, and the implementation and delivery of a locally and nationally led service. 
The findings from this study have already provided valuable insights and learnings 
that have been utilised within Boots itself as part of the development of new services. 
The publication of my work will also help to share this knowledge with the academic 
community [39-44]. 
 
The asthma services studied within my thesis were developed and implemented by 
myself as part of my development role within Boots, and are used as an example to 
study service implementation and delivery within community pharmacy. Although 
developed for commercial reasons, these services provided an ideal example to study 
as part of my PhD. The data collection methods that I have used within this study have 
been chosen with both research and commercial interests in mind. Whilst the research 
has been undertaken utilising resources available to me within my job at Boots, all 
analysis of the data presented within this study has been conducted by myself as a 
 4 
researcher conducting a PhD and independently outside of the work environment. 
Whilst my development role at Boots has provided me with a unique opportunity to 
undertake this large scale study, I recognise the potential conflict of delivering both 
commercial and research objectives concurrently, and discuss this in more detail 
within chapter nine.  
 
During the initial stages of my PhD I focused on the effect of the implementation 
route on the success of a service, but broadened this as my PhD progressed to include 
all factors affecting service delivery. At the time of study, I was also involved with the 
development of the service specifications for the new pharmacy contract, which 
affected the change in direction and increased breadth of my PhD to make it more 
relevant to todays practice environment. As I collected data from several sources 
throughout my study, I have been able to analyse the data to fit with the change of 
focus. Everything that I have learnt throughout this PhD has influenced the direction 
and development of not only these asthma services discussed within this thesis, but 
also other services that I have been involved with.  
 
Alongside the focus of pharmacy services on asthma during 2003/04, Asthma UK 
(formerly National Asthma Campaign (NAC)) was chosen as Boots charity of the 
year. The charity of the year involved a number of public relation events and fund 
raising activities, such as sale of pin badges and Christmas cards within Boots 
pharmacies. All activity related to the charity of the year was managed through a 
separate team and department at Boots head office, with separate aims and objectives. 
 
 
1.2 Aims and objectives  
The overall aim of this study was to investigate factors affecting service delivery 
within a national pharmacy chain, from the perspective of pharmacists and consumers, 
using asthma services as an example. The first three objectives listed explore the 
current environment and help to identify opportunities available to community 
pharmacy and the factors that may influence service provision. The last four 
objectives relate specifically to the factors affecting service delivery and 
recommendations for the future. Together, these objectives are used throughout this 
thesis to try and explore, and explain the numerous factors influencing the delivery of 
services within community pharmacy in the UK.  
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Objectives 
1. To identify opportunities for community pharmacists to help improve symptom 
control in people with asthma  
2. To describe consumers current choice, frequency of visit and use of community 
pharmacy 
3. To describe consumers and community pharmacists views on the extended role 
of the community pharmacist 
4. To investigate the impact of the design and route of service  
5. To discuss factors affecting the delivery of the asthma services  
6. To identify the benefits of service delivery; to the staff involved in running the 
service; the service user; and the company funding the service 
7. To identify any recommendations for future service delivery within community 
pharmacy 
 
 
1.3 Structure of the thesis 
I have presented the results from my study over a series of chapters, enabling me to 
paint a clearer picture of the numerous factors that could affect the implementation 
and delivery of services within community pharmacy. I have separated the results to 
investigate the factors affecting delivery based on the community pharmacists role, 
the opportunities for service delivery in asthma, the facilitators and barriers affecting 
the delivery of the asthma services themselves, and the motivators for service delivery. 
An overview of this structure is illustrated in Figure 1. 
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Figure 1: Structure of the thesis  
 
 
 
Chapter two begins by providing an overview of the literature relevant to this study. 
This chapter is split into two sections, the first exploring the development of the health 
services strategy in England, and how this has opened up a number of opportunities 
for community pharmacy. The second section of this chapter provides an overview of 
the factors affecting service delivery in community pharmacy as identified within the 
current literature.  
 
Chapter three details the methods of service implementation used for the brief 
intervention in asthma (service one) and the asthma service (service two). It then goes 
on to explore the methods of data collection and evaluation used throughout this study.  
 
Chapter four is the first of the results chapters, and is a small chapter providing a 
summary of the profile of the data presented within the results.  
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Facilitators and barriers 
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asthma services 
Chapter 8  
Motivators of service delivery 
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Factors affecting 
service delivery 
within community 
pharmacy 
INTRODUCTION 
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Chapter five is the first of the chapters investigating the factors affecting service 
delivery within community pharmacy. Within this chapter, I have investigated the 
perception of the pharmacists current and future role. The first section of this chapter 
looks at how consumers currently use community pharmacies, including the frequency 
and type of advice accessed. Within the second section of this chapter, I then go on to 
explore the changing role of the community pharmacist and the impact on, and views 
of both customers and pharmacists themselves. I also explore the confidence of 
pharmacists in delivering new services.  
 
Chapter six then goes on to explain why asthma was chosen as a condition area to 
focus on for this study, exploring general problems with the condition, and identifying 
the opportunities available for community pharmacy. As a result of this, I explore the 
factors that affect service delivery in relation to the asthma condition itself and 
opportunities available for pharmacist interventions. 
 
The results from the delivery of the asthma services are presented within chapter 
seven. This chapter is split into three sections, the first looking at the facilitators and 
barriers identified during delivery of the brief intervention in asthma, and the second, 
those identified during delivery of the asthma service. The third section within this 
chapter discusses the potential facilitators as identified by the customers and the 
pharmacists.  
 
The final results chapter is presented within chapter eight. Data on the benefits of 
service delivery to consumers, pharmacists, and the service provider are presented, 
from which motivators for delivery of the asthma services are identified. 
 
The final discussion of all the factors presented throughout this thesis is discussed 
within chapter nine, including how it supports and builds on current literature. Final 
conclusions and recommendations for future service delivery are presented, alongside 
recommendations for future research.    
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CHAPTER II 
Review of the literature 
 
2.0 Introduction to the chapter 
This chapter of my thesis reviews the literature relevant to my study. The chapter is 
split into two sections: the first of which explores the Governments health services 
strategy, policies and targets for England, and the opportunities this presents for 
community pharmacy. This review is not designed to be a comprehensive guide, but 
merely to demonstrate the changing health service environment, and the increasing 
number of opportunities becoming available for community pharmacy. Although 
Boots has pharmacies throughout the UK, the majority are within England and as such 
tend to shape the direction of service development for the company. The 
developments mentioned within this first section provide an indication of the 
opportunities available for community pharmacy, and although similar developments 
are occurring within Scotland, Wales and Northern Ireland, they are not presented 
within this thesis. 
 
Despite the Government legislation and policy changes within the health service 
environment, the extended role of the community pharmacist has not been developed, 
delivered and embraced by the profession as rapidly as one might expect. A number of 
factors are thought to affect the delivery of services in community pharmacy, and 
those identified within the literature are presented within the second section of this 
chapter.  
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SECTION ONE 
 
2.1 Development of health services policy in England, and the 
opportunities this presents for community pharmacists 
In July 1999, the Labour Government introduced the white paper Saving Lives: Our 
Healthier Nation [45], which set out their health strategy for the next ten years. The 
overall aims of the strategy were to improve the health of the population as a whole, 
and to reduce health inequalities. Specific targets were set for reducing death rates 
within four priority areas identified within the paper: cancer, Coronary Heart Disease 
(CHD) and stroke, accidents and mental health. The following year, in July 2000, the 
Department of Health (DH) launched The NHS Plan for England [34], which set out 
a radical and challenging programme of reforms for the NHS. This plan was based on 
a set of ten core principles for the NHS, which included; shaping care and services 
around the needs of the patient, helping to keep people healthy, reducing health 
inequalities, improving quality, and making better use of the skills of the NHS staff. 
Later that same year Pharmacy in the Future was published [46], which outlined the 
Governments plans for pharmacy in the new NHS. Community pharmacists were 
recognised as primary healthcare professionals in the NHS, who had vital roles to play 
in helping to deliver The NHS Plan [34]. The pharmacy strategy included plans for 
giving patients better access to pharmacy services and for helping them to use 
medicines more effectively, which would be achieved by restructuring services around 
the needs of the patients, better integration of the pharmacy profession into the NHS, 
and increasing the number of pharmacies. The report also committed the Government 
to developing a number of work strands that would enable community pharmacists to 
help deliver these plans. These included Information Technology (IT) development (to 
enable Electronic Prescription Services (EPS) and access to integrated care records), 
improving skill mix (to help free the community pharmacist up from supervising the 
whole of the dispensing process), legislation changes (to enable the community 
pharmacist to make changes to, and supply prescriptions without contacting the 
General Practitioner (GP)), and providing greater access to a wider range of medicines 
(through Patient Group Directives (PGD) and reclassification of medicines).  
 
In April 2002 Delivering the NHS Plan was published [47], detailing the next steps 
for investment and reform of the NHS. These steps included; securing the best use of 
resources, increasing patient choice, providing greater plurality in health service 
provision, devolving power to front line staff, local accountability, and reforming 
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funding flows. During April 2002, Derek Wanless also released his first review of the 
long term trends affecting the health service in the UK [48].This review described the 
vision of an NHS service in 2022, where patients were at its heart, demanding and 
receiving high quality services and treatment with fast access. He set out an 
assessment of the resources required not only to satisfy the NHS short term objectives, 
but also to invest in improving supply by building the capacity of the workforce, 
improving IT support, renewing premises, and by investing in reducing demand by 
enhancing promotion of good health and disease prevention. During May 2002, the 
DH launched their new strategy to providing wider availability of medicines through 
the reclassification process of prescription only medicines to pharmacy status [49]. 
This marked a major step in the Governments commitment to expanding the range of 
medicines available for self medication through pharmacies, as described in The NHS 
Plan [34]. The Government also recognised that this would lead to more efficient use 
of resources by freeing up GPs time and enabling community pharmacists to use their 
expertise to help manage minor ailments and chronic conditions. The DH recognised 
that extending the roles of pharmacists and pharmacy staff were key to delivering the 
aims set out within The NHS Plan [34], and so during late 2002, they published a 
strategy to help create a modern workforce that would maximise the contribution that 
pharmacy could make [50]. Included within this strategy was the continued extension 
of the role of the community pharmacist (through medicine management schemes, 
supplementary prescribing and Local Pharmaceutical Services (LPS)), and 
development of the pharmacy technician and support staff (including pilots schemes in 
which qualified technicians could dispense and supply medicines without the personal 
supervision of the pharmacist). The strategy aimed to increase the skills of the 
pharmacy support staff, enabling the pharmacist to deliver extended roles. Changes in 
legislation occurred in April 2003 to permit pharmacists to become supplementary 
prescribers [51], allowing trained pharmacists to make changes to medication supply 
under a clinical management plan agreed by the patient and GP.  
 
During July 2003, Tackling Health Inequalities highlighted the vital role that 
pharmacists could play in improving the publics health [52], and in particular, the 
importance of community settings and services in addressing health inequalities. 
During the same month, the DH released A vision for pharmacy in the new NHS 
[53] which recognised the good progress made in the first three years of Pharmacy in 
the Future[46], and set out the next steps for a continuing programme of reform for 
pharmaceutical services. Community pharmacists were recognised as having the 
skills, expertise and experience to be able to deliver services in the community that 
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were accessible to all. Specific roles identified within the paper included; supporting 
patients wishing to care for themselves, responding to the needs of patients, helping to 
deliver the aspirations outlined within National Service Frameworksb (NSF), helping 
to promote public health, tackling health inequalities and improving general health.  
 
The Office of Fair Trading (OFT) published a report in 2003 that recommended the 
abolition of control of entry restrictions on NHS pharmacy applications [38]. The 
control of entry system enabled Primary Care Organisations (PCO) to judge whether 
a new pharmacy contract was either necessary, or desirable to ensure adequate 
provision of NHS services locally. In 2004, the DH released new rules to control the 
location of pharmacies [54], which made it simpler and faster for new pharmacies to 
open and offer NHS services. This move by the DH to relax restrictions, offered the 
opportunity to improve patient choice and access to pharmacists and pharmacy 
services.  
 
During 2004, the Government produced four major publications which demonstrated 
their commitment to improving health and tackling health inequalities [55-58]. Firstly, 
Derek Wanless published his second report in which he focused on the prevention of 
ill health, and stressed the cost effectiveness of improving the health of the whole 
population and reducing health inequalities [58]. The development of the extended 
role of the community pharmacist was recognised as being important to expand 
overall capacity in the management of people with chronic conditions. The review 
concluded that achieving a society more fully engaged in health would result in longer 
and healthier lives, and reductions in the pressure on health services in the future. In 
June 2004, The NHS Improvement Plan was published [55], which set out key 
deliverables for the NHS including targets for inequalities in health, CHD, cancer, 
smoking, obesity, under eighteen contraception rate, and health outcomes for people 
with long term conditions. Immediately following on from this, the health and social 
care standards planning framework was released [57]. Finally in November 2004, the 
white paper for Choosing Health was published [56]. This paper described how the 
Government planned to make it easier for people to make healthier choices, by 
offering them practical help to adopt healthier lifestyles. It described how the goals 
within the NHS improvement plan [55] would be achieved. Key priorities for action 
included; tackling health inequalities, decreasing the number of people who smoked, 
tackling obesity, improving sexual health, improving mental health and wellbeing, and 
                                                 
b Long term strategies for improving specific areas of care 
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reducing harm and encouraging sensible drinking. The whole strategy was 
underpinned by the key principles of informed choice for all, personalisation of 
support to make healthy choices, and working in partnership to make health part of 
everyones business.  
 
In line with the Government reforms, contracts with healthcare professionals were 
renegotiated during 2003 and 2004 to enable focus and delivery on the key strategy 
outlined within The NHS Plan [34]. The new General Medical Services (GMS) 
contract for GPs [59] was introduced in April 2004, and placed emphasis on quality 
programmes with a large proportion of potential income linked to Quality and 
Outcomes Framework targets (QOF). The development of LPS allowed pharmacy 
contractors to move away from the conventional volume based contract towards more 
innovative and novel ways of operating. LPS enabled PCOs to focus on local health 
needs and make better use of pharmacists skills. During 2004, the Pharmaceutical 
Services Negotiating Committee (PSNC) successfully negotiated the new national 
NHS community pharmacy contract with the DH and NHS confederation [37]. The 
new contractual framework was recognised as providing an important vehicle for 
improving health: 
 
“My ambition remains to realise community pharmacy’s future as an integral part of NHS 
primary care service provision, embedded in NHS thinking and planning. Whether through 
helping patients make better use of their medicines, promoting healthier lifestyles or 
providing innovative services which really do make a difference to patient choice locally, I 
believe the new framework offers the right platform to raise the quality and standards of 
the services you provide and the right environment in which to make the best use of your 
clinical and professional skills.”    
Rosie Winterton MP, Minister of State [37]  
 
The contract focused on the Governments key priorities, and provided remuneration 
for improving public health, helping people in the management of long term 
conditions and supporting people to self care. It was based around three tiers of 
services; essentialc, advancedd, and enhancede. Although the majority of the pharmacy 
income would still be derived from dispensing income, there was the opportunity to be 
                                                 
c Funded centrally and provided by all contractors 
d Funded by ring fenced money locally, capped funding, and provided by accredited 
contractors only 
e Commissioned locally by PCOs, provided by accredited contractors 
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remunerated for specific services. The contract came into effect during April 2005, 
and was seen as something that would continuously evolve with the profession, so that 
over time, more services would become part of the essential and advanced part of the 
contract.  
 
In January 2005, the DH published two key documents [60, 61]. The first provided 
information on developing policy on support for self care, to empower people to treat 
themselves appropriately and avoid unnecessary medicine intake [60]. Community 
pharmacists were recognised as a source of advice for self care, and innovative 
pharmacy schemes for minor ailments were quoted as examples of good practice 
within the report. The second document focused on providing support for people with 
long term conditions [61], in which pharmacists were also recognised as playing an 
important role in helping people to manage their conditions better. In March 2005, the 
DH released their delivery plan for Choosing Health [62], and immediately 
following this, Choosing health through pharmacy was published [63]. This resource 
was developed to maximise the contribution of community pharmacists, their staff, 
and the premises in which they worked, to improve health and reduce inequalities.   
 
“We want to build on pharmacy’s strengths, to develop and further extend health 
improvement services, working closely with the wider public health team and expanding 
their role as advocates for health.”  
Melanie Johnson MP, Parliamentary Under Secretary of State for Public Health 
[63]  
 
Choosing health through pharmacy [63] set out the contribution that pharmacy could 
make to delivering Choosing Health [56]. This included; signposting, stop smoking 
services, sexual health services, drug misuse schemes, obesity programmes, 
identifying individuals with risk factors for disease, and helping people to manage 
long term conditions. Many good examples of pharmacy based services were quoted 
within the paper, including the asthma service studies which forms the basis of the 
services described in this thesis.  
 
In November 2005, the DH announced the extension of nurse and pharmacist 
prescribing to become independent prescribers [35]. It was hoped this would allow 
patients to have quicker and more efficient access to medicines, through qualified 
practitioners independently prescribing licensed medicines for any medical condition.  
 14 
Guidance and information on the implementation of independent prescribing in the 
NHS were published in April 2006, to support the timing of change in legislation [64]. 
 
In January 2006, the white paper Our health, our care, our say was released [65]. 
Prior to the writing of this paper, the DH conducted a consultation exercise with over 
40,000 people to understand what local people wanted out of their NHS servicef. The 
consultation showed the public wanted to see a wider range of professionals 
(particularly practice nurses and pharmacists) involved in health improvement, disease 
prevention and the promotion of independence. They also wanted pharmacists to have 
an increased role in providing support, information and care. This white paper outlined 
four main goals for the NHS; better prevention services with earlier intervention, more 
patient choice and a louder voice for people, more on tackling inequalities and access 
to community services, and more support for people with long term conditions. A 
number of opportunities were mentioned for pharmacy involvement, including a 
desire to encourage innovative providers from the independent and voluntary sectors 
to work together. A number of innovative pharmacy services were mentioned within 
the paper, including the Boots Chlamydia screening service. One of the priorities 
identified within the consultation exercise for Our health, our care, our say was for 
services based around the needs of people with long term conditions, to help them take 
control of their health, support their wellbeing, and enable them to lead an 
independent and fulfilling life. In response to this consultation, the DH published a 
document in February 2006 to support people with long term conditions to self care 
[66]. This document was a self help guide to help organisations locally deliver 
strategies to empower people with long term conditions to manage their own care, 
with the support of doctors, nurses and pharmacists.   
 
In September 2006, the DH published the national framework for pharmacists with 
special interests [67]. This document provided guidance on how local health 
communities could develop, commission and implement extended services in primary 
care. In particular, it supported the wider development of the pharmacy workforce 
including national standards for pharmacy roles, better skill mix, and the 
establishment of consultant pharmacist posts. This framework was intended to allow 
pharmacists to work with other primary care professionals to deliver care in new ways.   
 
                                                 
f Details of the consultation are included within the white paper Our health, our care, our say 
[65] 
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2.1.1 Summary of section one  
The current Government have committed to providing a health service that is based 
around the needs of the patient. It has focused on prevention programmes to help keep 
people healthy, making healthcare more accessible, and reducing health inequalities. 
The Government has recognised that health and social care will need to work together, 
along with new providers from the public and private sector, to deliver the vision for 
health outlined in The NHS Plan [34]. A number of opportunities exist for 
community pharmacy to get more involved in delivering NHS services that promote 
self care and improve the management of long term conditions. Legislative changes 
have also occurred to help community pharmacists extend their role, such as the 
extension of pharmacist prescribing responsibilities and supervision requirements. The 
new community pharmacy contract should also help as a vehicle for funding and 
remuneration for elements of these extended roles. This changing environment in 
health services policy should help to facilitate the extended role of the community 
pharmacist in the delivery of services. Despite these changes within the health services 
environment, and the opportunities available for community pharmacists, the delivery 
of service is still not routine practice. The following section of this chapter reviews the 
literature to help identify factors which may be responsible.  
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SECTION TWO 
 
2.2 Factors affecting service delivery in community 
pharmacy 
Despite the Government legislation and policy changes within the health service 
environment, and the recommendations of two major pharmacy reports [68, 69], the 
extended role of the community pharmacist has not been developed, delivered and 
embraced by the profession as rapidly as one might expect. A number of factors are 
thought to affect the delivery of services in community pharmacy, and those identified 
within the literature are presented within this section of the chapter.  
 
A literature review was conducted using the MEDLINE and EMBASE databases with 
a combination of the following search terms:  
pharmac$  AND  cognitive services  
OR pharmaceutical care  
OR services  
AND  barrier  
OR facilitator  
OR factor  
OR implementation  
OR motivator 
 
A search was also carried out on the MEDLINE and EMBASE databases of authors 
that were identified within the literature search, as was a hand search of key journals 
such as, the International Journal of Pharmacy Practice, and Patient Education and 
Counselling. Additional papers were identified by reviewing the literature quoted by 
authors discovered within the initial review. Papers not reported in English were 
excluded from the review.  
 
The literature review identified thirty-two papers that had conducted extensive 
research into the factors affecting service delivery in community pharmacy, a 
summary of which is provided in Table 1. The implementation and delivery of 
services within community pharmacies appears to have been problematic and slower 
than expected on an international level, as identified within the studies conducted 
within the United States of America (USA) [1, 4, 6, 9, 10, 14, 16-19, 21, 30, 31], UK 
[2, 3, 5, 13, 15, 25-28, 32], Denmark [11, 12, 23, 24], Malta [7], Netherlands [20], 
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Australia [22], New Zealand [8], and Europe wide [29]. Although the terminology on 
service delivery varies within the literature (pharmaceutical care, cognitive services, 
pharmacy services), all of these studies refer to factors affecting service delivery in 
community pharmacies, and as such are included within this review. Only six of the 
studies have investigated specific services [4, 6, 20, 21, 24, 28], compared to twenty-
six that have looked at the overarching concept of service delivery in community 
pharmacies [1-3, 5, 7-19, 22, 23, 25-27, 29-32]. The majority of these studies have 
used quantitative methods [1, 2, 4-10, 14, 15, 17, 19, 21, 23-25, 28, 30-32] to collect 
the data, as apposed to qualitative techniques [3, 11-13, 16, 18, 20, 22, 26, 29], and 
only one study conducted by Tann et al. [27] used a combination of techniques to 
triangulate the data. In addition, several literature reviews are also discussed [33, 70-
75].   
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Table 1: Summary of the literature identifying the facilitators and barriers to service delivery in community pharmacy 
(Please note that this table is presented over 16 pages) 
Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Zelnio, R. 
Nelson, A.  
Beno, C. [31]  
(1984) 
 
Country of 
study: USA 
To investigate the 
relationship between 
service provision and 
pharmacists 
willingness and 
competency. To 
characterise 
pharmacists who did or 
did not provide 
expanded levels of 
service 
Self 
administered 
mail 
questionnaire to 
890 community 
pharmacists  
Pharmacists willingness, 
practice setting 
(apothecary, independent), 
pharmacists characteristics 
(hold advanced degrees, 
completion of more 
Continuing Education (CE), 
more willing to participate 
in CE, work more hours per 
week) 
Pharmacist: lack of 
competency and lack of 
willingness  
Significant relationship 
between pharmacists 
willingness and ability, and 
the extent to which they 
provided expanded levels of 
service.  Some pharmacists, 
however, were willing and 
able but still did not provide 
expanded services 
Variable 
explained only 
a small 
amount of 
variation, 
other variables 
not measured 
by research, 
self reported 
data 
Nelson, A.R. 
Zelnio, R.  
Beno, C. [16]  
(1984) 
 
Country of 
study: USA 
Second phase of a two 
part investigation.  
Report focuses on why 
pharmacists who had 
expressed a willingness 
and competency to 
perform clinical 
pharmacy services in 
phase one had not 
developed such a 
practice 
Series of 11 
focus groups 
with 81 
pharmacists  
*Training and education, 
knowledge and experience, 
advertising, demand, 
manpower, revenue 
generation, improved 
pharmacist and physician 
attitudes and relationships, 
favourable pharmacy 
atmosphere,  
communication skills, 
access to patient 
information, proven 
benefits, legislation, 
equipment (e.g. computers) 
 
* Requisites  
Lack of revenue from 
service, pharmacists, 
physicians and patients 
attitudes, lack of time, legal 
barriers, lack of patient 
contact, pharmacist 
incompetence, lack of 
demand, services too 
costly, lack of facilities 
Authors suggest a plan: 
identify services needed by 
patients (cost effective), 
develop programmes to 
provide new skills, develop 
systems to increase 
pharmacist productivity, 
identify physicians willing to 
assist, redesign physical 
structure of pharmacy, 
increase patient awareness of 
service, educate patients on 
appointment system, research 
to investigate payment for 
services  
Self reported 
data, identified 
facilitators 
were 
hypothetical in 
nature 
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Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Raisch, D. [21]  
(1993) 
 
Country of 
study: USA 
To identify how 
pharmacists perceive 
barriers, the 
relationship between 
the barriers and the 
rate at which 
pharmacists provide 
Cognitive Pharmacy 
Services (CPS), To 
establish 
relationships between 
job or career 
satisfaction and the 
amount of CPS 
provided 
Survey of 64 
pharmacists 
(participants 
were pharmacists 
who had 
collected data on 
Cognitive 
Services (CS) for 
an earlier study) 
Not measured Excessive workload, lack of 
privacy, patient attitudes, 
store layout, difficulties in 
contacting physicians, 
physicians negative attitude 
towards pharmacists 
recommendations, and 
inadequate patient 
information 
Suggested methods to 
overcome barriers: structuring 
reimbursement and workload 
around CPS (not dispensing), 
redesigning pharmacies to 
provide counselling areas, 
changing pharmacist attitudes 
and abilities though education, 
using technology to promote 
information transfer between 
pharmacies and healthcare 
facilities 
Sample size 
dictated by 
previous study, 
preformed list 
of barriers 
specific to 
services 
assessed 
(factors may 
be missing)  
Mottram, D.R. 
Jogia, P. 
West, P. [15]  
(1995) 
 
Country of 
study: UK 
To identify activities 
perceived by 
community 
pharmacists to 
represent extended 
role, the extent to 
which these activities 
were implemented, 
and to measure the 
constraints against 
implementation 
Mail 
questionnaire to 
62 community 
pharmacists  
Not measured Time, finance, conflict with 
other healthcare 
professionals, threat to 
traditional role of 
community pharmacists 
Future of community 
pharmacy depends on adoption 
of extended role, but must be 
conducted in collaboration 
with GPs if community 
pharmacists are to be accepted 
as full member of primary 
healthcare team 
Self reported 
data, 
predefined list 
of constraints 
(factors may 
be missing), 
predefined list 
of activities 
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Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Miller, M.J.  
Ortmeier, B.G.  
[14] (1995) 
 
Country of 
study: USA 
Examined 
relationship between 
prescription payment 
methods and the 
number of pharmacy 
services provided at a 
community 
pharmacy. Also 
studied were 
pharmacists 
perceptions regarding 
pharmacy services, 
motivating factors, 
payment and barriers 
to service delivery 
Survey of 590 
community 
pharmacies 
**Financial incentives, 
professional reward, legal / 
contractual requirements of 
third party payment 
programmes  
 
**Motivators rather than 
facilitators 
Compensation for 
dispensing commodity 
rather than service, lack of 
time, capital requirements 
required to implement, 
develop and deliver services 
Without adequate financial 
incentives, legislative and 
contractual requirements will 
most likely fail to achieve 
level of motivation necessary 
to develop pharmacy services  
Self reported 
data, survey 
instrument not 
validated, 
sample bias 
towards 
independent 
pharmacies, 
preformed data 
(factors may 
be missing), 
no distinction 
between actual 
and perceived 
barriers 
Odedina, F.T. 
Segal, R. 
Hepler, C.D.  
[18] (1995) 
 
Country of 
study: USA 
To identify factors 
that providers and 
non providers believe 
influence their 
behaviour relative to 
the provision of 
Pharmaceutical Care 
(PC) 
Telephone 
interviews with 
ten providers of 
PC were 
compared with 
ten non providers 
Pharmacist commitment to 
patient care, physical layout 
of pharmacy, qualified 
personnel, practice 
orientation, patient 
expectation, physician 
cooperation, computer 
support, access to patient 
medical information, 
pharmacist competency 
Physical layout of 
pharmacy, qualified 
personnel, practice 
orientation, patient 
expectation, physician 
cooperation, computer 
support, access to patient 
medical information, 
pharmacist competency 
There are certain factors that 
community pharmacists can 
easily control to facilitate 
provision of PC, but there are 
also other factors that cannot 
be controlled by employee 
pharmacists without the 
assistance of management 
Small sample 
size, self 
reported data 
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Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Odedina, F.T 
Segal, R. 
Hepler, C.D. 
Lipowski, E. 
Kimberlin, C. 
[19] (1996) 
 
Country of 
study: USA 
To present findings 
about Pharmacists 
Implementation of 
Pharmaceutical Care 
(PIPC) factors 
(theoretical model) 
and community 
pharmacists self 
reported behaviour 
Survey of 617 
community 
pharmacists (two 
part study six 
weeks apart) 
Past behaviour recency, 
positive behavioural 
intention, perceived 
behavioural control, positive 
attitude, positive social 
norm, positive self efficacy, 
positive instrumental 
beliefs, positive affect 
Low perceived social norm 
by physicians, low 
perceived behavioural 
control, low self efficacies, 
low affect 
PIPC model proposes two key 
decision points for 
pharmacists to adopt PC, 
which can be used as targets 
for designing programmes to 
assist in providing PC. 
Interventions need to be 
developed for: motivating 
pharmacists to form an 
intention to provide PC, and 
transforming behavioural 
intention to actual trying 
Self reported 
data, although 
initial sample 
random  final 
subjects used 
were not 
Tann, J. 
Blenkinsopp,A
Allen, J. 
Platts, A. [27]  
(1996) 
 
Country of 
study: UK 
Explores hypothesis 
that innovation is 
related to a set of 
largely generic 
characteristics 
possessed by those 
who promote 
professional change, 
together with 
enabling elements in 
the work 
environment 
Triangulation of 
methods 
(structured 
interviews, 
critical incident 
analysis, 
psychometric 
test KAI) with 
37 community 
pharmacists. 
Comparison of 
data with control 
group  
Pharmacist processing 
characteristics of Leading 
Edge Practitioner (LEP), 
including patient centred, 
effective soft networkers, 
staff development, 
influencers 
Finance, time, space, GP 
relations and attitudes 
Work suggests that gap 
between policy and practice, 
as well as time lag in 
implementation, could be 
reduced by focusing on LEPs 
to pilot and implement 
recommended changes in 
practice.  Implications for 
training and recruitment 
policies 
Self reported 
data, poor 
representation 
of multiples 
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Odedina, F.T. 
Hepler, C.D. 
Segal, R. 
Miller, D. [17]  
(1997) 
 
Country of 
study: 
USA 
To develop a 
theoretical 
framework that 
explains pharmacists 
behaviour relative to 
the provision of PC 
617 community 
pharmacists were 
surveyed twice 
(mail survey) 
PIPC model developed 
postulates that behaviour is 
directly determined by past 
behaviour recency, 
behavioural intention and 
perceived behavioural 
control. Psychological 
appraisal process 
(instrumental beliefs, self 
efficacies, and affect 
towards means) influence 
behaviour through past 
behaviour recency. 
Behavioural intention is 
determined by attitude, 
social norm and perceived 
behavioural control 
Not measured PIPC model provides a formal 
scientifically validated 
theoretical framework that can 
be used to design successful 
interventions for PC 
implementation. Model 
provides specific factors that 
need to be addressed to 
motivate pharmacists in 
making two major decisions: 
forming an intention to 
provide PC, and enacting the 
behavioural intention 
Self reported 
data, although 
model 
developed 
from 
pharmacists 
behaviour, no 
work done to 
test how 
influence 
behaviour to 
improve PC 
delivery 
Venkataraman,
K. Madhavan, 
S. Bone, P.  
[30] (1997) 
 
Country of 
study: USA 
 
To determine the 
influence of various 
perceived facilitators 
and barriers on the 
provision of PC in 
rural communities  
Questionnaire to 
162 pharmacy 
owner / 
managers in rural 
communities 
Perceived patient attitude, 
pharmacist positive attitude 
towards patient care, 
pharmacists confidence (all 
found to be statistically 
significant) 
Lack of reimbursement (not 
statistically significant) 
Results suggest that 
pharmacists may need training 
on how to provide PC before 
they feel confident in their 
ability to provide services, and 
their attitudes and beliefs 
about PC may need to be 
changed 
Self reported 
data, only 
limited 
number of 
barriers and 
facilitators 
investigated 
(pre-defined)  
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Berger, B.A. 
Grimley, D. 
[4] (1997) 
 
Country of 
study: 
USA 
To apply the 
transtheoretical 
model of change to 
measure pharmacists 
readiness for 
rendering PC 
Self 
administered 
questionnaire 
completed at 
1996 American 
pharmacists 
association 
annual meeting 
by 148 
pharmacists 
CE, compensation Compensation, pharmacy 
redesign 
Authors concluded that one 
size fits all strategy will not be 
effective, and CE must be 
stage specific to be effective. 
Recommend that need to 
understand strategies for each 
stage in order to design 
programmes to assist 
pharmacists in taking the next 
step 
Convenience 
sample of 
respondents 
attending 
conference, 
results not 
generalisable 
Bell, H.M. 
McElnay, J.C. 
Hughes, C.M. 
Woods, A. [3]  
(1998) 
 
Country of 
study: UK 
To ascertain attitudes 
and opinions towards 
the concepts of PC 
and its 
implementation  
In-depth 
interviews with 
20 community 
pharmacists  
Improving public perception 
of pharmacy, professional 
training, remuneration, good 
working relationship with 
other healthcare 
professionals, access to 
patient medication records, 
private counselling area, 
collegial interaction, extra 
staffing resource 
Lack of time, little financial 
incentive, lack of private 
counselling area, low public 
expectation of pharmacy 
profession, poor relationship 
with GPs, lack of access to 
patient medication records, 
lack of competency  
Suggested support required to 
overcome barriers: improving 
public relations, professional 
training, support from 
Government and professional 
bodies, remuneration, money 
to employ additional staff, 
utilisation of CE courses, 
working with other healthcare 
professionals 
Self reported 
data, small 
sample size 
Bell, H.M. 
McElnay, J.C. 
Hughes, C.M. 
[2] (1999) 
 
Country of 
study: 
UK 
To investigate how 
community 
pharmacists currently 
use their time, to see 
if lack of time to 
implement PC really 
is a barrier to 
provision of extended 
patient care services 
Self reported 
work sampling 
study with 30 
pharmacists 
Improved time 
management, use of trained 
dispensary staff  
Amount of pharmacist time 
devoted to non professional 
activities  
Study found that 22% of 
pharmacists time was devoted 
to non professional activities 
which could have been 
performed by non professional 
members of the team. Authors 
recommended time 
management and use of staff 
would increase scope for 
pharmacists to integrate PC 
into routine practice 
Small sample 
size 
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Christensen, 
D.B. Hansen 
R.  [6]  
(1999)  
 
Country of 
study: USA 
To determine the 
influence of payment, 
pharmacy setting 
characteristics, 
pharmacist 
demographics, 
practice setting, and 
attitudinal 
characteristics on 
whether CS were 
performed by 
community 
pharmacists, and the 
volume of CS 
performed  
Mail survey to 
community 
pharmacists, 
randomised 
control trial. 
Study group was 
reimbursed for 
CS (n=110), 
whilst control 
group was 
offered no 
reimbursement 
(n=90) 
Participation in CS; job role 
(pharmacy owner or 
manager), communication 
and assistance regarding 
documentation so not 
perceived as burdensome, 
low prescription volumes  
 
Higher rates of CS: 
Reimbursement, practice 
setting (medical centre, rural 
locations), high proportion 
of eligible patients visiting 
pharmacy, environment 
with low prescription 
volumes 
Not measured To maximise effect of new CS 
programme then need to select 
pharmacy setting carefully, and 
develop communication and 
assistance to ensure 
documentation not burdensome. 
To enhance participation in 
existing CS then need to modify 
work environment, and change 
performance expectations of 
pharmacists 
Volume of CS 
service 
delivery was 
self reported, 
reference to 
documented 
CS activities 
only, factors 
influencing 
delivery of CS 
may be 
different to 
those 
influencing its 
documentation 
Farris, K.B. 
Schopflocher, 
D.P. [9]  
(1999) 
 
Country of 
study: 
USA 
To describe self 
efficacy, beliefs, 
evaluations and 
perceived 
behavioural control 
in the provision of 
PC, to quantify 
intention and 
behaviour to provide 
PC, and to examine 
the relationships 
between intention 
and behaviour  
230 community 
pharmacists 
undertook 
attitude survey 
followed by 
behaviour survey 
(mail) 
Perceived behaviour control 
and self efficacy  
Not measured Providing PC is not merely a 
function of individual decision 
making. Behaviour is strongly 
impacted by pharmacists 
perceived control over their 
practice environments. PC 
implementation programmes 
which address individual factors 
singly will not be successful  
Self reported 
data, pre 
formed 
questionnaire  
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Barner, J.  
Bennett, R. [1]  
(1999) 
 
Country of 
study: USA 
To measure the effect 
of a Pharmaceutical 
Care Certificate 
Programme (PCCP) 
in community 
pharmacists  
Survey of 36 
pharmacists 
participating in 
PCCP (baseline 
and one year) 
***Focusing on neediest 
patients, networking with 
other pharmacists, involving 
all staff in training, 
developing relationships 
with patients, support staff 
to free up pharmacist time, 
private counselling areas, 
marketing services, training 
programmes, documentation 
value services, computer 
software to support 
documentation and billing, 
participation in studies, 
management support, access 
to online research to inform 
recommendations  
 
***Solutions to barriers  
Lack of data / 
documentation systems, 
too many pharmacist 
interruptions, high 
volume dispensing, 
physical layout of 
pharmacy, patients not 
wanting service, poor 
workflow, lack of 
pharmacist education, 
lack of management 
support, management 
responsibilities, and 
attitude other pharmacist 
colleagues  
After undertaking PCCP 
programme, pharmacists in 
study improved their confidence 
in performing job, and felt 
significantly better prepared to 
perform PC components. Little 
change in the percentage of time 
spent delivering PC to patients 
after one year however 
Convenience 
sampling, self 
reported data  
Cordina, M. 
McElnay, J.C. 
Hughes C.M.  
[7] (1999) 
 
Country of 
study: 
MALTA 
To assess the 
importance Maltese 
community 
pharmacists placed 
on various aspects of 
PC and their 
willingness to 
provide such care 
Modified version 
of behavioural 
pharmaceutical 
care scale 
questionnaire 
was mailed to 
privately owned 
community 
pharmacies in 
Malta (n=99) 
Not measured Lack of reimbursement, 
time available, support 
staff, patient acceptance, 
doctor cooperation, access 
to medical information, 
pharmacist competency, 
unsatisfactory physical 
layout of pharmacy, non 
conducive structure of 
local healthcare system 
Although the majority of 
pharmacists were willing to 
provide PC, a series of strategic 
steps need to be taken to resolve 
issues. These include: 
standardised training, improving 
understanding between doctors 
and pharmacists, research and 
development programmes to 
promote PC provision, 
reimbursement system that 
supports PC 
Self reported 
data, 
participants 
had poor 
understanding 
of PC  
perceived 
barriers, 
results not 
comparable 
with other 
countries 
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Tully, M.P.  
Seston, E.M. 
Cantrill, J.A. 
[28] (2000)  
 
Country of 
study: UK 
To assess the strong 
motivators and 
barriers to the 
implementation of 
prescription 
monitoring and 
review services by 
community 
pharmacists either in 
pharmacies or in GP 
practices  
Two part Delphi 
survey to a 
purposive 
sample of 120 
community 
pharmacists  
** Improving the public and 
GPs perception of 
pharmacists, experiencing 
professional fulfilment and 
personal challenges 
 
 
**Motivators rather than 
facilitators 
Time consuming nature of 
services, locum 
difficulties, the 
prohibitive cost and 
unwillingness of 
pharmacy owners or GPs 
to fund services 
Overcoming the logistical and 
financial barriers to services may 
not be sufficient. Also need to 
address internal rivalries, and the 
structure and culture of the 
profession 
Self reported 
data, pre 
formed 
questionnaire, 
study based on 
single service 
(medication 
review),  
purposive 
sample, results 
not 
generalisable 
Rutter, P.R. 
Hunt, A.J. 
Jones, I.F. [26]  
(2000) 
 
Country of 
study: UK 
 
To investigate 
community pharmacy 
managers perceptions 
of their role in 
providing healthcare 
to patients and to 
compare these with 
their aspirations for 
future 
Two focus 
groups with 14 
pharmacy 
managers from 
one area of UK 
national 
pharmacy chain 
Delegation of services from 
prescribers to pharmacists, 
more formalised and open 
channels of communication 
with prescribers, moving 
away from performing 
technical duties, better 
qualified and trained staff, 
provision of additional 
pharmacy support, enhanced 
working environment 
Time, inappropriate levels 
of staff, lack of patient 
time, perceptions of 
others (healthcare 
professionals and general 
public), poor 
communication with head 
office, legal restrictions, 
current remuneration 
structure  
Empowering staff (through skill 
mix) would allow the pharmacist 
more opportunity to interact with 
patients and at the same time 
free them from routine 
dispensing  
Self reported 
data, small 
sample size, 
group 
polarisation 
effect of focus 
groups 
(enhanced as 
participants 
worked in 
same area so 
likely to know 
each other), 
main 
researcher was 
company 
employee  
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Heller, C. 
Arozullah, A. 
[10] (2001) 
 
Country of 
study: 
USA 
To evaluate and 
further develop 
evidence based 
implementation 
strategies that are 
effective and efficient 
(theory based) 
Review of three 
empirical 
frameworks  
Aligning programme with 
the strategic goals of the 
organisation, obtaining 
active senior leadership 
commitment, securing 
appropriate infrastructure to 
facilitate integration of 
recommended actions into 
daily practice, setting up 
systemic communications 
with all involved 
stakeholders 
Not measured Programmes were more likely to 
be successful if goals were also 
considered from the view of the 
various stakeholders and if all 
four factors were present 
Although 
conducted 
review of 
disease 
management 
programmes in 
literature after 
identified four 
components, 
limited general 
findings as 
theory not 
tested in 
designed study 
van Mill, J. 
De Boer, W. 
Tromp, T.  
[29] (2001) 
 
Country of 
study: 
EUROPE 
To establish the 
perceived barriers to 
the implementation 
of PC into 
community pharmacy 
practice in different 
European countries 
and the relevant 
importance of these 
barriers 
Structured 
interviews with 
representatives 
from national 
pharmaceutical 
organisations or 
pharmaceutical 
care researchers 
from 11 
European 
countries known 
to be attempting 
to implement PC 
Not measured Two most important 
barriers were lack of time 
and money 
(reimbursement for 
services). Other barriers 
also identified  but 
impact on implementation 
seemed to differ markedly 
over Europe 
European pharmaceutical 
associations need to pay 
attention to remuneration issues 
before attempting to implement 
PC in their countries, and also 
need to work continuously to 
change attitudes amongst 
pharmacists 
Self reported 
data, based on 
perspective of 
implementers, 
not providers 
of PC. Small 
sample size, 
only one 
person from 
each country 
was 
interviewed, 
findings not 
generalisable 
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Pronk, M.C.M. 
Blom, A.T.G. 
Jonkers, R. 
Van Burg, A. 
[20] (2001) 
 
Country of 
study: 
NETHERLANDS 
To identify barriers 
and facilitators into 
the diffusion stages 
of Rogers 
Innovations in 
Organisations model 
Qualitative study 
using focus 
groups with 
pharmacists 
(n=18) and 
pharmacy 
technicians 
(n=20).  
Task division among 
technicians, attention for 
special patient groups (e.g. 
diabetes), availability and 
use of a leaflet system, 
having a patient friendly 
layout in pharmacy, 
continuing education and 
motivation in specialist 
areas, use of protocols  
Lack of support from 
staff, documentation of 
the process, lack of a 
leaflet system, lack of 
privacy, time, use of 
protocols, guidance and 
lack of remuneration 
Findings from study indicate that 
pharmacists and technicians 
have different viewpoints. Both 
groups should be involved in 
initiatives concerning the 
improvement and evaluation of 
services such as patient 
education 
Low response 
rate so sample 
likely to be 
biased towards 
highly 
motivated 
individuals 
Ruston, A.  
[25] (2001) 
 
Country of 
study: UK 
To identify the 
characteristics of 
community 
pharmacists that 
influence adoption of 
an extended role in 
order to inform ways 
in which they could 
organise their 
businesses to achieve 
successful re 
professionalisation 
Postal 
questionnaire to 
731 community 
pharmacists 
Fostering levels of 
autonomy, promoting 
uptake of post registration 
education to provide the 
knowledge, skills and 
confidence required, 
establishing ways for 
pharmacists to leave 
premises and work with 
other professionals outside 
the pharmacy, having 
regular contact with health 
authority pharmaceutical 
advisor 
Shortage of time, 
insufficient remuneration, 
shortage of staff, no 
locum cover, lack of 
contact with other 
healthcare professionals, 
lack of confidence, 
shortage of skills  
Involvement in extended role 
activities more to do with 
pharmacist professional 
orientation than the setting in 
which they work. Data suggest 
that may be quite some time 
before extended role becomes a 
true reality for community 
pharmacists 
Self reported 
data, no clear 
explanation of 
how 
correlations 
between 
reports of 
activities and 
business / 
pharmacist 
characteristics 
of the 
respondent 
were made 
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Krska, J. 
Veitch, 
G.B.A.[13] 
(2001)  
 
Country of 
study: UK 
To obtain the views 
of key pharmacists in 
Scotland on a 
systemic approach to 
PC and on the factors 
important in its 
development 
Interviews with 
11 policymakers 
and five leading 
edge pharmacists 
Remuneration, time, support 
staff, consultation space, 
improvement to computer 
systems to support 
documentation, access to 
appropriate literature to 
support decision making, 
training on application of 
practice, good working 
relationship with GPs to 
facilitate access to medical 
information, perception of 
patients and healthcare 
professionals, structured 
research on benefits of PC, 
implementation of repeat 
dispensing, patient 
registration at pharmacy 
Not measured Authors recommend that 
planning of future services needs 
to involve community 
pharmacists. Also suggest that 
views obtained on repeat 
dispensing, patient registration, 
access to patient data and 
remuneration could be of 
importance to Scottish 
legislators, and may require 
legislative changes. Time 
management, pharmacy layout, 
access to literature and training 
may be issues for individual 
contractors to address 
Small sample 
size, many of 
those 
interviewed 
were known 
personally to 
interviewer, 
and all were 
aware of 
funding source 
 which may 
have led to 
bias 
Rossing, C. 
Hansen, E.H. 
Krass, I. [23]  
(2002) 
 
Country of 
study: 
DENMARK 
 
To examine the 
barriers and 
facilitators perceived 
and experienced by 
Danish community 
pharmacists 
regarding the 
implementation of 
PC 
Survey to 218 
community 
pharmacists in 
Denmark  
Post graduate training, 
raising profile of pharmacy, 
management support, better 
utilisation of existing 
personnel, allocation of time 
to deal with specialised 
issues  
Lack of financial and 
human resources in 
pharmacy, lack of time, 
lack of personnel, lack of 
co-operation with GPs, 
lack of education of 
pharmacists 
Implementation of PC would be 
promoted by allocation of 
further resources (dedicated to 
both internal and external 
activities) and development of 
strategic marketing plan  
Self reported 
data, pre 
formed 
questionnaire 
(factors may 
be missing)  
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Dunlop, J.A. 
Shaw, J.P. [8]  
(2002) 
 
Country of 
study: NEW 
ZEALAND 
 
To establish 
community 
pharmacists level of 
understanding of PC 
process, to determine 
their attitudes to the 
concept of PC, to 
determine the barriers 
to commencing PC 
practice 
Postal 
questionnaire 
with 348 
pharmacists 
Not measured Included: Lack of time, 
reimbursement, 
therapeutic knowledge, 
clinical problem solving 
skills, finance, space, 
patient demand, access to 
patient medical records, 
data on the value of PC 
Authors conclude that with 
impending changes in pharmacy 
education, service delivery and 
remuneration, many of these 
perceived barriers may be 
removed in the future 
Preformed 
responses, no 
opportunity to 
add additional 
data 
Blenkinsopp,A 
Celino, G. [5]  
(2003) 
 
Country of 
study: 
UK 
To establish current 
and planned local 
community pharmacy 
services, to identify 
drivers and barriers to 
local community 
pharmacy 
development, to 
determine the extent 
to which community 
pharmacy 
development was 
planned, to assess 
PCO pharmacists 
own perception of 
local progress 
Postal 
questionnaire 
completed by 
203 PCO 
pharmacy 
advisors / chief 
pharmacists 
Relationship with PCO and 
local pharmaceutical 
committee, new pharmacy 
contract, support of GPs, 
profile of community 
pharmacy in PCO, attitude 
of community pharmacists  
Access to funding, 
pharmacy resource at 
PCO, confidence in 
community pharmacists to 
deliver, attitude of 
community pharmacists, 
outcome of OFT report 
Authors concluded that local 
relationship / leadership issues 
appear to be driver and barrier to 
service development 
Viewpoint of 
PCO 
commissioners 
of services 
only 
 
 
 
 31 
Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Roberts, A. 
Benrimoj, S.I. 
Chen, T.  
Williams, K. 
Aslane, P. 
Gadiel, D.  
Ridoutt, L.  
[22] (2003) 
 
Country of 
study: 
AUSTRALIA 
To investigate the 
process of change in 
community 
pharmacy, and 
identify facilitators of 
practice change 
process as they relate 
to the implementation 
of community 
pharmacy CPS  
36 in depth 
interviews with 
pharmacy 
owners, 
employed 
pharmacists, 
pharmacy 
assistants, and 
pharmacy 
strategists. 
Organisational 
theory 
framework for 
data collection 
and analysis  
Remuneration of 
implementation and / or 
service,  
external support or 
assistance, reorganisation of 
the pharmacy structure and 
function, communication, 
internal leadership, 
delegation of tasks 
Not measured Sustainability of CPS at risk if 
pharmacists do not restructure 
and effectively trade off or make 
compromises with existing 
activities and commitments to 
give themselves appropriate 
space, time and resources to 
deliver new services 
Self reported 
data, purposive 
sample 
Hopp, T.R. 
Sorensen, 
E.W. Herborg, 
H. Roberts, 
A.S.  [12] 
(2005) 
 
Country of 
study: 
DENMARK 
To investigate the 
implementation 
process of CPS in 
professionally active 
pharmacies in 
Denmark, to describe 
factors that influence 
the implementation 
process in the context 
of organisational 
theory 
20 semi 
structured 
interviews with 
pharmacy staff 
and owners in 
professionally 
active 
pharmacies 
responsible for 
implementation 
of CPS from 16 
community 
pharmacies  
Included: In service 
training, activities to raise 
profile of pharmacy, 
management support, better 
utilisation of existing 
personnel, internal courses 
on relevant issues 
Lack of time and money 
are the first major barriers 
to overcome. If and when 
these barriers are 
overcome, lack of 
knowledge and lack of 
competence become 
barriers, followed by 
inadequate organisation of 
the pharmacy 
Many interdependent factors 
influence implementation 
process. Future models should 
support comprehensive and 
flexible strategies that can be 
adapted to the dynamics of the 
individual organisation  
Interviews 
with active 
pharmacies 
only, self 
reported data, 
small sample 
size  
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Rossing, C. 
Hansen, E.H. 
Traulsen, J.M., 
Krass, I. [24]  
(2005) 
 
Country of 
study: 
DENMARK 
 
To explore 
characteristics of 
community 
pharmacies with 
respect to 
implementing PC 
activities at reality, 
perceived and policy 
level 
Cross sectional 
questionnaire 
sent to all Danish 
community 
pharmacies. 
Response of 218. 
Identification of 
medicine related 
problems was 
used as outcome 
measure as proxy 
of PC activities 
Included: Co-operation with 
healthcare professionals and 
patient associations, skills 
enhancement, quality 
assurance, better utilisation 
of manpower, experience 
with PC 
Included: Shortage of 
pharmacist personnel, 
lack of computer support, 
lack of opportunity for 
patient counselling 
Difference between actual and 
perceived provider profiles 
mainly related to the external 
profiling of pharmacy and 
efforts of actual providers to 
enhance skills. Authors 
recommend that successful 
implementation of PC has to be 
based on full commitment of 
pharmacy profession 
PC practice 
was measured 
partly through 
behaviour 
(identification 
of medicine 
related 
problems) and 
partly through 
self report 
without giving 
a definition of 
PC  
Bradley, F. 
Elvey, R. 
Ashcroft, D. 
Noyce, P. [32]  
(2006) 
 
Country of 
study: 
UK 
To identify factors 
which PCOs consider 
to be barriers and 
drivers to the 
commissioning of 
services from 
community 
pharmacies 
Questionnaire 
completed by 
216 PCOs 
Pharmacy contract, 
relationship with PCO, 
awareness of community 
pharmacists within PCO, 
PCO capacity, attitude of 
pharmacists, PCO 
capability, experience of 
commissioning pharmacy 
services, confidence in 
pharmacists to deliver, other 
contractual options, 
evidence of the 
effectiveness of the service, 
support of GPs, access to 
funding 
Access to funding, PCO 
capacity, PCO 
reconfiguration, support 
of GPs, availability of 
training, ability to recruit 
to commissioning posts, 
evidence of effectiveness 
of service, other 
contractual options, 
confidence in pharmacists 
to deliver, experience of 
commissioning services, 
PCO capability, attitude 
of pharmacists, number 
awareness of community 
pharmacists within PCO, 
relationship with PCO 
Collaboration across PCOs was 
found to be widespread. Whilst 
PCO reconfiguration should 
address capacity issues, was also 
viewed as a large barrier to 
commissioning services. 
Self reported 
data, views of 
commissioners 
from the PCO 
perspective 
only 
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Authors Study objectives Method Facilitators Barriers Conclusions Limitations 
Hopp, T. 
Klinke, B. 
Sorensen, E. 
Herborg, H. 
Roberts, A. 
[11] (2006) 
 
Country of 
study: 
DENMARK 
 
To understand how 
projects for the 
implementation of 
CPS are perceived as 
facilitators of change 
from the perspectives 
of practitioners and 
strategists 
20 semi 
structured 
interviews with 
practitioners in 
professionally 
active 
pharmacies, and 
eight interviews 
with professional 
strategists in 
field of 
pharmacy 
practice 
Practitioners goals: 
competence development, 
implementation of CPS, 
marketing of the pharmacy, 
improvement of patients 
drug use and outcomes, 
professional and personal 
development, compensation, 
focusing on specific patient 
groups and increasing 
understanding of the patient 
perspective, maintaining 
and recruiting competent 
personnel, collaboration 
with other healthcare 
professionals 
Strategists goals: Same as 
first four above plus  
documenting CPS, 
implementation and 
dissemination of CPS, tools 
for implementation, 
attracting third party payers, 
optimising education of 
undergraduates, offering 
CPS to pharmacies 
Not measured Authors concluded that there 
were clear differences in the 
perspectives of strategists and 
practitioners. Two metaphors 
were developed as images of the 
different ways of perceiving 
CPS projects. The strategists 
developed projects as standard 
menus and the practitioners 
selected projects in which to 
participate as if they were one of 
many dishes on a buffet 
Self reported 
data, small 
sample size, 
views of 
professional 
strategists  
not company  
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Problems with service delivery in community pharmacy were first reported by Zelnio 
et al. in a two part study in 1984 [16, 31]. During the first part of their study they 
investigated the relationship between service provision, and willingness and 
competency of the pharmacist [31]. A significant relationship was found between the 
pharmacists willingness and ability, and the extent to which they provided expanded 
levels of service. In addition to this, they found that pharmacists delivering the 
services worked longer hours, tended to work in apothecary or independent 
pharmacies, held advanced degrees, and were more involved in continuing education. 
These variables explained only a small amount of the number of services offered, 
which was consistent with the finding that some pharmacists were willing and able to 
provide services, but did not. This led to Nelson et al. investigating this further to try 
and understand the factors influencing the development of clinical pharmaceutical 
services in retail pharmacy [16]. Data were collected via a series of focus groups with 
pharmacists that had been identified in the first phase of their study as varying in 
willingness, competency, and delivery of expanded services. The authors found that 
pharmacists were aware of common clinical services, but had given little thought to 
unique services orientated towards patients needs. A numbers of barriers were 
identified, along with motivators and hypothetical prerequisites for service delivery 
(refer to Table 1). Although the studies were conducted in 1984, the results are still 
very relevant, and similar factors have been identified in the more recent studies 
discussed within this chapter [1-15, 17-30, 32]. Based on the learnings from both 
studies [16, 31], the authors suggested a plan to increase community pharmacists 
involvement in expanded services, which included:  
a) Identifying services needed by patients that could be cost effective if delivered 
by pharmacists 
b) Providing pharmacists with new skills 
c) Developing systems to increase pharmacist productivity 
d) Identifying physicians willing to assist pharmacists 
e) Redesigning the physical structure of the pharmacy 
f) Increasing patient awareness 
g) Encouraging research to develop new payment mechanisms that rewarded 
pharmacists for provision of services    
 
During 2003, Roberts et al. [22] conducted research into the development of a 
business and professional model for community pharmacy in Australia. This research 
was initiated in light of the Third Guild Government Agreement in Australia, to enable 
the profession to incorporate cognitive pharmaceutical services as part of their core 
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business. The overall objectives of this research were to identify facilitators in practice 
change through experiences of those involved in services, and to design a theoretical 
model to take community pharmacy through the transition from its current business 
platform to one in which the delivery of cognitive pharmaceutical services were an 
integrated component. The research was conducted in a number of stages, and 
included a literature review, qualitative study, comparison of financial data, and the 
development of a change management model. Within the first phase of their research, 
Roberts et al. [22] reviewed the literature on the facilitators of implementation of 
cognitive pharmaceutical services, and distinguished between experiential (those 
actually experienced by study participants when changing their practice), and potential 
(those that have been proposed as possible factors that may assist in overcoming 
barriers to service implementation). They found that few studies attempted to identify 
facilitators that were based on experience, as the majority were based on views and 
opinions of either researchers or participants within the study. From their literature 
review, the authors concluded that there was a need to clarify how facilitators could be 
used in practice, with consideration of both the business and professional aspects of 
community pharmacy. They also identified a need to differentiate between the factors 
that facilitated the process of change and those that defined the right environment for 
change to occur, or motivated people so that they were ready to change. The 
qualitative study employed an organisational theory framework in order to adopt a 
community pharmacy approach to data collection and analysis, rather than at an 
individual pharmacist level. Participants were purposively selected based on their 
exposure and experience with cognitive pharmaceutical services, and included 
pharmacy owners, employed pharmacists, pharmacy assistants, and pharmacy 
strategists. Facilitators that were identified included; remuneration of service, external 
support or assistance, reorganisation of the pharmacy structure and function, 
communication, internal leadership, and delegation of tasks. The authors also 
identified that the desire for professional satisfaction, providing healthcare to the 
public, and fear of threats to the business, were motivators of practice change. The 
authors suggested that the sustainability of services were at risk if community 
pharmacists did not restructure and make compromises with their existing activities to 
give themselves the appropriate space, time and resources to deliver new services. 
There was a general feeling amongst the participants that although there may not be a 
profit to the community pharmacy initially from services, there would be a net gain in 
terms of customer satisfaction and loyalty. Some participants recognised that future 
business viability may depend on increased service provision as margins on 
dispensing decreased and retailing opportunities were increasingly lost to 
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supermarkets. Within the third phase of their study, Roberts et al. compared the 
financial statements with the qualitative study data for five pharmacies, and found that 
pharmacy owners were reluctant to invest money in their business for the purpose of 
incorporating services into practice. Although this was a small sample, it supported the 
findings from the qualitative study that pharmacists were taking on services in 
addition to other activities, and not making investments in staff or other resources to 
offset the increased workload. 
 
Following on from their original study, Roberts et al. published two further literature 
reviews during 2006 [33, 73]. The first of these was a review of the models and 
frameworks for the implementation of cognitive services in community pharmacy 
[33]. The authors found that many of the identified models focused on specific 
services and overlooked the complexity of the implementation process. Too much 
emphasis was placed on the skills, knowledge and attitude of individual pharmacists, 
with the assumption that improving these factors would automatically result in 
successful change. The majority of the models in which business and financial aspects 
were presented were conceptual in nature. The authors concluded that the 
implementation process was complex in nature involving a range of internal and 
external organisational factors, and was not just confined to the individual 
pharmacists. In response to the undeveloped concept of facilitating change, the authors 
conducted a second review investigating the facilitators of change in community 
pharmacy and their use in the implementation of cognitive pharmaceutical services 
[73]. They identified two types of facilitators  those that existed at an individual level 
and secondly at an organisational level. Many of the studies identified facilitators 
based on the views of researchers or participants in the study, with only a few studies 
identifying facilitators based on experience. The authors concluded that facilitators 
should be incorporated into programmes for service delivery, and be undertaken with 
both business and professional aspects in mind.  
 
Based on Roberts et al. [22] original work on distinguishing between experiential 
and potential facilitators, I have also carried out a similar exercise for all the factors 
affecting service delivery identified within the literature. I have updated Roberts et al. 
original table on facilitators (refer to Table 2), and produced new tables for motivators 
(refer to Table 3), and barriers (refer to Table 4). I have classed the study as 
experiential if the factors identified have been experienced by the participants when 
changing their practice, or where there is evidence to support these claims. Studies 
have been classed as potential where the results are based on perceived factors, and 
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there is no evidence, or experience to support the claims. Where studies have not 
distinguished between results gained from service providers and non providers then 
they have been placed in this latter group.  
 
Please note: For Tables 2, 3 and 4 
Those denoted with (*) were identified only in the literature relating to experiential facilitators 
/ motivators / barriers. All others had also been identified as potential facilitators / motivators / 
barriers. To avoid repetition, only the factors identified as potential facilitators / motivators / 
barriers that are not already included under experiential facilitators / motivators / barriers are 
listed in the third column.
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Table 2: Summary of the facilitators identified within the literature in relation to the delivery of services in community pharmacy [Based on Roberts et al. [22]] 
(Please note that this table is presented over three pages) 
 Experiential facilitators  Potential facilitators   
Customer need ̇ Attention for special patient groups* [11, 20]  ̇ Improvement in patients drug use and outcomes* [11]  ̇ Focusing service on neediest patients [1]  
Customer 
demand  ̇ Demand for service [16]  
Public attitude ̇ Improving public attitude and perception towards pharmacy 
services* [3, 12, 17, 18, 23, 30, 32]  
 
Pharmacist 
characteristics 
and attitude 
̇ Pharmacist commitment and positive attitude towards patient 
care* [5, 17-19, 30, 32]  
̇ Pharmacist experience of pharmaceutical care [16, 17, 19, 24]  
̇ Pharmacist characteristics (patient centred, effective soft 
networkers, staff development, influencers, participation in CE 
and higher degrees)* [27, 31]  
̇ Pharmacist willingness* [31]  
̇ High behavioural intention of providing pharmaceutical care* 
[17, 19]  
̇ Perceived ease of providing pharmaceutical care* [9, 17, 19]  
̇ Practising in role of pharmacy owner / manager* [6]  
̇ Fostering levels of autonomy [25]  
Training 
̇ Provision and promotion of pharmacist training programmes 
(internal, post graduate, CE) [1, 3, 4, 12, 13, 16, 20, 23-25]  
̇ Better qualified and trained support staff [13, 18, 26]  
̇ Pharmacist competency* [11, 18]  
̇ Professional and personal development* [11]  
̇ Communication / assistance re documentation so not perceived as 
burdensome* [6]  
̇ Involving all employees in training [1]  
̇ Tools for implementation [11]  
̇ Optimising education of undergraduates [11]  
Communication ̇ Improved communication (and skills) [16, 22]  ̇ Setting up communication with all stakeholders [10]  
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 Experiential facilitators  Potential facilitators  
Awareness of 
service 
̇ Advertising and marketing service to patients and healthcare 
providers [1, 11, 16]  
 
Recruitment ̇ High proportion of eligible patients visiting pharmacy* [6]   
Operational 
̇ Access to patient medical records / information [3, 16, 18]  
̇ Access to computer support [1, 16, 18]  
̇ Use of operational protocols and leaflet systems* [20]  
̇ Quality assurance* [24]  
̇ Access to appropriate literature to support decision making [1, 
13]  
̇ Developing relationships with patients [1]  
̇ Improvement to computer system to support necessary 
documentation [13]  
̇ Documentation of CPS [11]  
̇ Establishing ways for pharmacists to leave premises [25]  
̇ Implementation of repeat dispensing [13]  
Pharmacist 
confidence ̇ Pharmacist confidence* [9, 19, 30]   
Support 
̇ Management support and internal leadership [1, 10, 12, 19, 22, 
23]  
̇ Collegial interaction with pharmacists [1, 3]  
̇ External support or assistance* [22]  
̇ Aligning programme with strategic goals of organisation [10]  
Time ̇ Allocation of time to deal with specialised issues [13, 23]  ̇ Time management [2]  
Staff resource 
̇ Better utilisation and delegation of tasks amongst existing support 
personnel [2, 12, 13, 20, 22-24]  
̇ Provision of additional support staff [1, 3, 16, 26]  
̇ Maintaining and recruiting competent personnel* [11]  
̇ Staff resource at PCO* [32]  
̇ Securing appropriate infrastructure to facilitate integration into 
daily practice [10]  
Remuneration ̇ Remuneration of implementation and / or service [3, 6, 11, 13, 
16, 22, 32]  
̇ Attracting third party payers [11]  
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 Experiential facilitators  Potential facilitators  
Pharmacy 
environment 
̇ Private counselling area within pharmacy [1, 3, 13, 18, 26]  
̇ Favourable pharmacy atmosphere conducive to service provision 
[4, 16, 18, 22, 26]  
̇ Patient centred / friendly layout in pharmacy* [18, 20]  
̇ Practice setting (apothecary / independent)* [31] (medical centre 
/ rural locations)* [6]  
̇ Low prescription volumes* [6]  
̇ Patient registration at pharmacy [13]  
 
Healthcare 
professional 
relationships 
̇ Good working relationship with GPs / other healthcare 
professionals [3, 5, 11, 13, 16, 18, 19, 24, 32]  
̇ Co-operation with patient associations* [24]  
̇ Delegation of services from prescribers to pharmacists [26]  
̇ More formalised and open channels of communication with 
prescribers [26]  
̇ Improving GP attitude and perception towards pharmacy services 
[13]  
Evidence ̇ Proven benefits of service (including value of service) [1, 16, 32]  ̇ Participation in studies to justify services [1, 13]  ̇ Trying out action research and models [11]  
External 
environment 
̇ New pharmacy contract* [5, 32]  
̇ Relationship with PCO staff [5, 25, 32]  
̇ Profile of community pharmacy within PCO* [5, 32]  
̇ Experience of commissioning pharmacy services at PCO* [32]  
̇ Availability of other contractual options* [32]  
̇ Legislation [16]  
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Table 3: Summary of pharmacist motivators identified within the literature in relation to the delivery of services in community pharmacy 
 Experiential motivators  Potential motivators  
Public image of pharmacy  ̇ Improving the public and GPs perception of pharmacists [28]  ̇ Image enhancement [16]  
Pharmacists role ̇ To provide healthcare to the public* [22]  ̇ Pharmacists want to offer services [16]  ̇ Concern for patients [16]  
Job satisfaction ̇ Desire for professional satisfaction and fulfilment [22, 28]  ̇ Personal challenges for pharmacists [28]  ̇ Professional reward [14]  
Business ̇ Fear of threats to the business* [22]  
̇ Financial incentives [14, 16]  
̇ Building business [16]  
̇ Legal / contractual requirements [14]  
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Table 4: Summary of the barriers identified within the literature in relation to the delivery of services in community pharmacy 
(Please note that this table is presented over two pages) 
 Experiential barriers  Potential barriers   
Customer 
demand  ̇ Lack of patient demand [1, 8, 14, 16]  
Public attitudes ̇ Low patient / public expectation of pharmacy profession [3, 7, 16, 
18, 21, 26, 32]  
 
Pharmacist 
characteristics 
and attitude 
̇ Low perceived behavioural control (perception that very difficult 
to carry out PC)* [19]  
̇ Lack of pharmacist willingness* [31]  
̇ Low affect (low sense of enjoyment in carrying out PC)* [19]  
̇ Attitude and opinions of pharmacists [1, 5, 16, 29, 32]  
̇ Lack of pharmacist motivation [8]  
Training ̇ Lack of pharmacist competency [3, 7, 12, 16, 18, 31]  ̇ Insufficient knowledge or training [1, 8, 12, 14, 25, 29, 32]  
̇ Lack of communication skills [8, 29]  
̇ Lack of management skills and vision [29]  
̇ Insufficient management systems [8]  
̇ Lack of understanding of pharmaceutical care [8]  
Communication  ̇ Poor communication with head office [26]  
Recruitment ̇ Lack of opportunity for patient counselling [16, 24]   
Operational 
̇ Lack of access to patient information / records [3, 7, 8, 14, 18, 21]  
̇ Lack of data / documentation systems [1, 14, 20]  
̇ Lack of computer support [8, 18, 24]  
̇ Lack of use of protocols and leaflet system* [20]  
̇ Poor workflow [1]  
̇ Lack of access to drug information resources [8]  
Pharmacist 
confidence ̇ Lack of pharmacist confidence [5, 8, 19, 25]   
Support ̇ Lack of guidance* [20]  ̇ Lack of support from technicians* [20]  ̇ Lack of management support [1]  
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 Experiential barriers  Potential barriers  
Time 
̇ Lack of time [2, 3, 7, 8, 12, 14-16, 20, 23, 25-27, 29]  
̇ Excessive workload (including too many pharmacist interruptions, 
high volume dispensing and management responsibilities) [1, 21]  
̇ Time consuming nature of services [28]  
̇ Lack of patient time [26]  
Staff resource 
̇ Lack of support staff (suitably qualified) [7, 18, 23, 25, 26]  
̇ Lack of pharmacists and / or locum cover [23-25, 28]  
̇ Pharmacist resource at PCO* [5, 32]  
 
Remuneration ̇ Lack of remuneration [3, 4, 7, 8, 12, 15, 16, 20, 23, 25-27, 29, 30]  ̇ Access to funding* [5, 32]  
̇ Prohibitive cost of services (capital required to develop, 
implement and deliver) [14, 16, 28]  
̇ Unwillingness of pharmacy owners or GPs to fund services [28]  
̇ Compensation and focus of pharmacy on technical role 
(dispensing) [14]  
Pharmacy 
environment 
̇ Poor pharmacy environment (lack of / inadequate consultation 
space / privacy) [1, 3, 4, 7, 8, 16, 18, 20, 21, 27]  
̇ Inadequate organisation of pharmacy* [12]  
̇ Profit orientated practice orientation* [18]  
̇ High prescription turnover [2]  
Healthcare 
Professional 
relationships 
̇ Poor GP relations and attitudes towards pharmacists [3, 7, 8, 16, 
18, 19, 21, 23, 26, 27, 29, 32]  
̇ Lack of contact with other healthcare professionals [14, 21, 25]  
̇ Conflicts between pharmacists and other healthcare professionals 
[14, 15]  
Evidence ̇ Lack of data on the value of pharmaceutical care [8, 32]   
External 
environment 
̇ Outcome of OFT report* [5]  
̇ PCO reconfiguration* [32]  
̇ Availability of other contractual options* [32]  
̇ Experience of commissioning pharmacy services at PCO* [32]  
̇ PCO knowledge and awareness of pharmacy services* [32]  
̇ Relationship with PCO staff* [32]  
̇ Legal barriers and restrictions [14, 16, 26]  
̇ Non conducive structure of healthcare system / structure [7, 29]  
̇ Threat to traditional role of community pharmacist [15]  
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The facilitators and barriers identified within the literature can be grouped under 
general headings as outlined in Table 5. As can be seen within this table, the barriers 
identified within the literature are in fact the negatives from those identified for 
facilitators.  
  
Table 5: Summary of the factors affecting service delivery in community pharmacy, as 
identified from the literature  
Factor affecting service 
delivery 
Facilitators  Barriers 
Customer need Need for service  N/A 
Customer demand Demand for service No demand 
Public attitude  Positive Poor 
Pharmacist characteristics 
and attitude 
Favourable Poor 
Training  
Equipping staff with the right 
skills 
Lack of training and skills 
Communication  
Good communication with 
stakeholders 
Poor communication with 
stakeholders  
Awareness of service  Public awareness  N/A 
Recruitment 
Opportunity to identify 
customers 
Lack of opportunity  
Operational  Support for the service Lack of support 
Pharmacist confidence  Confident in service delivery Poor confidence 
Support Good Lack of support 
Time  Time available  Lack of time 
Staff resource Appropriate Lack of resource 
Remuneration Available Lack of funding 
Pharmacy environment Favourable Poor 
Healthcare professional 
relationships 
Good Poor 
Evidence of the value of the 
service 
Good evidence Lack of evidence 
External environment Receptive environment Poor environment  
 
As previously highlighted, a number of the studies referenced within the literature are 
internationally based [1, 4, 6-12, 14, 16-24, 29-31]. Although the results of the studies 
across the various countries tended to be similar in nature, caution is advised on the 
relevant ranking of each factor. Each country has different community pharmacy 
systems, settings, staffing structures, remuneration and funding streams, health 
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systems, level of support and pharmacist roles. A study by van Mill et al. [29] 
specifically looked at the factors affecting service delivery across Europe, to try and 
identify similarities and differences. Interviews were conducted with a representative 
from either a national pharmacy organisation or pharmaceutical care researcher, within 
eleven European countries, known to be actively attempting to implement 
pharmaceutical care. The specific objectives of the study were to establish the 
perceived barriers to the implementation of pharmaceutical care into community 
pharmacy practice, and the relative importance of these barriers. Respondents were 
asked to consider a list of twenty-five potential barriers, and to score the relative 
importance of each for their own country. The two most important barriers identified 
for the implementation of pharmaceutical care in European countries were lack of time 
and money. Other barriers were also identified, but their impact on implementation 
seemed to differ markedly over Europe. The authors recognised that the level of 
training of pharmacy support staff, and the influence of non pharmacist employers 
differed tremendously between countries, and could result in differences between the 
barriers for implementation of pharmaceutical care. For England, lack of money, lack 
of education, and lack of communication and documentation skills of the pharmacist 
were rated as the most important barriers affecting implementation. The least 
important barriers were identified as lack of space in pharmacies, lack of software for 
medication assessment, the attitude and opinion of staff, lack of education in public 
health, and legal problems. The authors concluded that European pharmaceutical 
associations should address the system of reimbursement of pharmacists before trying 
to implement services in their representative countries. The results from the study are 
limited due to the data being derived from the perspective of implementers, and not 
providers of pharmaceutical care. The authors also recognise the limitations from 
interviewing one person from each country. In a subsequent review, Van Mill et al. 
concluded that the constraints on the provision of pharmaceutical care in Europe do 
not differ much from the rest of the world [75]. 
 
Within the literature, ten studies have been identified that looked at factors affecting 
service delivery within the UK [2, 3, 5, 13, 15, 25-28, 32]. The first of these was 
reported in 1995 by Mottram et al. [15] who conducted a mail survey with a sample of 
community pharmacists in Liverpool to try to identify activities that represented the 
extended role, the extent to which they had been implemented and any constraints that 
had been experienced. The authors found that pharmacists had adopted activities such 
as health promotion and pregnancy testing that could be administered with minimal 
inconvenience to the traditional role, and that required little financial commitment. It 
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was recognised that many aspects of the extended roles (such as diagnostic testing) 
required considerable expense and time to set up and run, of which funding was not 
provided by the Government. Patients themselves were unwilling to pay for extended 
services from the community pharmacy, especially when they received them 
elsewhere at no cost.  
 
In 1996 Tann et al. [27] used a triangulation of methods to explore the hypothesis that 
the successful implementation of the wider role of the pharmacist was related to 
enablers in the work environment, as well as personal characteristics particular to 
Leading Edge Practitioners (LEPs). Within the study LEPs were found to initiate 
more actions, be more patient centred, be effective networkers, more focused on staff 
development, and more effective influencers. Barriers to implementation identified by 
the LEPs included lack of finance, time and space within the pharmacy. The authors 
suggested that the gap between policy and practice, as well as the time lag in 
implementation of services, could be reduced by focusing on LEPs to pilot and 
implement changes in pharmacy practice.  
 
In 1998, Bell et al. [3] conducted interviews with a sample of community pharmacists 
in Northern Ireland to ascertain their attitudes and opinions towards the concept of 
pharmaceutical care and its implementation. The degree of implementation of 
pharmaceutical care was restricted, and although all of the pharmacists questioned 
believed that they were involved with pharmaceutical care, this was primarily focused 
on patient education of medication. None of the pharmacists interviewed were 
involved with diagnostic or monitoring services. The authors found that the 
pharmacists were keen to develop their professional role, but identified a number of 
barriers which impeded this. These included lack of time, remuneration, private 
counselling area, access to patient medication records, low public expectation of the 
pharmacy profession, and lack of professional relationships. Proprietors of 
independent pharmacies displayed a higher degree of business orientation and were 
particularly concerned about lack of remuneration. The facilitators identified were the 
opposites of the barriers, and included having a private counselling area, developing 
professional relationships, increasing general public perception of the pharmacy, and 
having access to patients medication records. The location of the pharmacy was also 
considered important in developing a loyal customer base, with those pharmacists 
working near GP practices having particularly good relationships with GPs, and 
delivering services to a large number of patients. In 1999, Bell et al. [2] investigated 
whether lack of time to implement pharmaceutical care was a barrier to the routine 
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provision of extended patient care services. A self reported work sampling study was 
conducted with a sample of community pharmacists in Northern Ireland to investigate 
how they used their time. Staffing levels within the pharmacy were found to 
significantly influence the pharmacists involvement in a number of activities. The 
authors also found that pharmacists working in environments with a high prescription 
turnover were found to devote significantly less time to counselling patients. Almost a 
quarter of the pharmacists time was dedicated to non-professional activities that could 
have been performed by other members of staff. The authors concluded that improved 
time management and better use of trained support staff could improve the ability of 
pharmacists to integrate pharmaceutical care services into their routine practice.     
 
During 2000, Tully et al. [28] assessed the strong motivators and barriers to the 
implementation of a prescription monitoring and review service led by community 
pharmacists that was delivered within either the pharmacy or GP practice. The authors 
used a two part Delphi survey and measured the attainment of consensus as to whether 
the statements represented motivators or barriers. There were high levels of agreement 
that providing a prescription monitoring and review service would improve the public 
and GPs perception of pharmacists, help develop relationships with patients, and give 
pharmacists professional fulfilment. Other motivators included improving patients 
clinical parameters and adherence. Key barriers to the implementation of these 
services included their time consuming nature, locum difficulties, the prohibitive cost 
of providing the service, and the unwillingness of pharmacy owners or GPs to fund 
services. It was also noted that services would be hindered by not having access to the 
patients medical record, and if pharmacists did not have a cooperative working 
relationship with their local GP. The authors also discovered within the free text 
comments that internal rivalries, and the structure and culture of the profession may 
also represent barriers to the implementation of these services. They concluded that 
community pharmacists were motivated to participate in prescription monitoring and 
review schemes by a complex set of personal, professional and altruistic reasons. The 
authors recommend that for these services to be successful, adequate remuneration 
structures, internal rivalries, and the structure and culture of the profession itself 
would need to be considered.  
 
In 2000, Rutter et al. [26] reported on their study to investigate community pharmacy 
managers perceptions of their role in providing healthcare. Interviews were 
conducted with pharmacy managers within one area of a UK national pharmacy chain. 
Although participants shared the vision of wanting to play a more integral role in the 
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healthcare of patients, a number of barriers and obstacles were identified. These 
included a lack of awareness amongst healthcare professionals and the general public 
regarding pharmacists skills and attributes, the legislative restriction on pharmacists 
remaining on the premises, and the current remuneration structure. There was a call 
for professional bodies to intervene and campaign to improve the perceived role of the 
pharmacist. It was also recognised that empowering staff through the skill mix 
initiative would help to free up the pharmacists time and provide them with more 
opportunities to interact with patients.  
 
In 2001, Ruston [25] conducted a study to identify the characteristics of community 
pharmacists that influenced the adoption of an extended role, in order to inform ways 
in which they could organise the pharmacy business to achieve successful re-
professionalisation. Ruston found that involvement was low in extended activities 
which required skills not traditionally associated with community pharmacy (such as 
specialist screening services), whereas activities such as health promotion and advice 
giving were well established. The barriers identified within the study included 
shortage of time, insufficient remuneration, shortage of staff, and lack of contact with 
other healthcare professionals. Fostering levels of autonomy, promoting uptake of post 
registration activities to increase knowledge, skills and confidence, establishing formal 
links with other healthcare professionals, and identifying ways for the pharmacists to 
leave the pharmacy premises were some of the facilitators identified within the study. 
Although Ruston looked at the percentage turnover of NHS prescriptions, type of 
pharmacy, and provision of private consultation area, she concluded that pharmacist 
involvement in the extended role was more to do with professional orientation than the 
settings in which they worked.   
 
In 2001, Krska and Veitch [13] interviewed potential policy makers and innovative 
practising pharmacists in Scotland to obtain their views on a systematic approach to 
pharmaceutical care and the factors important in its development. Many of the 
participants expressed views on the need for remuneration, training, physical 
resources, relationships with GPs, repeat dispensing systems, and improvements to 
existing computer systems to facilitate pharmaceutical care. The perceptions of 
patients as well as other healthcare professionals were also viewed as important, and 
the majority considered that there was a need to educate patients on the role of the 
pharmacist.  
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In more recent years, studies have begun to look at the factors affecting service 
delivery in community pharmacy from the perspective of commissioners in more 
detail [5, 32]. In 2003, Blenkinsopp and Celino [5] conducted a postal survey with 
pharmaceutical advisors and chief pharmacists from the PCOs, to establish current and 
planned community pharmacy services, and to identify barriers for development. The 
majority of the PCOs were found to be commissioning additional NHS services with 
community pharmacists, although there was variability in the number of services 
commissioned. Those PCOs with less than three services were found to be less likely 
to employ someone to develop community pharmacy, and tended to take a fairly 
opportunistic approach to development with limited planning. In contrast, those 
commissioning more than seven services, tended to employ someone to develop 
community pharmacy, and took a planned approach to development. Local 
relationship and leadership issues tended to be the main drivers and barriers to service 
development. In 2006, Bradley et al. [32] conducted a survey to identify factors which 
PCOs considered to be barriers and drivers to the commissioning of services from 
community pharmacies. Access to funding, lack of staff capacity at the PCO and 
impending reconfiguration were found to be the major barriers, whilst the new 
pharmacy contract and local relationships with the PCO were found to be the main 
drivers. The majority of PCOs questioned were engaged with local pharmaceutical 
committees and local pharmacists to consider service opportunities for community 
pharmacy.   
 
In addition to the studies that have investigated factors affecting service delivery, a 
number of authors have also conducted extensive reviews of the literature [33, 70-75], 
of which the work by Roberts et al. has already been discussed [33, 73]. Based on his 
previous work, in 1993 Hepler [71] identified a number of issues that needed 
addressing when implementing pharmaceutical care, as illustrated in Figure 2. In his 
model, results referred to the outcomes of medication use for patients and the 
problems and concerns that needed to be addressed. After assessment of results, the 
re-evaluation and formulation of the purpose of practice needed to be performed. 
Following this, the identification of the activities necessary to achieve the purpose of 
performing these functions, and finally, identifying the relationships and resources 
required. Hepler emphasised the importance of the order in which to consider issues, 
and the fact that the cycle could be repeated more than once.  
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Figure 2: Hepler’s model of issues to consider when implementing pharmaceutical care 
[71]  
 
 
In 2000, Ramaswamg-Krishnarajan and Grainger-Rousseau [72] conducted a review 
of pharmaceutical care models being implemented in community pharmacies in 
Canada. They found that regardless of the model being implemented, the success was 
dependent on the development of a more collaborative system of patient care that 
blended with other primary care services. The authors concluded that evidence was 
required on how pharmacists could successfully provide pharmaceutical care in a cost 
effective manner that improved patient outcomes.  
 
UK literature reviews [70, 74] have also reported challenges for developing the role of 
the community pharmacist, and recommendations for future practice. A report 
commissioned by the RPSGB [70] to investigate how service delivery and 
organisation of community pharmacy was developing in the new environment, 
concluded that the challenges facing pharmacy were not unique to the profession, and 
mirrored those that had confronted organisations and professionals operating in the 
legal and banking sectors. The systematic literature review identified 324 papers of 
relevance, of which a number of common threads were recognised as essential to the 
future shape of community pharmacy. These included the need for community 
pharmacists to work in partnership with other healthcare professionals, the 
development of the skills of community pharmacist staff, changes to the process of 
remuneration, and the reconfiguration of the pharmacists role to enhance professional 
satisfaction. In 2004, Tann and Blenkinsopp [74] conducted a review of policy and 
research findings to recommend actions that PCOs could take to increase the 
likelihood of success when implementing innovation in community pharmacy. The 
recommendations included establishing a local team to review existing pharmacy 
services against local needs (including how community pharmacists would support the 
GMS and pharmacy contract), identifying funding for new services, identifying 
innovator and early adopter pharmacists, engaging and supporting local pharmacists, 
Purpose
Functions
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Results 
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- personal 
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and recognising the need to negotiate with pharmacy chains regarding decisions about 
innovation as well as local pharmacists.   
 
 
2.2.1 Summary of section two 
The implementation of services within community pharmacy is proving problematic 
and slower than expected on an international level, as identified within the literature 
reviewed in this chapter. The facilitators and barriers experienced appear to be the 
opposites of each other, meaning that once barriers are overcome, they can turn into 
facilitators for service delivery. The factors affecting service delivery can be grouped 
under key headings comprising: customer need and demand, public attitudes towards 
the pharmacist, pharmacist characteristics and attitude, training, communication, 
awareness of the service, recruitment to the service, operational aspects of service 
delivery, pharmacist confidence in service delivery, support for the service, time 
available, staff resource, remuneration, pharmacy environment, healthcare 
professional relationships, evidence of the value of the service, and the external 
environment. Although the international literature has identified similar factors, it is 
worth looking at the UK studies in detail due to the differences in community 
pharmacy structure and environment between the different countries. Within the UK, 
the specific facilitators identified from the literature include having favourable 
pharmacist characteristics and attitude, good public, GP and PCO perception of the 
role of the pharmacist, access to training to improve skills, knowledge and confidence, 
remuneration available for the service, good healthcare professional and PCO 
relationships, access to patient medication records, access to consultation space, 
appropriate level of staff resource, time available, evidence of the effectiveness of the 
service, and favourable external environment. The specific barriers identified within 
the UK literature include poor pharmacist attitudes, lack of time, lack of remuneration, 
poor healthcare professional relationships, lack of space, poor public, GP and PCO 
expectation of the pharmacist, lack of access to patient medication records, lack of 
skills, unfavourable external environment, and lack of staff resource. 
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2.3 Summary of chapter II: Review of the literature 
The health services environment is changing, with the Government committed to 
providing a health service that is based around the needs of the patient, and focusing 
on providing prevention programmes that help to keep people healthy, making 
healthcare more accessible, and reducing health inequalities. It is recognised that new 
providers are required to help deliver the NHS vision, and in particular, the 
importance of the role of the community pharmacist has been emphasised. However, 
despite the number of opportunities available for community pharmacy, the 
implementation and delivery of services is proving difficult and slower than expected. 
Although a number of factors have been identified from the literature, there is a need 
to understand more about the various factors affecting delivery of services in 
community pharmacy, and ways to overcome barriers and enhance facilitators and 
motivators. This would enable service providers and commissioners to identify key 
obstacles that would hinder service development and delivery, and focus on primary 
facilitators and motivators that would enhance them. This study investigates the 
factors affecting service delivery within a national pharmacy chain, using asthma 
services as an example. Data has been collected to explore the current environment 
and opportunities available to pharmacy, the factors affecting service delivery, and to 
identify any recommendations for the future. Throughout this thesis, I use the multiple 
sources of data collected to try and explore and explain the numerous factors 
influencing the delivery of services within community pharmacy in the UK. The 
following chapter details the methods that have been used to implement and evaluate 
the services used within this study. 
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CHAPTER III 
Methods 
 
3.0 Introduction to the chapter 
This chapter is split into two sections, the first of which details the service 
implementation methods used within this study for the nationally led brief intervention 
in asthma, and the locally driven asthma service. Following on from this, the second 
section of this chapter goes on to explore the service evaluation methods. These 
include an omnibus survey, audits, mystery customer research, customer and 
pharmacist interviews, and a review of the dispensing data.   
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SECTION ONE 
 
3.1  Service implementation 
3.1.1 Introduction to service implementation  
National guidelines exist to set priority targets and provide some standardisation. 
Within primary care in England, the NHS is currently focusing on targets outlined as 
quality indicators within the GMS contract [59], PCO performance indicators, and the 
DH priorities and planning framework [57]. The current Government is committed to 
reducing health inequalities and providing locally driven services to meet local needs, 
putting the person using the services at the heart of them [65]. Guidelines issued by 
the DH still require service development and implementation by the PCO that are 
responsible for managing health services within a local area. As such, the development 
and implementation of services locally can vary tremendously within individual 
PCOs.  
 
The strategic direction of community pharmacy is currently facilitated from a national 
level, be it through head office directing large multiples, national bodies facilitating 
independents and small chains, or via national guidelines. The future developments in 
practice and policy within community pharmacy are often shaped by strategies of 
large corporate pharmacies, and not by research evidence or initiatives of the 
pharmacy professional body [76]. Individual pharmacies also participate in a number 
of locally developed services that are commissioned and managed through the local 
PCOs. Participation in the delivery of services within community pharmacy can be as 
a result of corporate decisions within individual pharmacy organisations, or the result 
of local decisions by independent pharmacists, or store managers of a multiple 
pharmacy to participate within local PCO initiatives. Independent pharmacies can be 
more entrepreneurial in nature, have more autonomy in decision making, and 
flexibility in adapting services to meet local needs, than local pharmacists employed 
by multiples. Individual store managers employed by a multiple pharmacy will be 
directed by commercial targets and priorities identified at a company level. For both 
independents and multiples, the decision to participate in services or not at a local 
level is often based on commercial reasons. As a result of these national and locally 
driven initiatives, the implementation and delivery of national services or guidelines 
within pharmacies can vary tremendously at a local level. Within Boots, private 
pharmacy services are developed centrally and various techniques have been used to 
attempt to implement services on a national basis, however, the quality of 
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implementation and delivery of services varies at a local level. The same can be said 
to be true for advanced services that have been developed nationally as part of the new 
pharmacy contract, namely Medicines Use Reviews (MURs) [37]. The 
implementation and participation in this service varies tremendously across the whole 
of community pharmacy [77]. There is a need to understand the factors affecting 
private and NHS service delivery, not just within Boots, but across the community 
pharmacy profession itself.   
 
 
3.1.2 Action research 
Action research is undertaken by participants in social situations to improve their 
practices and their understanding of them, and is often orientated towards 
improvement and change [78].  It was founded by Lewin in 1956, and is a method of 
generating knowledge about a social system while simultaneously trying to change it 
[78]. The method has proved valuable in helping practitioners, managers and 
researchers make sense of problems in service delivery and in promoting initiatives for 
change and improvement. The role of the researcher is to act as a catalyst to help 
facilitate the process and stimulate, but not impose, people to change [79]. The 
essence behind action research is that the researcher looks at the way things are done, 
rather than the results achieved. Action research is a method that can be used to 
respond to local community needs, and as such does not treat the participants as 
subjects, but empowers them to act on their own behalf in making change [78]. It uses 
stakeholder groups as the primary focus of attention and source of decision making, 
rather than the authoritarian approach that is often seen in large corporate 
organisations [79]. Action research can be used within small and large projects and 
organisations, and can result in the initiation of change at both individual professional 
practice level and organisational processes [78].  
 
Hart and Bond [78] described seven criteria which distinguished different types of 
action research, and which together distinguished action research from other methods 
(refer to Figure 3).  
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Figure 3: Hart and Bond’s seven criteria of action research [78]  
1. Educative 
2. Deals with individuals as members of social groups 
3. Problem focused 
4. Content specific and feature orientated 
5. Involves a change intervention 
6. Involves a cyclic process in which research, action and evaluation are interlinked 
7. Founded on a research relationship in which those involved are participants in the change 
process 
 
Although action research uses the methods of social sciences, the research process is 
undertaken in a way that is user friendly for lay people and professionals, and has the 
potential of leading to solutions that are appropriate for local communities [80]. The 
phrase look, think, act has been used to describe the process of action research by 
Stringer [79]. Look means that participants should define and describe the problem 
to be investigated and its context; think means they should analyse and interpret the 
situation in order to develop their understanding of the problem, and act means that 
they should formulate solutions to the problem. A method that can be used when 
designing and implementing services locally.  
 
The technique of gathering information in action research is commonly referred to as 
rapid appraisal, and is a qualitative technique to gain insight into the communitys 
own perspective of its need [80]. Rapid appraisal often includes group meetings, 
unstructured interviews, structured surveys, mapping, analysis of local documents and 
workshops with participants. The scientific rigour and validity of the approach 
involves the use of triangulation of research methods. 
 
The principles behind action research have been used throughout this study, from the 
flexibility in delivering the brief intervention, to the design and implementation of the 
asthma service. It has also been used as a method to reflect on the delivery of both the 
services, and refine them as the study progressed. The use of action research has also 
enabled me to adapt other services outside of this study based on the learnings that I 
have gained throughout this PhD.  
 
 
3.1.3 Methods of service implementation used within this study 
As part of the investigation into factors affecting service delivery in community 
pharmacy, the impact of the design and route of service implementation were studied 
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through two different types of asthma services. The first service was designed 
centrally and implemented nationally throughout Boots during March 2003. This 
brief intervention in asthma was kept extremely simple to encourage pharmacists 
and staff to integrate the intervention into their current practice and role. The second 
service was designed and implemented by a group of pharmacists within their locality 
during May to September 2003. This asthma service was based around identifying 
people with asthma that would benefit from a consultation with the pharmacist on 
inhaler technique, medication use and general lifestyle advice. The impact on delivery 
between designing and implementing the service locally and nationally will be 
investigated throughout this study, as part of the factors affecting service delivery. 
 
3.1.3.1 National implementation of the ‘brief intervention’ in asthma 
The brief intervention was designed around pharmacists and healthcare staff asking 
customers with asthma three basic questions to find out their level of symptom control 
(refer to Table 6). The use of these questions was based on their ease of use as a tool 
to help identify people with poor control of asthma, as identified by the Royal College 
of Physicians (RCP) [81]. Based on the response to the questions, the pharmacist or 
healthcare staff could then provide appropriate lifestyle advice to the customer. 
 
Table 6: RCP questions [81] 
RCP question 
1 Have you had difficulty sleeping because of your asthma symptoms?  
2 Have you had your usual asthma symptoms during the day? 
3 Has your asthma interfered with your usual activities? 
 
All pharmacists within Boots were sent an information pack outlining the brief 
intervention during March 2003 (refer to Appendix A), along with a summary copy of 
the latest guidelines on asthma management [82]. The information within these 
documents was sent to these pharmacists in the form of a letter and not as a 
compulsory training package, allowing the pharmacists to be in a position to choose 
how much participation they wanted to have within this activity. Further paper 
communications were sent directly to each pharmacist on a quarterly basis to provide 
them with updated lifestyle advice that was relevant to people with asthma. Each 
communication (refer to Table 7) reflected the latest research developments and 
advice, that was appropriate for that particular time of year. 
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Table 7: Pharmacist communication themes 
Timing Fact sheet theme 
Q1 Patients with asthma: Lifestyle advice on how to manage their hayfever symptoms 
Q2 Lifestyle advice on how to manage childrens asthma 
Q3 Lifestyle advice on how to manage winter ailments 
Q4 
Lifestyle advice for pregnant women and young people on how to reduce risks of 
asthma 
 
This intervention was designed to be flexible for both pharmacists and customers, to 
be used opportunistically when people with asthma presented their prescriptions or 
purchased over the counter medicines. No records of the interventions were kept, 
making this very simple for the pharmacists and healthcare staff to deliver.  
 
Limitations  
The implementation of the brief intervention was extremely simple due to the 
communication method and standardisation of the key messages. Although 
standardisation aids scalability and can be beneficial for large organisations, it does 
not usually allow for local variation. The key principles behind the brief intervention 
were designed to try and overcome this, and encourage pharmacists to be flexible with 
service delivery, in the hope that they would integrate the service into their current 
practice. Although simple to deliver, pharmacists were not told, but encouraged to 
participate within the activity. This presents potential variations in participation 
between individual pharmacies and pharmacists. Individual pharmacists may also not 
have actively chosen to communicate activity to fellow pharmacy staff, or participated 
themselves.   
 
The sheer volume of mail delivered to the pharmacy also presents problems as specific 
communications such as this intervention can easily be mislaid. As this was the only 
method of communication with pharmacists about the intervention, it was limited in 
its reliability of delivery. Due to the simplicity of the brief intervention, no service 
support materials for recording or marketing the intervention were supplied to 
individual pharmacies. Although this made the service seem easier operationally, it 
did have limitations on its reliability on pharmacy staff to identify people with asthma, 
and introduce the service to them.  
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3.1.3.2 Local implementation of the ‘asthma service’ 
The local asthma service was set up to try and encourage pharmacists to develop, 
implement, and manage an asthma service within their locality. The local design and 
implementation of this service was framed around action research, and allowed the 
pharmacists to base the service on local needs, and encouraged local ownership in 
delivery. 
 
Regional teams nominated groups of pharmacists during March 2003, from which the 
final team were chosen due to demographics, team numbers, and available support 
from the local area. Eleven pharmacists were part of the final project team, based in 
eight pharmacies around the Woking and Guildford area. Ten of these pharmacists had 
store based roles such as store manager (n=1), pharmacy manager (n=3) and 
consultant pharmacist (n=6). The other pharmacist had the role of Professional 
Development Pharmacist (PDP), and assumed the position of local project manager. 
Research commissioned by the practice research division at the RPSGB [83], looked 
at the characteristics of innovators in community pharmacy and found that successful 
pharmacist innovators were characterised by a high awareness of developments in the 
health service, local health needs, pro-activity, networking, confidence and a 
willingness to involve the whole pharmacy team. All characteristics demonstrated by 
this particular PDP. 
 
The project team attended a half-day workshop in May 2003 to design the asthma 
service using the following core objectives;  
̇ To explore options for community pharmacy involvement in the provision of local 
asthma services 
̇ To identify an asthma project and implementation plan to make it happen 
̇ To increase the number of asthma scripts per pharmacy 
 
My role on the day was to facilitate the process, allowing the team free rein to decide 
on service options. By the end of the workshop the team had agreement on the basic 
patient journey and project proposal; including roles and responsibilities of the project 
team going forward (refer to Table 8). The service was based on pharmacy staff using 
the questions within the brief intervention to identify people with asthma with poor 
symptom control, and where appropriate, offer referral to the pharmacist for a full 
consultation. Within the full consultation the pharmacist would cover subjects such as 
inhaler technique, medication use, and general lifestyle advice.  
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Table 8: Roles and responsibilities of the local project team 
Role Responsibilities 
Project team Management of budget locally, design of all service materials 
Individual 
pharmacists 
Activity within their own pharmacy, communication with staff and local 
GPs 
PDP 
Managing and co-ordinating project locally, communication with internal 
stakeholders (Regional and Area managers), communication with external 
stakeholders (PCOs) 
Head office  Facilitation of the process, measuring and monitoring results 
 
The project team followed up this initial meeting with another between themselves to 
plan the work in more detail. At this meeting they discussed training plans and agreed 
that this should be organised locally based on their needs, and would be held on three 
separate occasions to maximise the number of pharmacists and healthcare staff that 
could attend from each pharmacy.  
 
The original patient journey was further discussed and agreement reached within the 
project team that each pharmacist would be able to vary the delivery of the service 
within their pharmacy to suit both the needs of their customers, the business and 
themselves. Some pharmacists chose to operate an appointment system, whilst others 
decided to offer consultations on an ad hoc basis. A questionnaire was designed by the 
project team to be used as a guide for the pharmacist based consultations (refer to 
Appendix B), which the project team felt would allow pharmacists to ask the customer 
the most appropriate questions in order to understand their particular needs. The 
project team also agreed to meet up every eight to ten weeks as a way of sharing best 
practice and agreeing any future actions.  
 
The project team were also encouraged to think about novel ways of marketing the 
service locally, and as a result each pharmacy drew up individual marketing plans. 
The plans for each pharmacy varied, but tended to include approaching fellow 
healthcare professionals such as GPs and nurses, and targeting areas such as schools, 
libraries, hospitals, smoking cessation groups, shops and bus stations to display 
leaflets and posters. In addition to this, pharmacies located within shopping centres 
also planned displays within the centre, whilst other pharmacies looked at leaflet drops 
within local newspapers.  
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Limitations 
Although the local design and implementation of this service was based on needs 
identified by the team of pharmacists, this is likely to be different within other 
localities and is dependent on the individuals involved. The resource required to 
design and implement this service locally was intensive, as the project team were 
required to meet on a number of occasions. The replication and scalability of services 
such as these can be extremely difficult and expensive, due to the duplication of effort, 
time and resource required. 
 
 
3.1.4 Summary of service implementation methods 
As part of the investigation into factors affecting service delivery in community 
pharmacy, the impact of the design and route of service implementation were studied 
through two different types of asthma services. The brief intervention in asthma was 
designed centrally and implemented nationally throughout Boots, whilst the asthma 
service was designed and implemented locally by a group of pharmacists. The 
principles behind action research are used throughout this study for the 
implementation and delivery of both services. The following section of this chapter 
explores the data collection methods that have been used to evaluate the factors 
affecting service delivery as part of this study. 
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SECTION TWO 
 
3.2  Service evaluation 
3.2.1 Introduction to service evaluation methods 
Evaluation is defined as the use of the scientific method and the rigorous and 
systemic collection of research data to assess the effectiveness of organisations, 
services, and programmes in achieving predefined objectives [84]. Evaluation can be 
further divided into two types; formative, which involves the collection of data while 
the programme is active with the aim of developing or improving it; and summative, 
which involves collecting data about the programme with the aim of deciding whether 
it should be continued or repeated [85]. The evaluation of health services is usually 
based on collecting data about the structure, process and outcomes of services, as well 
as the appropriateness of the services [80]. Bowling suggests that data on structure and 
inputs can be obtained by questionnaire and document analysis, and that the outcome 
measurements should include the impact of the condition and the service on the 
quality of life of the patient [80]. Many researchers evaluating services gather 
descriptive data on the views and experiences of service users in order to describe the 
population, to study associations between variables, and establish trends [80].  
 
Within the early stages of service development, new initiatives are often provided 
within a small number of pharmacies that have been selected based on suitable 
environments and enthusiastic staff. These studies can often be viewed as evaluating 
the efficacy of the intervention. Once this has been established, the effectiveness of 
the intervention can be evaluated, that is, does it work when extended to a normal 
range of practice and working environments [86]. Studies within defined geographical 
areas are common within health services research, as resources often do not permit 
nationwide projects. Although findings from a study that is carried out within a 
defined area cannot be generalised beyond its boundaries, it does not limit the 
usefulness and wider relevance of the data and conclusions [86].  
 
The question of which research method to use should not be based on the decision 
between using qualitative or quantitative techniques, but how to identify strategies for 
combining different perspectives of both methodologies in a single study, whilst at the 
same time respecting the distinct branches of philosophical thoughts from which they 
were derived [80]. The combining of different types of approaches, methods and / or 
data within the same research study is known as triangulation. In health services 
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research, triangulation is employed to provide different perspectives of phenomena, 
obtain data on a range of issues in relation to the research question, and to assess and 
demonstrate the validity of research findings. The rationale behind triangulation is that 
using a variety of methods helps overcome the shortcoming of any particular one [86]. 
An overview of the differences between qualitative and quantitative methods is 
outlined in Table 9. Qualitative and quantitative methods can be complementary to 
each other when applied to appropriate research questions, for example, in depth 
information collected during qualitative interviews, can help design questionnaires for 
use in subsequent quantitative studies.  
 
Table 9: Distinctions between qualitative and quantitative research methods 
Qualitative Quantitative 
Appropriate for how and why questions which 
explore processes and patterns in peoples thoughts 
and behaviours 
Appropriate for testing hypothesis, investigating 
frequencies of events, and quantifying relationships 
between clearly defined variables 
Flexibility of approach and receptiveness to 
respondents viewpoint is central to the research 
The direction and content of the questionnaire are 
predetermined and standardised by the researcher 
Essential for exploring new topics and obtaining 
data on sensitive or complex issues 
Appropriate if the issue is known about, relatively 
simple and unambiguous and amenable to valid 
and reliable measurement 
 
 
3.2.2 Introduction to qualitative research methods 
Qualitative approaches have gained an increased prominence in health services 
research in recent years [87], although the numbers of qualitative studies are small 
compared to those using survey methodologies [86]. A substantial amount of the 
literature looking at factors affecting service delivery in community pharmacy has 
used qualitative research methods [3, 11-13, 16, 18, 20, 22, 26, 27, 29]. The aims of 
the qualitative researcher are to collect and interpret data and describe or explain 
phenomena in the light of the situations, background and circumstances in which they 
occur [86]. The researcher is free to change their focus as the data collection 
progresses, which is a strength of using qualitative methods [80]. As in quantitative 
research, the basic strategy to ensure rigour in qualitative research is systematic 
research design, data collection, interpretation and communication [87].  
 
Qualitative work is sometimes described as respondent led due to the direction of the 
interview being determined by issues raised by the respondent. Data is often collected 
through individual interviews or focus groups. The distinguishing feature of focus 
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groups is the interaction amongst the participants, providing a stimulus for the 
generation of a wide range of ideas and issues than might arise within individual 
interviews. Focus groups, however, are less effective than interviews in examining the 
thoughts of individuals in detail [86]. Interviews with individual participants can take 
the form of unstructured or semi structured. An unstructured interview guide will list a 
few topic headings which are explored according to issues raised by the respondent. 
During the interview, the qualitative researcher will try to obtain the true meanings 
that individuals assign to certain events, and understand the complexities of their 
attitudes, behaviours and experiences [80]. Semi structured interviews, whilst allowing 
the respondent the opportunity to express their views, also obtains information relating 
to issues of interest to the researcher. Accurate transcripts are seen as an essential pre-
requisite for a detailed and valid qualitative analysis [86]. Interviews are often audio 
taped and transcribed at a later date, allowing the interviewer to concentrate on the 
behaviours of the participant, rather than making notes.   
 
Interviews are often conducted within the respondents natural setting such as their 
home, as independent settings often present additional administration, ethical and 
logistical problems [86]. Interviews conducted face to face offer the advantage of the 
interviewer being able to probe the participant for responses and clarify any 
ambiguities. Many detailed and complicated questions can be asked, and the 
interviewer is able to observe participant behaviour and body language in response to 
specific areas of discussion. Face to face interviews, however, can be expensive, and 
do have the potential for interviewer bias [80]. Interviews conducted by telephone can 
be useful for short, straightforward questionnaires and on non sensitive topics, but are 
considered limited to the extent to which they are suited to an in depth discussion [86]. 
Telephone interviews are an economical method in relation to time and resource, but 
are restricted to people with telephones. Interviews conducted by telephone appear to 
have equal accuracy in collecting data on health as face to face interviews [88]. They 
have, however, been found to suffer from a high rate of premature termination, where 
the respondent does not wish to continue with the interview [89]. Although the use of 
telephone interviews for qualitative studies is not common, it has been used within 
previous pharmacy studies including those looking at factors affecting service delivery 
[18], and consumers expectations when visiting pharmacies [90].       
 
Non random sampling is used within qualitative research, as the aim is to understand 
complex phenomena and generate hypothesis, rather than apply the findings to a wider 
population [80].  Sample sizes are kept small due to the detailed and intensive study 
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required [86], and although no clear guidelines exist, sufficient sample size is achieved 
when the same stories, issues and topics emerge from the participants [80]. An 
example of a sampling strategy that is often applied by qualitative researchers includes 
purposive, which involves the identification and selection of particular individuals 
who share characteristics relevant to the study. Representative sampling involves the 
inclusion of respondents from a number of centres to try and achieve a degree of 
representation [86]. Opportunistic sampling is similar to convenience, and involves the 
investigator seizing the opportunity to interview any respondent who is likely to have 
relevant information for the study [80].  Both convenience and opportunistic sampling 
are likely to be unrepresentative of the population of interest and may introduce bias 
[86]. Theoretical sampling is an iterative process that is sometimes employed in 
grounded research, where sampling strategies are redesigned at each stage of research 
to enable more detailed examination of the emerging theory [86]. Maximum variation 
sampling can also be used to cover examples of all the likely variations. The 
qualitative researcher should describe the sample in a way that enables readers 
wishing to apply the same process to their own population to do so.  
 
Community pharmacies are good sampling points for recruiting users of pharmacy 
services and specific patient groups, although data from infrequent or non users of 
pharmacies will be excluded. Despite this, they have been used for recruitment of 
respondents in previous studies [90-93]. The importance of recruitment procedures 
needs to be fully understood by pharmacists and staff when using them to select 
potential respondents and / or distribute questionnaires. Recruitment protocols need to 
be acceptable to customers, and workable within the pharmacy setting, to prevent any 
selection bias on behalf of staff. Pharmacy customers may also be reluctant to provide 
honest answers if they are concerned how this may reflect on their relationship with 
the pharmacist [86].    
 
In social sciences research it is common to develop Grounded Theory [80]; a process 
of discovering theory from data that have been systemically gathered and analysed 
[94]. Generating a theory from the data means that not only do the hypothesis and 
concepts come from the data, but they are systematically worked out during the course 
of the research [94]. Where there is little previous knowledge to inform the 
development of codes at the beginning of the study, coding is designed after analysing 
a representative sample of answers to questions. Inductive coding fits with Grounded 
Theory, and offers advantages in the flexibility, richness of the codes, and the 
opportunity to develop new categories which otherwise might not have been thought 
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of, but is time consuming in nature [80]. Coding is essential for the analysis of 
qualitative data, relating sections of the data to categories which the researcher has 
previously developed or is developing [94]. A storage and retrieval system permits the 
storage of the data under the relevant categories and allows for easy retrieval of data 
for analysis [80]. Computer software packages, such as QSR NVivo®, may be 
particularly useful in the management of large data sets. Although they cannot analyse 
the data, they do have a role to play in validation as they can quickly identify instances 
in which a particular issue or topic was raised. This enables the researcher to check 
their descriptions on the topic across all respondents, and identify any inconsistencies 
with their emerging theories [86].  
 
 
3.2.3 Introduction to quantitative research methods 
3.2.3.1 Survey research  
Quantitative research methods are appropriate for testing hypothesis, investigating 
frequencies of events, and quantifying relationships between defined variables. 
Quantitative research methods have been used in the majority of studies looking at the 
factors affecting service delivery within community pharmacy mentioned within this 
thesis [1, 2, 4-10, 14, 15, 17, 19, 21, 23-25, 27, 28, 30-32]. 
 
Social surveys are viewed as a quantitative approach that is a relatively quick and 
cheap method of obtaining factual information from a large number of respondents.  
Survey data collected from a sample of sufficient size can be used to quantify 
predetermined characteristics of a population, identify frequencies of events, establish 
the proportion of respondents who hold particular views, and describe association 
between variables; to enable generalisations to be made at a wider population [86]. 
Pharmacy related organisations and pharmacists frequently conduct surveys that focus 
on issues important to the profession and its development, often with the explicit aim 
of informing change and facilitating progress [86]. Approximately a third of the 
papers cited within this thesis which have looked at factors affecting service delivery 
have used survey methods [1, 2, 4, 5, 9, 14, 17, 19, 21, 23, 28, 32]. Other examples 
where surveys have been used in pharmacy practice research include pharmacy 
workforce issues [95, 96], and consumer perspectives of pharmacy services [91, 97, 
98]. 
 
Surveys designed to measure events, behaviour and attitudes of the population of 
interest are called descriptive surveys, as the information is collected from the 
 67 
population of interest, and descriptive measures calculated. Respondents are generally 
asked to report on events, feelings and behaviours retrospectively, and thus surveys 
are called retrospective [80]. Cross sectional surveys are carried out at one point in 
time and are a relatively economical data collection method in terms of time and 
resources, as large numbers of people can be surveyed relatively quickly, compared to 
longitudinal studies in which a sample is followed up over a period of time [80].  
 
It is important that the questionnaire used within the survey gathers relevant 
information effectively and efficiently, and that responses received are a reliable and 
valid reflection of the issues being measured.  Most pharmacy practice researchers 
develop their own questionnaires, devising questions to meet the study objectives. 
Those who use questions developed and tested by others save time and money in 
validation, and benefit in comparisons that can be made against other data and 
populations [86].  Survey questionnaires should be acceptable and attractive to 
potential respondents by being reasonable in length and well presented [86]. The 
reliability of the data can be affected by the use of pre coded responses in structured 
questionnaires, as they may not be sufficiently comprehensive, and force some 
respondents to choose inappropriate answers [80]. Questions that require respondents 
to recall events, or estimate their frequency, can also present reliability problems. 
Subjective quantifiers cannot be easily translated into numerical frequencies, as 
respondents will employ their own terms of reference to the answer, possibly 
comparing themselves to those around them, their expectations, or previous 
experiences. In essence, they are providing their perceived answer to the question, and 
not the actual response. As such, subjective quantifiers should be used with caution 
where researchers wish to provide some estimates of numerical frequencies of events, 
rather than perceptions of them [86].  
 
Surveys can be conducted by personal interviews, postal or other self completion 
questionnaire method or diaries. While face to face interviews have a good reputation, 
postal and telephone techniques have improved in recent years [99]. The internet is a 
relatively new option that is becoming increasingly popular as a data collection tool. 
The range of methods for collecting survey data has implications for both response 
rates and the cost of obtaining the samples. Personal and telephone surveys tend to 
achieve higher response rates than postal and internet surveys in general population 
samples, although this partly depends on the area of study [99]. Face to face 
interviews allow for more complex questions to be asked, and the opportunity to 
clarify any misunderstandings. The expense and time required to conduct face to face 
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interviews, and the development of computer technology, has encouraged growth in 
the use of telephone interviews [99]. The use of telephone interviews to collect data 
allows the interviewer to build rapport, and at the same time maintain respondent 
anonymity. Postal questionnaires are self administered so must be easy to follow and 
self explanatory. This method is cheaper to administer, but response rates tend to be 
lower than face to face and telephone interviewing [99]. It is important to ensure the 
consistent administration of the questionnaire when using multiple interviewers to 
collect the data. To minimise the scope of variation, questionnaires should be highly 
structured, procedures standardised, and directions made clear [86].  
 
Random samples are favoured within quantitative research as they allow the 
application of probability statistics and the generalisation of findings to the population 
from which the sample was drawn [86]. Methods of random sampling used within 
quantitative research include cluster and stratified, the latter allowing for increased 
precision in the sample reducing the chance of over or under representation of groups 
in the population [80]. Quota samples are often used within market research, and rely 
on the selection of specific numbers of individuals within different age groups and 
gender. Convenience sampling, the selection of the most readily accessible or willing 
individuals as participants, can be useful in the early or exploratory stages of survey 
research. Due to the non random nature of both quota and convenience sampling, care 
should be taken before making any generalisations of the results [86].  
 
A number of different approaches can be applied to obtain samples representative of 
the population of interest, with the ideal sampling frame containing a list of all 
members of the population. The use of electoral registers as sample frames within 
defined geographical areas include a high proportion of the population, but are less 
reliable within populations of high mobility, in particular inner city areas. The post 
code address file is useful in surveys collecting data by home interviews, where 
researchers randomly select individuals within particular households. Bias can be 
introduced by favouring individuals more likely to be at home, a factor which can be 
reduced by varying the times of day and week in which the researcher visits. 
Weightings can also be applied to adjust for different sized households. Although 
telephone directories can be used to sample individuals participating in telephone 
surveys, selection bias exists with ex directory numbers, households with multiple 
lines, and those without a telephone. General population samples can be recruited in 
public places such as shopping centres. Care needs to be taken in the choice of venue 
and recruitment times; although bias will exist as the most frequent shoppers will have 
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a greater chance of being included in the sample [86]. Postal and self completion 
surveys are more economical than interviews, as large samples of the population can 
be mailed relatively quickly. These methods are only suitable when the issues and 
questions are straightforward and simple, when the population is literate and speaks a 
common language, and when a sampling frame of addresses exists [80].    
 
Computer statistical packages, such as the Statistical Package for Social Sciences 
(SPSS), are generally used within the analysis of large data sets commonly generated 
from survey research. Statistical tests are used to establish whether the overall picture 
presented by the data occurred because of an actual association within the data, or 
whether the relationship was a chance phenomenon. The likelihood of the observed 
difference occurring by chance alone is expressed as the level of probability or P 
value. The smaller the P value, the greater the observed differences are due to chance 
alone. Conventionally, a P value of less than 0.05 is regarded as allowing us to reject 
chance as accounting for any observed difference, and is termed statistically 
significant [100].  
 
3.2.3.2 Mystery customer research 
Mystery customer research is defined as The use of individuals trained to experience 
and measure any customer service process, by acting as potential customers and in 
some way reporting back on their experience in a detailed and objective way [101].  
Within the literature, mystery customer research is known under a number of 
terminologies including: secret, phantom, anonymous, undercover, covert, surrogate, 
pseudo, and simulated customers / patients/ shoppers / clients. Methodologically, it is 
also known as participant observation research. Media coverage on the recent Health 
Which? reports has questioned the validity of using mystery customers to conduct 
research on pharmacy services [102].  Others have concluded that well designed 
mystery shopping studies can provide useful data on service quality in a range of 
settings [103], and that the reliability of mystery customer data is much higher than 
that of customer surveys [104]. 
 
A tremendous amount of effort goes into creating a service, but the impact that this 
makes on the customer will always depend on how well it is delivered [105]. Service 
standards are normally set by head office staff and senior management, but the actual 
task of delivering these standards rests with individual members of staff who deal with 
the customers. For consumer facing organisations, it is particularly important to ensure 
that their staff are delivering a consistent, positive customer experience, as this will 
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drive loyalty and market share. A number of commercial organisations monitor 
service delivery levels through the use of mystery customer research, which is often 
carried out by market research agencies [106]. For example, Unichem undertook its 
own mystery customer research to test staff confidence in recommending smoking 
cessation products to the public [107]. Other pharmacy chains have also used mystery 
customer research for a number of years to help assess and improve service delivery, 
but the results generally remain confidential [108]. There are an increasing number of 
examples whereby mystery customer research is used within the pharmacy 
professional bodies; the Prescription Pricing Authority (PPA) uses undercover 
investigators to visit community pharmacies to check that prescription exception 
checks are carried out [109], and the RPSGB are authorised to carry out direct covert 
surveillance under the Regulation Investigatory Powers Act 2000, as part of 
investigations to detect or prevent crime [110]. There has been a steady growth in the 
use of this methodology within pharmacy practice research over the past 30 years 
[111], and examples of use include assessing elements of health service delivery [102, 
112-114], and as part of training programmes [115, 116].  
 
Unlike customer satisfaction surveys, mystery customer research is used to measure 
the process rather than the outcomes of a service encounter [106]. The mystery 
shopper collects facts rather than perceptions [103], and is able to measure the service 
experience as it unfolds, looking at which procedures do or do not happen [106]. 
Judgements on the appearance of the premises and staff as well as the actions of staff 
in terms of politeness, product knowledge and helpfulness are slightly more 
subjective, but can be minimised by using rating scales with labels [106]. Scenarios 
need to be designed so that they are able to test exactly what is required, and that are 
relatively easy to remember by the trained individual [105]. The shoppers themselves 
have to be trained to be able to answer any question that a pharmacist may ask [103].  
 
 
3.2.4 Studies that require ethics committee approval 
The DH published the Research Governance Framework for Health and Social Care 
in 2001 [117], which set standards for research, including mechanisms for delivery 
and requirements for monitoring and assessment. The standards within the framework 
apply to all research which relates to the responsibilities of the Secretary of State for 
Health, of which compliance was expected in all areas by March 2004 [118]. An 
updated edition of the framework was published in 2005, which took into account new 
legislation, and provided further clarity on the roles of the sponsor, chief investigator, 
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and organisations involved in research [119]. Similar documents have been produced 
for Scotland [120] and Wales [121], which are fundamentally the same and differ only 
in the relevant organisations and legislation that they refer to [122]. 
 
Approval from the appropriate NHS research and ethics committee is required for any 
research proposal that involves patients and users of the NHS. This includes all 
potential research participants recruited by virtue of the patients or users past or 
present treatment by, or use of, the NHS, including NHS patients treated under 
contracts with private sector institutions [123]. Individuals identified as potential 
research participants because of their status as relatives or carers of patients and users 
of the NHS, and NHS staff recruited as research participants by virtue of their 
professional role, are also included within this definition. Ethical research is not just 
about the safety and wellbeing of the research participants, but also about their rights 
and dignity [122]. Potential participants have the right to chose whether they want to 
participate within a study or not, with full understanding of their involvement and any 
potential implications.   
 
Research conducted within community pharmacies is not as clear cut as the definition 
above [122]. If the study is conducted with patients presenting an NHS prescription, 
then the study needs to be submitted to an ethics committee, if they are coming in to 
buy general products then it does not. If they are purchasing Over The Counter (OTC) 
medicines then the position is unclear, as they may have been advised to buy these by 
their GP [122].  
 
Approval from the research ethics committee is not always required for medical or 
clinical audit projects, therefore determining whether your study falls within the 
definition of research or audit (refer to Table 10) can also affect the necessity to 
seek ethical approval or not [124].  
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Table 10: Comparison of ‘research’ and ‘audit’ projects [124]  
Research Audit 
Aims to increase the sum of knowledge 
through systematic investigation 
Systemically examines the peer review of 
care, treatments or services to identify 
opportunities for improvement 
May involve an element of randomisation to 
different treatments or services 
Never involves the random allocation of 
treatments or services 
May involve a new treatment or service Never involves a completely new treatment 
Often involves extra work over and above that 
involved in normal clinical management or 
service provision 
Never involves disturbance to the patients 
beyond that required for normal client 
management 
May involve the application of recruitment 
criteria before subjects are entered into a 
study 
May involve patients with the same problem 
receiving different treatments or services. 
However, the patient has a choice of the 
treatment or service they receive after full 
discussion of the known advantages and full 
disadvantages of each 
 
 
3.2.5 Methods of data collection used within this study 
In order to capture the information required to meet all of the objectives within this 
study, data were collected using a combination of quantitative and qualitative research 
methods. The use of multiple data sets and methods to measure specific objectives 
produces a more robust evaluation method, allowing for triangulation of the data. The 
objectives and measures detailed within Table 11 were collected as part of the baseline 
data, to update the literature sources, and to inform the service evaluation objectives 
listed in Table 12. The data collection methods used to inform each of the objectives 
and measures is also detailed within these tables. The use of these methods for data 
collection were based on both research and commercial reasons, and as a result, some 
of the data collected were not relevant to this study and have not been presented. 
Although anecdotal feedback was collected following the interaction with the 
pharmacist, no specific measurements were collected on patient outcomes or quality of 
life as this was not the focus of this study. 
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Table 11: Study objectives, measures and data sources for baseline data 
Objective  Measure Data source 
To identify opportunities for community 
pharmacists to help improve symptom 
control in people with asthma  
Customer need 
Omnibus survey 
Asthma audits 
Customer interviews 
To describe consumers current choice, 
frequency of visit and use of community 
pharmacy 
Feedback from customers 
Omnibus survey 
Asthma audits 
Customer interviews 
To describe consumers and 
pharmacists views on the extended role 
of the community pharmacist 
Feedback from customers 
and pharmacists 
Customer interviews 
Pharmacist interviews 
 
 
Table 12: Study objectives, measures and data sources for service evaluation 
Objective  Measure Data source 
To investigate the impact of the design 
and route of service  
Evidence of delivery of 
intervention 
Mystery customer 
research 
Customer interviews 
Pharmacist interviews 
To discuss factors affecting the delivery 
of the asthma services 
Evidence of delivery of 
intervention 
Factors affecting service 
delivery 
Asthma audits 
Mystery customer 
research 
Customer interviews 
Pharmacist interviews 
To identify the benefits of service 
delivery; to the staff involved in running 
the service; the service user; and the 
company funding the service 
Pharmacist and customer 
satisfaction 
Number of asthma 
prescriptions dispensed 
Customer response to 
advice given 
Asthma audits 
Dispensing datag 
Customer interviews 
Pharmacist interviews 
To identify any recommendations for 
future service delivery within 
community pharmacy 
Feedback from 
pharmacists and 
customers 
Customer interviews 
Pharmacist interviews 
 
Although data were collected at different points of time across the study, each source 
was accessed once, and as such the studies were cross sectional. The omnibus survey 
was conducted at the beginning of this study, allowing for information on customer 
need and pharmacy use to be identified early on within the general population. 
                                                 
g Limited information is available due to commercially sensitive data 
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Similarly, audits conducted within the pharmacies participating in the asthma service 
allowed for data to be collected on customer need and pharmacy use within a sample 
population of users of the pharmacy. Mystery customer research was used to assess 
the delivery of the services, and explore factors affecting this, and was an ideal tool to 
use when assessing a large scale service such as this. The use of interviews for both 
customers and pharmacists allowed the opportunity to explore some of the service 
details in more depth, including factors affecting delivery, service benefits, and future 
recommendations. Semi structured interviews were used to allow questions within the 
surveys to be duplicated, to compare and support evidence from several perspectives.  
 
An overview of the data collection methods and timings is displayed within Table 13, 
further details of which are provided later within this chapter.  
 
Table 13: Data collection methods and timings for baseline information (B), brief 
intervention (BI) and asthma service (AS) 
Data set B BI AS Collection method Date collected 
Omnibus Survey X   Face to face survey Mar 03 
Mystery customer 
research 
 X  Mystery customers 
May 03 
Jun 03 
Jul 03 
Aug 03 
Q
u
an
ti
ta
ti
v
e 
Asthma audits X  X 
Questionnaires in 
pharmacy 
Audit 1 Jun 03 
Audit 2 Nov 03 
Customer 
interviews 
X X X 
Semi structured 
telephone 
interviews 
Apr-Jun 03 (quarter one, 
Q1) 
Jul-Sep 03 (quarter two, 
Q2) 
Oct-Dec 03 (quarter three, 
Q3) 
Jan-Mar 04 (quarter four, 
Q4) 
Q
u
al
it
at
iv
e 
Pharmacist 
interviews 
X X X 
Semi structured 
telephone 
interviews 
Apr-Jun 03 (Q1) 
Jul-Sep 03 (Q2) 
Oct-Dec 03 (Q3) 
 
3.2.5.1 Use of research agencies 
As I was designing and managing this study from both a research and commercial 
perspective, it allowed me greater access to funding and resources for collecting data 
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than if I had approached it just from a research perspective alone. I was able to take 
advantage of existing data collection methods within the company, from several 
different sources. Boots regularly uses agencies to collect data for them, all of which 
are registered and regulated, to ensure a high standard of delivery by specialist trained 
individuals. The use of an agency also helps to prevent any bias towards the company 
when collecting these data.  
 
At the time of the study, mystery customer research was carried out on a monthly 
basis within Boots by a specialist research agency. Pharmacies were aware that they 
were visited on a regular basis by the mystery customer, but they were unaware of the 
scenarios that were used. Each department within the pharmacy was assessed 
separately, using various scenarios. Taking advantage of this resource, I decided to 
design an asthma scenario for use by the mystery customers during the months of 
May, June, July and August 2003.  
 
Research agencies were also used to conduct the omnibus survey, and perform the 
interviews with both customers and pharmacists. The sheer volume of work involved 
with the omnibus survey, and the timely manner for which it was required for business 
decisions, favoured this approach. Research agencies were also better placed in 
conducting the customer and pharmacist interviews as they provided anonymity to the 
interviewee. I felt that the respondents were more likely to be honest within the 
interviews if they were not talking to a healthcare professional from the company 
concerned, or in respect of the pharmacists, a fellow work colleague.  
 
Although these data were collected by specialised agencies, the decision to use them, 
who to use, the approach to the research, the design of the questionnaires and guides, 
and the analysis of the data were conducted by myself. The research agencies were 
used to collect the data only. 
 
Limitations 
There are disadvantages to using a research agency, as you are relying on someone 
else to do the work for you. Careful selection of the research agency minimises risk, 
but I do not know whether the interviewers from the agency performed to the same 
standards and consistency as I would have done myself. Although it is important to 
regulate data when evaluating services for commercial reasons, the processes do not 
have to be as stringent as when collecting data for research purposes. To help 
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minimise risk, clear guidelines were discussed with the agencies prior to collecting 
data about the requirements for this particular study. 
 
The use of existing data collection methods allowed me to collect from several 
sources, but did present constraints as to the type of information that could be 
collected. Mystery customers were used for data collection within the company on a 
monthly basis, and as such, operated within certain guidelines. The design of the 
asthma scenario and collection of data were limited within these existing constraints.  
 
3.2.5.2 Omnibus survey research 
To help assess customer need and identify the current level of pharmacist activity 
within asthma, an omnibus survey was conducted prior to implementing any services. 
National surveys are a useful tool to collect the views of the general population, and 
can be conducted relatively quickly. Ethics approval is not required for surveys such 
as this, as recruitment is conducted within the general population.  
 
The questionnaire (refer to Appendix C) was designed to collect some baseline data to 
help identify customer need, and recognise areas which pharmacists could help people 
with asthma. Particular questions were asked on knowledge of asthma, medication 
use, frequency of symptoms, and the use of the pharmacist for advice. Although the 
literature is rich with information on many of these areas, (see chapter 6), this survey 
has helped to update and reinforce findings from previous work. 
 
Baseline data were collected for diabetes, hypertension, high cholesterol, and 
osteoporosis, as well as for asthma.  Data for the other chronic conditions was 
collected to assist with additional trials being conducted at the same time within the 
company, but for the purpose of this study, only the data from asthma has been used. 
In order to obtain a reasonable sample of people with these conditions within the 
general population, 2000 people were targeted to take part in this survey. The survey 
was conducted through a research agency using a face-to-face approach. Interviewers 
recruited people to the survey using quota sampling methods, and approached 
participants within their home environment. 
 
The omnibus survey was carried out in England during March 2003. A total of 1954 
people were questioned, of which 255 had asthma themselves, or a partner or child 
with asthma. The survey was done to reflect the views of a national sample, and not 
just those people that shop at Boots.  
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Limitations 
Surveys are an effective tool for collecting large volumes of data on the population of 
interest, however, the reliability and validity of data depends on the respondents being 
able and willing to provide the information requested. Respondents may consistently 
over or under estimate the information they provide [86]. Survey methods are a useful 
tool for collecting facts, but can be unreliable when asking for people to remember 
timings of events, or rate particular experiences, as one persons perception can be 
very different from another. Although parents and partners of people with asthma 
often help to manage the condition, data collected from these sources may not be as 
reliable as from the person themselves. There is no flexibility at the time of interview, 
as the data collected in surveys is predetermined and structured, and does not allow for 
further questioning. There is scope for framing bias in interview studies in which the 
respondent replies are influenced by the design of the pre coded response choices [80]. 
Bias may also exist in the recruitment method, as although respondents were recruited 
within their own homes at different times of the day and week, the method will always 
be biased towards the selection of those that were more likely to be at home at the 
time.  
 
3.2.5.3 Asthma audits 
To help assess customer need and identify the current level of pharmacist activity 
within asthma, a baseline audit was conducted within the participating pharmacies 
prior to the commencement of the asthma service, and was repeated following the 
implementation of the service.  The use of a structured questionnaire that could be 
completed by customers within the pharmacy, allowed the collection of data in a 
quick, timely, and cost effective manner. The content of the questionnaire was similar 
to that of the omnibus survey, to allow for some comparison of data sets. Data were 
collected on condition knowledge, medication use and symptom occurrence. Within 
the second audit, additional questions were asked on whether they had received advice 
from the pharmacist on asthma, what this was about, and how they rated the quality of 
it. Ethics approval was not required for this audit.      
 
The questionnaire (refer to Appendix D) was designed so that customers could 
complete the survey within the pharmacy area in a matter of minutes. Staff within 
each pharmacy asked a sample of customers the questions over a period of two weeks 
prior to starting the asthma service, and again once the service had commenced. 
Asthma customers were recruited opportunistically when they approached the 
pharmacy for advice or over the counter medicines. Once identified, customers were 
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then asked whether they wanted to participate within the survey. All information was 
treated as confidential and no customer details were recorded. These data were 
collected during June and November 2003, and once completed, the forms were sent 
through to me for analysis. Data were analysed using SPSS v 11.5 software.  
 
The initial baseline audit took place in all eight pharmacies participating in the asthma 
service during June 2003, and the total sample collected was 119. The second audit 
took place during November 2003, with only seven of the eight pharmacies 
participating, and a total sample of 114. The breakdown of questionnaires completed 
by customers within each of the participating pharmacies is shown in Table 14. The 
asthma service commenced during September 2003, although all of the pharmacies 
would have been involved with the brief intervention activity during the course of the 
summer. These data collected during audits one and two were not from the same 
customers.  
 
Table 14: Number of completed questionnaires from each pharmacy participating in the 
asthma service during audits one and two 
Pharmacy identification number Audit 1 Audit 2 
96 18 19 
817 18 25 
906 12 10 
950 16 16 
953 15 16 
975 11 8 
976 17 20 
1017 12 0 
TOTAL 119 114 
 
 
Limitations 
The findings from the asthma audit provide a useful insight into the current knowledge 
and medication use of people with asthma visiting that particular pharmacy, but can 
not be generalised due to the small sample size and bias in the opportunistic sampling 
method used. Recruitment of respondents was reliant on staff within the individual 
pharmacies, and bias may exist on who the staff approached and when, depending on 
how approachable the person was, and how busy the pharmacy was at the time. 
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Despite the recruitment bias, the asthma audits did support other data and helped to 
strengthen the case for the role of the pharmacist. The second audit was used as a 
proxy measure for the impact of the service locally, due to increased activity and 
awareness, but is limited in its reliability due to the data being cross sectional, and not 
longitudinal in nature. As with the omnibus survey, the questionnaires were structured 
so did not allow for any further questioning at a local level.  
 
3.2.5.4 Mystery customer research 
At the time of the study, mystery customer research was regularly carried out on a 
monthly basis within Boots, pharmacies aware that they were visited on a regular basis 
by the mystery shopper, but unaware of the scenarios that they were placed under. 
Each department within the pharmacy was assessed separately, and staff bonuses were 
paid according to the results. Although pharmacy scenarios were carried out monthly, 
pharmacies were not scored on the quality of pharmacist advice given. To provide 
evidence of delivery of the brief intervention, mystery customer research was used 
during the months of May, June, July and August 2003. The use of mystery customers 
enabled me to randomly assess staff use of the brief intervention on a national basis. 
Although every single pharmacy was assessed by the mystery customer, the asthma 
scenario was not carried out if more than four customers were present in the pharmacy 
at the time of assessment, so as not to disrupt the pharmacy staff and customers even 
further. Ethics approval was not required as the research was carried out on staff 
within the organisation.  
 
Mystery customers presented at the pharmacy with the asthma scenario outlined in 
Figure 4 during the months of May to August 2003, and assessed the pharmacy on a 
single visit each month. 
 
Figure 4: Mystery customer asthma scenario 
You want to enquire about your brother / sister who has asthma. It is coming up to the hayfever 
season and his / her asthma is getting worse. You do not feel that he / she controls his / her 
asthma very well as he / she is always running out of his / her blue inhaler. Ask whether or not 
you can get replacement inhalers directly from the pharmacist rather than having to go to the 
doctor for a prescription.  
If asked, your brother / sister seems to suffer from wheezing symptoms quite regularly which is 
leading you to believe that they are not controlling it well. The pharmacist may ask about the 
brown inhaler  say that your brother / sister does not use this very much and has not had it 
replaced for months. 
NB The blue inhaler is for relief of symptoms and the brown inhaler is for prevention. 
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Information was collected regarding who served them, which of the three RCP 
questions were asked, and whether any lifestyle advice was given by the pharmacy 
staff (refer to Appendix E). Based on the store identification number, additional 
information was collected on pharmacy size and type, using existing company 
databases. The number of pharmacies assessed varied on a monthly basis, as the 
asthma scenario was not carried out if more than four customers were present at the 
pharmacy counter at the time of assessment. 
 
Over the four month period from May to August 2003, a total of 2756 asthma 
scenarios were carried out within 1222 Boots pharmacies. These data were inputted 
into SPSS v 11.5 and analysed to help assess the delivery of the intervention. 
Descriptive statistics were collated, and tests of association explored against each of 
the factors. The hypotheses that service delivery was affected by pharmacy format / 
pharmacy size / personnel were explored. Tests of association for each of the factors 
were explored for significance using the chi-square test at a level of p < 0.05.  
 
Limitations  
The scale of this study has great strengths in the amount of data that can be collected 
through the use of mystery customers, and provides a fairly reliable snapshot of 
service delivery throughout the pharmacy chain. However, the interaction recorded 
takes place in one pharmacy on one day, and is a false situation between two people, 
whereby one person is lying. There may be circumstances within the pharmacy on that 
day which effect the interaction, and are not recorded as part of the data collection 
process. Mystery customer research should be used alongside other data, as caution is 
advised when it is used on its own to influence strategy and policy decisions [108].  
 
As these data were collected as part of the regular mystery customer assessment 
within this pharmacy chain, it has presented a number of limitations within this study. 
These data collections had to fit in with the standard parameters that had already been 
set within the regular monthly assessments, and this has resulted in the mystery 
customers collecting information only on the quantity, and not quality of advice given. 
The member of staff assessed will also vary at a local store level, depending on who is 
available to serve customers at the time of assessment.  
 
To assess the longevity of this type of service delivery, data would have ideally been 
collected over the full twelve month period, but unfortunately this particular scenario 
could not be used for longer than four months. Mystery customers did not carry out 
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the pharmacy scenario if there were more than four customers present at the pharmacy 
counter at the time of assessment. This restriction was one of the pre set parameters, 
so that the mystery customers did not disrupt the pharmacy counter any further during 
busier times. If these data had been collected, they would have provided a more 
accurate snapshot of the advice given during busier times 
 
3.2.5.5 Customer interviews 
Interviews were conducted with customers to explore in more detail some of the 
findings from the initial survey data, and to obtain feedback on the service itself. 
Feedback from the customers was important to understand whether they perceived the 
interaction with the pharmacist as useful, whether they acted on the advice given, and 
whether they would come back to the pharmacy for advice in the future. In line with 
this, it was also important to establish how they currently accessed the pharmacist, and 
how they saw the pharmacists role changing in the future. Interviews were preferred 
to focus groups, as respondents were being questioned on individual experiences 
following an intervention. Ethics approval was not required for the evaluation of this 
service, as respondents were recruited after participation in the service.  
 
Interviews were conducted by a research agency using a semi structured questionnaire 
(refer to Appendix F). The use of a semi structured questionnaire allowed me to have a 
core structure to the interview and control elements of the data captured, whilst still 
allowing the interviewers to have some flexibility in exploring issues personnel to the 
respondents at the time of the interviews. Telephone interviews were conducted to 
allow greater coverage throughout England, and provide interviewees with anonymity. 
Conducting the interviews over the telephone also provided convenience for the 
interviewees, and allowed them to give honest feedback in a non threatening 
environment of their choice.  
 
Respondents were recruited to research by pharmacists and staff following an 
intervention or service in asthma. Pharmacists and staff were ideally placed to do this, 
as they could introduce the study to the customer at the end of the asthma service, and 
get their agreement locally to participate. Recruitment by a third party within the 
pharmacy environment would have been a costly exercise, and may have put people 
off the service in the first place.  
 
Within each quarter, ten pharmacies were selected to recruit customers to research 
over a period of one to two weeks, using a purposive sampling method. Pharmacies 
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participating in the brief intervention were targeted to recruit customers for interview 
during quarters one, two and three, and pharmacies participating within the asthma 
service were asked to recruit customers within quarter four. Quarterly sampling was 
adopted to allow for interviews to be conducted throughout the year.  Pharmacies 
participating within the brief intervention were initially selected based on a variety of 
formats and geographical locations. 
 
The principal pharmacist within each pharmacy selected received a telephone call 
explaining the purpose of the research, and a verbal agreement of the pharmacys 
participation was confirmed. This was then followed in writing to the named 
pharmacist, along with customer letters to explain the procedure. Each participating 
pharmacy was asked to record the names and contact details of customers they had 
spoken to about their asthma over the recruitment period. Once completed these forms 
were sent directly to the research agency. A random selection process was adopted at 
the research agency to select ten names to contact customers for interviews, to reduce 
any potential bias within the pharmacist recruitment process. No incentives were 
offered to customers to participate in the study.  
 
Due to recruitment problems within the pharmacy, the quota for the quarter one 
interviews were not reached, and this led to additional selection criteria being used 
over the subsequent months. Data collected from the mystery customer research was 
used to target those pharmacies that had a positive result in delivering the brief 
intervention; had asked all three RCP questions and given lifestyle advice. By 
targeting pharmacies in this way, the number of customers that pharmacists managed 
to recruit to research following the brief intervention increased. Within quarter three, 
pharmacies were targeted if they had consistently delivered the intervention over the 
four month mystery customer assessment period, and if they had a pre-registration 
graduate. This was to try and encourage the pharmacists to devolve responsibility for 
recruitment to the pre-registration graduates, if time was an issue for them.  
 
The customer interviews were conducted for both the brief intervention and asthma 
service during 2003, and early 2004. The breakdown of these interviews, including 
timing and coding, is shown in Table 15. The majority of the interviews were taped 
and transcribed in full. Unfortunately all of those collected in quarter one, and one in 
quarter four were not recorded, so were transcribed from the interviewers notes. The 
transcripts were put into QSR NVivo® v2.0 software package, to help manage the 
data. The data within the transcripts were sorted by initial themes, and as additional 
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transcripts were added, further themes emerged. The data was segregated by emerging 
themes, and was revisited and resorted on several occasions before settling on the final 
themes. The transcripts were analysed using principles from the Grounded Theory, as 
the theory behind the factors affecting service delivery emerged from the data itself. 
 
Table 15: Breakdown of customer interviews conducted between April 2003 and March 
2004 
Quarter Data set Sample Codes 
1 BI 8h C1, C2, C3, C4, C5, C6, C7, C8 
2 BI 6 C9, C10, C11, C12, C13, C14 
3 BI 10 C15, C16, C17, C18, C19, C20, C21, C22, C23, C24 
4 AS 10 C25, C26, C27, C28, C29, C30i, C31, C32, C33, C34 
 
 
Limitations 
Due to the semi structured nature of the interviews, there was variability on the 
content of the data collected between individual respondents. This was also increased 
by the use of interviewers from a research agency, as interviewees were probed to 
varying degrees, on different questions. The likelihood of this may have been reduced 
by the use of a more structured questionnaire, but would have resulted in less rich 
data. Bias may also exist within the interviews as the issues raised may be a reflection 
of the interviewees pressing concerns at the time of data collection.  The use of a 
research agency to collect the data also resulted in the transcripts within quarter one 
being transcribed manually. This may compromise the comprehensiveness of the data 
collected, as being preoccupied with transcribing, the interviewer is less able to pick 
up and develop issues as they are raised by the respondent. The richness of the data 
will also be compromised as the interviewers notes will be less comprehensive than 
the original transcripts.  
 
Although there were advantages in the use of pharmacists and staff to recruit 
customers to research, this was extra work for them, and bias may have existed in their 
recruitment method. Staff may have varied recruitment depending on the perceived 
customer response, and how busy the pharmacy was at the time. Individuals who 
chose to participate in the first place are often self selecting, and their comments may 
                                                 
h All eight customer interviews within quarter one have been transcribed from the interviewers 
notes  
i Transcripts for C30 were taken from interviewers notes due to tape recorder failure 
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not be applicable to the wider population. The findings may provide useful insights 
into the service for those who use it, but be limited on why others do not [86].  
 
3.2.5.6 Pharmacist interviews 
Interviews were conducted with a sample of pharmacists to explore in more detail 
some of the findings from the initial survey data, and to obtain feedback on the service 
itself. Feedback from the pharmacists on the service was important to draw upon their 
multiple experiences with customers to try and understand the factors affecting service 
delivery from both a delivery and receiver perspective. Alongside this, it was also 
important to establish what they thought about the extended role of community 
pharmacists, and understand their confidence in delivery of services. Interviews were 
preferred to focus groups, as respondents were being questioned on individual 
experiences. Ethics approval was not required for the evaluation of this service, as 
respondents were employed by the company directly, and not the NHS.  
 
Interviews were conducted by a research agency using a semi structured questionnaire 
(refer to Appendix G). The use of a semi structured questionnaire allowed me to have 
a core structure to the interview and control elements of the data captured, whilst still 
allowing the interviewers to have some flexibility in exploring issues personal to the 
respondents at the time of the interviews. Telephone interviews were conducted to 
allow greater coverage throughout England, and provide interviewees with anonymity. 
Conducting the interviews over the telephone also provided convenience for the 
interviewees, and allowed them to give honest feedback in a non threatening 
environment of their choice.  
 
Pharmacist interviews were planned to be conducted during quarters one and three, 
with a target of ten interviews per quarter. Theoretical sampling was applied to select 
the pharmacists for interview, as the pharmacy selection criteria were the same as used 
within the customer interviews. The pharmacists that were selected for interview were 
often the ones that were responsible for recruiting these customers to research within 
that pharmacy.  
 
The questionnaire (refer to Appendix G) was designed to try and understand 
pharmacists views about undertaking the intervention, and where they saw their role 
extending to in the future. Due to the lack of response in recruiting customers to 
research within quarter one, I decided to conduct interviews with pharmacists within 
this first quarter using a slightly different questionnaire (refer to Appendix H). This 
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revised questionnaire was designed to find out why pharmacists had problems 
recruiting customers to research, in an attempt to try and address any issues in 
preparation for subsequent customer recruitment. 
 
The pharmacist interviews were conducted for both the brief intervention and asthma 
service during 2003. The breakdown of these interviews, including timing and coding, 
is shown in Table 16. The majority of the interviews were taped and transcribed in 
full. Unfortunately, two of those collected in quarter one were not recorded, so were 
transcribed from the interviewers notes. One of the interviewees in quarter three was 
actually a pre-registration graduate and not a pharmacist at the time of the interview. 
The transcripts were put into QSR NVivo® v2.0 software package, to help manage the 
data. The data within the transcripts were sorted by initial themes, and as additional 
transcripts were added, further themes emerged. The data was segregated by emerging 
themes, and was revisited and resorted on several occasions before settling on the final 
themes. The transcripts were analysed using principles from the Grounded Theory, as 
the theory behind the factors affecting service delivery emerged from the data itself. 
 
Table 16: Breakdown of pharmacist interviews conducted between April and December 
2003 
Quarter Data set Sample Codes 
1 BI 7 P1, P2, P3j, P4, P5, P6, P7j 
2 BI 1 P8 
3 BI 3 P9k, P10, P11 
3 AS 6 P12, P13, P14, P15, P16, P17 
 
Limitations 
Due to the semi structured nature of the interviews, there was variability in the content 
of the data collected between individual respondents. This was also increased by the 
use of interviewers from a research agency, as interviewees were probed to varying 
degrees, on different questions. The likelihood of this may have been reduced by the 
use of a more structured questionnaire, but would have resulted in less rich data. The 
use of a research agency to collect the data also resulted in some of the transcripts 
within quarter one being transcribed manually. This may compromise the 
comprehensiveness of the data collected, as being preoccupied with transcribing, the 
                                                 
j Transcripts for P3 and P7 were not recorded. Interviewers notes were used for these 
transcripts 
k P9 was a pre-registration graduate at the time of interview 
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interviewer is less able to pick up and develop issues as they are raised by the 
respondent. The richness of the data will also be compromised as the interviewers 
notes will be less comprehensive than the original transcripts.  
 
Bias may exist in the content of the pharmacists interviews as although they were 
feeding back through a third party, the data was ultimately for the company that 
employed them As a result, they may not have been as honest as they would have been 
if reporting back to an external source. 
 
3.2.5.7 Dispensing data 
To understand the financial benefits to the company of delivering services such as this, 
data were collected on the volume of asthma medication dispensed throughout both 
studies. Volume was measured instead of value as this was a more accurate measure 
of the market and was unlikely to be effected by constant fluctuations in the market. 
Data were collected over a national sample on a weekly basis.   
 
If a patient acts on the advice that a pharmacist gives then the use of preventer 
medication may increase, and that of relievers decrease. This measure could be used 
as a proxy to patients response, and as such, the ratio of type of medication dispensed 
was monitored over the course of the study on a weekly basis. 
 
Unfortunately, due to the commercial sensitivity of these data, I have been unable to 
present the findings in full. I have, however, included a summary as I feel that these 
data are an important factor in affecting the decision to deliver services, both from a 
national and local level. The analysis of all data includes the impact of market trends 
during the course of the study. 
 
Limitations 
Ideally, the number of asthma customers presenting at the pharmacy would have been 
measured throughout the study, but this was not possible at the time of the study, or 
indeed now. The volume of asthma medication dispensed can be used as a proxy 
measure, but does not distinguish between the number of new customers coming to 
Boots, and the number of existing customers that are coming more frequently. There is 
also difficulty in measuring the true impact of the brief intervention, as data were 
collected from all pharmacies and would have included those that were actively 
participating, and those that were not. Control data was not possible, as all pharmacies 
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were invited to participate within the brief intervention. The same will also be true on 
the ratio of asthma medication dispensed.  
 
 
3.2.6 Summary of service evaluation methods 
A triangulation of qualitative and quantitative methods has been used throughout this 
study to investigate the factors affecting service delivery in community pharmacy. 
These methods include an omnibus survey, audits, mystery customer research, 
customer and pharmacist interviews, and a review of the dispensing data. A profile of 
the customer and pharmacy data used within this study are provided within the 
following chapter.     
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CHAPTER IV 
Profile of the data  
 
4.0  Introduction to the chapter 
This chapter provides a summary of the gender and age of customers who participated 
within the omnibus survey, asthma audits and customer interviews. Following on from 
this, the chapter then goes on to summarise the size and locations of pharmacies that 
have been used within this study. 
 
 
4.1 Customer profile 
4.1.1 Gender 
Data on the gender of customers were collected for respondents with asthma that 
participated within the omnibus survey, asthma audits and customer interviews, as 
shown in Figure 5. No data on gender was collected for the pharmacist interviews.  
 
Figure 5: Gender of customers participating within the omnibus survey, asthma audits 
and customer interviews 
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Of those respondents participating within the omnibus survey with asthma themselves, 
69.6% were female, and 30.4% were male. Within the first asthma audit, 61.3% were 
female, and 38.7% male, and within the second, 54.4% were female, 43.9% male, and 
1.8% unknown. Of those respondents participating within the customer interviews, 
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67.6% were female, and 32.4% were male. A detailed breakdown of the gender of 
respondents participating in the customer interviews is shown in Table 17. 
 
Table 17: Breakdown of respondents participating in the customer interviews by gender 
Gender Respondent Sample 
Female 
C1, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C16, C17, C18, C19, 
C22, C24, C25, C27, C28, C30, C31, C32 
23 
Male C2, C3, C14, C15, C20, C21, C23, C26, C29, C33, C34 11 
 
 
4.1.2 Age 
Data on the age of the customers were collected for respondents participating within 
the omnibus survey, asthma audits and customer interviews, as shown in Figure 6. No 
data on the age of those pharmacists participating within the interviews were 
collected. 
 
Figure 6: Age distribution of customers participating within the omnibus survey, asthma 
audits and customer interviews 
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The age of 32.4% of respondents participating in the customer interviews, 1.8% of 
participants from audit two, and 0.8% of participants from audit one were unknown. 
There were a higher proportion of people aged under 18 participating within the 
asthma audit one (10.9%) and audit two (10.5%) than both the customer interviews 
(2.9%) and the omnibus survey (2.4%). The percentage of participants within the age 
group of 18  44 were similar across all four data sets (audit two 51.8%, audit one 
47.9%, customer interviews 47.1%, and omnibus 43.2%). As a percentage, there were 
far fewer respondents aged 45-64 participating within the customer interviews (8.8%) 
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than the omnibus survey (32.0%) and the asthma audits one (28.6%) and two (21.1%). 
There were many more participants within the omnibus survey that were aged 65 and 
over (22.4%) compared to all the other data sets (audit two 14.9%, audit one 11.8%, 
and customer interviews 8.8%). A detailed breakdown of the age of many of the 
respondents participating in the customer interviews is shown in Table 18.  
 
Table 18: Breakdown of respondents participating in the customer interviews by agel 
Age band 
(years) Respondent Sample 
< 18 C7 (17) 1 
19  30 
C4 (27), C6 (24), C8 (27), C9 (25), C15 (23), C19 (30), C20 (30), 
C21 (29), C22 (25), C23 (27), C34 (30) 
11 
31  40 C1 (32), C2 (35), C5 (33), C12 (33), C24 (34) 5 
41  50 C10 (50) 1 
51  60 C3 (55), C13 (53) 2 
> 61 C11 (74), C14 (67), C18 (67) 3 
 
 
4.2 Pharmacy profile 
4.2.1 Categorisation of pharmacy size and format within Boots 
At the time of the study Boots had 1412 pharmacies that were a variety of sizes, 
located in a variety of settings. The pharmacies were classified into six different 
categories of sizes, as defined in Table 19.  
 
Table 19: Categorisation of pharmacy size within Boots 
Coding Size (m2) 
A 0-149 
B 150-299 
C 300-599 
D 600-1199 
E 1200-1899 
F 1900-3000+ 
 
The pharmacies were also categorised based on where they were located, as described 
in Table 20. 
                                                 
l No data on age was recorded for eleven of the respondents participating within the customer 
interviews 
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Table 20: Categorisation of formats within Boots 
Small Destination Predominantly based in high street locations in district or local centres 
Large Destination Based in major regional centres including high street or shopping centres 
Work Based in transport locations (airports / train stations) or major city centres 
Pop in Based in small towns or local suburban shopping areas 
Health centre Located near to or in the GP practice 
Edge of Town Located within edge of town retail parks 
 
 
4.2.2 Brief intervention 
Over the four month period between May and August 2003, a total of 2756 asthma 
scenarios were carried out by the mystery shoppers within 1222 Boots pharmacies. 
Not all of the pharmacies were assessed on the brief intervention by the mystery 
customer, and a number of pharmacies were assessed on more than one occasion, as 
shown in Table 21.  
 
Table 21: Frequency of pharmacies assessed by the mystery customer between May and 
August 2003 
Number of times 
assessed 
Number of 
pharmacies 
Percentage of total pharmacies 
assessed 
Once 268 21.9 
Twice 477 39.0 
Three times 374 30.6 
Four times 103 8.4 
TOTAL 1222 100.0 
 
The size of all the pharmacies assessed on the brief intervention by the mystery 
customer over the period commencing May 2003 to August 2003 can be seen in 
Figure 7. The majority of pharmacies assessed were the smaller sized pharmacies A 
and B, followed by the middle sized C and D, and lastly the larger sized pharmacies 
categorised as E and F. This is consistent with the distribution of pharmacy sizes 
within Boots at the time of the study.  
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Figure 7: Distribution of size for all pharmacies assessed by the mystery customer 
between May and August 2003 (n=2756) 
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The format of all the pharmacies assessed by the mystery customer over the period 
commencing May 2003 to August 2003 can be seen in Figure 8. The majority of 
pharmacies assessed were the pop in and small destination formats, followed by large 
destination and work formats, and lastly edge of town and health centre pharmacies. 
This is consistent with the distribution of pharmacy formats within Boots at the time 
of the study.  
 
Figure 8: Distribution of format for all pharmacies assessed by the mystery customer 
between May and August 2003 (n=2756) 
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 93 
4.2.3 Asthma service 
The size of each pharmacy that participated within the local asthma service (n=8) is 
shown in Figure 9. None of the pharmacies that participated in this activity were the 
smaller size A or the larger size F. 
 
Figure 9: Distribution of size for the pharmacies participating within the asthma service 
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The format of each pharmacy that participated within the asthma service (n=8) is 
shown in Figure 10. No edge of town or health centre pharmacies participated within 
this local activity. 
 
Figure 10: Distribution of format for the pharmacies participating within the asthma 
service 
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4.3  Summary of the data 
Over half of the participants taking part in the omnibus survey, asthma audits and 
customer interviews were female. The biggest group of participants were aged 
between 18 and 44 years, followed by the 45 to 64 age group, the over 65s, and lastly 
the under 18s.   
 
Over the four month period between May and August 2003, a total of 2756 asthma 
scenarios were carried out by the mystery shoppers within 1222 Boots pharmacies. 
Not all of the pharmacies were assessed on the brief intervention by the mystery 
customer, and a number of pharmacies were assessed on more than one occasion. The 
majority of pharmacies assessed were the smaller sized A and B, followed by the 
middle sized C and D, and lastly the larger sized pharmacies categorised as E and F. 
The majority of formats assessed were the pop in and small destination, followed by 
large destination and work, and lastly edge of town and health centre pharmacies. 
Both the size and format of pharmacies assessed by the mystery customer were 
consistent with the distribution of pharmacies within Boots at the time of the study.  
 
None of the pharmacies that participated in the local asthma service were the smaller 
size A or the larger size F. Also, no edge of town or health centre pharmacies 
participated within this local activity. 
 
The following chapter is the first of the results chapters looking at the factors affecting 
service delivery within community pharmacy, and explores the perception of the 
pharmacists current and future role.  
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CHAPTER V 
Factors affecting the utilisation of 
community pharmacies and pharmacists’ 
role in services 
 
5.0  Introduction to the chapter 
This chapter of my thesis presents the first set of results looking at the factors 
affecting service delivery in community pharmacy. In order to understand the multiple 
factors that could affect service delivery, it is important to firstly understand when and 
how people currently use community pharmacies, including the type of advice they 
ask pharmacists for, and what they think about the quality of that advice. It is also 
important to understand how pharmacists feel about an extended role, and how 
customers feel about seeking additional advice and help from pharmacists.  
 
The chapter is split into two sections, the first of which looks at the current utilisation 
of community pharmacies. Previous studies have looked at the utilisation of 
community pharmacies in depth, and as such, an overview is provided at the start of 
this section. The results that follow help to support previous findings and are discussed 
in line with the literature at the end of the first section.  
 
The second section explores customers and pharmacists views on an extended role. 
The general literature surrounding these factors has been explored in detail within 
chapter two, and as such is not repeated within this chapter.  
 
The factors that may be affecting the utilisation of community pharmacies and the 
pharmacists role in services are summarised within each section, and initial 
conclusions drawn at the end of this chapter. The final discussion and conclusions of 
all the factors identified within this study are detailed in chapter nine.  
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SECTION ONE 
 
5.1  The public’s utilisation of community pharmacies 
There are a number of potential factors that affect the utilisation of community 
pharmacies. A thorough understanding of current use of pharmacies would provide 
some insight into potential facilitators and barriers for accessing services in the future.  
 
The RPSGB commissioned a report in 1996 to find out who uses what type of 
pharmacy, when, for what purpose, and in what location [125]. Although no data was 
collected on consumer activities relating to general retail use, they did discover that 
94% of the population had used a community pharmacy in the last year related to 
health service provision (prescription, health product purchase, and / or advice). Other 
studies that have looked at how frequently people visit community pharmacies have 
found results ranging from 6-23% visiting once a week or more [91, 126], and 45-68% 
visiting once a month or more [91, 126-128]. The Community Pharmacy Research 
Consortium commissioned a report on the publics use of community pharmacies as a 
primary health care resource in 1999 and found that the frequency of use of 
community pharmacies was high, with people visiting a pharmacy more frequently 
than their GP [129].  
 
Previous studies have found that women appear to be more frequent visitors to 
community pharmacies compared to men [125-127, 129]. People with young children 
[91, 125], those with long term conditions, carers and pregnant women [91] have also 
been found to be frequent users of the pharmacy.  The 1996 RPSGB report also found 
that respondents appeared to be the main person they visited the pharmacy for, 
followed by purchases or advice for other members of the immediate family [125]. 
 
The choice of pharmacy varies between individuals and can be influenced by a 
multitude of factors. Jepson et al. found that 45% of the general population used 
multiple chains as their main pharmacy provider, 32% used independent pharmacies, 
and 3% small chains [126]. From this same study, they also found 60% of consumers 
were loyal to one pharmacy [126], whilst Stergachis et al. found that 26% of 
respondents regularly used two or more pharmacies [130]. For 48% of these 
respondents, the reason for using multiple pharmacies was their convenience and 
location. The 1996 RPSGB report found that over half of the respondents questioned 
(56%) used a single pharmacy for prescriptions and advice, whilst 18% used different 
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pharmacies [125]. Some consumers choose to go to pharmacists they know for advice, 
but prefer a more anonymous approach to purchasing medicines, particularly those of 
a personal nature [90]. Jepson et al. found that consumers using two or more 
pharmacies based their choice of pharmacy depending on whether there was an urgent 
need for the goods, or not [126]. Phul et al. [128] used data from the EPS pilot to 
examine how and why the choice of pharmacy services differed between consumers. 
They found that those consumers participating in EPS regularly used the same 
pharmacy, whilst those not participating in EPS were found to be more flexible in 
their choice. Patient choice was often found to be related to how convenient they 
perceived the service to be, as well as their personal circumstances.  
 
There have been many studies looking at the reasons why people chose one pharmacy 
over another, and convenience is cited as the primary reason in the majority of these 
studies [38, 91, 125-131]. Convenience can mean different things to different people, 
but is often associated with location such as proximity to home, school, work or shops. 
Other studies have also found pharmacy choice to be affected by prompt service [127, 
128, 130-132], good advice [91, 127, 131], personal service from staff [125, 126, 
132], medication being in stock [128, 132], privacy and design of pharmacy [128, 
131], customers knowing the pharmacy staff [128, 131], price [130], and the range of 
consumer goods and services available [131]. Whilst convenience factors appear to be 
the most important in determining the chosen pharmacy, service related factors 
become important in creating competitive advantage where a choice of convenient 
pharmacies exists, as in many urban areas [126]. 
 
Abu-Omar et al. [132] conducted a study to explore the existence and nature of the 
pharmacist and customer relationship between small chain and large multiple 
pharmacy customers. They found that customers favouring multiple pharmacies gave 
reasons such as medication being in stock, whilst those using small chains tended to 
cite personal reasons relating to staff characteristics. Multiple chain pharmacies were 
thought to be impersonal and were often associated with being money minded. The 
authors also found that different customers had different needs and even the same 
customer seemed to have different needs from a pharmacy on different occasions. 
Sometimes an anonymous service was sought, while at other times, a personal service 
was preferred. Multiple pharmacies were mainly used for medication supply whilst 
local pharmacies were viewed as healthcare resources where further services and 
advice were sought.  
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The negative drivers that appear to deter people from using certain pharmacies include 
poor personal service such as inattentive counter assistants [125, 126, 130], and is the 
reason cited as to why consumers switch pharmacy providers. Other reasons cited for 
avoidance of certain pharmacies include a slow or busy service [125], lack of stock 
[125], and the lack of privacy and space in some pharmacies [126, 129].  
 
The 1996 RPSGB report investigated what the public had visited community 
pharmacies for within the last year and found that 89% had done so to get a 
prescription dispensed, 81% to purchase a product without advice, 34% to seek 
specific advice, and 11% to seek general health advice [125]. The study did not 
investigate non health related visits, so is not representative of usage of large multiple 
pharmacy chains. Other studies have found between 70-80% of respondents were 
visiting the pharmacy for a medical reason, and 25-30% for a non medical reason [91, 
133]. Previous studies have also found that younger people visiting the pharmacy were 
more likely to be purchasing non medical related items [91] or non prescription 
medicines [127]. People who are not high prescription users were also more likely to 
purchase OTC medicines from pharmacies [126].  
 
In a literature review on the factors influencing the use of community pharmacies as a 
primary health care resource, the use of the pharmacist as a first port of call for 
treatment of minor ailments was much lower than the high usage of pharmacies for 
prescriptions [134]. The literature showed that the first response to minor ailments was 
often some form of self care, with or without medication. The results of a recent 
survey commissioned by the DH showed that 95% of the public said that they were 
confident they had the knowledge and understanding to treat their own minor ailments 
without seeking medical advice [135]. Previous studies have also found that when 
individuals did decide to seek professional care, most visited their GP in preference to 
other healthcare professionals [127, 134].  
 
The pharmacists area of expertise is perceived to be related to medicines in particular, 
rather than to health in general [97, 126, 129, 132]. Multiple studies have shown that 
very few of the general population ask the pharmacist for advice about keeping 
healthy or general health [97, 98, 125, 126, 129, 133], particularly when it is 
independent of the function of selling or dispensing medication [133]. The range of 
symptoms presented in pharmacies is very broad and most are minor and self limiting 
rather than more serious health problems [134]. Common advice sought includes skin 
and allergy complaints [98, 126, 136], coughs and colds [98, 126], stomach and 
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indigestion [98, 126], pain [98, 136], ear and eye [98], and bites and stings [136]. 
Awareness that pharmacists could give advice on areas such as contraception or 
conditions such as asthma or diabetes was found to be low [136], and more serious 
complaints such as chest pain and severe headaches were seen as requiring 
consultations with the GP [98]. The amount and type of advice that pharmacists give 
to customers is often determined by the customers motivation, the type of medication, 
the customers abilities, and the time available [137].  
 
When asked why advice would be sought from a pharmacist rather than the GP, 
McElnay et al. found that 67% of the public indicated that this was because they felt 
the condition was not serious enough to visit a GP, and 14% indicated that they would 
visit the pharmacist if they did not have time to wait for a GP appointment [127]. A 
further 17% cited that they would never ask a pharmacist for advice [127], a finding 
that has been found in other studies [129]. Reasons cited for not visiting a pharmacy 
for advice included their own knowledge, previous experience of an illness, and the 
availability of information from other sources [129]. Rather than using the pharmacist 
as an alternative to the GP because of their specific expertise, use of pharmacies as an 
alternative often appears to be closely associated with the view that the GPs time is 
more important than the pharmacists, and is too valuable to waste [129]. People may 
also choose to see the pharmacist because the staff are viewed as more helpful, their 
GP is unsympathetic, or they are dissatisfied with the treatment received from their GP 
[129]. Easier accessibility in relation to the prompt and immediate advice also 
suggests that pharmacists are the preferred alternative in some circumstances [134]. 
Pharmacy customers sometimes use pharmacists as a stepping stone to general 
practice, taking their advice about the necessity of a visit to their GP [129, 132].  
 
The publics beliefs about the inadequacy of self medication products and perceptions 
about the pharmacists role as advice givers may encourage the public to continue to 
use general practice [134]. The nature of illnesses presented in pharmacies limits the 
extent to which individuals need pharmacy advice. Many consumers are also informed 
about their illness based on previous experience or other sources such as family, 
friends and the media, and as such are pre informed of products before entering the 
pharmacy. The cost of prescription and OTC products may also affect the usage of 
community pharmacies [134].  
 
Both age and sex appear to be associated with peoples attitudes towards symptom 
advice from the pharmacist. Young people [91, 125] and the elderly [98, 125, 129] 
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appear less likely to seek advice from the pharmacist, whilst women [98, 125, 134] 
and those with children [125, 134] appear more likely to ask for advice. Differences 
between age groups may signal changing public perceptions of the roles of different 
primary healthcare professionals, and suggests that developments in community 
pharmacy services may become increasingly more acceptable to the general public 
[98]. Studies that have looked at satisfaction of those asking for general pharmacy 
advice have found that 85% [91] to 95% [126] of respondents have found pharmacy 
advice useful.  
 
The outcome of the 1996 RPSGB report concluded that the influences on community 
pharmacy utilisation were based on demographics (who used the service), organisation 
and structure (with location and accessibility encouraging use, and lack of space and 
privacy discouraging use), attitudes and beliefs of customers and healthcare 
professionals, need and demand (self limiting nature of minor ailments and availability 
of other sources of advice), and economic resources available to purchase non 
prescription medicines [125]. 
 
The results presented within this section build on the literature presented on the 
current utilisation of community pharmacies by the public, including the frequency of 
visit, choice and use of pharmacy, the type of advice that is sought, and views on the 
quality of that advice. The results used within this section are taken from the omnibus 
survey, asthma audits, and customer interviews. From these data, I discuss factors in 
more detail that may be affecting service delivery within community pharmacies.  
 
 
5.1.1 Results 
5.1.1.1 Frequency of visit to a community pharmacy 
Within the customer interviews, respondents were asked how frequently they visited a 
community pharmacy, and separately, how frequently they visited Boots. Results for 
both questions are displayed in Figure 11. Two thirds of respondents (66.7%, n=14) 
visited a community pharmacy once a month or more, of which 47.6% (n=10) visited 
monthly. Only 14.3% (n=3) of respondents used a community pharmacy once a week 
or more. When questioned about the frequency of visit to Boots, 89.5% (n=17) visited 
once a month or more, and 57.9% (n=11) once a week or more. Only 10.5% (n=2) of 
respondents visited a Boots pharmacy regularly once a month. 
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Figure 11: Customer interviews “How often do you visit pharmacy stores / Boots in 
general?”  
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All of the respondents that visited the pharmacy once a week or more (n=3) were 
female, and of those that visited once a month or more, 64.3% (n=9) were female. The 
majority of respondents that visited Boots on a regular basis were also female; 81.8% 
(n=9) of those that visited once a week or more, and 76.5% (n=13) of those that visited 
once a month or more. 
 
5.1.1.2 Choice of community pharmacy 
As part of the customer interviews, respondents were asked which community 
pharmacy they tended to use the most. Out of a total of 31 respondents, 61.3% (n=19) 
used Boots as their main pharmacy, 22.6% (n=7) used a combination of pharmacies, 
9.7% (n=3) used independent pharmacies, and 6.4% (n=2) used other chain 
pharmacies.  
 
Of those respondents that used Boots as their main pharmacy, 36.8% (n=7) seemed to 
do so out of loyalty to Boots. The use of other pharmacies was very rare in this group, 
as respondents would go out of their way to use Boots as their pharmacy choice on the 
majority of occasions;  
 
C26 “Invariably use Boots, simply because it’s a household name: I’ve known them since I 
was a child.” 
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Over a third of respondents, 36.8% (n=7), used Boots as their main pharmacy due to 
convenience. These pharmacies tended to be located on bus routes, or near to where 
people worked; 
 
C17 “Every month I go to the pharmacist, Canterbury Boots…..It’s where I work so I can 
pop in there on my way to work.” 
 
Two of the respondents tended to use Boots because of the convenience that the repeat 
prescription service offered; 
 
C25 “I tend to use Boots because I can put the prescription in at the surgery and after I 
finish work I can put it in at Boots and it’s waiting for me a couple of days later. 
Boots is the main in town.”  
 
Two of the respondents also liked the convenience of the location, and used the 
opportunity to link shopping with the collection of prescriptions. One of these 
respondents also liked Boots because of the speed of service; 
 
C19 “I tend to go to Boots because I live just off the town centre and Boots is in the town 
centre. There is a closer one to my surgery, but it’s very slow. There are quite a few 
closer to me but I tend to go to Boots just because it’s quick or if I can go and pop my 
prescription in and then go and do some shopping, kill two birds with one stone I 
guess really.” 
 
Boots was the pharmacy of choice for 21.1% (n=4) of respondents because of the level 
of service offered. Boots was seen to offer a higher quality service than other 
providers, including better trained staff; 
 
C24 “I always go to Boots. If I need a prescription I would always go to Boots, even if 
there was a Superdrug with a pharmacy or a supermarket with a pharmacy all in a 
row I would always go to Boots. I think you’re guaranteed they’ll have the product in 
you want, pharmacy wise, and then also I think because I feel confident that the 
person that’s going to be there is going to have the knowledge that you’re going to 
need if you ask a quick question or say something, they’re going to be able to help 
you, whereas if you go to a supermarket they will have some form of formal training 
but I don’t feel it’s as thorough you’d get through a Boots pharmacy. Maybe it’s just a 
recognised name, somewhere you can rely on.” 
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Some of the respondents had got to know the staff within the pharmacies, and liked 
going to the same place. There was also a perception that Boots gave you the top 
brand drugs to fulfil prescriptions. 
 
A couple of the respondents had regularly received poor service from another 
pharmacy provider, and as a result had switched to Boots;  
 
C25 “I didn’t have very good service originally when I was picking it up from the doctors 
and going across to the chemist across the street and I went one time, it was quite late 
but they weren’t to close for another 15 minutes and they’d locked their doors. And 
another time I’d put it in at the doctors and they were supposed to be at the chemists 
and I went to the chemists and it turned out it was at the doctors and I was to-ing and 
fro-ing and that got a bit irritating. Whereas one time when I went to put the 
certificate in at the surgery to be delivered to Boots I went to pick it up at Boots and 
they couldn’t find it and it turned out they’d misplaced it. Later that evening they 
actually sent somebody to deliver it to my door when they’d found it and I was 
impressed.” 
 
One of the respondents used Boots as their main pharmacy provider because they felt 
that they had no other choice. They believed that Boots was responsible for the closure 
of some of the independent pharmacies within their area;  
 
C2 “…..most of the Independents in the South East have been kicked out by Boots”.  
“I work for a big corporation myself; that doesn’t mean I approve of what they do.”  
 
Of the total respondents questioned, 22.6% (n=7) used a combination of pharmacies to 
dispense their prescriptions. Although respondents tended to use the most convenient 
pharmacy for them at that particular time, they tended to split their prescriptions 
between two places. Over half of these respondents, 57.1% (n=4), tended to use either 
Boots or an independent pharmacy; 
 
C13 “I go into Boots a few times a week – probably go to the pharmacists about once a 
week for things like painkillers. And then of course I have to pick up my prescription 
every month and I tend to split those between my local chemist and Boots in town. It 
just depends which one I’m nearer to when I have my prescription.” 
 
The remaining 42.9% (n=3) of respondents tended to split their prescriptions between 
Boots and a supermarket pharmacy; 
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C18 I go to Boots if Im down town or Sainsburys when I do my weekly shop. 
 
A total of 9.7% (n=3) of all respondents questioned regularly used an independent 
pharmacy to dispense their prescriptions. Individual pharmacists working within 
independent pharmacies appeared to be well known to some respondents, and 
appeared to have been working within that community for some length of time; 
 
C13 “I must admit I like my local guy. It’s just the fact I guess that I know him quite well 
now and he’s helped me out of quite a few times…..over the years he’s answered quite 
a few of my concerns.”  
 
Only 6.4% (n=2) of respondents used other pharmacy chains on a regular basis. One 
of the respondents used Tescos as their pharmacy provider, as it was convenient for 
them to pick up their prescription from the GP practice on route to their weekly shop. 
The mother of another respondent managed her prescription refills, and regularly used 
Lloyds as the pharmacy provider.   
 
5.1.1.3 Use of the community pharmacy 
Within the customer interviews respondents were asked what they tended to use the 
pharmacy for. A total of 16 respondents answered this question, of which 37.5% (n=6) 
used their pharmacy for prescriptions and advice. Most of these respondents tended to 
use the pharmacy on a regular basis for prescriptions, and only asked for advice 
occasionally, as and when they needed it;  
 
C10 “…I’ve asked her about products that they used to have and they don’t have any more 
and could she recommend something….” 
 
One particular respondent (C2) used national chains to get their prescriptions 
dispensed, but would always go to an independent pharmacy for advice.  
 
The remaining 62.5% (n=10) of respondents used their pharmacy to dispense 
prescriptions or to buy medicines such as paracetamol. Most of these respondents did 
not seem to visit a pharmacy on a regular basis, other than for prescriptions;  
 
C34 “Like I say if I need something in particular I’ll go in there for it but I don’t go in 
there specifically for any other particular product. I don’t use pharmacies a whole lot.  
Because I’m asthmatic I have to stick to paracetamol as a pain killer so that’s the only 
thing I ever have, I can’t go round messing about with other things.  I’ve got a two 
 105 
year old boy which you can probably hear in the background, he needs things like 
Calpol etc. and I’d go in for that.” 
 
A third of these particular respondents (n=3) mentioned specifically that they did not 
visit the pharmacy for advice; 
 
C16 “Just go to collect prescriptions not for advice.” 
 
Within the customer interviews, 23 respondents were asked what they tended to visit 
Boots for. A total of 69.6% (n=16) of respondents shopped in Boots on a regular basis, 
often weekly, for toiletries and make-up;  
 
C11 “I go in for makeup, although I’m 74 I still like my eye shadow and my mascara and 
the shampoos and my husband colours my hair for me, so I just chat away to them.” 
 
C12 “I guess I’m in Boots twice a week as we have one fairly locally and with a baby 
there’s always things I need. I was in yesterday for some sudocrem for a rash he’s 
developed.” 
 
One particular respondent was a regular visitor to the Boots pharmacy, but not 
specifically for their asthma; 
 
C31 “Visit Boots for other things all the time, but not for my asthma. Buy everything and 
anything, mainly toiletries also do photo processing and occasionally I even buy food 
at lunchtimes.” 
 
A further 21.7% (n=5) of respondents said that they visited Boots for their 
prescriptions and general toiletries;  
 
C10 “Well I have to drop off my prescription once a fortnight and then if I need some 
antibiotics. Yes I use them for skin products or makeup. On average about twice a 
week.” 
 
C32 “Don’t go to other pharmacies but I go into Boots quite often for repeat prescriptions, 
but I also buy other things in Boots like toiletries or make up, so I go in a lot for them 
more than the pharmacy counter.” 
 
Only 8.7% (n=2) of respondents said that they went to Boots for prescriptions only. 
One particular respondent found that Boots was quite expensive for general toiletries;  
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C25 “It depends if sometimes I’m passing through and I need something it’s handy but not 
as much as I used to. I find that there’s cheaper things. It’s mainly the pharmacy.” 
 
5.1.1.4 Type of advice accessed from community pharmacies 
Within the customer interviews, respondents were asked what type of advice they 
would normally ask the pharmacist about. Of the fifteen respondents who were asked 
this question, 20.0% (n=3) stated they would not generally ask the pharmacist for 
advice about their asthma, or anything else. The remaining 80.0% (n=12) of 
respondents had spoken to the pharmacist for advice in the past, and would carry on 
doing so. There was a general view amongst respondents that they would speak to the 
pharmacist about minor ailments and queries on medication. For anything more 
serious than this, then most respondents would speak directly to their GP. One 
particular respondent had been brought up to always ask the pharmacist for advice 
first before going to the GP; 
 
C13 “I do sometimes if I think it’s quite minor and not worth troubling the doctor over. 
Like if I have a rash or something – I’d speak to the pharmacist first and if he 
recommends I see the doctor then I will make an appointment. But I was brought up to 
seek the pharmacists advice first – its something my mum always did. She even used to 
say that the pharmacist knew more than the doctors as they kept more up to date and 
were often younger and fresher out of college.” 
 
Pharmacists were also seen to be easily accessible, especially for unplanned care and 
advice;  
 
C12 “I asked them about Daniel’s rash and they recommended the sudocrem. I could 
possibly think of loads of instances like that. It’s just so much easier than going to the 
doctors and trying to get an appointment.” 
 
Pharmacists were perceived as having expert knowledge in medication and its use, and 
the majority of advice seemed to centre on this. One respondent in particular stated 
they would always speak to the pharmacist before taking any medication; 
 
C14 “Well they would probably tell you what benefit you would get from whatever it is 
you’re taking. Or the effect that it would have on you. What you should come to expect 
from it. I mean, when you choose whatever tablets to take you always have a reaction 
or something. You know one road or the other. They give you a prescription or a 
tablet to cure something and they can help advise you. They can just let you know 
what might happen.” 
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Only a couple of the respondents had spoken to the pharmacist about inhaler use, but 
more commonly, many of the respondents had sought advice on OTC remedies;  
 
C24 “I have done previously, nothing to do with asthma, something else, but when I was 
poorly and bought some medication over the counter and just asked for some advice, 
the pharmacist spoke to me.” 
 
The role of giving advice was seen as something that pharmacists had always done, 
and were able to do so because of their good breadth of knowledge on minor ailments 
and conditions, from crabs to heart disease (C2).   
 
Respondents within the customer interviews were asked what role Boots currently 
played within their asthma management, of which a total of nine respondents 
answered. Five of the respondents had regularly asked the Boots pharmacist for advice 
on their asthma, in particular on concurrent medication use;  
 
C25 “A couple of years ago I was buying something and I did get some extra information. 
I tell you what also when you’re buying something, I think I had a cold and I was 
getting some information, they do check when they’re selling it to you ‘Do you have 
asthma?’ It was Ibuprofen, they wouldn’t sell it to me because I had asthma and she 
was right because one time I had a headache and I took one and I really got short of 
breath quite quickly. Whereas you know at Boots they will check that it’s suitable for 
you.” 
 
A couple of the respondents felt that the Boots staff were helpful and gave useful 
advice. If they had any queries regarding their asthma then they would go to Boots 
pharmacists for advice; 
 
C18 “Yes if I’d had any queries they’re always quite useful.” 
 
One particular respondent had received advice from the pharmacist in the past which 
they had found quite useful, but stated they would always mention this advice to the 
GP next time they saw them; 
 
C29 “As far as I was concerned, as long as it didn’t clash with anything that my doctor did 
then it was perfectly ok. Obviously I mentioned it to the doctor next time I saw him.” 
 
Boots pharmacy role within asthma management was seen as nothing more than a 
convenient place to collect prescriptions for three of the respondents, although one of 
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them stated that they had read the odd leaflet from Boots. Consistent with his hostility 
towards national chains and Boots, another respondent had a particularly reductive 
view about Boots role in his asthma management; 
 
C2 “It supplies the drugs I need. That’s it.” 
 
One respondent had previously used Boots to help manage the collection of her 
asthma prescriptions when she used to work in the city, but due to parking restrictions 
that had been implemented, she no longer found Boots convenient for her asthma 
prescriptions;  
 
C12 “I would have to find somewhere to park and rush in so I only go to Boots now when I 
go shopping in town with my Mum. That way she can drop me off with Daniel and 
then go and park because you can’t park easily in the centre anymore since they 
introduced the new restrictions.” 
 
Boots role in their asthma management was limited for one respondent because of the 
regular use of an independent pharmacy near their GP practice.  
 
As part of both the omnibus survey and asthma audit, respondents were asked whether 
they had asked the pharmacist for advice relating to their asthma within the last few 
months. The results from both sets of data are shown in Table 22. Within the omnibus 
data, 12.9% (n=33) of respondents had spoken to the pharmacist about their asthma 
within the last six months, and 29.5% (n=26) of respondents participating within the 
asthma audit had spoken to a Boots pharmacist about their asthma in the last three 
months. 
 
Table 22: Response to questions within the omnibus and asthma audit two data as to 
whether respondents had recently asked for advice on asthma from the pharmacist  
Percentage 
response 
Data 
source 
Sample Question 
Yes No 
Omnibus 
survey 
255 
Have you / they asked the pharmacist for advice 
related to you / your childs / their asthma in the 
last six months? 
12.9 87.1 
Asthma 
audit two 
88 
Have you spoken to a Boots pharmacist about your 
asthma in the last three months? 
29.5 70.5 
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Those respondents within both the omnibus survey and the second asthma audit, who 
had asked pharmacists for advice about their asthma within the last few months, were 
also asked a further question about the type of advice that they had sought help on, the 
results of which are shown in Figure 12. Respondents were able to indicate a positive 
response to more than one answer, and many had asked pharmacists for advice on 
more than one subject area. Within both sets of data, respondents had most frequently 
asked pharmacists for advice on medication, 84.6% (n=22) within the asthma audit 
and 72.7% (n=24) within the omnibus data. Within the omnibus survey, the second 
most frequent advice had been about symptoms, 48.5% (n=16), followed by products, 
33.3% (n=11), and then lifestyle, 18.2% (n=6). Within the asthma audit the second 
most frequently asked advice had been about lifestyle, 38.4% (n=10), followed by 
symptoms, 26.9% (n=7), and then products, 23.1% (n=6). Within both sets of data two 
respondents had asked about other topics, 6.1% within the omnibus data and 7.7% 
within the asthma audit, and no respondents had asked about services. 
 
Figure 12: Omnibus data and asthma audit two; if they had asked the pharmacist for 
advice on their asthma within the last three / six months, “What was the advice about?” 
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5.1.1.5 Quality of advice accessed from community pharmacies 
Within the customer interviews some of the respondents were asked how they rated 
the quality of information that they had been given by pharmacists generally in the 
past. Out of the six respondents questioned, all were very positive about the 
information and advice that they had received from pharmacists in the past. One 
particular respondent recalled positive experiences with pharmacists, and thought that 
Boots and independent pharmacists were equally as good at advising them on asthma. 
Another favoured independent pharmacists, as they believed they offered a better 
service, and advised them of the best product as apposed to selling own labels. In 
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contrast, other respondents preferred multiples such as Boots as they were able to 
recommend cheaper alternatives; 
 
C13 “They have always helped me whenever I’ve needed it and they can recommend 
cheaper versions of prescription products which is always good.” 
 
Respondents felt that the pharmacist accessibility allowed them to ask for advice 
fairly easily, of which the responses they had received in the past had always been 
very helpful;  
 
C10 “They’re very helpful; they always have time for you if you have a question….” 
 
When talking about the quality of pharmacists advice, three of the respondents all 
seemed to refer to a regular pharmacy that they visited. One of these respondents 
talked about a particular experience where they had asked the pharmacist for advice 
about their granddaughter. Although the pharmacist was unable to supply anything, 
this respondent was impressed with the advice given; 
 
C11 “…I’ve had my granddaughter in and she gets cystitis. So I went to the chemist and 
she said that she couldn’t do anything as she was too young. You can do that here 
they’re very good. They’ll fetch your prescriptions from the surgery they’re 
brilliant…...” 
 
A total of thirteen respondents within the customer interviews were questioned on 
their view of Boots, and the quality of advice that they received. The majority of 
respondents, 84.6% (n=11), had an extremely positive view of the company. Some of 
the comments received were based on the companys history and reputation; 
 
C1 “Reputable, helpful, I trust them………..Been around for donkey’s years.” 
 
Other respondents believed that they had got to know the staff within the pharmacies 
over the years, and in some circumstances had grown up with them. These 
respondents felt that the staff were well trained and approachable; 
 
C11 “Well I know most of them that work there, my daughters have grown up with most of 
the people that work in there we’re on first name terms. I’ve gone through my married 
life with them.” 
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C28 “But I like Boots because people are approachable in there and they’re kind of 
knowledgeable if you ask anything.” 
  
C1 “They have people who are trained to talk to you, and staff you know and can talk 
to.” 
 
There was also a feeling within this group that the staff took an interest in the 
customers. For one respondent, the pharmacist always came over to find out how they 
were; 
 
C29 I think it’s great, absolutely great” 
 
A couple of the respondents felt that Boots had better trained pharmacists and staff 
who were more knowledgeable than other pharmacies. One respondent stated that they 
would use the Boots pharmacy more frequently if it was closer to them; 
 
C13 “Well I think they might have more knowledge. You just feel they’re a bit more up to 
date but I could be wrong. I’ve asked them about things and they always seem to be 
able to help. It’s just I don’t go there that often so if they were closer I would 
probably use them more.” 
 
Two of the respondents felt that Boots was a good place to go to for advice, 
particularly when you were looking for that bit extra. In particular, one respondent 
felt that Boots was good at referring you to a GP when appropriate; 
 
C25 “You do tend to think of Boots more as a place where you can ask for advice, even 
when you have other minor ailments that you don’t feel like going to the doctor about, 
that you can live with, but you might get more advice form a pharmacist. Sometimes 
going down the doctors it’s not worth it. But there’s also all these other places that 
don’t have pharmacy counters and just sell a lot of the same things as Boots, you just 
think oh I’ll buy my certain things that are set up there but if you were looking for a 
bit extra advice, definitely I think of Boots.” 
 
One particular respondent felt that Boots pharmacists were good at telling you about 
more effective and cheaper alternatives for medicines;  
 
C12 “Plus they can sometimes tell you about better brands that might be more effective 
and possibly cheaper. I know my husband now uses some different brands for his 
hayfever due to something the pharmacists in Boots said.” 
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A couple of the respondents felt that Boots was very convenient for them and stocked 
most of the brands that they liked. Another respondent had very positive experiences 
of Boots and always recommended them to others; 
 
C17 “I recommend Boots to others often anyway, as it’s so good.” 
 
Only 15.4% (n=2) of respondents had a negative view about Boots. One particular 
respondent had visited Boots in the past but was reluctant to visit at the time of the 
interview as they felt the pharmacies were too warm, which worsened their asthma. 
Another respondent was negative about national chain pharmacies, in particular Boots. 
He recalled an incident where an assistant had given him bad advice for his eczema, 
which had left him feeling very sceptical about receiving any further advice from 
national chains.  
 
Within the omnibus survey, any respondent asking the pharmacist for advice on 
asthma within the last six months was asked a further question about the quality of 
that advice. The results from this additional question can be found in Table 23. The 
majority of respondents, 84.9% (n=28), rated the asthma advice from the pharmacist 
as very good or excellent. No respondents rated the advice received as poor. 
 
Table 23: Omnibus data “On a scale of one to five, where one is very poor and five is 
excellent, how would you / they rate the quality of information you / they were given by 
the pharmacist?” (Those who responded yes at Table 22, n=33) 
Quality of advice Percentage distribution 
1 (poor) 0.0 
2 0.0 
3 6.1 
4 45.5 
5 (excellent) 39.4 
Dont know 9.1 
 
As part of the second asthma audit, any respondent who had asked the Boots 
pharmacist for advice on their asthma within the last three months were asked a 
further question about how useful they found that advice. The results from this 
additional question can be found in Table 24. The majority of respondents, 91.7% 
(n=22), rated the advice as very useful or useful. No single respondent rated the advice 
poorly.  
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Table 24: Asthma audit two “On a scale of one to five, how useful did they find the 
information that the pharmacist gave them?” (one not very useful, five very useful) 
(Those who responded yes at Table 22, n=24) 
Score Percentage distribution 
1 (not very useful) 0.0 
2 0.0 
3 8.3 
4 25.0 
5 (very useful) 66.7 
 
 
5.1.2 Discussion of the results  
The results presented within this section build on the existing literature of the current 
utilisation of community pharmacies by the public, including the frequency of visit, 
choice and use of pharmacy, type of advice that is sought, and views on the quality of 
that advice. From these data, I discuss factors that may be affecting service delivery 
within community pharmacies.  
 
The results presented within this section on how frequently people visit the pharmacy 
for general use support that found within previous studies, where between 45  68% of 
people visit once a month or more [91, 126-128]. Boots is a large retailer that is as 
renowned for selling its health and beauty products, as is its pharmacy heritage. Many 
people visit Boots to purchase non medical related products on a daily basis, so it is 
not surprising to learn that of those questioned, nine out of ten visited once a month or 
more, and six out of ten, once a week or more. Some of the respondents questioned as 
part of this study actually came into Boots on a daily basis to purchase lunchtime 
products. Although such respondents are not visiting the pharmacy area, there seems 
to be an opportunity to target key messages at them whilst they are shopping within 
other parts of the store. Consideration does however need to be given as to how 
receptive consumers would be in receiving healthcare messages whilst shopping for 
general products.  
 
Frequent visitors to both the general pharmacy and Boots were predominantly female, 
as found within other studies [125-127, 129]. Even so, the percentage of men visiting 
the pharmacy once a month or more was surprisingly high within these data, 36% for 
general pharmacy, and 24% for Boots. This is in contrast with other studies which 
have looked at the use of pharmacies by men, and found that they were used 
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infrequently [129]. Visitors to the community pharmacy may also be acting on behalf 
of other potential purchases of health services, such as carer, partner, or parent, as 
demonstrated by a number of respondents within these studies. Opportunities exist to 
target wider messages to this audience aimed at not only the patient, but also the carer, 
partner, or parent for further dissemination.  
 
Due to the fact that these respondents were recruited for interview whilst visiting a 
Boots pharmacy, it is not surprising to discover that the majority of respondents (61%) 
used Boots as their main pharmacy provider. This was not the case with all of the 
respondents however, as 10% used an independent pharmacy as their main provider, 
and 6% used other pharmacy chain providers. A previous study within the general 
population found that 45% used multiple chains as their main pharmacy provider, 32% 
independent pharmacies, and 3% small chains [126]. Although due to the biased 
nature of recruitment within this study, these data are not comparable, it is useful to 
highlight the differences in usage. What is also interesting to note is that although 
respondents were recruited whilst in Boots, 16% did not use Boots as their main 
pharmacy provider.  
 
From these data, we can see that over three quarters of respondents, (77%), regularly 
used one pharmacy, whilst 23% used a combination of pharmacies for their needs. 
Other studies have found 60% of consumers loyal to one pharmacy [126], and 26% 
respondents regularly using two or more pharmacies [130]. Consumers have a variety 
of reasons for using a particular pharmacy, which although often due to location and 
convenience rather than the services provided and the personal relationship with the 
staff, could vary depending on the service they require. Some may choose to go to 
pharmacists they know for advice, but prefer a more anonymous approach to 
purchasing medicines, as found in a previous study [90]. Another study also found that 
the choice of pharmacy depended on whether there was an urgent need for the goods, 
or not [126]. The usage of multiple pharmacies has implications for any future 
services including the monitoring of long term conditions and EPS, although access to 
central patient medication records would help facilitate this. The use of pharmacies for 
different purposes rejects the idea of one pharmacy suits all, but supports different 
types of pharmacies and services to suit different needs of the population.  
 
The main reasons that respondents chose Boots as their pharmacy provider were 
because of loyalty (37%), convenience (37%), and the quality of staff and service 
(21%). There have been many studies looking at the reasons why people chose one 
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pharmacy over another, and convenience is cited as the primary reason in the majority 
of these studies [38, 91, 125-131]. Convenience can mean different things to different 
people, but is often associated with proximity to home, school, work or shops. Within 
this study, those respondents choosing other chain pharmacies mainly did so out of 
convenience, whilst those visiting independent pharmacies did so primarily because of 
the personal relationship with the staff and the level of service offered. These 
differences underlying the choice between independent pharmacies and multiples has 
also been noted in other studies. Abu-Omar et al. found that consumers favouring 
multiple pharmacies gave reasons such as medication being in stock, whilst those 
using small chains tended to cite personal reasons relating to staff characteristics 
[132]. 
 
One particular respondent had received poor service from another pharmacy provider 
so had switched to Boots. This was the main reason cited within other studies [125, 
126, 130] as to why consumers switched pharmacy providers. Although unhappy with 
receiving pharmacy services from Boots, another respondent felt that they were unable 
to switch providers due to lack of choice. This, they felt, was due to the large 
multiples putting independent pharmacies out of business.  
 
Approximately two thirds of respondents questioned used the pharmacy for 
prescriptions and to purchase OTC medicines, with the remaining third using the 
pharmacy regularly for prescriptions and advice. Of those that used the pharmacy for 
advice, they were also regular prescription users, findings that have been found in a 
previous study [91]. The literature includes studies where the percentage of people 
asking the pharmacist for advice varies enormously, and includes values such as 5.5% 
[129], 15% [91], and 73% [98]. These studies have also found that whilst the elderly 
are frequent users of the prescription service, they are the least likely to use 
pharmacies for advice [98, 129]. Within both groups of those that used the pharmacy 
for advice, and those that did not, there seemed to be wide distribution of age ranges, 
23-67, and 17-55 respectively. There was also representation of males and females 
within both groups.  
 
Three of the people interviewed stated that they would never use the pharmacy for 
advice. Previous studies have also found that there is a number of people within the 
population that would not go to the pharmacist for advice, for reasons such as personal 
knowledge, previous experience of illness, and availability of information from other 
sources [127, 129].  
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Those respondents who came into the pharmacy to purchase medicines, tended to do 
so as and when required. Respondents appeared to be quite knowledgeable about what 
they needed, and would tend to ask for medicines by name, rather than seeking advice. 
A study by Morris et al. looking at the use of questioning within pharmacies when 
purchasing OTC medicines, found that the majority of people viewed decisions about 
medicine purchases as their sole responsibility [90]. With this in mind, there appears 
to be an increasing tendency within the general population to self treat. As within this 
study, Jepson et al. also found that people who were not high prescription users were 
more likely to purchase OTC medicines from pharmacies [126].  
 
One particular respondent stated that they used national chains for their prescriptions 
and an independent pharmacy for advice. This has also been found within a study 
looking at differences between customers using multiple and small chain pharmacies. 
Abu-Omar et al. found that customers used multiple pharmacies for medicines supply, 
and smaller pharmacies for advice, and that several of the customers of large multiple 
pharmacies had their own different pharmacist whom they used for more personal 
advice and counselling [132].  
 
Seven out of ten of the respondents questioned regularly visited a Boots pharmacy to 
purchase non medical related products such as toiletries and make up. For the 
remaining respondents, visits to Boots were mainly for prescriptions, medicines, or 
general purchases. Within the literature, studies have quoted between 70-80% of 
respondents were visiting a pharmacy for a medical reason, and 25-30% for a non 
medical reason [91, 133]. Due to the vast array of health and beauty products that 
Boots sells, many customer visits are not in relation to the purchase of medical related 
products, but more general sales. The fact that a pharmacy is part of a shop may make 
it more user friendly and so encourage people to use it who might be put off by a more 
formal establishment [68]. 
 
Within the omnibus data, 13% respondents had spoken to a pharmacist about their 
asthma within the last six months, and within the asthma audit, 30% had spoken to a 
Boots pharmacist within the last three months. The omnibus survey took place within 
the general population, and is a representative figure of standard activity. As the 
asthma audit results were collected as part of the second audit, one would expect the 
percentage to be greater than the standard collected within the omnibus survey, due to 
the increased asthma activity within these pharmacies.  
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Within both the asthma audit and omnibus data, the majority of respondents had 
spoken to the pharmacist about their asthma within the last three to six months 
regarding medication queries. Just under a half of respondents within the omnibus data 
had asked for advice on symptoms, and a third on products. Within the asthma audit, 
over a third of respondents had asked for advice on lifestyle from the pharmacist. The 
pharmacists and staff within these Boots pharmacies had been encouraging customers 
to talk to them about their asthma over this period, which could have had an impact on 
the level of lifestyle advice sought. Only a quarter of respondents who participated 
within the asthma audit had asked for advice on symptoms and products within the last 
three months. Those respondents within the customer interviews who had spoken to 
the pharmacist in the past had done so for advice on minor ailments or medication 
queries. Pharmacists were seen to be experts on medication and its use, and were an 
easily accessible healthcare resource. Previous studies have found that the 
pharmacists role is viewed as a medication expert [126, 129, 132], and as an advisor 
on minor ailments [132]. A review of the literature [134] concluded that pharmacies 
are used by the public for advice about medicines and minor ailments in particular. 
For anything that was perceived to be more serious than a minor ailment or medication 
query, then respondents would seek advice directly from their GP, as also found 
within a previous study [98]. When unsure of the seriousness of a problem, some 
respondents would seek reassurance and advice from the pharmacist about whether or 
not to go to their GP. The role of the pharmacist as a stepping stone to general practice 
has also been found in other studies [129, 132].  
 
Although lifestyle advice was mentioned in both the omnibus survey and asthma 
audit, not one respondent within the customer interviews mentioned going to the 
pharmacist for general health advice. Previous studies have also found that very few 
people have asked the pharmacist for general health advice [97, 98, 125, 126, 129, 
133]. As such, the level of lifestyle advice within the omnibus survey and asthma audit 
were higher than expected. Given the pharmacists were perceived as experts on 
medication within the customer interviews, it is surprising to learn that very few had 
spoken to the pharmacist about inhaler use, as many of the queries had been regarding 
OTC medication.  This was consistent with the responses regarding the role that Boots 
played within their asthma management, as the majority of those respondents 
questioned on this had spoken to the Boots pharmacist for advice on their asthma in 
the past, particularly around concurrent medication use, and not inhaler technique. 
Unfortunately, no further data was obtained from the omnibus survey or asthma audits 
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to find out whether the queries on medication were about their inhaler use, or 
concurrent OTC medication.   
 
One particular respondent stated they would seek advice from the pharmacist on their 
asthma, but would always repeat this advice to their GP next time they were visiting 
them. They seemed to perceive the pharmacists role as supporting the GP, and hence 
the respondent would never do anything without the GPs final say so. Some 
respondents appeared to be unsure of the role of the pharmacist and were not confident 
in their expertise on minor ailments and medication use, and as such did not access 
them for advice.  
 
The general feeling amongst those respondents that were questioned about the quality 
of advice they had received from pharmacists in the past was extremely positive. The 
majority of respondents appeared to seek out particular pharmacists for advice. 
Pharmacies were seen as somewhere to access advice, without necessarily having to 
purchase products. The majority of respondents within both the omnibus and asthma 
audit, who had spoken to the pharmacist for advice about their asthma within the last 
three to six months, also rated this advice as very good or excellent. Other studies 
have looked at satisfaction of those asking for general pharmacy advice, and have 
found 85% [91] to 95% [126] have found this advice useful. Not one single 
respondent rated the advice poorly. As part of the omnibus survey, 9% rated the 
advice as dont know. This is likely to have been respondents who were answering 
the questions on behalf of their partner with asthma. Once consumers accessed advice 
from the pharmacist, the majority appeared to be pleased with the quality of advice 
received. Those that had received good advice in the past, tended to access the 
pharmacist again for further advice. 
 
 
5.1.3 Summary of section one  
Most of these data presented within this section support and further extend work that 
has been conducted within previous studies and reviews. Potential facilitators and 
barriers that have been identified within this section are summarised in Table 25. 
 
 
 
 
 119 
Table 25: Potential factors affecting service delivery identified from the publics’ current 
utilisation of community pharmacies  
 Facilitators Barriers  
Frequency 
of visit 
̇ High frequency of visit to 
pharmacy for general 
purchases 
̇ Poor frequency of visit to pharmacy for 
health related reasons  
Choice of 
pharmacy 
̇ Use of different types of 
pharmacies for different 
services  
̇ Poor loyalty to one pharmacy  
requirement for access to centralised 
medication records  
Pharmacy 
use 
̇ Wider target audience for 
dissemination of advice 
(patient, carer, parent, 
partner) 
̇ Good use of pharmacy for 
general purchases  
̇ Poor use of pharmacy for general health 
̇ Expectations when in pharmacy 
depending on shopping mode for health 
or general purchases, and receptiveness 
for advice 
Type of 
advice 
̇ Good use of pharmacy for 
medication related queries  
̇ Poor use of pharmacy for general health 
queries  
̇ Perceived limitations of pharmacy 
advice 
̇ Poor perception of the role of the 
pharmacist compared to other healthcare 
professionals 
Quality of 
advice 
̇ Previous good experience 
of pharmacist advice 
̇ Previous poor experience of pharmacist 
advice  
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SECTION TWO 
 
5.2  Views on the extended role of the community pharmacist 
As previously discussed, changes within Government legislation and policy within the 
health services environment are opening up a number of opportunities for community 
pharmacists to get more involved in delivering NHS services that promote self care 
and improve the management of long term conditions. Legislative changes that have 
occurred to help community pharmacists extend their role include the extension of 
pharmacist prescribing responsibilities [49] and supervision requirements [50]. The 
new community pharmacy contract [37] should also help as a vehicle for funding and 
remuneration for elements of these extended roles. This changing environment in 
health services policy should help to facilitate the extended role of the community 
pharmacist in the delivery of services.  
 
This section of the chapter focuses on what pharmacists and consumers think about 
the extended pharmacist role. Despite the changes in the health service environment to 
open up a number of opportunities for community pharmacy, pharmacists will still 
need to embrace their new role in order to deliver the services that are expected of 
them. Likewise, there must be a demand and need for consumers to access any new 
services delivered by community pharmacists.  
 
A study by Varnish [138] explored the extent to which consumers viewed pharmacy 
as a fully fledged profession that commanded and fulfilled a legitimate role in the 
primary healthcare team. The results from the focus groups suggested that pharmacy 
was held in high esteem by its customers and continued to be seen as a prestigious 
profession. Pharmacists were seen to have expert knowledge regarding drugs, 
although the GP was seen to be superior and ultimately responsible for patients 
health. Pharmacists were perceived to be answerable to the GP and had little 
responsibility for the choice of medication. Varnish concluded that these attitudes may 
have implications for pharmacists desire to extend the services that were offered. A 
survey by Williamson et al. [98] found that there was considerable public support for 
an extended role for pharmacists, in particular providing more information on 
prescription medicines, and the opportunity to discuss minor symptoms. There was 
less support for discussing health, and cost was found to be the major obstacle in the 
acceptability of diagnostic testing. In contrast, a separate study by Jepson et al. [126] 
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found that most consumers expressed an interest in extended diagnostic services in 
community pharmacies.  
 
Following their literature review, Hassell et al. [134] concluded that if demand in 
primary care was to be better managed with more care channelled towards pharmacy, 
then a shift in consumer understanding and expectations about pharmacists expertise 
was needed before larger numbers of the public begin to utilise the pharmacy as a first 
port of call. A number of recent surveys [65, 135] have highlighted an increased 
public demand for pharmacists to have a more active role in providing health care. In a 
survey commissioned by the DH [135], 13% of respondents said that they currently 
used the pharmacist as a source of information on self care, but this figure rose to 21% 
for respondents wishing to use them as an information source in the future. During the 
consultation exercise for the white paper Our health, our care, our say [65], the 
public  said that they want to see a wider range of professionals – particularly 
practice and community nurses and pharmacists – involved in health improvement, 
disease prevention and the promotion of independence. In particular, they wanted 
pharmacists to have an increased role in providing support, information and care.  
 
Despite these surveys, there is still confusion as to where the public should go when 
they are feeling unwell [139]. A recent survey reported that although 76% of people 
wanted to choose what health service to use when they were unwell, they often used 
the wrong service due to confusion over where to go to access different health services 
[139]. This problem was highlighted not only for emergency services, but also for 
routine problems as 13% of people in the study stated that they would have difficulty 
knowing where to go for routine problems such as a chesty cough. The study 
concluded that people were still lacking advice on how to cope with minor health 
problems and how to use NHS services properly. 
 
The effect of public opinion on the use of services provided by pharmacists has been 
discussed in previous studies looking at the factors affecting service delivery within 
community pharmacy. Improving the publics attitude and perception towards 
pharmacy services has been found to a facilitator in service delivery [3, 12, 17, 18, 23, 
30, 32]. Similarly, low patient and public expectation of the pharmacy profession has 
been found to be a barrier in service delivery [3, 7, 16, 18, 21, 26, 32]. 
 
Pharmacists opinions towards service delivery are critical to delivering the vision of 
the extended role. Previous studies looking at the motivators for pharmacists providing 
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services have found the desire for professional satisfaction and fulfilment to be 
important [14, 22, 28], alongside business reasons [14, 16, 22], the need to improve 
the public and GPs perception of pharmacists [16, 28], and a professional desire to 
provide healthcare to the public [16, 22]. The attitudes of pharmacists are equally 
important and have been identified as both facilitators [5, 17-19, 30, 32] and barriers 
[1, 5, 16, 29, 32] in service delivery. In addition pharmacist characteristics [27, 31], 
intention to provide services [17, 19], perception of ease of delivering services [9, 17, 
19], experience [16, 17, 19, 24], confidence [9, 19, 30], and willingness to provide 
services [31] all act as facilitators for service delivery. Lack of confidence [5, 8, 19, 
25], lack of willingness [31], low sense of enjoyment [19], perceived difficulty in 
carrying out services [19], and lack of pharmacist motivation [8] have all been found 
to be barriers for service delivery. Further details of all these studies are provided 
within the literature review in chapter two, and as such are not repeated here. 
 
The results presented within this section build on the current research available to 
provide views of pharmacists on their changing role, their confidence in service 
delivery, and their views on services. The final results presented are based on the 
views of customers accessing additional advice and services from community 
pharmacies. The results used within this chapter are taken from both the customer and 
pharmacist interviews. From these results, potential motivators, facilitators and 
barriers for service delivery are discussed at the end of this section. 
 
 
5.2.1 Results  
5.2.1.1 Views of pharmacists on their changing role  
During the interviews, eight of the pharmacists were questioned about how they saw 
their role changing. Comments were made about the benefits of the accessibility of the 
pharmacist, particularly for advice on minor ailments and general health; 
 
P8 “I’ve always had a strong feeling that the pharmacist is probably the most accessible 
member of the primary healthcare team. I suppose that means you’re on show, you’re 
at the front and you are available for advice, etc.” 
 
There was also the understanding that pharmacists dealt with a wide variety of 
requests that was not always recognised, making the job of the pharmacist unclear; 
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P14 “I think in pharmacy we do an awful lot of that, people come in with strange requests 
or we sort them out but you don’t actually ever record it. I think that’s why sometimes 
people are a bit unclear of the role of pharmacists.” 
 
Some of the pharmacists expressed frustration at the lack of opportunities to date, and 
believed that pharmacists were under utilised; 
 
P11 “To be honest I think that pharmacists are totally under-utilised and I’m not just 
talking about myself. “ 
 
This frustration was felt to be partly due to the timing of the new pharmacy contract 
negotiations, and in part to decisions by professional organisations and companies; 
 
P17 “A lot of it we’re waiting for the RPSGB and Boots to decide what we’re going to do 
and the new pharmacy contract but yes it’s what we’re supposed to be doing, it’s what 
pharmacy’s going to be all about.” 
 
Due to pharmacists not being able to utilise their clinical skills fully within companies 
such as Boots, many were going to work elsewhere, either instead of working at 
Boots, or as an additional second job; 
 
P11 “There are a lot of pharmacists out there who have a massive amount of knowledge, 
people with diplomas and a lot of them have to go outside Boots to be able to do more 
clinical stuff with people….” 
 
There was also a sense of frustration felt by the under utilisation of pharmacists by the 
GPs, and a feeling of resentment towards the extended professional role of the nurse; 
 
P11 “I also think that doctors don’t really use us as well because doctors know that we’ve 
got this kind of information and there could be a better link between doctors and 
pharmacists, which there isn’t and I think that’s where the nurses are starting to take 
over really. Because the nurses have the links with the doctors, the doctors are 
starting to utilise the nurses more than what they are the pharmacists, when really the 
pharmacists are probably better qualified to answer the questions.” 
 
There was a general enthusiasm by most of the pharmacists regarding an extended 
role; 
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P1  “….I reckon all pharmacists would welcome the opportunity to get more involved 
with customers…..” 
 
This enthusiasm was also expressed on behalf of the pharmacy staff as well; 
 
P2 “I have chatted to all the staff on the counter and all would welcome a job role that 
isn’t just that of a glorified sales assistant.” 
 
Some of the pharmacists were very hopeful that the profession had reached a turning 
point and that the role would change a lot over the next year. In preparation for this, a 
couple of the pharmacists had started to undertake personal development activities 
such as clinical diplomas;  
 
P14 “I’m really hoping that it’s going to change a lot in the next year or so. I think it will, 
I think we can do a lot more clinical work which is why I’m doing the diploma.” 
 
The asthma service was perceived as moving in the right direction for the extended 
role of the pharmacist, and was something that pharmacists welcomed; 
 
P17 “Well I hope so because this is what we should be doing, this is the extended role of 
the pharmacist and it’s been a long time coming. In this store it’s very welcome.” 
 
There was a hope that pharmacists would be able to deliver more services like this as 
part of the new pharmacy contract, including additional activities such as 
supplementary prescribing;  
 
P16 “Well I’m really quite keen on the supplementary prescribing. It’s not something I’m 
doing yet but it’s something that I see as a sort of lead in to that and I think we could 
be able to offer those services when the new pharmacist contract comes in. As long as 
we’ve got pharmacists who are confident, it’s an opening point of expressing to the 
public, and the doctors surgeries, that we can do more that we have in the past, we 
can offer more services and we’re able to do this.” 
 
5.2.1.2 Pharmacists’ confidence in service delivery 
During the interviews, a couple of the pharmacists commented that some of the 
pharmacy support staff were not confident in talking to customers. This was 
particularly noticeable in dispensers who worked mainly in the dispensary and very 
rarely had any customer contact.  One particular pharmacy had tried to overcome this 
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by encouraging the dispensers to have more contact with customers at the prescription 
desk and over the counter. To help this process they also ran a staff incentive; 
 
P13 Some of the team are fine about it, others aren’t that confident.” 
 
Three of the pharmacists questioned did not feel very confident delivering the asthma 
service, although one of these commented that their confidence with the service grew 
once they had actually delivered the intervention;  
 
P17 “As with anything new, intimidating to start with but once you’ve done a couple it’s 
OK.” 
 
One particular pharmacist commented that they would feel more confident delivering 
the service as long as it fitted in with their routine, and if customers were willing to 
listen;  
 
P5 “I would feel totally confident in offering the service as long as it could fit into my 
routine I’d have more than happy to talk to customers for longer, providing they were 
willing to listen to what I had to say.” 
 
Three pharmacists questioned felt completely confident in delivering the service. They 
felt that it was important to prepare and feel confident in delivering interventions like 
this, as customers would be able to identify if this was not the case; 
  
P8 “It’s something that I was more than happy to do and was confident to do. There’s a 
centre for pharmacy postgraduate education on asthma and that was something that 
I’d done some time ago, so trying to refresh myself on that so that I was able to give 
the best possible advice. Because some of it is actually the pharmacist being confident 
in what they’re about because if you’re not confident it shows and the patients rapidly 
realise when they’re not getting the best possible advice.”  
 
This was equally true for when talking to other healthcare professionals about the 
asthma service;  
 
P16 “I think you do need that awareness because you’ve got to appear confident. 
Especially if you’re going into doctors’ surgeries and approaching themselves and the 
nurses.” 
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There was recognition by some of the more confident pharmacists that some of their 
colleagues might not feel as comfortable talking to the public more as part of the 
pharmacists extended role;   
 
P8 “I’ve always been more confident in talking directly to the public, working in front of 
the public whereas I know that some of my colleagues sometimes aren’t and prefer to 
remain in the background.” 
 
5.2.1.3 Pharmacists’ views on the delivery of services 
Many of the pharmacists questioned saw brief interventions such as asthma as being 
part of their core job, and something that they were trained to do;  
 
P6 ”I do it for most prescriptions I hand out – it’s all part of the job and what we’re 
trained to do.” 
 
This core counselling extended to other condition areas, and not just asthma;  
 
P15 “I find it quite comfortable, when we give out prescriptions we always do counselling 
if they need information on the prescription whether it’s asthma or not.” 
 
And was the same for any medication dispensed;   
 
P11  “…personally I don’t like to give anything out knowing that I don’t know whether the 
person has ever had it before or they don’t know what they’re doing with it because 
it’s as much use as a chocolate fireguard to be honest.” 
 
Even though one pharmacist did not feel that they had been delivering the brief 
intervention, on reflection, they decided otherwise. This service was not seen as an 
intervention as such, but something that was delivered as part of their day job; 
 
P5 “Its basic stuff but probably in a way I have also been offering the service – just not 
necessarily what I would term intervention – more common sense and what I see as 
part of my every day job.”  
 
Although the brief intervention was seen as a core activity for many pharmacists, for 
some, it did help to highlight how much they did already;  
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P14 “I think it makes you realise that we do a lot of things and take it for granted and 
when you suddenly start recording it, it highlights that we do this sort of thing all the 
time anyway but don’t record it.” 
 
Other pharmacists involved within the asthma service had used the asthma 
intervention as an extension to their current activity; 
 
P16 “I’ve always in the past checked people – you know that they know how to use their 
inhaler and offer to show them. But we are taking it that bit further if we’re having the 
intervention and offering to measure their peak flow and spend a bit more time just 
checking they’re using the inhalers properly.” 
 
A couple of the pharmacists questioned, although positive about the brief intervention, 
felt that they had constant demands on their role that limited their long term delivery 
of initiatives such as this; 
 
P10 “ ….we have so many things we’d like to do more of, you know one comes to the 
surface and you think OK, we’ll do this for a bit and then something else comes along. 
You can only do so much at once.  
 
Overall, there was a lot of enthusiasm amongst the pharmacists about new initiatives 
and services such as the brief intervention and asthma service;  
 
P1 As pharmacists we always love getting involved in trials and new initiatives” 
 
P14 I’m fully supportive of it and would like to do a lot more.” 
 
Interventions such as these were seen as adding professionalism to the pharmacist 
role; 
 
P10 “…I think it is much more of a professional role than just sticking a label on it and 
signing it off and handing it over to the patient.” 
 
P8 “So in many respects it’s been very useful purely from the pharmacist’s point of view 
and the professional service we’re able to offer.” 
 
It was also seen as something that Boots needed to deliver in order to avoid the 
independent pharmacies gaining a competitive advantage in the future services 
market;  
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P2 “I love the whole idea of intervention and getting closer to our customers. Its 
definitely the way forward for Boots to go on the pharmacy counter. It’s all about 
more service and adding value these days and that also applies to us now. We can’t 
just sit on our laurels and be taken over by all the independents offering a higher level 
of service.” 
 
One particular pharmacists view stood out from the other interviews, and was quite 
clear that they saw the pharmacists role as dispensing, and any advice or information 
should be obtained from the customers GP; 
 
P5 “There just isn’t the time to be offering long consultations. If they want that type of 
information they’ll go to their GPs. We’re here to get them their medication and 
anything other than that we just don’t have the time. A quick chat, bag up their goods 
and off they go.” 
 
Many of the pharmacists questioned felt that interventions such as the asthma service 
encouraged them to proactively speak to customers with asthma, and was a good 
opportunity to encourage customers to talk to them about any problems they may 
have; 
 
P14 “Its good to focus in and it does encourage you to go in and be proactive, speaking to 
patients. I mean I’ve got a lot of regular patients with asthma and if they don’t say to 
me that they’ve got a problem then I might not actually…I might just hand out their 
regular monthly prescription so it does prompt you to speak to people a bit more.” 
 
Although some pharmacists would target customers during quieter times, others had 
used the opportunity to try and speak to every person with asthma;  
 
P15 “But sometimes when you are very, very busy and you think well I haven’t got time 
but with the intervention campaign I feel that I’ve got to do it time or not. So in that 
respect it makes me think I’ve got to do it every single time rather than just when I 
have time.” 
 
Brief interventions were seen as a good way of targeting customers opportunistically 
whilst they were in the pharmacy, particularly as the pharmacist could give them 
advice without the need for an appointment;  
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P16 “It has been very useful, the idea that there is someone who can give information to 
the customer straightaway as they’re standing there, they don’t have to make an 
appointment.” 
 
The brief intervention gave customers the opportunity to ask questions that they might 
not have thought about before. This was seen as particularly important for those 
people who might fall out of or be overlooked by GP services; 
 
P12 “….I think the doctor, it’s the same with every medication really, they explain some 
bits and if they’re really not sure about it then they come to the pharmacy and if we 
are busy maybe they don’t bother to ask. But if you start then they, you are giving 
them the chance to ask you about it so I think it’s good in this way.” 
 
5.2.1.4 Customers’ views on accessing additional advice from the 
pharmacist 
During the customer interviews, respondents were questioned on the extended role of 
the pharmacist, in particular pharmacists providing additional services and advice on 
asthma. The majority of respondents were in favour of receiving additional advice 
about asthma from the pharmacist, as they did not always receive all of the advice they 
needed from their GP practice;  
 
C10 “I wouldn’t mind really, because not everyone knows the certain things about asthma, 
it’s just hit and miss.” 
 
Receiving information on a long term condition was not always felt to be appropriate 
at the GP practice. There was a recognition that information could be given to people 
with asthma when they presented at the pharmacy with a prescription;  
 
C25 “I don’t know because if you don’t go to the doctors very often you don’t want to have 
the information put out there. And to be honest you go to the doctors when you’re 
feeling ill and you don’t want to be reading information. I think a chemist when 
you’re buying things or you’re getting a prescription isn’t a bad idea.” 
 
Respondents also liked the fact that they could talk to someone for advice about their 
asthma; 
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C14 “Well I think myself that anyone that suffers from anything, whether its asthma or 
whatever, it is nice to talk to someone that you think can give you a bit of advice if you 
understand them. You know, rather than going to the doctors.” 
 
Pharmacists were perceived as knowledgeable, and respectful when speaking to 
individual customers; 
 
C22 “I have to admit with regard to anything, not just my asthma, the guys in Boots are 
really, really helpful, they know their stuff obviously, they don’t talk to you like you’re 
two sandwiches short of a picnic. They give you some respect which is always nice.” 
 
Respondents were confident when receiving advice from the pharmacist, as they felt 
that if pharmacists did not know something, they would ask other people, or refer 
them; 
 
C18 If the pharmacist doesn’t know stuff they will ask other people.” 
 
Although there was a general recognition of the expertise and knowledge of the 
pharmacist, the confidence in the pharmacy staff was low. Because of this, one 
particular respondent stated they would always ask to speak to the pharmacist;  
 
C10 I think that the pharmacists are very good but I’m not sure about the actual workers 
who give you the medicine but I ask to speak to a pharmacist anyway.” 
 
The GPs time was seen as a valuable resource, and as such some respondents would 
seek advice from the pharmacist for minor ailments. For anything more serious than a 
sore throat or cough, or for in depth information on a condition, the GP would be the 
first line for advice;  
 
C25 “But you always feel that the doctor’s busy and you don’t want to make an 
appointment if you don’t have to whereas you don’t mind popping into the chemist, 
you’re paying for the service and it feels different. ……..Sometimes it’s quicker if you 
can just get simple straight forward advice form a chemist if it’s a minor ailment.” 
 
Receiving more in depth advice from the pharmacist was attractive to many of the 
respondents due to the inconvenience of having to make an appointment, and wait to 
speak to someone at their GP practice;  
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C34 “It would be easier because obviously if I needed to go and speak to my doctor, the 
nurse or the asthma clinic I would need to book it well in advance to do it and 
sometimes that’s a bit difficult or inconvenient or whatever, whereas if there was 
someone I could just go and have a chat to or someone who knows what I’m talking 
about while I’m there, sort of off the cuff, that would be great.” 
 
Speed of access to a healthcare professional was important to many respondents; 
 
C15 “Yeah they seem to know what they’re talking about and a lot quicker than the GP, 
they point you in the right direction.” 
 
Access to extended advice from the pharmacists was particularly important to those 
respondents that did not feel that they were getting the right level of support from their 
own GP;  
 
C18 “Go to pharmacists rather than the doctor as I have to ring and book an appointment 
at the doctors. Also our doctor isn’t very helpful.” 
 
A couple of the respondents liked the idea of being able to access information from 
the pharmacist, but only as a safety net for when their GP or asthma nurse was 
unavailable;  
 
C26 “From my point of view I don’t really need it but if I did and the doctors were closed 
and the asthma nurse wasn’t around I’d go and see the pharmacist. They’ve got all 
my information there - its jolly handy. I like this idea of open information.” 
 
Pharmacist advice was seen as limited, because although they could tell people with 
asthma about new treatments, consumers would always have to go back to their GP to 
change anything;  
 
C1  It is only advice – you’d have to go to your GP to change anything. 
 
One particular respondent commented that pharmacists should have more ability to 
change certain elements of a prescription without going back to the GP; 
 
C23 “With the qualifications the pharmacists have I think it would be fine to suggest 
something different as long as medication the same, just different packaging easier for 
a child to take, pharmacist should be able to make that choice.” 
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The future role of the pharmacist was favoured by many respondents, who saw the GP 
as someone who diagnosed a condition, and the pharmacist who advised on 
medication;  
 
C17 “Is brilliant it’s save me going to the doctors, the doctors just do the test, but the 
pharmacist will advise me.” 
 
One respondent recalled an experience he had encountered with a pharmacist abroad, 
where they had been able to prescribe tablets for him that he could not get from the 
pharmacists within the UK. They felt that giving the pharmacists more responsibility 
within the UK would free the GPs up to do other things; 
 
C11 “Well anywhere in Spain you can go for advice I remember being once being bitten 
and they told me what to do. You can go to the chemist there and they tell you what to 
do. It would leave the doctors more free to do other things.” 
 
Pharmacists were very much seen as a supportive role to provide additional advice 
that supplemented that of the GP and asthma nurse by three respondents. Although 
these respondents saw the advice giving role as predominately belonging to their 
asthma clinic, they felt that if they were to ask a pharmacist for advice on their asthma, 
they would rather them being able to answer than not. General information on asthma, 
including the latest news and developments on medication was felt to be the best 
advice a pharmacist could provide, and would fulfil a function that the GP and asthma 
nurse does not; 
 
C13 “We will always need our GPs. They (pharmacists) just help you out when you’re out 
and about. Keep up the good work is all I can say.” 
 
A couple of the respondents would take advice from the pharmacist, but would always 
prefer to go directly to the GP, or alternatively, check it out with the GP at a later date. 
 
C31 “I would listen to it but probably wouldn’t take it as gospel. Would much prefer to see 
a doctor for advice.  They definitely know what they are talking about.” 
 
In total, five of the respondents had strong views that the pharmacists did not, and 
should not have a role in providing advice on asthma, as this was seen as something 
that should only be provided by the GP or asthma clinic. 
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C3  I don’t think they could give you anything a GP couldn’t give you. They won’t 
commit themselves because they’re not GPs – I’d expect them to refer me to my GP 
anyway.” 
 
C11 “I think personally that they should advise them if its asthma, to go to the doctor 
because I know that most doctors have an asthma clinic. And it’s not just using them 
but it’s how to use the products a lot of the time.” 
 
 
5.2.3 Discussion of the results   
The results presented within this section build on the current literature of the views of 
both customers and pharmacists towards an extended role for community pharmacists. 
From these data, I discuss factors that may be affecting service delivery within 
community pharmacies.  
 
Pharmacists were seen to be an accessible healthcare resource and the benefits of 
receiving further advice from them included not having to make an appointment, the 
speed of access, the perceived lack of interest from some GPs, and the inconvenience 
of seeing a GP, findings that have also been found in previous studies [127, 129]. 
Others saw advice from the pharmacist as a safety net when a GP or nurse was 
unavailable. Although the benefits of accessibility of advice were recognised by both 
pharmacists and customers, there was some confusion over exactly what their role 
entailed due to the wide range of requests they dealt with. At the time of the study, 
pharmacists advice was felt to be limited compared to their counterparts abroad, as 
they had no ability to change medication, and had to refer to the GP anyway. This is 
something that will change over time with the implementation of extended prescribing 
rights and further reclassification of medicines from prescription to pharmacy status.  
 
Consistent with the results and literature presented within section one of this chapter, 
there was a cohort of customers who did not believe that it was the pharmacists role 
to provide advice on serious conditions such as asthma, as this was something that 
should be reserved solely for GPs or nurses. The role of the pharmacist was perceived 
as someone who could advise on medication and minor ailments, but anything more 
serious would require referral to the GP. Some of the customers interviewed perceived 
asthma as something with which they could talk to the pharmacist about, whilst others 
perceived it as something that was too serious to discuss with the pharmacist. Those 
who were positive about seeking extra advice and information on asthma from the 
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pharmacist tended to feel that current information sources on the condition were hit 
and miss. They did not want to read information on the condition whilst visiting the 
GP practice as they went there when they were ill and so were not in the best mindset. 
Pharmacists were seen as a good alternative to providing such information and offered 
the availability of having a healthcare professional to talk to as and when required.     
 
There was general enthusiasm amongst many of the pharmacists about getting more 
involved in services, as it was seen to add professionalism to the role. This enthusiasm 
for change was felt not only by the pharmacists themselves, but also the pharmacy 
staff. The asthma service was seen as moving in the right direction, and there was a 
feeling that the profession had reached a turning point where the role itself would 
change. At the time of the study the new pharmacy contract was being negotiated, and 
pharmacists had high hopes for what it would deliver. There were high expectations 
regarding the changes and opportunities this would bring about.  
 
Those pharmacists that were already delivering brief interventions prior to the asthma 
activity saw this as part of their core role, and the initiative in asthma just made them 
concentrate on that particular condition area. It gave customers the opportunity to ask 
pharmacists for advice when they might not necessarily have thought about doing it. 
Other pharmacists found that interventions like this were difficult to fit into their 
current roles due to the constant demands and pressures that they were put under. 
Additional tasks were placed on the pharmacists without any work being taken away, 
and this, coupled with changing initiatives and priorities, made it difficult for 
pharmacists to participate in additional services. Savage [140] conducted a review in 
1999 to determine whether there was any evidence as to whether professional policy 
shift away from dispensing towards patient focused care was reflected in the way 
community pharmacists actually used their time. She concluded that the proportion of 
time pharmacists spent on customer communication had increased three fold since 
1973, but was not mirrored by a decline in time spent dispensing. She suggested that 
the reprofessionalisation process in Britain was hampered by the continued need for 
re-dispensing and the limited availability and use of trained support staff. 
 
Pharmacists felt that they had to feel confident in delivering services, and those that 
did not felt uncomfortable with the concept. Factors that had improved the 
pharmacists confidence included preparing beforehand, experience of delivery of the 
service over time, and the receptiveness of consumers. Those pharmacists that had 
tried to improve confidence felt this to be important, as they felt customers would be 
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able to detect lack of confidence in the service delivery, as well as when talking to 
other healthcare professionals. There was also a lack of confidence in delivery of 
services by pharmacy staff, particularly those with minimal customer contact.  
 
Despite the enthusiasm for change and hope that the pharmacy contract brought, there 
was still frustration amongst the pharmacists regarding the lack of progress and 
opportunities in service delivery to date. This was felt to be brought about by national 
organisations representing pharmacy, and pharmacy employers. Those pharmacists 
who had developed their clinical skills felt that they were forced to look for 
opportunities to deliver extended services outside of community pharmacy. 
Pharmacists also appeared to demonstrate some resentment towards nurses and the 
development of their roles, and felt that there was some encroachment on professional 
boundaries. Although it was evident that some pharmacists were frustrated with the 
slow pace of change, very few spoke about what they had done to embrace the new 
role and to make change happen more quickly within their local community. There 
was still a perception that some pharmacists would not embrace an extended role and 
were happy with just dispensing prescriptions, either because they preferred not to 
deliver services and have little contact with customers, or because they did not feel 
that it was appropriate for pharmacists to offer this type of advice. Although there was 
a mix of pharmacists attitudes and enthusiasm towards the extended role, it is unclear 
how divided the professionals in the field are towards it, and whether age or gender 
would have an impact on their views. The slow pace of change for the profession may 
be as much due to the behaviour and attitude of individual pharmacists as it is to 
national organisations and corporations. An editorial by van Mill [141] also concluded 
that if pharmaceutical care was to stand a chance in the future then pharmacy facilities 
would need to create enthusiastic professionals who were dedicated to care. In his 
view, enthusiastic pharmacists could overcome barriers, and would not only stimulate 
staff, but also engage patients and healthcare professionals.  
 
 
5.2.4 Summary of section two 
Most of these data presented within this section support and further extend work that 
has been conducted within previous studies and reviews. Potential motivators, 
facilitators and barriers that have been identified within this section are summarised in 
Table 26 and Table 27. 
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Table 26: Pharmacist motivators affecting service delivery  
 Motivators  
Opportunity to deliver 
extended role 
̇ Enthusiasm for involvement in services and trials by 
pharmacists and staff 
̇ Personal development 
̇ Adding professionalism to the role 
 
 
Table 27: Potential factors affecting service delivery identified from the views of 
customers and pharmacists  
(Please note that this table is presented over two pages) 
 Facilitators  Barriers  
Public attitude 
towards the 
role of the 
pharmacist and 
pharmacist 
advice 
̇ Accessibility (speed of access 
and no appointment required) 
̇ Customer receptiveness to 
advice when in pharmacy 
̇ Pharmacists seen as 
knowledgeable and respectful 
̇ Confidence in advice and ability 
to refer as appropriate 
̇ Alternative source of advice to 
GP (GP time valuable, previous 
poor experience, speed of 
access) 
̇ Unclear role because of breadth 
of requests for advice, and no 
records made  
̇ Poor confidence in advice from 
staff 
̇ Limitations of pharmacist advice 
(referral, lack of commitment, 
inability to prescribe) 
̇ Poor expectations of 
pharmacists role 
Pharmacists 
attitude 
towards their 
role within 
services 
̇ Services that are incorporated as 
part of day job 
̇ Expectation that pharmacists 
core role includes services and 
advice 
̇ Expectation that pharmacists 
role should be dispensing only  
and advice should be given by 
GP 
̇ Frustration of pharmacists  
̇ Resentment of pharmacists 
towards nurses 
Service 
structure 
̇ Services that provide 
opportunity to talk (proactive) 
̇ Focus on key services   
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 Facilitators  Barriers  
Pharmacists 
confidence in 
service delivery 
̇ Staff incentives to encourage 
participation in services 
̇ Experience in delivering 
services 
̇ Customers willing to listen 
̇ Pharmacist confidence in service 
delivery 
̇ Good preparation prior to 
service delivery 
̇ Lack of customer contact  
̇ Lack of confidence in services 
Time  
̇ Constant demands competing 
for pharmacist time 
Healthcare 
professional 
relationships 
 
̇ Underutilisation of pharmacists 
by GPs 
External 
environment 
̇ Opportunities within new 
pharmacy contract 
̇ Lack of opportunities to deliver 
extended service 
̇ Delay in new pharmacy contract 
̇ Decisions by professional 
organisations and companies 
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5.3 Summary of chapter V: Factors affecting the utilisation  
of community pharmacies and pharmacists’ role in 
services     
This chapter of my thesis has looked at when and how people currently use 
community pharmacies, including the type of advice they ask pharmacists for, and 
what they think about the quality of that advice. It has also looked at how pharmacists 
feel about an extended role, and how customers feel about seeking additional advice 
and help from pharmacists. From both sections, the factors that may be affecting 
service delivery are summarised below.  
 
As found within the literature review in chapter two, many of the factors affecting 
service delivery are the opposites of each other, where a factor acting as a facilitator 
can be reversed to act as a barrier to service delivery. Potential factors affecting 
delivery can be grouped as follows: the frequency of visit to the pharmacy, choice of 
pharmacy, utilisation of the pharmacy, type of advice sought, quality of advice 
experienced, public attitude towards the role of the pharmacist and pharmacists 
advice, pharmacists attitude towards their role in services, the service structure, 
pharmacist confidence in service delivery, time, healthcare professional relationships 
and the external environment. A summary of all the facilitators and barriers identified 
as potentially affecting the utilisation of community pharmacies and pharmacists role 
in services from the results presented within this chapter are summarised in Table 28. 
Where similar themes have also been identified within previous literature, this has also 
been indicated. In addition to the facilitators and barriers identified within this chapter, 
the motivators for the pharmacists participating in the study included; enthusiasm for 
involvement in services and trials, personnel development, and adding professionalism 
to the role. Similar themes have also been identified within previous literature [14, 16, 
22, 28]. 
 
All the factors identified from this chapter will be discussed in more detail in chapter 
nine where final conclusions will be drawn. The next chapter of this thesis goes on to 
explore the factors that affect service delivery in relation to the asthma condition itself, 
and the opportunities available for pharmacist interventions.  
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Table 28: Potential facilitators and barriers affecting the utilisation of community pharmacies and pharmacists role in services  
(Please note that this table is presented over three pages)  
 Facilitators Barriers 
Frequency of visit ̇ High frequency of visit to pharmacy for general purchases ̇ Poor frequency of visit to pharmacy for health related reasons  
Choice of pharmacy 
̇ Use of different types of pharmacies for different services  ̇ Poor loyalty to one pharmacy  requirement for access to 
centralised medication records  
[3, 7, 8, 14, 18, 21] 
Pharmacy use 
̇ Wider target audience for dissemination of advice (patient, carer, 
parent, partner) 
̇ Good use of pharmacy for general purchases  
̇ Poor use of pharmacy for general health 
̇ Expectations when in pharmacy depending on shopping mode for 
health or general purchases, and receptiveness for advice 
Type of advice 
̇ Good use of pharmacy for medication related queries  
[6]  
̇ Poor use of pharmacy for general health queries  
 
Quality of advice ̇ Previous good experience of pharmacist advice ̇ Previous poor experience of pharmacist advice  
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 Facilitators Barriers 
Public attitude towards the 
role of the pharmacist and 
pharmacist advice 
̇ Accessibility (speed of access and no appointment required) 
̇ Customer receptiveness to advice when in pharmacy 
̇ Pharmacists seen as knowledgeable and respectful 
̇ Confidence in advice and ability to refer as appropriate 
̇ Alternative source of advice to GP (GP time valuable, previous 
poor experience, speed of access) 
 
 
 
[3, 12, 17, 18, 23, 30, 32]  
̇ Unclear role because of breadth of requests for advice, and no 
records made  
̇ Poor confidence in advice from staff 
̇ Limitations of pharmacist advice (referral, lack of commitment, 
inability to prescribe) 
̇ Poor expectations of pharmacists role 
̇ Perceived limitations of pharmacy advice 
̇ Poor perception of the role of the pharmacist compared to other 
healthcare professionals 
[3, 7, 16, 18, 21, 26, 32] 
Pharmacists attitude 
towards their role within 
services 
̇ Services that are incorporated as part of day job 
̇ Expectation that pharmacists core role includes services and 
advice 
 
[5, 17-19, 30, 32]  
̇ Expectation that pharmacists role should be dispensing only  and 
advice should be given by GP 
̇ Frustration of pharmacists  
̇ Resentment of pharmacists towards nurses 
[1, 5, 16, 29, 32] 
Service structure 
̇ Services that provide opportunity to talk (proactive) 
̇ Focus on key services   
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 Facilitators Barriers 
Pharmacists confidence in 
service delivery 
̇ Staff incentives to encourage participation in services 
̇ Experience in delivering services 
̇ Customers willing to listen 
̇ Pharmacist confidence in service delivery 
̇ Good preparation prior to service delivery 
[9, 19, 30]  
̇ Lack of customer contact  
̇ Lack of confidence in services 
 
 
 
[5, 8, 19, 25] 
Time 
 ̇ Constant demands competing for pharmacist time 
[1-3, 7, 8, 12, 14-16, 20, 21, 23, 25-29] 
Healthcare professional 
relationships 
 ̇ Underutilisation of pharmacists by GPs 
[3, 7, 8, 14-16, 18, 19, 21, 23, 25-27, 29, 32] 
External environment 
̇ Opportunities within new pharmacy contract 
 
[5, 32]  
̇ Lack of opportunities to deliver extended service 
̇ Delay in timing of new pharmacy contract 
̇ Decisions by professional organisations and companies 
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CHAPTER VI 
Opportunities available for pharmacists in 
the delivery of asthma services 
 
6.0  Introduction to the chapter 
This chapter of my thesis provides an overview of why asthma was chosen as a 
condition area to focus on as part of this study. It explores general problems with the 
condition, and identifies opportunities for community pharmacists to get more 
involved in helping people with asthma manage their condition better. Many 
publications exist for asthma, but are not explored in this thesis due to the fact that this 
study is not investigating the asthma condition itself, nor the outcomes of the service 
intervention on asthma. Instead, asthma is used as an example to identify factors that 
affect service delivery such as customer need and demand, which has been identified 
as both a facilitator and barrier in previous studies [1, 8, 11, 14, 16, 20]. The chapter 
begins by providing an introduction to asthma itself, the prevalence of the condition, 
and an overview of the burden that asthma places on both the patient, and the NHS. 
The results from my study are then presented, followed by a general discussion and 
initial conclusions on the factors affecting service delivery.  
 
 
6.1 An introduction to asthma  
Asthma is a respiratory condition that causes people to have difficulty breathing due to 
inflammation in the airways restricting the flow of air. Symptoms of asthma include 
recurrent wheezing, breathlessness, tightness in the chest and cough. Currently, there 
is no cure for asthma, although medication is available to prevent and relieve 
symptoms. Triggers such as house dust mite, pollen, exercise and smoke can often 
worsen or prolong asthma symptoms. 
 
It is estimated that 5.2 million people within the UK are currently being treated for 
asthma [142], with 8 million people having been diagnosed with the condition at some 
point in their lives [143]. Although asthma is the most common long-term childhood 
medical condition, it also affects a considerable number of adults [142]. Boys are 
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more likely to have asthma than girls, but are also more likely to grow out of it as they 
grow older, as by adulthood, 60% of people with asthma are women [144]. 
 
The goals of asthma treatment are well established as people with asthma should have 
very few or no asthma symptoms, little or no use of relief medicines, very few or no 
long term symptoms, very few or no restrictions on daily activities, and very few or no 
emergency visits to hospitals [145]. The majority of people with asthma, however, are 
not managing their condition as well as they could be, as the current level of asthma 
control falls far short of guideline recommendations for long term management [146]. 
Asthma UK estimates that approximately 4.6 million people in the UK who should be 
leading a relatively healthy and active life have everyday asthma. More than 3.5 
million people however, 75% of people with everyday asthma, still experience 
symptoms that regularly restrict their everyday activities [144]. The same study 
reports that more than 500,000 of these people with everyday asthma have had an 
asthma attack almost every day. Severe asthma symptoms are experienced by 2.1 
million adults and 500,000 children in the UK, and approximately half a million of 
these people have asthma that is difficult to control despite taking high doses of 
medication [147]. For the remaining 2.1 million, their symptoms are severe because 
their asthma is not well managed [147].  
 
Not only does asthma have a significant impact on the person with asthma, but there is 
also a financial impact on the NHS. The annual cost of asthma to the NHS has been 
estimated at £889 million, and for a local PCO, £4 million [142]. Asthma also has an 
impact on the workload of GPs as it is estimated that there are 14,500 first or new 
episodes of asthma presented each week, and a total of 4.1 million consultations per 
year [142]. The implications of poor asthma control are widespread, as it can often 
lead to hospital admission, or even death. Of the 69,000 hospital admissions for 
asthma [142], it has been suggested that up to three quarters could have been 
prevented by different prior care [148]. In addition, the financial cost of treating an 
asthma attack in hospital is over three and a half times as much as treating well 
controlled asthma [149]. As many as 1,400 people in the UK die from asthma each 
year [142], of which over 80% are thought to be associated with avoidable factors 
[150]. 
 
The results presented within this chapter explore customer need and demand for 
services in asthma. I investigate the problems that people with asthma experience 
including the type of symptoms they suffer from, the level of control they have over 
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their condition and the restrictions that asthma places on their life. I have also looked 
at some of the potential reasons behind poor control, including the level of customer 
knowledge and understanding of their condition and use of medication. These data are 
then used to explore the opportunities available to community pharmacists, and the 
factors affecting service delivery. This study does not investigate the outcomes of 
customers that have participated within the asthma services in any detail, as this is not 
the focus of the study. The results used within this chapter are taken from the omnibus 
survey, asthma audits, and customer interviews.  
 
 
6.2 Results  
6.2.1 Condition knowledge  
6.2.1.1 Current knowledge of asthma  
Respondents that participated in the omnibus survey and the customer interviews were 
questioned on how knowledgeable they felt about their asthma condition. The results 
from the omnibus survey are presented in Figure 13. Only 38.0% (n=97) of 
respondents believed that they, or their partners or child, were very knowledgeable 
about their condition, with a further 42.0% (n=107) feeling quite knowledgeable. A 
total of 18.8% (n=48) of the respondents stated that they were not knowledgeable 
about their asthma. 
 
Figure 13: Omnibus data "How knowledgeable would you say you / they are about your / 
your child's / their asthma?" (All with asthma, n=255) 
38%
42%
5%
10%
4%
1%
Very (n=97)
Quite (n=107)
Neither / Nor (n=13)
Not very (n=25)
Not at all (n=10)
Dont know (n=3)
 
 
Within the customer interviews, a total of 27 people were questioned about their level 
of asthma knowledge, of which, 37.0% (n=10) felt that they had a good level of 
knowledge about their condition. Of those that felt very knowledgeable about asthma, 
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40.0% (n=4) of the respondents thought that their knowledge was as a result of them 
being diagnosed with the condition since childhood; 
 
C10 I feel after this length of time that I know quite a bit about it anyway. 
 
A third of the respondents questioned (n=9) believed that they had some knowledge of 
asthma and knew enough about their condition. One particular respondent felt that her 
mother was more knowledgeable about her asthma than herself, but she knew enough 
to get by, and did not particularly want to know anymore; 
 
C9 “I reckon I know enough to get by and make sure I don’t make it worse. I don’t think 
I’d want to know anymore. I mean like I said my mum would probably know more but 
as for me I know to avoid running and stuff and not to go swimming.” 
 
The remaining 29.6% (n=8) of respondents felt that they had very poor knowledge 
about their asthma; 
 
C20 “I don’t really know anything about it, I don’t know what causes it.” 
 
6.2.1.2 Information sources  
Respondents that participated within the customer interviews were questioned on 
which information sources that they had used to gain knowledge on their condition, of 
which 23 answered. Most respondents used a variety of information sources over the 
period of time since they had been diagnosed. Literature sources such as information 
leaflets, medicines packaging, newspapers and Sunday magazines were used by 52.2% 
(n=12) of respondents to gain knowledge; 
 
C13 “When I went to the clinic I got given some leaflets to look at which I did and I found 
it quite useful. It told me some things to avoid like mowing the grass and the thing 
about the manmade and natural duvet fillings. I tend to pick up any leaflets I see on it 
and any new ideas or help I might find.” 
 
Asthma nurses and clinics were used by 43.5% (n=10) of respondents to gain some of 
their knowledge on asthma. Respondents appeared to receive very good advice from 
the asthma nurse and clinic when they were first diagnosed. A few of these 
respondents still attended asthma clinics on a regular basis as they found them 
extremely useful. Other respondents felt that they were no longer getting any benefits 
from attending the clinics so had stopped attending; 
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C16 “I went to the nurse at the clinic several times, from making an appointment, they 
tested my breathing and how it was, it was pretty poor at that time, they gave me a lot 
of information what to do / leaflets, etc.” 
 
Friends and family were used as a resource by 26.1% (n=6) of respondents to inform 
them about their asthma; 
 
C13 “….and my husband finds things occasionally and either tells me about them or picks 
up a leaflet. And since I’ve had it I’ve spoken to others about it. You don’t realise 
until you have it how many people have it and carry inhalers about.” 
 
Both GPs (n=4) and pharmacists (n=4) were used as an information source by 17.4% 
of respondents to gain their asthma knowledge; 
 
C22 “I always ask questions and that’s probably why I am managing it myself, I ask a lot 
of questions and the doctor always explains it to me, but there are always things you 
don’t know and it would be useful if there was something like that.” 
 
The television was also used as an information source by 8.7% (n=2) of respondents, 
as was the internet (n=2);  
 
C13 I tend to like to read the medical pages in the ‘Daily Mail’ too and of course the 
‘This Morning’ doctor is quite good on updating you.” 
 
6.2.1.3 Customer need for new information 
Within the customer interviews, 20 respondents were asked whether they would like 
to know more information about their condition. Only two of the respondents were 
actively seeking out new information on asthma; 
 
C24 “I feel more knowledgeable than I did, but there’s still quite a bit more to work out 
and know about it.” 
 
A further three respondents stated they would listen to information that was in the 
media at the time, but would not actively go out and look for it. All the information on 
asthma was seen to be very repetitive and say exactly the same thing; 
 
C12 “Only if I hear stuff but I don’t look out for anything.” 
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New information or treatments that would make their asthma easier to manage was of 
interest to approximately a third (n=6) of the respondents questioned; 
 
C31 “I feel I am in control of my asthma, but always on the look out for new products. So I 
am interested in things that are new or may help.” 
 
Just under half of the respondents (n=9) were not interested in finding out any more 
information about their asthma. Some respondents seemed to have a fear of finding 
out more; 
 
C14 “I haven’t read anything on it. I think the less you know about things the better you 
are. I mean it’s the same with tablets. There’s all these leaflets in and I think at the 
end of the day if you read them all you wouldn’t have anything would you?” 
 
 
6.2.2 Asthma medication 
6.2.2.1 Medication knowledge  
Respondents within both the asthma audit and the customer interviews were 
questioned on their understanding of the medication they were using for asthma. As 
part of the asthma audit respondents were specifically asked whether they knew what 
their GP had prescribed for them in terms of frequency of taking which medication, 
the results of which are shown in Table 29. The majority of respondents in both audits 
could accurately say what was on their prescription, although approximately one in ten 
of those questioned did not know what they had been prescribed. 
 
Table 29: Asthma audit "Do you know what your doctor / asthma nurse has prescribed 
for you in terms of frequency of taking which medication?" 
Percentage distribution 
Medication knowledge 
Audit 1 (n=119) Audit 2 (n=112) 
Can accurately say whats on the prescription = yes 86.6 88.4 
Doesnt know / not sure = no 13.4 11.6 
 
As part of the customer interviews, 33 respondents were asked about the type of 
medication they were taking for their asthma, and the directions for use. The majority 
of respondents were on a combination of medications to help control their asthma, and 
described them in a variety of ways. Two fifths (n=13) of the respondents were very 
knowledgeable about their medication and directions for use. Most of the inhalers 
were described as branded names, as opposed to the drug name. This was particularly 
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apparent with Ventolin® inhalers, which was only mentioned by the name salbutamol 
on three occasions; 
 
C10 “Well Symbicort® has steroids to keep the asthma at bay and build my chest up. And 
the Bricanyl® is just to relieve when the tubes in my throat are starting to close. To 
give me relief.” 
 
Over half (n=17) of the respondents were aware of the directions for use of their 
asthma medication, but described their inhalers by colour alone, typically blue and 
brown; 
 
C12 “I just have a blue inhaler as they found that I don’t always need help but only when I 
get short of breath.  I always keep a few in the house as I’m terrified of not having any 
and having an attack. I’m more careful about that since I had Daniel. It kind of gives 
you a new perspective.” 
 
Only three respondents described their inhalers typically as relievers and 
preventers; 
 
C33 “For five - six years that I can remember I wasn’t on correct medication, just on 
relievers.  Now they’ve got me on a couple of medications and for the last four years I 
haven’t really had to use Ventolin® at all while on those preventers.  On those 
preventative medications it’s really well controlled.” 
 
6.2.2.2 Use of medication 
Respondents were asked about their use of asthma medication within the omnibus 
survey, asthma audit and customer interviews. The majority of respondents, their 
partners and children (56.9%, n=145) within the omnibus survey regularly took 
medication for their asthma (refer to Figure 14), with a further 33.7% (n=86) taking 
medication only when symptoms occurred. No medication was taken by 8.2% (n=21) 
of respondents. 
 
 
 
 
 
 
 
 149 
Figure 14: Omnibus data "Do you / they take any medication for your / their asthma?" 
(All with asthma, n=255) 
57%
34%
8% 1%
Yes, regularly (n=145)
Yes, only when have symptoms
(n=86)
No (n=21)
Dont know (n=3)
 
 
Within both asthma audits, respondents were questioned as to whether they regularly 
picked up all the medication on their prescription. The results for audits one and two 
were very similar, as shown in Figure 15. The majority of respondents regularly 
picked up all the medication on their prescription, however, 12.8% (n=15) of 
respondents within audit one, and 15.0% (n=17) within audit two, did not regularly 
pick up all of their medication that had been prescribed for them.  
 
Figure 15: Asthma audit "Do you pick up all the medication on your prescription?" 
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Within both asthma audits, respondents were asked how many times they took their 
reliever medication, the results of which are shown in Table 30. Over half of the 
respondents within both audits (61.2% (n=71) in audit one and 56.6% (n=64) in audit 
two) regularly used their reliever medication once a day or more. Only 15.5% (n=18) 
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of respondents in audit one, and 15.0% (n=17) of respondents in audit two, used their 
reliever medication less than once a week. 
 
Table 30: Asthma audit "How many times do you take your reliever medication?"  
Percentage distribution 
Frequency of use 
Audit 1 (n=116) Audit 2 (n=113) 
More than once a day 41.4 41.6 
Once a day 19.8 15.0 
More than once a week 16.4 19.5 
Once a week 6.9 8.8 
Less than once a week 15.5 15.0 
 
Respondents were asked whether they used their medication as often as prescribed by 
the GP within both the omnibus survey and asthma audits, the results of which are 
shown in Table 31. Within all three data sets approximately one fifth of respondents 
did not regularly take their medication as prescribed by the GP.  
 
Table 31: Omnibus and asthma audit "Do you / they use your / their medication as often 
as advised by the doctor?"  
Medication use Omnibus data (%) 
(n=255) 
Audit 1 (%) 
(n=118) 
Audit 2 (%) 
(n=114) 
Yes, all the time 63.2 52.5 47.4 
Yes, most of the time 15.2 23.7 31.6 
Sometimes 10.8 21.2 15.8 
Rarely 7.8 2.5 2.6 
Never 3.0 0.0 2.6 
 
Within the customer interviews, 20 respondents were questioned on the use of their 
asthma medication. Just under half (n=9) of the respondents always used their 
medication as directed by the GP. One particular respondent had been using his 
inhalers incorrectly for years until a new GP had explained it to him; 
 
C25 Yeah, originally when I first got it I had an absolutely useless doctor and he didn’t 
explain it properly to me and for years I was using too much of the blue, the 
Ventolin®, I didn’t know that I should have been taking the steroid regularly to 
prevent the more use of the blue one. A few years ago I got it explained to me so I just 
do as the doctor said, take the Becotide® regularly and the Ventolin® when I need it.” 
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Medication was taken as directed some of the time by approximately one third (n=6) 
of respondents. The use of medication was very often determined by social events, 
anticipated triggers, or feeling unwell;  
 
C27 “Not often no, it just depends on certain circumstances, you know if you’ve been to 
the pub the night before or……if I’ve got a cold coming on my chest starts to get a bit 
sore and I take it then.” 
 
The use of medication when symptoms occurred and when required, was used by four 
of the respondents; 
 
C22 “I basically take my inhalers as and when I need it as opposed to every day like I did 
up to when I was about 20, so the last five years I’ve just taken them when I’ve either 
been feeling a little unwell or when I’ve been short of breath.  That’s about it really.” 
 
Only one respondent admitted to rarely or never taking the medication as directed, and 
had subsequently suffered as a result; 
 
C24 “I didn’t get into the habit of using the steroid based ones every day like he said cos I 
didn’t actually need it anymore. So I stopped using it and then I changed jobs about 
four months ago and became an animal nurse and the triggers came back again.” 
 
6.2.2.3 Confidence in medication 
Only two of the respondents felt comfortable enough with their medication to increase 
the dosage, without medical advice when they were felling unwell; 
 
C22 “It really depends on my general health is with regard to inhalers, because if I’m well 
I’ll only need probably three of each inhaler a year, if I just have a slight colds and 
stuff. If I have say two chest infections a year I’m going to need a hell of a lot more 
than that because I get through them a lot quicker, because what I tend to do is even 
when my chest infection is gone I’ll use it for a couple of weeks afterwards. It might 
seem as though I’m better but I know if I don’t keep it up I’ll go back and have a chest 
infection straight away. I don’t know if that’s the right thing to do or not, my doctors 
never told me that it’s not, but it seems to work for me and I think if it works you 
should do it.” 
 
Some respondents had a fear of their medication and tried to maintain control of their 
condition to avoid further exposure to drugs such as steroids; 
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C11 “When you’ve had one bad do like I had you don’t want to go back onto steroids it 
was awful and I’m managing well at the moment.” 
 
C29 “Exactly, I was taking enough (medication) as it is, so if I can avoid it psychologically 
I do, but once you realise it’s good for you and is not really growing a third head or 
something, you never know, mutation is always a problem!” 
 
 
6.2.3 Symptom control 
6.2.3.1 Triggers of asthma  
Out of the 28 questioned within the customer interviews, the majority were fully 
aware of what triggered their asthma. The most common trigger cited was physical 
exercise or exertion which affected the daily life of two fifths (n=11) of the 
respondents;  
 
C14 “Well if I’m just normally going about me day I’m OK.  But if I come to exert myself 
for instance carrying something upstairs, by the time I get to the top I’m short of 
breath.  And also bending does it. Even bending down to tie me shoe laces, I have to 
rear up and take a few breaths.  I’m gasping by the end of it.” 
 
Some of the respondents also suffered from hayfever, and consequently pollen was a 
trigger for their asthma. This affected over a third (n=10) of respondents; 
 
C13 “Well I actually think I’ve got a bit of hayfever because I tend to feel worse in the 
summer.  I try not to go out late at night as the pollen seems to get to the back of my 
throat and causes me to wheeze a bit.” 
 
Cold or damp weather was also a common trigger, and affected over a third (n=10) of 
respondents; 
 
C17 “It is quite restrictive everywhere you go, in the garden if there’s pollen, if it’s too 
cold if it’s windy.”  
 
Dust was a trigger for a third (n=9) of the respondents, some of which had to remove 
all the carpets within their house to control their condition. Stress at work or home was 
also a common trigger that affected one fifth (n=5) of respondents; 
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C25 “It’s mainly a cough but every now and again if I get excited about something I start 
coughing or if I get stressed out and nervous about something I get short of breath 
and I start coughing then as well.” 
 
Animals appeared to affect one fifth (n=5) of respondents, although this did not 
always stop them from owning one; 
 
C22 “Anything can set me off, coupled with the asthma, I’m also allergic to cats and 
things like that which sets my asthma off, so if I’m around cats my asthma gets worse 
obviously.” 
 
Pollution affected four of the respondents, the majority of which was discovered by 
moving residence or symptom free episodes during vacations;  
 
C26 “I went out to Spain a few weeks back, I was there for a week and I only needed to use 
it a couple of times. So pollution in this country doesn’t help, obviously because this is 
why all the kids have got it these days.” 
 
Only three respondents recognised colds and flu as a trigger for their asthma. Smoke, 
feathers and solvents all affected a couple of the respondents; 
 
C26 “Certain solvents if I’m doing a bit of cleaning, I either have to do it outside or just 
not use them.” 
 
Only one respondent had experienced a worsening of her asthma due to pregnancy. A 
further four respondents were not fully aware of what triggered their asthma.  
 
6.2.3.2 Type of symptoms  
A total of 27 respondents within the customer interviews were asked to describe the 
symptoms they suffered as a result of their asthma. Some of the descriptions were very 
personal, although the individual symptoms can be broken down into four main areas. 
Many of the respondents experienced multiple symptoms, the most common being 
breathlessness and difficulty in breathing, which was described as a symptom by 
two thirds (n=18) of respondents;  
 
C12 “I feel like my throat is expanding and almost that I might swallow my tongue.” 
 
C28 “Shortness of breath, uncomfortable, it can wake me up in the middle of the night - I 
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hard to imagine if you’ve never had asthma - it’s like a weight on your chest, pressing 
on you and you can’t breathe properly.” 
 
Just under half (n=13) of respondents described wheezing as a common symptom of 
their asthma; 
 
C33 “Shortness of breath, unable to breathe, really wheezy” 
 
Tightness of the chest was experienced by a quarter (n=7) of respondents;  
 
C10 “Very tight feeling in the chest and not being able to get any air basically.” 
 
Coughing was the least common symptom, and was only experienced by five of the 
respondents; 
 
C11 “My eyes itch it’s coughing mainly. But then it can make eyes itch and my nose run 
and my ears hurt. They feel as though they’re being pulled from the inside.” 
 
6.2.3.3 Frequency of asthma symptoms  
Within the omnibus survey, asthma audits, and customer interviews, respondents were 
asked how frequently they experienced symptoms from their asthma. The results from 
the omnibus survey are shown within Table 32, with just under a third of respondents, 
27.1% (n=69), experiencing symptoms on a daily basis or several times a week. A 
total of 16.1% (n=41) were experiencing asthma symptoms weekly or once every two 
to three weeks, and 54.9% (n=140) were suffering from symptoms on a monthly basis 
or less. 
 
Table 32: Omnibus data "How frequently do you / they experience symptoms of your / 
their asthma that effect your / their life, by which I mean you cannot do things you 
normally would do?" (All with asthma, n=255) 
Frequency symptoms Percentage distribution 
Everyday 16.1 
Several times a week 11.0 
Weekly 7.1 
Once every two  three weeks 9.0 
Monthly 12.2 
Less often 42.7 
Dont know 2.0 
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Respondents who participated within the asthma audits were questioned about their 
level of symptom control, by asking whether they had experienced any of the RCP 
questions within the last week (refer to Table 33 for sample sizes). 
 
Table 33: RCP questions  
Sample size 
RCP question Audit 
one 
Audit 
two 
Q1 
Have you had difficulty sleeping because of your asthma 
symptoms? 
119 114 
Q2 
Has your asthma interfered with your usual activities such as 
housework, work or school? 
117 112 
Q3 
Have you had your usual asthma symptoms, such as coughing, 
wheezing, tight chest, or feeling breathless during the day? 
119 113 
 
A graphical representation of the results from the RCP questions are shown in Figure 
16. Within audit one, 27.7% (n=33), and within audit two, 18.4% (n=21), of those 
questioned had difficulty sleeping because of their asthma symptoms. Many 
respondents experienced regular symptoms from their asthma, 62.2% (n=74) within 
audit one, and 38.1% (n=43) within audit two. Only 23.1% (n=27) within audit one, 
and 17.9% (n=20) within audit two, of respondents felt that their asthma had interfered 
with their usual activities. 
 
Figure 16: Response to RCP questions within asthma audit one (A1) and audit two (A2) 
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Within the customer interviews, 13 respondents were asked how frequently they 
experienced symptoms as a result of their asthma. The majority of respondents, 84.6% 
(n=11), experienced symptoms on a daily basis; 
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C33 “I think people notice that I wheeze constantly but I think it’s something that I don’t 
realise that I’ve been doing it.  I do have a slight wheeze all the time.” 
 
The remaining 15.4% (n=2) of respondents experienced asthma symptoms on a 
weekly basis;  
 
C13 “Oh I’d say about three times a week.  That’s about the amount of times I have to use 
my emergency one.  I know it’s there for when I need it and just make sure I carry it at 
all times.  It’s my safety net.” 
 
 
6.2.4 Control of asthma 
6.2.4.1 Level of control 
Within the customer interviews respondents were asked whether they believed that 
their asthma was under control. A total of 21 responses were collected, of which three 
quarters (n=15) felt that they were in control of their asthma. The feeling of control, 
for some, was as a result of having the condition for a number of years. For others, 
control came from management of the condition through use of preventative 
medication and avoidance of triggers; 
 
C12 “Oh I would say almost completely (in control) now.  I haven’t had any scares for 
years.  I ‘m just much more careful and the older I’ve got the more sensible in 
avoiding things and places that set me off.” 
 
The remaining quarter (n=6) of respondents stated that they were not in control of 
their condition, and were unsure as to how to gain more control; 
 
C10 “I’d like more control really because I’ve always got to look how much spray I’ve got 
left and have I got another one in the drawer.” 
 
C29 “It is getting slightly worse, but I’m doing everything I’m supposed to do, and I can’t 
do more than that.  I wouldn’t know how to control it apart from what do you do, take 
your lungs out and wash them?  There’s nothing I can do, I can merely follow what’s 
proposed to me and follow it properly.” 
 
6.2.4.2 Restrictions on life  
As part of the customer interviews, respondents were asked whether they believed that 
their asthma restricted them in their day to day life. A total of 19 responses were 
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gained, of which over half (n=10), felt that their asthma had severely restricted their 
life in some way. It stopped them from doing certain things such as exercise, and for 
some had a financial impact as their asthma restricted the type of work they were able 
to undertake. For others who had difficulty walking, it limited the shops they were 
able to access;  
 
C10 “Well it’s a nuisance, I know it could be a lot worse because there’s bronchial 
asthma, which is the worst, but it does hold me back from certain things I want to do.” 
 
C14 “I mean I have to be careful everyday what I do…… You know what you can and 
can’t do at the end of the day.”   
 
C17 “It is quite restrictive everywhere you go.” 
 
Over a third (n=6) of respondents felt that their asthma did not affect their life, but 
admitted that it did limit them in the activities they could do. There was an acceptance 
that they just lived with the symptoms and that there were certain activities which they 
could no longer undertake;  
 
C11 “If I take my medication, to be quite honest I can do more or less what I want to do. 
By the time you reach my age you’re not wanting to climb, having said that we used to 
be big walkers but once you get arthritis you can’t do that either.” 
 
C19 “I suppose it does really, but I’ve had it for so long it doesn’t affect me in that it stops 
me doing things.  I mean, I might wake up wheezy and I might be wheezy during the 
day if a friend has a cat and it’s made me wheezy but I take my Ventolin® and I carry 
on.  Unless I’ve been, say, sick with bronchitis doesn’t really effect my day to day 
being in which I really don’t do much.” 
 
Only three of the respondents believed that their asthma did not restrict them from 
doing anything, although they stated that their inhalers were with them at all times;  
 
C33 “No, it doesn’t stop me doing anything, no.  I might have to take a reliever every now 
and again but it doesn’t stop me doing anything.” 
 
C28 “Nothing prevents me doing what I want to do, I still play squash and things but I am 
aware that these days I can’t go anywhere at all without taking my inhaler with me. 
I’m very aware that I now need to make sure I take it with me. If I’m going out with a 
small bag to a dinner or up to London to a gig I have to make sure I have it.” 
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6.2.4.3 Management strategies  
As part of the customer interviews, respondents were asked how they controlled their 
asthma. Out of the 15 responses, over three quarters (n=11) of the respondents avoided 
specific triggers which they knew aggravated their condition. For some, this meant 
avoiding activities such as mowing the lawn and housework. Others had spent a 
considerable amount of money replacing items in the house, such as carpets to wooden 
floors, and cotton sofas to leather. Some respondents had changed their behaviour or 
lifestyle, by walking to and from work outside rush hour, or by simply limiting the 
activities they did. One particular respondent was also conscious of avoiding places 
which could potentially trigger asthma in her son; 
 
C12 “It certainly feels like that and I’m very careful to avoid things I know might cause me 
problems and land me in hospital.  Plus I want to make sure my Daniel (baby son) 
doesn’t get it.  So I’m definitely avoiding smoky places for him.” 
 
C19 “I don’t honestly know if there’s an awful lot more I can do, you know I’ve changed 
my sofa to leather, all the things that trigger dust and stuff, I’ve got wooden floors, 
I’ve got hardly any carpet in my house, those kind of things have obviously helped so I 
don’t know if there is an awful lot more I can do, cos I’m quite diligent in taking my 
preventer and if I get sick I’ll up it to three times a day instead of twice a day and 
things like that. I don’t think there’s much more could be done.” 
 
Smoking had a detrimental effect on one respondents asthma, and as a result they had 
recently given up smoking and noticed a vast improvement in their condition;  
 
C22 “I did start smoking again, but have stopped again.  Obviously smoking didn’t help 
and it did make my asthma worse.  Within a few weeks of stopping I felt a 100% 
better.” 
 
A third (n=5) of respondents felt that their asthma was controlled by their medication, 
and a quarter (n=4) of respondents felt that regular exercising helped to improve their 
breathing and control their asthma; 
 
C25 “If I take more exercise. Swimming is good for it because it controls the breathing, 
you either breathe properly or you drown. And also because the air is moist obviously 
with the water. Yeah I do find that when I swim more my breathing does definitely 
improve.” 
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6.3 Discussion of the results  
The results presented within this chapter have explored customer need and demand for 
services in asthma. I have investigated the problems that people with asthma 
experience including the type of symptoms they suffer from, the level of control they 
have over their condition and any restrictions that asthma places on their life. I have 
also looked at some of the potential reasons behind poor control, including level of 
knowledge, understanding of their condition, and use of medication.  
 
Two fifths of respondents from both the omnibus survey and customer interviews 
believed their asthma knowledge was good, with some feeling that their knowledge 
came from having the condition for so long. In contrast, one fifth of respondents 
within the omnibus survey admitted to knowing very little about their condition. This 
figure was slightly higher within the customer interviews, where a third of respondents 
felt that they had poor knowledge about their asthma. A European telephone survey of 
people with allergies, including asthma, also found that only one third of patients 
questioned claimed they had a good knowledge of their condition [151].  
 
As with other studies [152, 153], participants sought information from a variety of 
professional and lay sources. Information from healthcare professionals was accessed 
by a number of media, including face to face, and literature. Other sources of 
information came from newspapers, magazines and friends and family. Even though 
these latter sources were not always validated, the quality of information was regarded 
quite highly by respondents, in particular, advice from friends and family. A survey 
commissioned by the DH looking at information sources for self care, also found that 
after GPs, family and friends, magazines and the media were the most popular sources 
of information [135]. The internet was not widely used as a source of information 
within this study, as it was only cited by two respondents. A study by Raynor et al. 
also found that the internet was not widely used as an information source, as too much 
information was available, and most was from unknown sources and could not be 
trusted [152]. A more recent survey by the DH found that the internet was used as an 
information source by 12% of those questioned [135]. However, both the internet and 
pharmacists were found to be underutilised, where preference to use as an information 
source outweighed current usage.  
 
Asthma nurses and clinics were quoted by two fifths of respondents as an information 
source for their asthma, with many respondents attending asthma clinics when first 
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diagnosed, or following an emergency hospital admission. Very few respondents were 
still in attendance of these clinics as they no longer felt they were getting any benefits. 
Alongside nurses, GPs have also been frequently mentioned as a main information 
source in another study [152]. This study also found that pharmacists were widely 
used to gain information on the medicines themselves. Within these data, only a 
handful of respondents had used their GP or pharmacist to gain knowledge on their 
asthma.  
 
Previous studies have found that patients value individualised information that is 
delivered by face to face advisors, and generally find these more helpful than 
medicines leaflets [152].  An evaluation of various methods of asthma education by 
the Global Institute for Asthma initiative, however, found that patient preference did 
not always equate with effectiveness [145]. Information needs to be available in 
several different formats, and should give consistent advice which reinforces the same 
message [154].  
 
Even though the majority of respondents did not feel very knowledgeable about their 
asthma, very few wanted to actually find out any more information. Current asthma 
information was seen to be very repetitive, and not say anything new or different. 
Other respondents felt that they knew all they needed to know. Previous studies have 
found that many people with asthma continue to have unmet information needs [155]. 
A study by Caress et al. to gain insight into key information needs of people with 
asthma, found that three out of nine core information needs were related to medicines 
[155]. A further study found that a quarter of people questioned wanted to know more 
about the long term effect of medicines, and one fifth were interested to know about 
alternative medicines and complementary therapies [153]. Some respondents within 
the customer interviews seemed to have a fear of finding out any more information as 
they did not think they would like what they were going to hear. This seems to be 
particularly apparent when it comes to the long term use of medication. 
 
Although many respondents were not looking for information, there was an interest in 
anything that was seen to be new advances in technology, new medication or new 
information that would help them. The media was seen as a good source for people not 
actively looking for new information. The need for new information supports findings 
from previous studies [152, 155], particularly where new developments may lead to 
safer drugs or a reduction in medication doses [155].  
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Respondents were recruited into the asthma audit whilst they were within the 
pharmacy, either as a result of a dispensing or healthcare interaction. Within both 
audits, one tenth of respondents did not know what their GP had prescribed for them 
in terms of frequency of taking which medication. Although this number is 
surprisingly high, it is likely to be an underestimate of the true response due to the 
nature of recruitment of the respondent, and the fact that they may have been handing 
in a prescription at the time. The majority of respondents within the customer 
interviews were on a combination of medication to help control their asthma. As with 
another study [152], most respondents were fairly knowledge about their medication 
and directions for use, although these inhalers were described in a variety of ways. 
Many described their inhalers by brand name, which was particularly apparent with 
Ventolin®. Others described their inhalers by colour alone, blue or brown, or by 
inhaler use, reliever or preventer. Respondents were very conscious of having the 
ability for immediate access to a supply of Ventolin®, blue, or reliever inhaler, as this 
was seen as their life line in case of an asthma attack, and was often described as 
their emergency inhaler.  
 
Over half of the respondents within the omnibus survey regularly took medication for 
their asthma. Medication was taken only when symptoms occurred with a third of 
respondents, and just under a tenth took no medication at all. It is unclear whether 
these latter respondents possessed any reliever medication for emergencies, but as it 
was rarely used classed themselves as taking no medication. Unfortunately, the nature 
of an omnibus survey does not allow further questioning.    
 
Approximately one in seven people within both asthma audits admitted to regularly 
not picking up all of the medication that had been prescribed for them by their GP. 
This number is likely to be an underestimate of the true response due to the nature of 
recruitment, and the fact that the respondent may have felt uncomfortable admitting 
this to the pharmacist. Unfortunately, due to the nature of the audit I was unable to 
question the respondent further as to why they did not pick up all of the medication. A 
study by Watts et al. also investigated how many prescriptions were fulfilled after 
being issued by the GP, and found that only 70% were dispensed [156]. Within the 
current data systems, the information regarding uncollected medicines does not 
normally filter back to the prescribing GP, although the development of the integrated 
patient care records may resolve this issue to some extent. Cost can be a deciding 
factor in whether or not people take their medication [157], and could explain why 
some people with asthma only pick up the inhalers which are absolutely necessary, for 
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example the reliever. A survey conducted by Asthma UK found that 94% of people 
with asthma believed that free prescriptions were vital to effective asthma control 
[157], although at the present time they are not exempt from prescription charges. 
 
A number of studies have concluded that compliance with asthma medication is poor 
[157], and as little as 65% of patients within the UK regularly take their prescribed 
medicines [158]. When the DH questioned the public on general medicines use [135], 
only 82% admitted to taking their medication all or most of the time when their GP, 
nurse or pharmacist had asked them to. Within the omnibus data and both asthma 
audits, one in five respondents admitted to not using their medication as directed by 
their GP. Within the customer interviews, the use of medication was often triggered by 
feeling unwell, or the occurrence of symptoms. Many respondents also used their 
reliever medication if they knew they were going somewhere that would affect their 
asthma, such as a smoky pub, or undertaking an activity such as exercise. A study by 
Asthma UK also found that medication use varied [147], with some people admitting 
to easing off their medication when they were feeling well, whilst others religiously 
followed their drug regime.  
 
Asthma patients are typically prescribed daily preventer medication, such as a 
corticosteroid inhalers or leukotriene antagonists, supplemented with a reliever inhaler 
for when symptoms occur. Non compliance problems typically involve an under use 
of preventer medication, and an overuse of reliever medication [157]. Many patients 
consider that their asthma can be controlled through the use of reliever medication, 
rather than the regular use of a preventer [159]. Some evidence of this can be seen 
through the asthma audits, where three out of five respondents admitted to using their 
reliever inhaler once a day or more, and six out of seven once a week or more. In the 
month prior to the Asthma Insights and Reality in Europe survey [146], over 60% of 
respondents had used reliever medication to alleviate symptoms, but only 23% of 
those questioned had used an inhaled corticosteroid. Other studies have shown that 
almost three quarters of asthma patients use a short acting bronchodilator at least twice 
a day [160]. A study looking at the relationship between patients beliefs and their 
reported adherence with medication regimes found that asthma patients were the least 
likely to believe that their medicines were necessary, the most likely to say that the 
medication costs outweighed their benefits, and were the least compliant in using their 
medication [161].  
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Some respondents within the customer interviews had a fear of their medication and 
attempted to control the condition psychologically to avoid exposure to steroids. Only 
two respondents felt comfortable enough to manage their medication, and increase the 
dosage of both their inhalers if they were feeling unwell. A study by Asthma UK 
found that people with asthma were concerned about side effects with their 
medication, and many were discouraged from taking their medicines as a result [147]. 
This was particularly apparent with parents of children with asthma and younger 
people. Although people with asthma recognise the central role of medications in the 
management of their condition, fear and concerns about the adverse effects of 
prolonged medicine taking is still common [155, 158].   
 
Studies such as the Needs of People with Asthma survey have found that 44% of 
people with asthma knew about allergies, their possible effects and triggers of asthma 
symptoms [153]. Within the customer interviews, there was a good level of awareness 
amongst respondents of what triggered their asthma. Triggers such as exercise, 
hayfever, weather, dust, stress, animals and pollution were commonly recognised by 
people with asthma. For some respondents, being aware of the trigger allowed them to 
put in place measures to avoid exposure, such as replacing carpets for wooden floors 
to minimise dust. Allergen avoidance has been linked with the desire to achieve 
greater control of asthma by eliminating the cause, resulting in a reduction in 
medication use [155]. For others, avoidance of the trigger was not always an option, 
so the respondents managed the resulting symptoms from exposure with medication. 
This was particularly apparent with respondents with pets which triggered their 
asthma. Symptoms displayed amongst the respondents were common place with 
people with asthma, namely difficulty in breathing, wheezing, tightness of the chest 
and coughing. The way in which respondents described these symptoms however, was 
extremely personal.  
 
A person with good control and management of their asthma should lead a relatively 
symptom free life [145]. This was not the case however, within all three data sets 
where the regular occurrence of asthma symptoms was high. Within the omnibus data, 
34% of respondents suffered from symptoms on a weekly basis or more. As part of the 
asthma audits, (62% within audit one, and 38% within audit two) respondents had 
experienced regular symptoms from their asthma in the last week, and the majority of 
respondents within the customer interviews experienced symptoms daily. Other 
studies such as the Impact of asthma survey have also found symptom control to be 
poor, with as many as 42% of people with asthma experiencing symptoms on all or 
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most days, and 71% experiencing symptoms weekly [162]. Other surveys have found 
that as asthma severity increase, so does the frequency of symptoms [153].  
 
Difficulty sleeping was experienced by 28% of respondents with audit one, and 18% 
within audit two. Other studies have reported figures of sleep disturbance ranging 
from 25% to 44% where people with asthma were waking at night more than once a 
week [146, 147, 162]. 
 
Respondents seemed to accept the occurrence of daily symptoms as part of their 
normal life, and something they had to live with.  When questioned as part of the 
asthma audits, only one fifth of respondents felt that their asthma interfered with their 
usual activities. This number could be an underestimate if people with asthma accept 
the restrictions that their condition places on them. People with asthma seem to accept 
the restrictions that the condition places on their lifestyle as demonstrated by key 
findings from the Asthma Control and Expectations survey [159]. Of those patients 
who said they usually felt well, around a third experienced daily symptoms, of which 
just over half accepted limitations on their lifestyle. Other studies that have 
investigated the impact of asthma on peoples lives have also found that only a quarter 
of respondents said that asthma had a major impact on their life, despite the high level 
of symptom occurrence amongst two fifths of total respondents [162].  
 
Given the previous data presented in this section regarding the use of medication and 
frequency of symptom occurrence, it is surprising to discover that three quarters of 
respondents questioned within the customer interviews believed that their asthma was 
under control. Other studies have reported that approximately half of patients with 
severe asthma symptoms considered themselves to be completely or well controlled 
[146]. People with asthma tend to underestimate the severity of their condition, and 
overestimate the level of control, and settle for much less than could be achieved 
through better management strategies [146]. A quarter of respondents within the 
customer interviews admitted to their asthma being poorly controlled, but were unsure 
as to how to improve this. What is good control? To a healthcare professional this 
would be someone who was relatively symptom-free, to a person with asthma it could 
mean not being on steroid tablets, or in hospital.  
 
The self care survey found that among those with a long term condition, 43% said that 
their condition limited their activities [135], equating to a quarter of the English 
population being limited by a long term condition. Asthma symptoms can have a 
 165 
major impact on the quality of life of people with asthma by limiting everyday 
activities [146, 153]. It can place severe restrictions on the life of someone with the 
condition, and was seen to do just this in over half of the respondents participating in 
the customer interviews. The emotional and physical impact of asthma varied amongst 
respondents, and ranged from life changing activities such as giving up work, through 
to the avoidance of certain situations. Many of the respondents had to change aspects 
of their life to help them mange their asthma symptoms. This included having to shop 
in certain places that were within easy walking distance, through to changing their 
working hours to avoid rush hour traffic and pollution. In a large scale survey by 
Asthma UK [142], they also found that 42% of people with asthma avoided walking 
and shopping in congested areas due to traffic fumes, and 40% avoided smoky pubs. 
Many respondents also avoided exercise because they felt that this was something that 
they could no longer do, yet research shows that taking exercise and staying fit can 
help to keep asthma symptoms under control [142]. Conditions like asthma can have a 
financial impact on individuals by reducing their working income or by changing the 
home environment to reduce exposure to triggers such as dust.  Over a third of 
respondents felt that their asthma did not restrict them in any way, but did feel that it 
limited the activities that they could participate in. There seemed to be a general 
acceptance amongst respondents of the restrictions that their asthma placed on them, 
and that this was part of their everyday life. It has been suggested that some patients 
may see symptoms and lifestyle restrictions as integral aspects of having asthma 
[159]. This research supports recent activity undertaken by Asthma UK [147] which 
also showed that people with severe asthma either continued with their lives despite 
their asthma symptoms, or undertook limited activities as they found control of their 
symptoms difficult. In addition, Asthma UK also found that women were more likely 
to report a heavier burden of symptoms and limitations on daily life, particularly when 
it came to exercise and work. Within the customer interviews, there was no difference 
in reporting of restrictions between males and females, which would not be expected 
within the small sample of this study. 
 
Despite the level of knowledge a person with asthma has on their condition, there is 
still a large cohort of people that have poor control of their condition and who 
experience regular symptoms. As a result of this, many accept the restrictions and 
limitations that asthma places on their lives. There is an opportunity for community 
pharmacists to help to identify people with poor control of their asthma through the 
use of simple questions, such as the RCP. Pharmacists can act as an information 
source for people wanting general advice on asthma, or can proactively target 
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customers when they are in the pharmacy. Information could be provided in several 
formats, and across a variety of topic areas to cater for varying customer needs. 
Pharmacists could also find a way of highlighting new information and research as 
and when it becomes available.  There is also a need to help people to understand and 
manage their condition better by helping them to recognise trigger factors for their 
asthma, and identify strategies for managing symptoms. Pharmacists can also help 
improve concordance by helping customers to understand their condition better, and 
by improving their understanding and confidence with medication.  
 
Problems with poor levels of knowledge and understanding of a condition, use of 
medication, levels of management of a condition, and quality of life are not unique to 
asthma and are experienced by many people with a long term condition [135]. 
Although this study uses asthma as an example, the customer need and demand for 
such services is not unique to this condition. The difficulty is being able to help 
patients recognise the need for help, and their willingness to access services that 
provide support and advice from the community pharmacist.  
 
 
6.4 Summary of chapter VI: Factors affecting the 
opportunities available for pharmacists in the delivery of 
asthma services  
Although the results presented in this chapter are not new findings, they have helped 
to update and reinforce previous research carried out that identifies the problems that 
people with asthma experience. This chapter has highlighted the fact that many people 
with asthma still have a relatively poor knowledge of their condition and its 
management. To some, there is a fear of finding out more information about their 
asthma, but to others they simply believe that they know enough already. Use of 
medication is poor, with many patients not always picking up all of the medication 
that their GPs have prescribed. There is a high use of reliever medication, and an 
under use of preventer inhalers. The majority of patients still experience regular 
symptom occurrence as a result of their asthma, and readily accept the restrictions that 
it places on their lifestyle.  
 
People with asthma need to be able to access up to date and reliable information on 
their condition through a number of medium, including the regular reinforcement of 
key messages by all healthcare professionals. Most people appear to be responsive to 
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new information that can help to improve symptom control, or reduce medication use. 
The expectations of people with asthma need to be raised so that the majority are 
aiming to be relatively symptom free, with few or no restrictions on their lifestyle. 
People with asthma need to have a better understanding of how to control their 
condition, including management strategies and the use of medication.  
 
There is an opportunity for community pharmacists to help to identify people with 
poor control of their asthma through the use of simple questions. Pharmacists can act 
as an information source for people wanting general advice on asthma, or can 
proactively target customers when they are in the pharmacy. There is also a need to 
help people to understand and manage their condition better by helping them to 
recognise triggers for their asthma, identify strategies for managing symptoms, and 
improve understanding and confidence with medication. Although this study uses 
asthma as an example, the concept around customer need and demand for such 
services is not unique to this condition, and as such could be applied to other condition 
areas.  
 
From the opportunities identified within this chapter, a summary of the potential 
factors that could affect service delivery are summarised in Table 34. Where similar 
themes have been identified within previous literature, this has also been indicated. As 
found within chapter five, many of the factors affecting service delivery are the 
opposites of each other, where a factor acting as a facilitator can be reversed to act as a 
barrier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 168 
Table 34: Potential factors affecting service delivery identified from the opportunities 
available to pharmacists in the delivery of asthma services  
 Facilitators Barriers  
Customer 
need 
Customer need for service, including; 
̇ Poor knowledge  
̇ Poor symptom control 
̇ Poor use of medication 
̇ Poor management of condition 
̇ Poor quality of life 
[1, 11, 20] 
No customer need for service, good 
control and management of 
condition 
 
 
 
 
Customer 
demand 
Demand for service, including; 
̇ Interest in accessing additional 
information  
̇ Interest in improving 
management of condition  
[16] 
No demand for the service, or 
interest in improving condition 
 
 
 
[1, 8, 14, 16] 
Recruitment 
Pharmacists able to identify 
customers easily that require help or 
support  
Customers not easily identifiable  
Public 
attitude 
Customers interested in accessing 
services and advice on particular 
condition area  from the pharmacist 
Customers not willing to access 
services and advice on particular 
condition area from the pharmacist 
 
All the factors identified from this chapter will be discussed in more detail in chapter 
nine where final conclusions will be drawn. The next chapter of this thesis presents the 
results from the delivery of the two asthma services within Boots, and identifies the 
facilitators and barriers that may have affected service delivery.  
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CHAPTER VII 
Facilitators and barriers affecting delivery 
of the asthma services 
 
7.0  Introduction to the chapter 
So far within this thesis, I have looked at the changes within the health service 
environment concerning community pharmacy, and the factors affecting service 
delivery that have been identified within the literature. These results have been 
presented over a series of chapters, enabling me to investigate the numerous factors 
that could affect the implementation and delivery of services within community 
pharmacy. The first of the results chapters looked at the factors affecting the publics 
utilisation of the community pharmacy and the pharmacists role in service delivery. 
Following this, I looked at the factors affecting the opportunities available for 
pharmacists in the delivery of asthma services. The results presented within this 
chapter are following the implementation of two asthma services used in this study in 
an attempt to identify experiential and potential facilitators and barriers affecting 
service delivery. Details of the two services including implementation methods were 
provided in chapter three.  
 
Data is presented on the views of pharmacists and customers, as well as operational 
and environmental factors collected through quantitative methods. Due to the large 
quantities of data presented within this chapter, I have segmented the presentation of 
the results into three sections. The first section presents the results from the delivery of 
the brief intervention in asthma, which was a national service developed centrally. The 
second section of this chapter presents the second asthma service, which was 
developed and managed locally. The last section in this chapter looks at the 
recommendations that have been made by customers and pharmacists for future 
service delivery, i.e. the potential facilitators. Each section presents the results, a brief 
discussion, and a summary of initial conclusions. The findings from all the results 
presented within this thesis are discussed in more detail in chapter nine.  
 
The factors affecting service delivery identified within the literature have already been 
discussed within chapter two, and are therefore not repeated within this chapter.  
However, a summary is provided as an aide memoir when reading this section. The 
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factors can be grouped under key headings comprising: customer need and demand for 
the service, public attitude, pharmacist characteristics and attitude, training, 
communication, awareness of the service, recruitment to the service, operational 
aspects of service delivery, pharmacist confidence in service delivery, support for the 
service, time, staff resource, remuneration, the pharmacy environment, healthcare 
professional relationships, evidence of the value of the service, and the external 
environment.  
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SECTION ONE 
 
7.1 Delivery of the brief intervention in asthma (service one) 
The brief intervention in asthma was designed centrally and implemented nationally 
throughout Boots during March 2003. The intervention was designed around 
pharmacists and healthcare staff asking customers with asthma three basic questions to 
find out their level of symptom control. Based on the response, the pharmacist or 
healthcare staff would then provide appropriate lifestyle advice to the customer. This 
brief intervention was kept extremely simple to encourage pharmacists and 
healthcare staff to integrate the intervention into their current practice and role. 
 
Within this section, I provide the results from the delivery of the brief intervention in 
asthma in an attempt to explore the various factors that could affect service delivery. 
Data is provided from the customer and pharmacist interviews, along with the mystery 
customer research. The results presented explore implementation of the service, 
recruitment to the intervention, delivery rates, frequency of questions that were asked, 
personnel delivering the interventions, the type of lifestyle advice given, asthma 
advice provided, the pharmacy environment, and factors affecting delivery as 
identified by the pharmacists participating in the service.  
 
 
7.1.1 Results 
7.1.1.1 Implementation of the brief intervention 
During the interviews, a number of the pharmacists commented on the implementation 
of the brief intervention, and were extremely positive. The literature that they had 
received helped to refresh their knowledge on asthma, and the content was found to be 
very relevant for interactions with customers;  
 
P9 “…I thought it was good, we had all the information and the pharmacist went through 
it with me, was quite clear to follow. Got all the letters, thought was a good way of 
putting it across.” 
 
The intervention consisted of asking three simple questions about symptom control 
and then offering basic lifestyle advice. The pharmacists found this simple structure 
useful and easy to follow; 
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P10  “…quite useful, to give it a more structured view, more professional patter, quite 
useful to have it done for you.” 
 
One pharmacist thought that the lifestyle advice was excellent, but would have liked 
the opportunity to talk through it in more detail with a colleague before they offered 
the service.  
 
7.1.1.2 Recruitment to the brief intervention  
During the interviews, many of the pharmacists were asked how they approached 
customers about the brief intervention. All of the pharmacists questioned about this 
responded by saying that they targeted customers when they came in to the pharmacy 
with an asthma related prescription. This had worked well in most areas, although 
pharmacies serving high numbers of the elderly population had actually found that this 
identified more patients with Chronic Obstructive Pulmonary Disease (COPD) than 
asthma;  
 
P9 “What we’ve done is we’ve looked at any patients that were asthmatics, looked at 
their prescriptions and then had a word with them if we had time, what we found was 
a lot of our patients were COPD patients, with it being an elderly population in 
XXXXX, rather than asthma.” 
 
One of the pharmacists had also actively looked at targeting customers that came in to 
purchase OTC medicines;  
 
P1 “The few that I did were from different routes. Some were prescription led and the 
other girl I spoke to was as she asked me for advice on hay fever and how best she 
could control it.” 
 
A number of the pharmacists stated they would try and speak to customers as they 
handed out their prescriptions, and would target those that were particularly at risk;  
 
P10 “Different ways, sometimes if you see someone with two or three salbutamol inhalers 
on their own we pick up, or someone who says they don’t want a betamethasone. If 
you see someone with just a reliever which they shouldn’t use a lot of on their own 
you would pick that up and think actually why are they using so much of that. Maybe 
pick up people at risk, scripts that you can see that are new, have come from the 
hospital, or handwritten by a GP and you just really gauge it, if you’re not busy and 
that person doesn’t look like they want to rush off, it’s intuition, sometimes if you try 
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and push too much information at someone who doesn’t want it, it can actually go the 
wrong way.” 
 
Pharmacists that were actively targeting groups of customers for repeat prescription 
services found the brief intervention to be a useful addition; 
 
P8 “For me it was very easy because we have a policy of targeting particular groups of 
patients to see if they want to come onto our repeat prescription collection service so 
and the types of patients that we go for with that are asthmatics, diabetics, people who 
have regular repeat medication. Because then it guarantees us those repeat 
prescription items, also it means we can manage our workload better. So to a degree 
a lot of the patients were being targeted anyway so this was just something extra we 
were able to offer.” 
 
Although marketing materials were not provided for the brief intervention, one 
pharmacist had designed a poster themselves to proactively try and get customers to 
ask about the service;  
 
P1 “…what I did was design a poster to put up on the counter. I guess as I panicked that 
I wouldn’t be able to recruit anyone myself at the counter I opted for the route of 
promoting the service.” 
 
As the intervention was so simple, pharmacists tried to use this to encourage 
customers to talk to them about their asthma, without feeling pressurised;  
 
P8 “It was more in the way of, this is something that we’re doing, you may feel that it is 
of benefit to you and if so we’re more than happy to progress and go through it with 
you. What we didn’t want to do was to pressurise or sort of force people into it.” 
 
As part of the customer interviews, respondents were asked how they were 
approached by the pharmacists for the brief intervention. Although the majority of 
respondents were approached in the pharmacy whilst collecting a prescription or 
shopping, over half of these claimed that they were approached to take part in a 
survey; 
 
C9 “…they said they were doing a survey into asthma and asked if I would mind doing a 
short interview.” 
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C22 “Basically I was getting my prescription for my inhalers and there’s a guy that asked 
me if I wanted to take part in some asthma research and I think any kind of asthma 
research is a good thing, there are far too many people that have got it, …..” 
 
A couple of the respondents had been recruited to the survey by the pharmacists 
talking to their partners, who had gone in to pick up their regular prescriptions; 
 
C20 “I wasn’t there so I can’t say. The pharmacist must have mentioned when handing 
over the inhaler can we take your fiancée’s details or whatever and then someone 
phoned me a few weeks ago, I don’t mind doing it, anything to help, but I don’t really 
know anything about it.” 
 
Over a quarter of the respondents questioned had been approached directly by the 
pharmacist about their asthma whilst they had been picking up their prescription. 
Following the discussion, the pharmacist had asked them whether they would be 
willing to participate in a survey;  
 
C10 “I went to pick up my prescriptions and she asked me about them and then asked if I 
would be interested in taking part in an interview regarding the asthma.” 
 
A total of three respondents had approached the pharmacist themselves, either about a 
general enquiry on their asthma or with inhaler difficulties;  
 
C13 “…I was in town and my inhaler didn’t seem to be working properly so I popped in 
and asked if they could have a look at it for me. I have to say the sales assistant was 
really helpful and got the pharmacist for me. He realised the cartridge wasn’t fitted 
properly so got me a new one.” 
 
7.1.1.3 Delivery rates of the brief intervention  
The delivery rates of the brief intervention in asthma were measured using the mystery 
customer research as a proxy to identify those pharmacies that had implemented, and 
were delivering the intervention. The total number of mystery customer assessments 
between May and August 2003 for the asthma scenario was 2756, within 1222 
pharmacies. To understand the delivery process in more detail, these data have been 
broken down for analysis into sub sets for those delivering the brief intervention, 
pharmacies that were consistently positive, and those pharmacies that delivered the 
full intervention (refer to Table 35). Due to the nature of these data, there will be an 
element of overlap within the different data sets.  
 175 
Table 35: Definition and sample size of all mystery customer data sets 
Data set Definition Sample  Pharmacies 
All data (AD) Total number of pharmacies assessed with the 
asthma scenario throughout the four month 
period 
2756 1222 
Brief 
intervention (BI) 
Pharmacies that asked one or more RCP question 
and / or gave lifestyle advice 
1989 1105 
Consistent 
positive (CP) 
Pharmacies that were assessed more than once 
and were consistently positive in delivering the 
BI 
1002 410 
Full intervention 
(FI) 
Pharmacies that asked all three RCP questions 
and gave lifestyle advice 
41 40 
 
Over the four month period, 2756 mystery customer assessments for asthma were 
carried out. Of these, 72.2% (n=1989) carried out the brief intervention, 36.4% 
(n=1002) were consistently positive in performing the intervention, and 1.5% (n=41) 
delivered the full intervention.  
 
Brief intervention 
Throughout the mystery customer assessment period, pharmacies were classed as 
using the brief intervention if they had asked one or more of the RCP three questions, 
and / or gave lifestyle advice. During May, 65.7% (n=496) of pharmacies assessed 
were using the intervention. This rose to 84.3% (n=591) in June and 83.8% (n=650) in 
July, and then dropped to 48.1% (n=252) in August (refer to Table 36). 
 
Table 36: Overview of mystery customer results between May and August 2003 
  May June July August 
Total number pharmacies assessed 1263 1265 1395 1406 
Pharmacies where asthma scenario carried out 755 701 776 524 
No advice given (%) 34.3 15.7 16.2 51.9 
Some lifestyle advice given (%) 23.6 26.5 25.9 6.7 
Asked one or more RCP question (%) 46.8 61.1 62.2 46.2 
Asked all three RCP questions and gave lifestyle advice (%) 
1.7 0.9 1.3 2.3 
Asked one or more RCP question and / or gave lifestyle 
advice = BRIEF INTERVENTION (%) 
65.7 84.3 83.8 48.1 
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Consistent positive data 
Over the four month period a total of 2756 asthma scenarios were carried out within 
1222 pharmacies, of which a number were assessed on more than one occasion. In 
total, 21.9% (n=268) of pharmacies were assessed once, 39.1% (n=477) were assessed 
twice, 30.6% (n=374) were assessed three times, and 8.4% (n=103) were assessed four 
times (refer to Table 37). 
 
Table 37: Frequency of pharmacy assessment versus results for all mystery customer 
data (n=2756) 
Number of 
pharmacy 
assessments 
Brief 
intervention 
No 
intervention 
Total number 
assessments 
Number 
pharmacies 
1 187 81 268 268 
2 703 251 954 477 
3 795 327 1122 374 
4 304 108 412 103 
Total 1989 767 2756 1222 
 
Of those pharmacies assessed twice, 53.7% (n = 256) were consistent in delivering the 
brief intervention. This decreased slightly to 33.7% (n = 126) consistent delivery in 
those pharmacies that were assessed three times, and 27.2% (n = 28) in those assessed 
four times. Over the total four month period of those pharmacies that were assessed 
more than once, 43.0% (n = 410) were consistently positive in delivering the brief 
intervention. 
 
The detailed breakdown of delivery within consistent positive pharmacies can be seen 
in Table 38. One or more RCP questions were asked on 75.5% (n=757) of occasions, 
whilst all three RCP questions and advice on lifestyle was given on 1.4% (n=14) of 
occasions. Lifestyle advice alone was given on 29.5% (n=296) of occasions.  
 
Table 38: Delivery of brief intervention within consistent positive pharmacies (mystery 
customer data, n=1002) 
  Frequency Percentage 
Some lifestyle advice given  296 29.5 
Asked one or more RCP question  757 75.5 
Asked all three RCP questions and gave lifestyle advice  14 1.4 
Asked one or more RCP question and / or gave lifestyle advice 1002 100.0 
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Full intervention data 
Pharmacies that asked all three RCP questions and gave lifestyle advice were classed 
as conducting the full intervention. Over the four month period, a total of 41 mystery 
customer visits met these criteria, across 40 pharmacies. 
 
During May, 1.7% (n=13) of pharmacies assessed with the asthma scenario conducted 
the full intervention. This dropped slightly in June to 0.9% (n=6), and then rose again 
to 1.3% (n=10) in July and 2.3% (n=12) in August.  
 
7.1.1.4 Frequency of question asked by staff 
The mystery customer research collected data on which RCP questions were asked. 
These data have been analysed in sub sections for those pharmacies delivering the 
brief intervention, those that were consistently positive in delivering the asthma 
intervention, and those that delivered the full intervention, to be able to compare the 
results. The views of pharmacists on the use of the RCP questions are also presented.  
 
Brief intervention data (n=2756) 
Across all four months data, pharmacy teams consistently asked people with asthma 
the third of the three RCP questions more frequently than the other two, followed by 
the second and then the first (refer to Table 39). 
 
Table 39: Frequency of question asked as a percentage of total pharmacies assessed 
(mystery customer data) 
Percentage of pharmacies assessed 
RCP question May  
(n=755) 
June  
(n=701) 
July  
(n=776) 
August 
(n=524) 
q1 
Have you had difficulty sleeping because of 
your asthma symptoms?  
12.1 14.3 16.8 18.7 
q2 
Has your asthma interfered with your usual 
activities?  
24.2 21.1 26.3 32.3 
q3 
Have you had your usual asthma symptoms 
during the day?  
28.5 46.4 41.2 39.1 
Pharmacies asking one or more RCP question 46.8 61.1 62.2 46.2 
 
The sum of the frequency of pharmacies asking each individual question is greater 
than the total number of pharmacies asking any RCP question, as many pharmacies 
asked more than one question during the period of assessment. 
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Table 40 shows the distribution of personnel asking each RCP question, as a 
percentage of the number of that personnel assessed. There was a significant 
difference between the personnel asking question two, with pharmacists and 
unknown personnel more likely to ask this than non pharmacist personnel 
(Ȥ2=16.493; p<0.05). Pharmacists were also more likely to ask question three than 
other personnel (Ȥ2=7.276; p<0.05). 
 
Table 40: Type of personnel asking RCP questions, as a percentage of personnel assessed 
(mystery customer data) 
RCP question (%) 
Personnel assessed 
q1 q2 q3 
Pharmacist 14.7 28.9 41.6 
Unknown 17.2 28.4 37.8 
Non pharmacist 15.1 22.0 36.3 
 
Consistent positive data (n=1002) 
Pharmacies that were consistently positive, asked question one on 21.4% (n=214) 
occasions, question two on 34.9% (n=350) occasions, and question three on 54.1% 
(n=542) occasions. Question three was the most frequently asked question, regardless 
of the number of pharmacy assessments, followed by question two, and then question 
one (refer to Table 41). 
 
Table 41: Frequency of question asked as a percentage of consistent positive assessments 
(mystery customer data) 
Number of pharmacy assessments (%) 
RCP question Two  
(n=512) 
Three  
(n=378) 
Four  
(n=112) 
Total  
(n=1002) 
q1 Have you had difficulty sleeping because of 
your asthma symptoms?  
22.1 20.6 20.5 21.4 
q2 
Has your asthma interfered with your usual 
activities?  
30.1 38.1 46.4 34.9 
q3 
Have you had your usual asthma symptoms 
during the day?  
53.3 54.0 58.0 54.1 
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Full intervention data (n=41) 
By definition, the full intervention involves the pharmacy asking all three RCP 
questions and giving lifestyle advice, so each pharmacy asked all three questions on 
all 41 occasions. 
 
Comparison of data sets 
Within the full intervention data, 100.0% (n=41) of pharmacies asked all three RCP 
questions. Across all the other data sets, question three was the most frequently asked, 
followed by question two, and lastly question one (refer to Table 42). Consistent 
positive pharmacies asked all three RCP questions more frequently than the BI 
pharmacies.  
 
Table 42: Frequency of question asked for all mystery customer data sets 
Percentage of pharmacies assessed 
Data set 
q1 q2 q3 
Brief intervention (n=2756)  15.2 25.5 38.6 
Consistent positive (n=1002) 21.4 34.9 54.2 
Full intervention (n=41)  100.0 100.0 100.0 
 
Pharmacist views on RCP questions 
During the interviews, eight pharmacists were specifically questioned on their use of 
the RCP questions. Half of the pharmacists were extremely positive about the 
questions, and thought that they were extremely easy to use; 
 
P2 “They seemed to work really well and at least it was an easy way of approaching 
customers in a way that they understood. You know, not too scientific so it put them 
off.” 
 
Many of the pharmacists would ask the RCP questions to people that they knew had 
asthma, or those that seemed interested when collecting their prescription; 
 
P4 “Where appropriate I managed to ask them, but only those who seem interested or 
that I have seen regularly when they come in to collect their prescriptions. I might ask 
how they are getting on with their inhaler and include some of the questions in that.” 
 
A couple of the pharmacists questioned stated that they used to speak customers with 
asthma prior to the intervention, so had integrated the RCP questions into that. To 
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these pharmacists, this type of intervention was seen as something that they should be 
doing anyway; 
 
P6 “Usually I just do simple checks with customers whether they have used their asthma 
medication before and if they haven’t I’ll take them through it briefly just so they 
understand how it will work and what they should be doing. I do it for most 
prescriptions I hand out – Its all part of the job and what we’re trained to do.” 
 
One of the pharmacists did not use the RCP questions in particular, but had come up 
with their own version of questioning that they had started to use when speaking to 
customers with asthma;  
 
P5 “I haven’t really used it I have to admit. You just get on with your job on a day to day 
basis and if you haven’t got it in your hand you don’t tend to think about it. Although 
to be fair I have managed to chat to asthma sufferers, particularly if someone has a 
child with them. I might ask them a few questions if I hear them coughing. Then I 
might ask if this is mainly at night and whether or not they have been tested for 
asthma before or if it runs in the family. Then if I think they might have it and they 
haven’t been diagnosed by their GP I might ask if they are worse if they do any 
exercise. Its basic stuff really but probably in a way I have also been offering the 
service – just not necessarily what I would term intervention – more common sense 
and what I see as part of my every day job.” 
 
Three of the pharmacists questioned had negative views on the use of the RCP 
questions. For one respondent, this was because they felt that it was not appropriate 
for the pharmacist to be asking questions like these; 
 
P9 “You know the 3 questions, we didn’t really look into that as much as that was more 
the kind of thing that they would probably inform their doctor or nurse if they were 
wanting a change, you know sleeping difficulties, or about their symptoms 
interfering.” 
 
The questions were seen to be slightly obtrusive to customers by one pharmacist, and 
difficult to bring into the conversation;  
 
P10 “I think that it’s a question of time to work out the best way of asking them. I think by 
asking ‘is your sleep being disturbed’ I think some people would think ‘what – this is 
asthma’, they don’t connect the two, have to make them realise that there’s a 
connection before you ask the question.” 
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The use of the RCP questions was also seen to be very formal, and some pharmacists 
found it much easier to talk to people generally rather than asking specific questions;  
 
P11 “When we talk to them it’s much easier to talk to them generally how they’re getting 
on as apposed to giving them three - four questions to say ‘are you doing this and are 
you doing that’, and that tends to put them off when you ask them direct questions as 
opposed to talking to them about the general state of what their asthma is like.” 
 
7.1.1.5 Personnel delivering the brief intervention in asthma 
As part of the mystery customer research, the personnel delivering the intervention 
were recorded as either pharmacist, non pharmacist or unknown. Non pharmacist 
was the terminology that was used to represent healthcare and pharmacy assistants 
working on the pharmacy counter and unknown personnel was used if the mystery 
customer could not distinguish as to whether the person being assessed was a 
pharmacist or non pharmacist. During the four month period, the mystery customer 
assessed the pharmacist on 40.3% of the occasions (n = 1112), non pharmacist 
personnel on 47.6% occasions (n = 1313), and unknown personnel on 12.0% 
occasions (n = 331).  
 
Brief intervention data 
Of the total pharmacists that were assessed over the four month period, 78.7% (n = 
875) delivered the brief intervention, and of the non pharmacists assessed, 67.5% (n = 
886) delivered the brief intervention. Of the unknown personnel, 68.9% (n = 228) 
were found to be delivering the brief intervention throughout the assessment period. 
These data show that pharmacists were significantly more likely to deliver the brief 
intervention than the other personnel (Ȥ2=39.68; p<0.05). 
 
The percentage of unknown personnel conducting the intervention rose in July and 
August, as shown in Table 43.  
 
Table 43: Number of ‘unknown’ personnel conducting the brief intervention between 
May and August 2003 (mystery customer data) 
 May June July August 
Conducted BI 35 58 96 39 
% of total assessed 7 10 15 16 
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Consistent positive data 
Pharmacists carried out the intervention on 42.5% (n=453) occasions, non pharmacist 
personnel on 43.1% (n=432) occasions, and unknown personnel on 11.7% (n=117) 
occasions (refer to Figure 17). A Chi test was performed, but no significant difference 
was found between the personnel that were delivering consistent positive 
interventions. 
 
Figure 17: Breakdown of personnel delivering consistent positive interventions (mystery 
customer data, n=1002) 
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Full intervention data 
The breakdown of personnel delivering the full intervention can be seen in Figure 18. 
Pharmacists delivered the full intervention on 48.8% occasions (n=20), non 
pharmacists on 22.0% of occasions (n=9), and unknown personnel on 29.3% 
occasions (n=12). 
 
Figure 18: Breakdown of personnel delivering the full intervention (mystery customer 
data, n=41) 
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Comparison of data sets 
Across the brief intervention and consistent positive data sets, pharmacists delivered 
the interventions more frequently than the other personnel, followed by unknown 
personnel, and lastly non pharmacists (refer to Table 44). For the full intervention 
data, 3.6% (n=12) of unknown personnel assessed delivered the intervention, 
compared to 1.8% (n=20) of pharmacists assessed, and 0.7% (n=9) of non pharmacists 
assessed.  
 
Table 44: Delivery of the intervention by personnel shown as a percentage of the type of 
personnel assessed (mystery customer data) 
Percentage performing intervention 
Data set Pharmacist
(n=1112) 
Non pharmacist 
(n=1313) 
Unknown 
(n=331) 
Brief intervention 78.7 67.5 68.9 
Consistent positive 40.7 32.9 35.3 
Full Intervention 1.8 0.7 3.6 
 
 
7.1.1.6 Type and frequency of lifestyle advice provided 
Mystery customers recorded whether advice was given during the brief intervention, 
and if so, the type of advice given to them. The data presented here has been sub 
divided to look at the differences between advice given as part of the brief 
intervention, those pharmacies that were consistently positive in delivering the 
intervention, and those that delivered the full intervention. 
 
Brief intervention data 
Of the total number of pharmacists assessed, 26.1% (n = 290) gave some lifestyle 
advice. For non pharmacists assessed, only 17.6% (n = 231) gave some lifestyle 
advice, and for unknown personnel, 23.3% (n = 77) gave lifestyle advice.  This 
difference between staff groups was found to be significant (Ȥ2=26.03; p<0.05). 
 
Figure 19 provides an overview of the type of advice the pharmacy teams gave to 
people with asthma over the four month assessment period. During May, June and 
July 2003 the most common type of advice that the pharmacy teams gave involved a 
referral to a GP (n = 337). This was followed by advice on inhaler technique (n = 
110). Pharmacists were more likely to give advice on inhaler technique (n = 70), than 
non pharmacist (n = 29), and unknown personnel (n = 11) (Ȥ2=59.931; p<0.05). Very 
few referrals were made to the asthma nurse or clinic (n = 10).  
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Figure 19: Type of advice delivered as part of the brief intervention between May and 
August 2003 (mystery customer data, n=598) 
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Consistent positive data 
Lifestyle advice was given on 29.5% (n=296) of occasions within consistent positive 
pharmacies. This was delivered by the pharmacist on 48.6% (n=144) of occasions, non 
pharmacists on 38.2% (n=113) occasions, and unknown personnel on 13.2% (n=39) of 
occasions. A chi test was performed but no statistical difference was found between 
the personnel giving lifestyle advice.  
 
The type of advice given was recorded on 99.7% (n=295) occasions, with one set of 
case notes uncompleted. Mystery customers were referred to the GP on 55.9% 
(n=165) occasions, given inhaler advice on 20.0% (n=59) occasions, advice on 
prescriptions on 9.5% (n=28) occasions, advice on lifestyle management on 8.8% 
(n=26) occasions, other advice on 3.7% (n=11) occasions, and referred to the asthma 
nurse / clinic on 2.1% (n=6) occasions (refer to Figure 20). Staff were more likely to 
refer mystery customers to the GP compared to giving other types of lifestyle advice 
(Ȥ2=15.896.; p<0.05). 
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Figure 20: Type of advice given by those pharmacies delivering consistent positive 
interventions (mystery customer data, n=296) 
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Full intervention data 
Lifestyle advice was given on all 41 occasions within pharmacies delivering the full 
intervention. The mystery customer was referred to the GP on 31.7% (n=13) 
occasions, given advice on lifestyle management on 29.3% (n=12) occasions, given 
advice on inhaler technique on 14.6% (n=6) occasions, referred to the asthma nurse on 
2.4% (n=1) occasions, given advice on prescriptions on 2.4% (n=1) occasions, and 
other advice on 19.5% (n=8) occasions (refer to Figure 21). 
 
Figure 21: Type of lifestyle advice that was given by those pharmacies delivering the full 
intervention (mystery customer data, n=41) 
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Figure 22 shows the breakdown of this advice by personnel. Pharmacists appeared to 
be more likely to refer people to the GP (n=9) compared to other personnel (n=4). 
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Pharmacists also appeared to give more advice on inhalers (n=5) compared to other 
personnel (n=1).  
 
Figure 22: Type of lifestyle advice that was given by personnel delivering the full 
intervention (mystery customer data, n=41) 
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Comparison of data sets 
Pharmacies conducting the full intervention gave lifestyle advice on all occasions 
(n=41). Those pharmacies that delivered a consistent positive result gave lifestyle 
advice on 29.5% (n=296) occasions, and those pharmacies delivering the brief 
intervention on 21.7% (n=598) occasions.  
Within all the data sets, referring customers to the GP was by far the most common 
piece of lifestyle advice given. The ranking of other lifestyle advice varied between 
interventions, as can be seen in Table 45. 
 
Table 45: Order of frequency of lifestyle advice given for all mystery customer data 
 Brief Intervention Consistent Positive Full Intervention 
Refer to GP 1 1 1 
Advice on inhaler 2 2 4 
Advice on prescription 3 3 5 
Advice on lifestyle 4 4 2 
Other 5 5 3 
Refer to asthma nurse 6 6 5 
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7.1.1.7 Type of asthma advice provided by pharmacists and staff 
From the eleven pharmacists that were questioned about the type of advice they had 
discussed with customers, all recalled incidents relating to advice on medication. The 
majority of these interactions seemed to be based around the customers understanding 
of their inhaler type and use; 
 
P10 “Lack of understanding of different inhalers, certainly as the range has increased 
now to preventers, controllers and combination controllers, One gentleman had an 
inhaler which was red and thought that was just for emergency use only, which 
actually is quite logical if you see red, but obviously is not what it has been dispensed 
for but what he has decided on, so better understanding of the different types of 
inhalers and definitely with steroid inhalers, use of them, getting rid of the powder 
being left in the mouth, that kind of thing.” 
 
There was a feeling amongst some of the pharmacists that the reason why most people 
were keen to talk about their inhaler use, was because they did not get the chance to do 
this with their GP after their initial diagnosis; 
 
P2 “It was all medication based. That’s where they seemed to have most of their issues. 
All three wanted advice on better use of their inhalers. They just don’t seem to get the 
chance to ask their GP very often as they’re really just collecting prescriptions.” 
 
P4  “And if they appear to have a few problems with it I might offer them some advice 
such as rinsing their mouth out after use and always checking that they have it with 
them as a precaution. Pretty basic stuff really but it all seems to help as most people 
don’t get much help after they initially get their inhalers.” 
 
The pharmacists felt confident in referring customers through to the GP if appropriate;  
 
P1 “I also referred someone to their GP who seemed to be coughing a lot while they 
were standing at the counter. They sounded to me like asthma symptoms and they 
themselves hadn’t thought of this before and took it well when I suggested she speak 
to her GP and have some tests run.” 
 
One particular pharmacist had actually spoken to the customers GP directly, and as a 
result had changed their inhaler type; 
 
P11 “Most of it has just been with inhaler technique. There’s a particular women who felt 
that her therapy wasn’t working particularly well, she was on high doses of 
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prednisolone to try and control her asthma and she was on a maximum dose of 
Ventolin® and after talking to her about inhaler technique and whether it was worse 
at night and all that stuff, it turned out that she just really didn’t know how to use her 
inhalers and then obviously I advised her it might be worth going for easy breathes, I 
spoke to the GP about it, the GP said they’d give her a go on easy breathe inhalers to 
see if it made a difference. So only time will tell I suppose.” 
 
The brief intervention and advice were also relevant for people with COPD. The 
interaction with customers was seen as just giving general advice, rather than an 
intervention itself; 
 
P9 “One lady we had it wasn’t asthma, it was COPD, she didn’t know how to use her 
Volumatic® spacer, so I just showed that to her. We had another inhaler where the 
lady, her husband, wasn’t sure how to use it, went through it with her as didn’t have 
patient information leaflet, so just more technique, not interventions as such that 
we’ve changed anything. Mainly given advice.” 
 
Over half of the pharmacists could also recall incidences where they had spoken to 
people with asthma about identifying triggers of their condition and how to minimise 
or alleviate these; 
 
P8 “It’s covered a multitude of sins really from basic inhaler technique to how to take 
care of their inhaler……..Talking about things that may make their condition worse – 
coughs, colds and things and what to do in that sort of eventuality.” 
 
The majority of the lifestyle advice that was given within the first set of interviews 
was mainly related to hayfever and allergies;  
 
P5 “I’ve been talking a lot at the moment about hay fever and how they could help 
themselves if they kept away from flowers and stuff.” 
 
The pharmacists felt that although they were not telling customers anything that they 
would not necessarily know already, they were helping to remind them of how they 
could help themselves; 
 
P4 “I told one lady to avoid being out in the evening when pollen is at its highest and that 
she shouldn’t cut the lawn. She seemed pleased with that idea and added that she 
would now tell her husband that he had to cut it as it would improve her 
condition………..And then I told another lady to hoover every day to lower the dust 
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levels in her house and to hoover her mattress every time she changed the sheets. 
They kind of know they should be doing this but it feels like it works as you’re 
reminding them of how they can help themselves.” 
 
The lifestyle advice was seen as practical and simple, and pharmacists believed that 
most customers they had spoken to seemed interested to listen to this advice;  
 
P1 “I also gave some general advice to use things like allergy free bedding and to stay 
outdoors. Fairly practical and simple stuff but most seemed interested to listen.” 
 
Some of the pharmacists varied the length of the consultation period depending on 
how receptive the customer was at talking about their asthma;  
 
P11 “Again it depends how receptive the person is. Some people want to talk for 20 
minutes; other people don’t want to know. Most of the time you’re probably talking 
about five minutes, not much longer than that really because again, they’ll answer 
your questions but you can almost see they’re holding back for whatever reason, 
they’re wondering why you’re asking all these questions all of a sudden.” 
 
For other pharmacists, the length of the consultation period depended on how busy 
they were at that time, or whether they had an additional pharmacist supporting them 
in the pharmacy; 
 
P10 “It really does depend how busy, if I’ve got a second pharmacist then you can 
obviously do more, so it’s difficult to say on a day to day basis, you just try and speak 
to the patients as you hand the medicines out and it might only be 10 – 20 seconds and 
if you’ve got more time you could spend a couple of minutes.” 
 
If the pharmacist or the customer were busy and did not have the time to spare straight 
away, some of the pharmacists used the opportunity to ask customers to come back at 
a later time to talk about their asthma; 
 
P8 “The other thing is that it gave us the opportunity to say perhaps by taking part in this 
you could come back at a quieter time and go through it and we were able to give 
them more advice about inhaler technique, etc.” 
 
During the customer interviews, respondents were asked what type of things the 
pharmacist had spoken to them about during their asthma discussion. Each customer 
described the interaction slightly differently. Although many of the customers felt they 
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knew quite a bit about their condition already, the interaction with the pharmacist was 
seen as a chance for them to discuss their condition with someone. The pharmacist 
interaction varied in length, with some spending a few minutes with the pharmacist, 
whilst others took about 15  20 minutes. The content of the discussion also varied 
between individuals, but tended to cover areas such as inhaler technique, medication 
use, symptom control, general information on asthma, and lifestyle tips;  
 
C13 “He asked me if my symptoms had changed and stuff and if there was anything he 
could help with.” 
 
One pharmacist / customer interaction was particularly helpful as the customer had 
come into the pharmacy to purchase cough medicine, but on further questioning by the 
pharmacist they realised that they needed further guidance from their GP for a 
problem with their asthma;   
 
C16 “She was most helpful went in for something else, she wanted to know what medicines 
I was on I had a list and one was the asthma, I said I haven’t taken it for two years, 
she gave me a booklet, asked if I understood everything and said I should see my GP 
again, as I originally went in for cough medicine.” 
 
Following the interaction with the pharmacist, two of the respondents also received 
printed literature. The content of the information provided was not found to be useful 
in the main, as the respondents felt they knew most of it already. Both did however 
discover one new piece of information, one in relation to brown inhalers causing sore 
throats, and the other to mould triggering their asthma.  
 
To five of the respondents, the interaction was perceived as a quick conversation with 
the pharmacist about their asthma medication, and nothing more. Other respondents 
that had spoken to the pharmacist did not really feel that they received any new 
advice; 
 
C12 “Well they didn’t really discuss it. They just asked me how I was feeling and whether 
there was anything I had noticed about my asthma that he could help with. So I 
mentioned the flower rash thing and all they could really say is to avoid having them 
in the house which is really what I already do. But I know they were just trying to 
help.” 
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A total of nine respondents claimed that they received no advice from the pharmacist, 
and their interaction with them was purely focused on asking them to participate in a 
survey; 
 
C9 “No, they just said someone would ring me to chat about it and I gave my name and 
they asked for my number and a good time to call.” 
 
C22 Just taking part in the research…………...” 
 
Although one of these particular respondents had not received any advice or 
information from the pharmacist on this occasion, they did recall a previous 
experience where they had received extremely positive advice from the pharmacist; 
 
C22 “They were, they have a really good herbal range of treatments, but with regards to 
my asthma they said the same as my doctors always said, it’s a steam, eucalyptus 
stuff, stuff to open my airways. They did recommend when I had a really bad chest 
infection to get one of those vaporises things, like a triangle that you put tablets in, 
and they heat it up and it puts eucalyptus and menthol in the air. It’s a Boots thing, 
I’ve never seen it anywhere else, and it’s absolutely fantastic. Quite a few of my 
friends and people I know with little children, because they cough the same way we 
can and it seems to help.” 
 
7.1.1.8 Delivery of the brief intervention within different pharmacy 
environments 
The delivery levels of the intervention across the mystery customer data sets, for each 
sizem of pharmacy are shown in Table 46 and displayed visually in Figure 23. The 
brief intervention and consistent positive data followed a similar distribution of 
pharmacy size to the total pharmacies assessed. Within the full intervention data, there 
was a larger percentage of A (39.0%, n=16) and B (39.0%, n=16) pharmacies 
compared to the other data sets. Pharmacies that were classed as size C represented a 
very small proportion of those carrying out the full intervention (4.9%, n=2). 
 
 
 
 
                                                 
m An explanation of the sizing codes are detailed in chapter four 
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Table 46: Distribution of pharmacy size as a percentage of pharmacies delivering the 
intervention (all mystery customer data) 
Percentage distribution 
Pharmacy 
size 
All data 
(n=2756) 
Brief intervention 
(n=1989) 
Consistent 
positive (n=1002) 
Full intervention 
(n=41) 
A 30.8 31.1 33.1 39.0 
B 32.3 32.0 30.5 39.0 
C 18.0 17.3 16.2 4.9 
D 10.7 11.5 11.1 9.8 
E 5.2 5.2 5.9 4.9 
F 3.0 2.9 3.2 2.4 
TOTAL 100.0 100.0 100.0 100.0 
 
 
Figure 23: Distribution of pharmacy size for all mystery customer data sets 
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The different delivery levels of the intervention across the mystery customer data sets 
for each type of pharmacyn are shown in Table 47 and displayed visually in Figure 24. 
The brief intervention and consistent positive pharmacies follow a similar distribution 
to the total pharmacies assessed. The full intervention pharmacies had a higher 
percentage of pop in (58.5%, n=24), large destination (12.2%, n=5) and work 
pharmacies (9.8%, n=4) compared to the other data sets. Small destination 
pharmacies did not perform as well as they did within the other data sets (19.5%, n=8). 
No health centre or edge of town pharmacies performed the full intervention. 
 
                                                 
n An explanation of the format codes are detailed in chapter four 
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Table 47: Distribution of format as a percentage of pharmacies delivering the 
intervention (all mystery customer data) 
Percentage distribution 
Pharmacy 
format 
All data 
(n=2756) 
Brief intervention 
(n=1989) 
Consistent 
positive (n=1002) 
Full intervention 
(n=41) 
Pop in 52.0 52.2 53.0 58.5 
Small 
destination 
28.4 28.8 27.9 19.5 
Large 
destination 
8.4 8.2 8.3 12.2 
Work 6.9 6.5 6.2 9.8 
Edge of town 2.9 3.2 3.6 0.0 
Health centre 1.4 1.0 1.0 0.0 
TOTAL 100.0 100.0 100.0 100.0 
 
 
Figure 24: Percentage distribution of pharmacy format for all mystery customer data sets 
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Brief intervention data 
The brief intervention data for pharmacy size follows a similar distribution to that of 
the total pharmacies assessed, as shown in Table 46. Further breakdown of the data to 
show the percentage of pharmacies per size delivering the brief intervention is shown 
in Table 48. No significant association was found between the delivery of the brief 
intervention and size of the pharmacy. 
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Table 48: Brief intervention data as a percentage of the pharmacy size assessed (mystery 
customer data) 
Pharmacy 
size 
Brief intervention data 
(n=1989) 
All data 
(n=2756) 
Pharmacies performing BI as a 
percentage of size assessed 
D 228 295 77.3 
E 104 142 73.2 
A 618 849 72.8 
B 637 890 71.6 
C 345 497 69.4 
F 57 83 68.7 
 
Differences in the delivery of the brief intervention were found between the different 
pharmacy formats, as shown in Figure 25. Health centre locations had the lowest 
score of 52.6% (n = 20) for delivering the brief intervention, whilst edge of town 
sites had the highest delivery rates of the brief intervention at 81.0% (n = 64). Health 
centre pharmacies were the least likely to conduct the brief intervention compared to 
the other pharmacy formats (Ȥ2=7.323; p<0.05).  
 
Figure 25: Delivery of the brief intervention within the different pharmacy formats 
(mystery customer data, n=2756) 
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There were also differences between the pharmacy formats as to whether lifestyle 
advice was offered as part of the mystery customer assessment, as shown in Figure 26. 
Lifestyle advice was given in 24.7% (n=57) of large destination pharmacies that 
were assessed, 22.4% (n=176) of small destination pharmacies, 21.9% (n=314) of 
pop in pharmacies, 19.9% (n=38) of work pharmacies, 18.4% (n=7) of health 
centre pharmacies and 7.6% (n=6) of edge of town pharmacies. Edge of town 
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pharmacies were the least likely to give lifestyle advice compared to the other formats 
(Ȥ2=9.596; p<0.05).  
 
Figure 26: Delivery of lifestyle advice against pharmacy format (mystery customer data, 
n=2756) 
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Consistent positive data 
The consistent positive data for pharmacy size follow a similar distribution to that for 
the total pharmacies assessed as shown in Table 46. Further breakdown of these data 
to show the percentage of pharmacies per size delivering the brief intervention is 
shown in Table 49. The larger pharmacy sizes E, F and D, and the smaller size 
A, were more likely to deliver a consistent positive result compared to the middle 
pharmacy sizes B and C. There was a significant difference between the sizes 
within those pharmacies that were consistent in delivering a positive brief intervention 
result (Ȥ2=36.44; p<0.05).  
 
Table 49: Consistent positive data as a percentage of the pharmacy size assessed (mystery 
customer data) 
Pharmacy 
size 
Consistent positive 
data (n=1002) 
All data 
(n=2756) 
Pharmacies performing CP as a 
percentage of size assessed 
E 50 142 41.5 
A 332 849 39.1 
F 32 83 38.6 
D 111 295 37.6 
B 306 890 34.4 
C 162 497 32.6 
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The distribution of format of consistent positive pharmacies assessed by the mystery 
customer is shown in Table 47. Further breakdown of these data to show the 
percentage of pharmacy format assessed that were consistently positive is shown in 
Table 50. There was a significant difference between consistent delivery of the 
intervention within the different pharmacy formats (Ȥ2=21.292; p<0.05), with edge of 
town pharmacies more likely to be consistently positive, and health centre pharmacies 
the least likely.  
 
Table 50: Consistent positive data as a percentage of the pharmacy format assessed 
(mystery customer data) 
Pharmacy 
format 
Consistent positive 
data (n=1002) 
All data 
(n=2756) 
Pharmacies performing CP as a 
percentage of format assessed 
Edge of town 36 79 45.6 
Pop in 531 1433 37.1 
Large 
destination 
83 231 35.9 
Small 
destination 
280 784 35.7 
Work 62 191 32.5 
Health centre 10 38 26.3 
 
Full intervention data 
Table 51 shows the number of pharmacies by size delivering the full intervention, as a 
percentage of the total number of pharmacies within that size that were assessed. 
Pharmacies that were sized A and B appeared more likely to deliver the full 
intervention compared to other pharmacy sizes, whilst pharmacies sized C seem the 
least likely to deliver. 
 
Table 51: Pharmacies delivering the full intervention as a percentage of the total 
pharmacy size assessed (mystery customer data, n=41) 
Pharmacy size Frequency full intervention Percentage of total pharmacy size assessed 
A 16 1.9 
B 16 1.8 
D 4 1.4 
E 2 1.4 
F 1 1.2 
C 2 0.4 
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The format of pharmacies conducting the full intervention when assessed by the 
mystery customer is shown in Table 47. Over half of the interventions were conducted 
by pop in pharmacies, with small destination pharmacies delivering a fifth of the 
interventions. Health centre and edge of town pharmacies did not deliver any full 
interventions across all four months data. Table 52 shows the full intervention data as 
a percentage of the total format assessed. From this we can see that large destination, 
work and pop in pharmacies appeared to deliver the full intervention more so than 
the other formats. 
 
Table 52: Delivery of full intervention within pharmacies as a percentage of the total 
pharmacy format assessed (mystery customer data, n=41) 
Pharmacy 
format 
Frequency full 
intervention 
Percentage of total pharmacy format 
assessed 
Large destination 5 2.2 
Work 4 2.1 
Pop in 24 1.7 
Small destination 8 1.0 
Health centre 0 0 
Edge of town 0 0 
 
 
7.1.1.9 Factors affecting service delivery as identified by the pharmacists 
delivering the service  
Pharmacy environment 
Within the interviews, pharmacists were asked what factors they thought had affected 
the delivery of the asthma brief intervention. Of those questioned, two of the 
pharmacists felt quite strongly that the pharmacy environment had played a large 
factor in the level of service delivery. One of these pharmacists worked in a non 
dispensing pharmacy and found it extremely difficult to talk to people when they came 
in to purchase OTC medicines. The second pharmacists pharmacy had just undergone 
a major refit. Their old dispensary had not been designed in a way that allowed them 
to have much customer contact, although this had improved dramatically with the new 
dispensary. The new environment had made a huge difference to them being able to 
offer opportunistic advice to customers, and as a result of this they had managed to 
offer extended advice to four people with asthma on the morning of the interview; 
 
P8 “The set up that we have now is that we’ve got a combined reception and dispensary 
area for the quick items which are primarily the asthma items, you know the inhalers 
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and stuff like that. Very often it’s literally me that’s dispensing out front and I’m able 
to talk to the customers as I’m doing it, give advice as I’m dispensing which is the 
thing that’s completely different.” 
 
One pharmacist thought that the retail environment was not the ideal place to offer 
advice on asthma, and that this kind of service would be better suited to practice based 
pharmacists;  
 
P6 “It would run better I reckon via a practice-based pharmacist. They would be more 
suited to talk to patients and be able to spend more time than those of us who are 
retail based.” 
 
Pharmacy resource 
Pharmacy resource came up as an issue that affected service delivery by all of the 
pharmacists questioned. Many of the pharmacists commented that they could have 
approached more people with asthma, but did not due to their lack of time and 
resources;  
 
P2 “I imagine I could have approached 100 over the few weeks as we have lots of asthma 
related prescriptions. But I would have had to be able to solely do this and not also 
dispense all the other prescriptions.” 
 
The pharmacists stated they had a number of demands on their time, and this was seen 
to some pharmacists as yet another job to undertake;  
 
P4 “It’s just not really possible to fit into the daily routine, we’re busy enough as it is. 
We just don’t really have the time.” 
 
Pharmacists stated they were fully occupied during the busy period which is when 
they saw the majority of opportunities to talk to people with asthma. During the 
quieter periods they did not always get people in that wanted to talk about their 
asthma;  
 
P2 “At the busy times like mid morning and lunchtimes there is no way you could offer 
the service and that’s when the bulk of customers pass through the store.” 
 
Some of the pharmacists particularly struggled to deliver the intervention when they 
were the sole pharmacist, and as such had varying demands put on their time; 
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P6 “Time was the sole reason, it’s difficult because I’m usually checking prescriptions on 
my own, without another pharmacist with me.”  
 
The intervention itself was not seen as difficult to deliver, but having the right staff in 
place to support them was important; 
 
P10 “Just having the time to do it. Really that’s it, and staff to support you covering your 
job if you’re stood talking to a patient.” 
 
Some of the pharmacists mentioned that the intervention may have worked better if 
they had a second pharmacist, or someone from the pharmacy counter helping them 
conduct the intervention;  
 
P2  ”I guess it might have been more effective if I had someone else to help me or if 
another staff member on the counter was also involved in the trial and offering the 
service.” 
 
One of the pharmacists actually planned the delivery of the intervention when they 
knew that they had more staff in; 
 
P8 “I must admit I sometimes did it on particular days when I knew that either I had 
more staff in or trying not to do it on busy days because sometimes Thursdays and 
Fridays are mad and on such days it’s just not possible to do the service provision. 
But generally it wasn’t a problem.” 
 
A number of the pharmacists commented that the intervention may have worked better 
in their pharmacies compared to other pharmacies due to the involvement of other 
pharmacy staff in the service. This was particularly true in pharmacies with pre-
registration graduates who had the motivation, enthusiasm, and time to spend with 
individual customers.  
 
One particular pharmacist felt that the age of the pharmacists delivering the service 
may have been a factor in the delivery levels in that pharmacy. They perceived older 
pharmacists as not being so interested in services like this; 
 
P7 .they just want to be glorified dispensers until they retire”  
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Customer interest and need for the service 
A number of the pharmacists commented that a factor affecting them delivering the 
asthma service was customers not having the time to talk to them when they came into 
the pharmacy for prescriptions;  
 
P1 “And people really don’t have that much time to chat when they’re just popping in to 
hand in their prescriptions.” 
 
Despite those customers that appeared interested, few returned at a later date to have a 
discussion with the pharmacist;  
 
P8 “The general response I suppose was initial interest and then a very common reply 
was either ‘Oh I haven’t got the time to do that now or I’ll do it next time that I’m in’ 
and then maybe I’ve not been in and they haven’t seen me or maybe they’ve never 
come back I don’t know.” 
 
Although pharmacists had proactively spoken to many customers with asthma, the 
majority of customers had not appeared interested in talking about their asthma with 
them; 
 
P4 “We did manage to speak to quite a few customers though but most just didn’t seem 
interested or want to get involved……They just want to come and go as quick as 
possible and not stop for a chat.” 
 
The lack of interest by many customers was because of their long term use of inhalers 
and as such customers perceived that they did not need any additional advice; 
 
P8 “And then the other response has been ‘I’ve been using my inhalers for X number of 
years and I’m more than happy with what I’m doing and I don’t need any advice.” 
 
There was also a suspicion from some customers as to why they were being asked 
questions, and what additional advice the pharmacist would be able to offer them over 
and above what they had already received from their GP or asthma nurse; 
 
P11 “It’s a difficult thing really because people tend to, when you start asking them things 
about their asthma treatment, they tend to be almost suspicious as to why you’re 
asking the question, also a lot of them tend to say ‘I’ve seen the nurse about it and its 
fine’ or ‘my doctor says its OK’, but when you get to the root of some of the problems 
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that people are having a lot of it is because of misinformation been given by either 
doctors or nurse or friends really.” 
 
Pharmacists found that they struggled to identify people for the service in areas such 
as mining communities, as many of their customers were found to have COPD and not 
asthma;  
 
P6 “A lot didn’t want to listen however and some that I approached weren’t asthma 
sufferers, a lot had bronchial conditions relating to mining, which is no surprise 
thinking of the area that we’re in.” 
 
Pharmacists also stated that they did not like to keep other customers waiting whilst 
they were talking to people with asthma, so stated that this was a factor as to whether 
they delivered the service or not; 
 
P6 “We all have demands on our time these days and you can’t keep customers waiting 
just so you can chat a few minutes to those that have asthma.” 
 
Pharmacists were also conscious that customers would feel uncomfortable if they were 
talking to them whilst there was a queue of customers waiting to be served;  
 
P10 “…but if you haven’t got time to do it and then it’s impossible and then they  feel 
pressurised as well because there are other people waiting for prescriptions or advice 
and they start to feel uncomfortable.” 
 
 
7.1.2 Discussion of the results  
Within this section I have presented the results from the delivery of the brief 
intervention in asthma to understand the various factors affecting service delivery. The 
first section of the results looked at the pharmacists feedback regarding the 
implementation of the service. Pharmacists were sent a briefing pack about the 
intervention and encouraged to participate themselves as well as involving other 
members of their pharmacy teams. Although only a few comments were obtained 
from pharmacists, the general feedback about the implementation of the service was 
positive. Pharmacists found the literature helpful, the structure very simple to follow, 
and the content very relevant when talking to customers. Due to the simplistic nature 
of the intervention, the implementation felt more like a briefing for staff rather than 
the implementation of a service. Although pharmacists were encouraged to deliver the 
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intervention, it was left entirely up to them as to whether they disseminated the 
information to their staff, and whether the staff and they themselves delivered it. By 
keeping the intervention easy to follow, and making the content relevant for customer 
queries at that time of the year, many of the pharmacists and staff appeared to have 
taken up the intervention. Using this simple structure and format appears to have 
worked well for this intervention. 
 
Many of the customers recruited for the intervention appeared to have been identified 
when they came into the pharmacy with an asthma related prescription. Only one 
pharmacist questioned had actively tried to recruit customers when they came into the 
pharmacy to purchase OTC products. Although the pharmacists questioned 
represented a very small sample of the total pharmacists delivering the intervention, it 
is disappointing that more of the pharmacists did not actively try and target people 
purchasing OTC medicines. The likelihood of these customers having uncontrolled 
asthma and purchasing products to relieve symptoms may have been greater than 
customers presenting with prescriptions. Unfortunately no other members of the 
pharmacy staff, such as pharmacy assistants working on the healthcare counter, were 
interviewed so I am unable to determine whether these staff actively targeted people 
purchasing OTC medicines.  
 
Pharmacists appeared to have been very flexible in the delivery of the intervention, 
performing it when they had the time to do so, or when they felt that the customer 
would be interested. If customers did not look like they were in a rush, or wanted to 
chat, then the pharmacist would open a dialogue with them about their asthma using a 
non-threatening approach so that customers did not feel pressurised. The pharmacists 
targeted people with certain prescriptions that they thought would help identify those 
with uncontrolled asthma, including those with two or three relievers on their 
prescription, if they actively said they did not want their steroid inhaler, if it was a new 
prescription, or if the prescription was handwritten (suggesting an emergency 
prescription). The intervention was also used by staff as a tool to recruit customers 
into the prescription collection service, linking it with other initiatives and activities at 
that time. Although marketing materials were not supplied as part of this service, one 
pharmacist had actually designed their own poster to try and improve awareness of the 
intervention and encourage people to ask about it. This particular pharmacist had used 
their initiative to adapt the service locally. Although not included within this research, 
anecdotal discussions with several other pharmacists showed that they also recognised 
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the opportunities for service delivery in asthma, and expanded the service they 
provided within their individual pharmacies.   
 
As part of the recruitment to research process, samples of pharmacists were asked to 
recruit customers following an intervention in asthma. This appears to have caused 
some confusion as half of the customers questioned in this research claimed to have 
been recruited specifically for the research with no apparent intervention with the 
pharmacist. This confusion could have been caused by a couple of factors. Firstly, the 
intervention itself was so simple that customers may not have realised that they were 
taking part in an intervention and as a result believed that they were just having an 
informal chat with the pharmacist. This could have been misinterpreted by both the 
customer and the interviewer. Secondly, the pharmacist may have just approached the 
customer directly about the survey and not performed the intervention. As the 
customer data are used to explore a number of factors throughout this research relating 
to the delivery of general services by pharmacists, the views of all customers were 
seen as important, and as such, these data have not been separated out.   
 
Mystery customer research has been used as a proxy measure for the delivery of the 
brief intervention. This has provided me with a guide as to whether pharmacists 
implemented the intervention, disseminated the information to their staffs, and were 
delivering the intervention. Although the mystery customers only assessed one person 
on each visit, it provides an indication of implementation and delivery. By repeating 
the mystery customer assessment over a period of four months, this increased the 
likelihood of assessing different members of staff, and therefore provided a more 
accurate assessment of implementation and delivery of the asthma intervention. From 
the results we can see that many pharmacies were performing this particular 
intervention, but the extent of delivery varied across the study period. It is interesting 
to note that the second pharmacist communication went out to the pharmacies during 
the month of June 2003, and could account for the rise in delivery levels during this 
month and the following. Within previous internal trials, I have learnt that pharmacists 
like to receive regular communication and updates. The fall in activity during August 
2003 could be accounted for by the fact that it had been three months since the 
pharmacists last communication, and they were due for another during September 
2003. If this is so, then regular communications could be appropriate for this target 
audience to keep them interested and the project sustainable. Service delivery levels 
may have been prevented from falling if the pharmacists had received two monthly 
communications, which is something to consider for future service delivery. A number 
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of pharmacies were assessed on more than one occasion, and delivered a consistent 
response with the asthma intervention, which helps to support the evidence that the 
pharmacists integrated this intervention into their current practice.  
 
Pharmacists and staff did not ask all three RCP questions to each customer. Across all 
four months data, staff asked the question about daily symptom occurrence (question 
three) more frequently than the other two. This was followed by the use of the second 
question, and then lastly by the first. One explanation for this could be the pharmacy 
staff or customers perceived relevance of each question, and its ease of use. Question 
three Have you had your usual asthma symptoms during the day?” is more in line 
with the content of the conversations that pharmacists and staff might normally have 
with customers, whereas they may not feel as comfortable asking about asthma 
interfering with activities or sleep. The use of the questions seemed to vary amongst 
the type of personnel, with pharmacists using them the most frequently. This supports 
the notion that the use of specific questions may be related to confidence. One 
exception to this was the use of question one, which was most likely to be asked by 
unknown personnel (as a percentage of personnel assessed). It appears that many of 
the pharmacists and staff felt confident to adapt the intervention as appropriate. This is 
further supported from findings from the pharmacist interviews, where many of the 
pharmacists used variations of the brief intervention when speaking to customers. 
Even those pharmacists that found the RCP questions confrontational and too formal 
used the concept of the intervention to talk to people with asthma more generally 
rather than ask specific questions. Interestingly, the pre registration graduate (P9) 
interviewed expressed quite strong opinions regarding the use of the RCP questions, 
and believed that this was something that should be delivered by the GP or nurse 
rather than the pharmacist. As this was the only pre registration graduate interviewed, 
I am unable to compare their views to others to see whether it is an individual 
perspective, or something felt by other pharmacy graduates. Whether as an individual 
opinion or something that is shared amongst many pharmacy graduates, this point of 
view could be linked to confidence and lack of experience in service delivery.    
 
Over the four month assessment period, the majority of staff that were assessed 
delivered the brief intervention, whether they were pharmacists or healthcare staff. 
Although pharmacists were significantly more likely to deliver the intervention 
compared to other personnel, this is not unexpected. A large proportion of non 
pharmacist and unknown personnel assessed also delivered the intervention. Given 
that communications regarding the brief intervention were sent to named pharmacists, 
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and not any other personnel, it is not unreasonable to conclude that a large majority of 
pharmacists must have disseminated the information to their healthcare teams. A study 
by Banks et al. which looked at the role of the medicines counter assistant, found that 
customers recognised the legitimacy of the medicines counter assistant role to ask 
questions about symptoms and pharmaceutical consumption [163]. In their study, on a 
third of the interactions studied where customers had asked for advice, they found that 
the counter assistants had acted independently without involving the pharmacist. The 
counter assistants were found to be very positive about their role, highlighting the 
stimulating nature of their job. The continued deregulation of prescription to pharmacy 
medicines is shifting the role of the pharmacy support staff away from retail sales 
towards healthcare provision.  
 
Although half of the full interventions were delivered by pharmacists (as a percentage 
of personnel assessed), unknown personnel were more likely to deliver the full 
intervention compared to others. Questions remain about why unknown personnel 
were unknown as staff are usually easily identifiable in pharmacies. Within Boots all 
healthcare staffs wear white and blue uniforms (whereas pharmacists are in suits), and 
all staffs wear name badges with job roles. Confusion may have arisen due to 
pharmacists taking their jackets off in the summer heat, or newly qualified 
pharmacists not wearing name badges. The percentage of unknown personnel 
conducting the intervention rose in July and August which further supports the theory 
that unknown personnel were likely to be pharmacists.  
 
Over the four month assessment period, the majority of lifestyle advice given was 
regarding referral to the GP, followed by advice on inhaler use. This result could be 
seen to be surprising, given the regular communication and updates that were sent to 
each pharmacist with updated lifestyle advice. However, because of the scenario that 
the mystery customers presented to Boots staff this was the main outcome expected. 
The mystery customers also presented the scenario regarding a relative who had 
asthma, so the pharmacist would have been limited in the amount of advice they could 
give to them as a third party. An alternative explanation to this finding could be the 
pharmacists confidence and ease in referring the customer to the GP; however, it is 
most likely to be due to the use of the asthma scenario. Unfortunately this is one of the 
limitations of using mystery customers, and perhaps could have been avoided by the 
use of a slightly different scenario. There was a significant difference between the 
personnel delivering the advice as pharmacists were more likely to give advice, 
followed by unknown personnel and lastly non-pharmacists. Pharmacists were also 
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more likely to give advice on inhaler technique than any of the other personnel, again 
something that could be linked to the pharmacists confidence and experience. 
Overall, advice on general lifestyle management was quite low across all the data sets, 
but was more likely to be given from those pharmacies delivering the full intervention. 
Tips on lifestyle management and general advice were given throughout the 
pharmacists communications, and although it is disappointing in the overall delivery 
data, it is not surprising that pharmacies delivering the full intervention responded to 
the advice from the communications.      
 
According to the sample of pharmacists interviewed, the main topic of conversation 
with customers was around the use of their medication, and in particular the 
misunderstanding of inhaler type and use. Other frequent topics of discussion included 
advice on symptom control, general information on asthma and lifestyle tips. 
Pharmacists were surprised at the amount of people that did not know basic 
information such as rinsing the mouth out after steroid inhaler use, so found the 
lifestyle advice simple and useful for customers. The intervention offered people the 
chance to talk about their asthma as this was something that pharmacists felt that many 
people did not get the chance to do with their GP on initial diagnosis. The pharmacists 
appeared confident in referring people through to the local GP, although the extent of 
the relationship with the GPs varied tremendously between individual pharmacists. 
Those with good relationships appeared to have the confidence to discuss changes in 
medication directly with the GP.  
 
The length of the consultation with customers varied, with some pharmacists spending 
a few minutes with the customers, and others spending up to twenty minutes. The 
length of this interaction seemed to be dependant on a number of factors including 
how receptive the customer was, how busy the pharmacy was, and whether a second 
pharmacist was present. Some customers perceived this interaction to be a quick 
conversation with the pharmacist, whilst others saw it as a service that was provided. 
If the pharmacist was busy at the time, or the customer wanted a more in depth 
discussion, then many pharmacists would ask the customer to return at a later time or 
date. The interactions seemed to be quite personalised with the topic of conversation 
and length of interaction varying on an individual basis. Pharmacists appeared 
confident to be able to adapt the services based on both customer and business needs, 
with some pharmacists even developing an extension of the service they provided to 
their customers based on the principles of the initial asthma intervention. 
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Although no significant difference was found between the sizes of the pharmacies 
delivering the brief intervention, size D pharmacies performed the best (measured as 
a percentage of size assessed). The larger pharmacy sizes E, F, and D, and the 
smaller size A, were more likely to deliver a consistent positive result compared to 
the middle size B and C pharmacies. Pharmacies that were sized A and B 
appeared to be more likely to deliver the full intervention, whilst pharmacies sized C 
seemed to be the least likely. Although the full intervention pharmacies represent a 
very small sample, it is interesting that the smaller pharmacies appeared to be the least 
likely to deliver this. These pharmacies were most likely to be resourced by a single 
pharmacist with a small team of support staff. The larger size pharmacies delivering 
the brief intervention were likely to be resourced by a number of pharmacists and a 
larger team of support staff. The middle sized pharmacies appeared to be the least 
likely to deliver any of the intervention, and were probably the ones with limited 
pharmacist and support staff resource (too small for multiple pharmacists yet have a 
larger business to support than some of the smaller sized pharmacies). The slight 
differences noted between the sizes of the pharmacies could be accounted for by the 
number of personnel and size of business. Unfortunately no true conclusions can be 
drawn from these data due to the variability in personnel assessed by the mystery 
customer within the individual pharmacies.      
 
Very few studies have investigated the variations in service delivery which may exist 
between pharmacies operating in different locations [6, 31, 132, 133]. Differences in 
service delivery have been found within the individual studies, where practice delivery 
favours independent pharmacies [31], and pharmacies located in medical centre and 
rural locations [6]. A study by Abu-Omar et al. [132] found that multiple pharmacies 
were mainly used for medication supply whilst local pharmacies were viewed as 
healthcare resources where further services and advice were sought. An ethnographic 
study by Rogers et al. [133] concluded that differences in the environment within 
which pharmacies were located (socio economic status and compositional effects) 
influenced the services and advice giving role of the community pharmacy. Those 
pharmacies that were located nearest to the health centre were dominated by 
dispensing activities and not advice, whilst those sited in small towns away from the 
health centres were dominated by product requests. Within my study, health centre 
locations had the lowest score for delivering the brief intervention, whilst edge of 
town pharmacies had the highest. The same was also true for delivering a consistent 
positive result. Arguably health centre pharmacies are ideally placed to target 
customers directly from the GP practice, and perform a number of brief interventions. 
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On the other hand, health centre pharmacies rarely have more than one pharmacist 
on site at any given time and are extremely busy dispensing pharmacies, leaving the 
pharmacist with very little time for customer interaction and interventions. A study by 
Sleath [164] also found that pharmacists were less likely to interact with patients when 
less people were waiting nearby. At the time of this study, the majority of edge of 
town sites assessed did not have NHS dispensing contracts. The pharmacists within 
these pharmacies had more time and flexibility to spend with each individual 
customer, and this could account for the high response to the brief intervention. In 
contrast to the successful delivery of the brief intervention in edge of town locations, 
these pharmacies were the least likely to provide lifestyle advice compared to all the 
other formats assessed. Although the number of edge of town locations is small 
compared to some of the other types of pharmacies, it is surprising and disappointing 
that they did not deliver advice alongside the RCP questions, particularly given the 
extra time and availability that pharmacists were likely to have within these locations. 
The majority of these pharmacies were unlikely to have NHS dispensing contracts, 
and customers may have felt more uncomfortable discussing their asthma condition 
when purchasing OTC products or general goods at the pharmacy counter. For the 
purpose of these results, the anomaly in the data is more likely to be due to the false 
scenario presented by the mystery customer and the lack of opportunity for advice and 
discussion. The number of pharmacies performing the full intervention is small 
compared to the other data sets, but it is interesting that no health centre or edge of 
town pharmacies were part of this group. There appeared to be a larger percentage of 
pop in, large destination, and work pharmacies performing the full intervention 
compared to the other data sets. This fits with the data collected on the sizing of the 
pharmacies, in particular the small number of size C and small destination 
pharmacies performing the full intervention.  
 
Pharmacists identified a number of factors which they felt could have affected the 
delivery of the brief intervention. Pharmacists working in non dispensing 
environments believed that this affected the number of people with asthma that they 
were able to speak to. Although they were able to talk to customers that presented with 
queries at the pharmacy counter, they felt that these people tended to be generally 
shopping and were not necessarily in the right frame of mind to discuss their asthma. 
Very few pharmacists commented on the lack of consultation space available to them, 
as most saw the asthma intervention as a brief conversation, and something that was 
most suited to be delivered over the counter. Where dispensary refits had brought the 
pharmacist closer to the customer, this was seen as allowing a greater opportunity to 
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speak to the customer whilst dispensing prescriptions. This was particularly true for 
customers who waited for their prescriptions, as pharmacists were able to speak to 
them as they were dispensing their prescription. Although a captive audience, the 
pharmacists recognised the potential lack of confidentiality due to other people 
waiting nearby. One pharmacist felt that the retail pharmacy environment was not the 
best place to talk to people with asthma, and that this was better placed within GP 
practices. This is an interesting perspective, as often people with asthma, particularly 
those with uncontrolled symptoms, do not present themselves at GP practices unless it 
is to collect their prescriptions. Providing opportunistic advice at the pharmacy 
provides an opportunity for the pharmacist to help the person with asthma recognise 
their level of control, and the chance for the customer to talk about their condition. 
Without further data, it is unclear whether many pharmacists feel uncomfortable 
talking to people with asthma in the pharmacy environment, or whether this is the 
view of a few select pharmacists.   
 
Time and pharmacy resource were seen as a large factor that affected delivery of the 
intervention, and was mentioned by all of the pharmacists questioned. Although the 
busiest times presented the greatest number of opportunities to talk to people with 
asthma, this was often the time when pharmacists found it difficult to deliver the 
service. Pharmacists felt that they already had huge demands on their time, and this 
service was seen to some pharmacists as adding yet another task to their already busy 
schedule. Those pharmacists that involved other support staff and pre registration 
graduates felt that the intervention worked well within their pharmacies. This was also 
true for single handed pharmacies who struggled to deliver the intervention if they did 
not have good support staff in place. The involvement of support staff appeared to 
help the pharmacists deliver the service, and provided a greater number of 
opportunities to target people with asthma presenting at the pharmacy counter. 
Interestingly, there was a perception by one pharmacist that some of their older 
colleagues close to retirement age, were not as interested in delivering services like 
these or extending their role. Differences in the views of pharmacists of varying age 
on an extended role is not covered within this thesis, but may potentially have an 
impact on the enthusiasm for change and delivery of services. A review by Berenguer 
et al. [165] concluded that pharmacists themselves may be the most important barrier 
towards the development of pharmaceutical care, particularly older generation 
pharmacists who may lack the professional skills necessary to manage drug therapy 
and cling to the traditional role of drug dispensers.  
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Customer time was also seen as a factor that influenced delivery of the intervention, as 
many customers appeared to be in a rush when visiting the pharmacy and therefore did 
not have time for a discussion regarding their asthma. This could be influenced by the 
perception of what they came into the pharmacy for, as often many see the speed of 
dispensing of a prescription as a determinant of the decision to use that pharmacy, as 
apposed to the level of service and type of advice available. Many people drop off 
prescriptions for dispensing in between busy work schedules or during lunch breaks, 
and often do not have the time, nor the expectation to spend time talking to the 
pharmacist. Many pharmacists also found that those customers that had been using 
their inhalers for years questioned the need for further advice. Other pharmacists 
found that even though some people had been provided with incorrect information by 
GPs, nurses or friends, the confidence and expectation in advice provided by the 
pharmacists appeared to be low in some customers. Some pharmacists perceived this 
as a lack of authority in the advice they provided, compared to that advice delivered 
by GPs and nurses. The environment and awareness of other customers was not felt to 
help this, as many pharmacists were conscious of not embarrassing or pressurising the 
customer into talking to the pharmacist whilst other people were stood waiting. This 
was particular apparent and problematic for pharmacists dispensing in busy single 
handed pharmacies, where time spent talking to customers meant delays for other 
customers waiting. A study by Sleath investigating the pharmacist-patient relationship 
also found that pharmacists were more likely to interact with patients when less people 
were waiting nearby [164]. She concluded that the busier a pharmacy was, the less 
likely pharmacists were to interact with patients.  
 
 
7.1.3 Summary of section one  
The brief intervention in asthma was a service that was designed to be very simple to 
deliver and through the dissemination strategy pharmacists were encouraged to take 
local ownership and adapt the service delivery to meet local requirements. This 
service was successful in being implemented and delivered as shown by the high 
delivery rates over the four month period. Regular communications to the pharmacists 
appeared to have kept the project active and sustainable over a longer period of time. 
Many pharmacists appeared to have disseminated the information to their healthcare 
staffs, who were then able to offer opportunistic interventions themselves. As the 
service was very simple, pharmacists and staff were able to integrate it into their 
everyday practice and use elements of the intervention as they deemed appropriate. 
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From these data presented within this section, I have identified a number of factors 
that appeared to have influenced the delivery of this intervention, some helping to 
facilitate, and others acting as barriers. Those factors affecting the delivery of the brief 
intervention in asthma are summarised within Table 53.    
 
Table 53: Summary of the experiential factors affecting delivery of the brief intervention 
in asthma 
(Please note that this table is presented over two pages) 
 Facilitators  Barriers 
Customer need 
̇ Usefulness of basic tips and 
advice 
̇ Ability of service to help to 
identify potential customers 
̇ Perception that do not need 
advice (particularly if using 
inhalers for number of years) 
Public attitude  
̇ Poor level of confidence in 
pharmacist advice 
̇ Level of authority of pharmacist 
advice compared to other 
healthcare professionals  
Pharmacist 
attitude 
 
̇ Poor attitude towards role 
expectations 
̇ Limitations of role    
Implementation 
of the service 
̇ Simple structure 
̇ Ability to adapt and extend 
service locally 
 
Recruitment 
̇ Captive audience available e.g. 
when dispensing prescriptions 
̇ High volume target customers 
visiting pharmacy 
̇ Less opportunity to identify 
patients, particularly in non 
contract pharmacies 
Pharmacist 
confidence in 
service delivery 
̇ Confidence to deliver and adapt 
service to meet customer and 
business needs  
̇ Lack of confidence and comfort 
in using particular RCP 
questions 
̇ Lack of confidence in giving 
advice not related to medicines 
(outside comfort zone) 
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 Facilitators  Barriers 
Service 
structure (brief 
intervention) 
̇ Content relevant for time of year 
̇ Flexibility in service delivery 
(content and length of 
intervention) 
̇ Good fit with other initiatives 
and activities 
̇ Ability for pharmacists to 
expand the service locally, 
̇ Regular and updated 
communications 
̇ Simple intervention 
̇ Opportunity to improve 
awareness of symptom control 
̇ Providing opportunity to access 
healthcare professional advice 
̇ Intervention too simple so not 
perceived as a service 
Time  
̇ Lack of pharmacist time 
̇ Lack of customer time 
̇ Pharmacy workload 
Staff resource 
̇ Involvement of all pharmacy 
support staff in service delivery 
̇ Adequate staff resource 
available (pharmacy and support 
staff)  
 
Pharmacy 
environment 
̇ Service sited in large and small 
size pharmacies, and edge of 
town locations (potential link to 
resource and how busy 
pharmacy is) 
̇ Accessibility of pharmacist  
 
̇ Services sited in middle size 
pharmacies and health centre 
locations (Potential link to 
resource and how busy 
pharmacy is) 
̇ Non contract pharmacies (less 
opportunity to target customers) 
̇ Busy pharmacies (customers 
waiting) 
 
In contrast to this centrally developed and nationally implemented brief intervention, 
the second asthma service was designed, implemented and managed within a local 
community setting. The second section of this chapter presents the results from the 
delivery of this local asthma service. 
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SECTION TWO 
 
7.2 Delivery of the asthma service (service two) 
The asthma service was designed and implemented by a group of pharmacists within 
their locality during May to September 2003. This asthma service was based around 
identifying people with asthma that would benefit from a consultation with the 
pharmacist on inhaler technique, medication use and general lifestyle advice. 
Questions around symptom control were used by the pharmacy team to identify people 
with asthma, who were then offered a consultation with the pharmacist. This 
consultation was based around medication use, inhaler technique, and simple lifestyle 
advice. 
 
Within this section, I provide the results from the delivery of the asthma service to 
explore the factors that could affect service delivery. Data is provided from the 
customer and pharmacist interviews and the asthma audits. The results are presented 
to explore implementation of the service, external communication of the service, 
recruitment to the service, delivery rates, structure of the service, personnel delivering 
the service, the type of asthma advice provided, and factors affecting delivery as 
identified by the pharmacists participating in the service.  
 
 
7.2.1 Results 
7.2.1.1 Implementation of the service 
At the beginning of the project for the asthma service, a group of pharmacists sat 
down together to design the service and associated materials. This group of 
pharmacists decided to design the consultation guidelines in the form of a 
questionnaire. The pharmacists were pleased with the opportunity to design the service 
itself, and felt that they had a good team working on the project; 
 
P16 “No I think we have very good meetings to start with when we set up the project and I 
think the pharmacists who were doing it were all ones who were doing diplomas or 
were clinically minded so I think they had quite good basic grounding in asthma to 
start with.” 
 
Everybody on the team had the chance to input into the service design, and as a result 
felt confident on the setting up and running of the service;  
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P15 “The only difference is the decision when you’ve got a customer in front of you, but 
how it should be run on the whole, we all put input and I’m happy that my input is in 
there. So I’m quite happy how the thing was set up and how we’re supposed to run 
it.” 
 
Although pharmacists pretty much kept to the structure of the questionnaire, there was 
some personalisation of the operational aspects of the consultation within their 
particular pharmacy environment; 
 
P17 “The only thing I had to work out in my mind after the training, because did a lot of 
work on placebo inhalers and how to use them and how to use an AIMso machine 
…and then we got a questionnaire saying this is the type of format for an intervention 
but it didn’t necessarily ask OK if you get a problem here this is the track you’re 
going down with inhaler technique, if you get a problem here this is what you’re 
going to be looking at so you pretty well had to work that out for yourself. But they 
did say that the questionnaire was only a suggested format and that we could 
personalise it or use it ourselves.” 
 
As part of the service set up, the pharmacists organised a training day locally for 
themselves, other pharmacist colleagues, and pharmacy support staff. Pharmacists 
found the training day very useful, in particular the opportunity to gain hands on 
experience with some of the respiratory equipment; 
 
P14 “We went to a half day training day because a lot of it was hands on, the spirometer, 
which measures how hard you can breathe in and therefore which inhaler device. It 
was really good to actually be able to use and try out some of those things because I 
don’t think you’d be able to pick that up from a booklet because it was very 
practical.” 
 
The brief intervention information and fact sheets were also found to be useful prior to 
the training, both for pharmacists and support staff; 
 
P16 “We had quite a lot of information, obviously we had the asthma guidelines booklet to 
start with and we had fact sheets as to how to use the inhalers and then we got the 
placebos so we were able to play around with them and make sure we were confident 
using those and the peak flow meters.” 
 
                                                 
o Aerosol Inhalation Monitor (AIM) 
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The additional training had helped give pharmacists the confidence to speak to people 
about their asthma;  
 
P14 “I suppose because we had a bit of training it’s a bit of revision, a bit more 
confidence to go out and speak to people about that.” 
 
Other pharmacists felt that their input into the service set up and the additional training 
had given them extra tools to offer additional and new advice;  
 
P17 “What it’s given us is, because we’ve had some extra training, it’s given us the tools 
to offer a new area of advice.” 
 
Many of the pharmacists had already completed clinical diplomas, although a couple 
were still undergoing the training. These pharmacists had taken it upon themselves to 
read up on asthma in preparation for the initial meetings;  
 
P16 “But because I’m doing the clinical diploma, one of my modules has been respiratory 
problems and I have done CPPEp asthma as well so I had actually done quite a lot of 
reading around the subject anyway. And a lot of that information is available really to 
any pharmacist.” 
 
There was also a feeling of professional responsibility and pride in wanting to make 
sure they had prepared themselves for the service as much as possible;  
 
P14 “Personally, I’m doing the respiratory module for my diploma at the moment so I 
made sure I did that to sort of gem myself up. We would expect a certain standard of 
knowledge from pharmacists on the topic and if they haven’t got it and they’re going 
to go into a scheme like this then you’d want them to do something about it themselves 
really. I think it’s a professional responsibility really.” 
 
Following the initial set up of the service, the team decided to have regular meetings 
as a group so that they would have the opportunity to share best practice and 
learnings;  
 
P16 “We’re just feeding back on what we’ve been doing, how the project’s been going, 
any things which have been good, things which have been tricky. Because it’s all the 
stores we’re able to put our points of what we’ve done and it’s just pooling lots of 
                                                 
p Centre for Pharmacy Postgraduate Education (CPPE) 
 216 
resources and ideas. Then we look at where we’ve gone and where we want to go, 
what information head office are wanting us to record as the next thing and just look 
at what we want to do with it – next steps.” 
 
7.2.1.2 External communication of the asthma service 
Many of the pharmacists participating in the asthma service had approached local 
schools, GP practices and businesses to raise awareness of the service by displaying 
leaflets and posters. This had been met with enthusiasm from most of the sites that had 
been approached to the extent that some pharmacists had been asked to speak on the 
subject at local schools;  
 
P14 “We’ve been sending out posters to local schools and places like that where people 
will see them and maybe come in and talk to us about it.” 
 
Some pharmacies had additional activities planned for the New Year to try and 
increase recruitment to the service. In particular, pharmacies within shopping centres 
planned to host stands outside the pharmacy; 
 
P17 “After Christmas we’re going to have a table outside in the precinct and we’re going 
to do it out of the store to try to capture non – Boots customers but at the moment it is 
only people that are coming into the store.” 
 
In addition to this, one pharmacy had also approached a local asthma nurse to work 
with them in helping to raise awareness of asthma and the service;  
 
P13 “We’re actually putting stands outside, it’s an indoor shopping centre, in the new 
year for a week and one of our asthma nurses she’s going to just come and be there 
for a couple of hours on two afternoons. So if we can advertise the fact that so and so 
asthma nurse is going to be there as well just to see if that increases people wanting 
to be involved.” 
 
All of the pharmacists involved within the asthma service had been to see their local 
GP practices to talk about the service prior to it starting;  
 
P16 “Well we gave them the information that we were asking them the three questions 
round the asthma guidelines just to see if people are getting attention and if there are 
any problems just to see if we can kind of rectify them, just by explaining how to use 
their inhalers, offering to explain and check their technique if they wish us to, 
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obviously with a referral if we think that there are any problems. That’s an important 
thing to stress I think, that we would be referring people with the patients consent if 
we felt there was an underlying problem.” 
 
Many of the pharmacists had also discussed referral criteria for the service with their 
local GPs and asthma nurses;  
 
P13 “Well basically I went round to our four surgeries and had a meeting with the 
practice nurse / practice manager and one or more of the GPs and discussed at what 
level they wanted interventions as apposed to phone calls and where they wanted the 
intervention sent, whether they wanted it to go to the asthma nurse or the individual 
GP.” 
 
Where referral criteria were in place, pharmacists would share this information with 
other pharmacist colleagues. One particular pharmacy had even gone as far as pinning 
a list of criteria and referral points in the dispensary to help other pharmacists that 
might be covering on their days off within the pharmacy; 
 
P13 “So I wrote a list down and put it in the dispensary because there are other 
pharmacists working here. Then if we need to make an intervention on it we know who 
to send it off to.” 
 
Overall, pharmacists reported that the feedback from the GP practices was very 
positive; 
 
P16 “Some surgeries are very keen on the fact that, anything we can give advice on 
asthma or smoking cessation which is linked to it, they’re very keen on that.” 
 
In some cases, this was related to the benefits of the service helping the GPs meet 
some of their new contract targets;  
 
P14 “I don’t think it’s a problem for GPs, I think probably as the contracts change they’re 
probably quite grateful for any assistance.” 
 
Although the GPs were keen at one practice, the pharmacist had got the impression 
that the nurses were not due to the professional competition felt between roles;  
 
P16 “But I have actually had a surgery where they weren’t quite so keen because 
sometimes the nurses think maybe you’re a bit after their job. Of course because the 
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doctors contracts are coming out and lots of implications there. I think the doctors are 
quite keen it’s more the nurses that may be a little bit on tenterhooks as to what 
exactly we’re doing.” 
 
In contrast to this, the relationships with asthma nurses at one practice had taken some 
time to build but had resulted in them being positive about the service. Despite the 
support from the nurses, the practice managers and GPs had remained unsupportive;  
 
P17 “We went round and say all of them and talked to all the asthma nurses and got a 
very lukewarm reception from them. I actually didn’t go, it was the lead pharmacist 
who is also one of the supplementary prescribing trainees so she is supposed to be 
getting familiar with them anyway. Whether it was the time of day that she went, it 
was lunchtime so it should have been quiet enough for the practice managers or 
asthma nurses to see her. She has built relationships with the nurses, it’s particularly 
the practice managers and the doctors that have been indifferent. We haven’t had any 
issues with the asthma nurses being protective of their role or thinking that we’re 
treading on their toes or anything like that.” 
 
One pharmacist had used the asthma service as an opportunity to build links with their 
local Primary Care Trust (PCT). From this, they were working together to try and 
work closely with a particularly difficult GP; 
 
P14 “Yes the local surgery, he’s a rather difficult individual and that was a bit tricky but 
because of that I have actually developed a stronger relationship with the prescribing 
pharmacist at the PCT and they’re working with me to try and make him understand 
that we’re all trying to achieve the same thing rather than me trying to find his faults 
which I think is what he thinks. Every doctor has a different attitude so that’s just a 
one off really.” 
 
7.2.1.3 Recruitment to the asthma service 
Despite the positive reception received at the GP practices, very few pharmacists had 
seen any direct referrals from GPs come through to the service; 
 
P15 “There was very positive feedback from the surgery but I haven’t actually seen a 
referral at this stage.” 
 
Many of the customers appeared to have been recruited into the service whilst 
collecting prescriptions in the pharmacy rather than from the posters;  
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P17 “We haven’t had any feedback from anybody, we haven’t had any clients coming in 
and saying I saw this on the notice board at work or anything. All the people we have 
done consultations with have been people we’ve captured or from prescriptions.” 
 
The external marketing had been extremely time consuming for pharmacists and staff 
and many felt that they had not got a lot back from spending the time doing this; 
 
P14 “The marketing side of it has been quite time consuming. I’m not sure we’ve got a lot 
back from that to be honest.” 
 
All of the pharmacists had been targeting customers for the service when they came 
into the pharmacy with a prescription;  
 
P15 “At the moment it’s through staff approaching them when they bring a prescription 
in.” 
 
Some pharmacists had used the RCP questions to recruit customers to the service 
when handing out prescriptions;  
 
P16 “When I’ve been getting prescriptions we’ve been doing it actually asking them the 
questions as the pharmacist is handing the prescriptions out.” 
 
One pharmacist had also been targeting people over the counter as well as when they 
presented with prescriptions. This pharmacy had also decided to attach leaflets to 
prescription bags to raise awareness of the service when they were too busy to talk to 
people with asthma directly;  
 
P17 “Well, we are targeting people over the counter, trying to use the lever of people with 
coughs and colds who are coming to us anyway. We have been trying to keep an eye 
out for children with a persistent night time cough but we haven’t had many of those 
show up. We’re also targeting prescription people with inhalers and at the very least 
even if we’re busy we’re attaching one of the leaflets to the bag so that when we give 
it out there’s a prompt to remind them of the new service that we offer.” 
 
This particular pharmacy had actually found that targeting people over the counter was 
much more successful than targeting those with prescriptions. They felt this was 
because people presenting over the counter for cough medicines tended to have more 
problems with their asthma;  
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P17 “We haven’t had much feedback from the prescriptions but most of our people, our 
new clients as it were, are being captured from the over the counter sales. A lot of 
prescription clients are happy and they know what they’re doing already.” 
 
Within the customer interviews, eight of the respondents were questioned on how they 
were approached about the asthma service. All eight respondents were recruited by the 
pharmacist when collecting their prescription;  
 
C32 “I was going in for a repeat prescription and they were quite helpful, they were 
helpful and friendly.” 
 
One respondent spent time with the pharmacist going through the consultation 
questionnaire; 
 
C25 “She very nicely asked if I would….Now let me see, what was it? She was very nice 
and very polite and it was sort of if there was anything she could help me with my 
asthma, just asked me a few questions. I had plenty of time, I was in no hurry so we 
just filled out a little questionnaire.” 
 
Another respondent had been working quite closely with their local Boots pharmacist 
anyway, and had helped them out by writing an asthma diary for their clinical 
diploma;  
 
C29 “I wrote a report for XXXX (Boots pharmacist) there, detailing what had happened to 
me because he was doing research at the time and he is now a qualified Asthmatician 
or whatever it is: ‘Diary of a hopefully short-term asthma condition’” 
 
Three of the respondents had not actually participated in the asthma service with the 
pharmacist, but had been approached specifically to take part in the survey;  
 
C27 “The lady behind the counter asked me, I was picking up my Dad’s prescription as 
well, and she said would he be interested in taking part in a survey. And I said no not 
really, he’s 84 and he wouldn’t know what you were talking about but I said, I’m 
asthmatic if you want to do it on me.” 
 
Even though these respondents had not received any advice, they were willing to 
participate in asthma surveys with a view to helping people with asthma in the long 
term; 
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C34 “Yeah, I took a prescription in so when I went back in they had a stack of forms 
behind the counter and asked me if I would mind, as an asthma sufferer, taking part in 
a survey which was designed to further the understanding of asthma and hopefully do 
something about it, so it seemed in a good cause.” 
 
As part of the second asthma audit, those respondents who had spoken to the 
pharmacist for advice on their asthma were asked a further question about how they 
had heard about the service. The results from the audit are shown in Table 54. The 
majority of respondents had heard about the service from within the pharmacy, and 
very few people had been made aware of the service through posters or leaflets outside 
of the pharmacy.   
 
Table 54: Asthma audit two “How did they find out about the additional pharmacist 
advice?” (n=48) 
Method Percentage distribution 
In pharmacy 87.5 
Poster / leaflet outside of pharmacy 6.2 
Other 4.2 
Referral from another 2.1 
Family / friend 0.0 
Referral from GP 0.0 
 
 
7.2.1.4 Delivery rates of the asthma service 
Pharmacists and staff were not asked to record details of all the interventions they 
carried out within the pharmacy. Pharmacists were however asked the average number 
of consultations they carried out on a weekly basis during the interviews. The number 
and type of consultations varied between individual pharmacists and pharmacies. 
Many of the pharmacists conducted brief or mini interventions on a frequent basis, but 
would infrequently hold full consultations. One particular pharmacist had completed 
two full consultations at the time of interview and over fifty mini interventions. Other 
pharmacists were regularly averaging about two or three brief interventions a day, and 
two full consultations a week; 
 
P16 “I’d say probably, in the day we’re probably looking at about three, obviously 
different levels of intervention. We’re probably only doing about two a week of 
anything of any depth.” 
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The level of delivery would sometimes vary depending on the number of pharmacists 
within the pharmacy and who was on duty;   
 
P17 “I’ve done a couple today so I would think probably two or three each day. It depends 
which pharmacist you’ve got on and how many pharmacists you’ve got on duty to be 
honest.” 
 
7.2.1.5 Structure of the asthma service 
A couple of the pharmacists took time to prepare for a full consultation before the 
customer came in. This would involve looking at their prescription details to gather as 
much information as possible, and partially filling in some of the details on the 
consultation questionnaire beforehand; 
 
P12 “What I normally do is initially when I make the appointment for them obviously I 
have their prescription at hand so what I do is photocopy the prescription and attach 
it to the questionnaires then before they come for their appointment I fill in as much 
as I can with reference to their prescription.” 
 
Another pharmacist had organised all the service materials required for the 
consultation in a single box so that everything they needed was to hand;  
 
P17 “We have a box already filled with the placebo inhalers, the peak flow meter, the peak 
flow meter diaries and the Boots asthma and allergy leaflets so that we’ve got all the 
things that we need to help them.” 
 
Many of the pharmacists had decided to use the three RCP questions as an initial 
prompt into the service as these were found to help identify people with poor symptom 
control; 
 
P16 “But it is the three main questions that is the sort of introduction to try and work out 
what kind of advice they might  need because it gives you a guideline as to how well 
controlled their asthma is or not.” 
 
The RCP questions were rated highly by many of the pharmacists who used them; 
 
P14 “They’re quite good because a lot of people would say their asthma is well controlled 
but they’ll still answer yes to those questions so they are quite good ones. I think 
they’re the ones that the British Thoracic Society use as well.” 
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Although many of the pharmacists followed the same core structure for both the brief 
interventions, and longer consultations, they did vary this according to local need. If 
the pharmacist was too busy at the time, or the customer did not have much time, they 
would reduce the number of questions and the length of time they spent with an 
individual customer; 
 
P15 “I haven’t actually asked everyone the same question but I think they also find it quite 
comfortable, as long as they haven’t got a queue of customers.” 
 
Many of the pharmacists found that customers preferred to have a brief or mini 
intervention rather than a full consultation with the pharmacist;  
 
P16 “Most of the interventions are just checking when they’re using them and they’re 
using them as directed……. the minor interventions as we’re calling them.” 
 
These interventions tended to focus on problems related to inhaler use and technique;  
 
P15 “The main area is whether they wake up in the middle of the night with asthma 
symptoms, whether it affects their work, whether they know how to rinse out their 
mouth after a steroid inhaler, whether they have any problems with their technique. 
Those are the main points.” 
 
The structure of the longer consultations tended to follow the questionnaire that the 
pharmacists designed locally. By following this line of questioning and discussion the 
pharmacists tended to find that any issues would arise as part of the questioning and 
conversation; 
 
P17 “Well, we were largely following the questionnaire we were given and using that as a 
prompt because as you go through the questions and queries from the patient and 
issues come up as you’re talking to them.” 
 
As previously indicated, the majority of pharmacists found that they conducted far 
more brief informal interventions than full consultations, but this varied depending on 
customer need and how busy the pharmacy was at the time of interaction; 
 
P15 “So far it hasn’t been a problem because when I’m really busy I just do a shorter 
version.” 
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Some of the pharmacists had many of their conversations with customers on the shop 
floor, and as such tended to have quite an informal interaction with them; 
 
P14 “Because most of mine, the main ones have been when I’ve been approached by 
customers while I’ve been on the shop floor and you don’t suddenly say ‘stop a minute 
while I get my sheet of paper’, so you don’t run it as per the pro forma that we’ve got, 
you run it by what the customer is asking you and what’s relevant to them. I would say 
they have been more of the informal type.” 
 
Pharmacists found it far easier to encourage people to talk about their asthma through 
opportunistic and brief interventions, rather than asking people to come back at a later 
date; 
 
P17 “I think it’s the ten minute, would you like to come back and see the pharmacist to 
review your asthma, those are the ones we’re having less of but we are having more 
spontaneous interventions, in fact you can often start an interaction going more 
spontaneously than you can asking people to come back, especially at this time of 
year because people are just so busy.” 
 
This was particularly true for some of the smaller stores, who found it much easier to 
interact with people in this informal way; 
 
P13 “Yes, because we are a smaller shop we don’t actually have that many full blown 
consultations so the last few weeks we’ve actually been doing quite a lot of informal 
chats where we’ve just been checking the patient knows how to use their inhalers, 
which inhaler to use when, the dosages on them.” 
 
Customer need also varied between individuals, and therefore pharmacists stated they 
would vary the type of advice in response to patient needs; 
 
P14 “Some people are quite competent at using their inhalers whereas other people 
haven’t got a clue so obviously the level of information you’re pitching is totally 
different for every customer.” 
 
This was also the case for those customers that had little time to spare; 
 
P15 “Obviously there are a few that haven’t got time but when you just say….because we 
don’t have to go through the whole long list of the intervention you can just pick out 
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tips or give them information to get this illness under control so most of them are very 
grateful and very pleased that we’ve helped them.” 
 
The length of time the pharmacist would spend with each customer varied 
enormously, not only between individual customers, but also individual pharmacists. 
Brief, informal interventions would take approximately two to five minutes, with 
some pharmacists spending between ten and thirty minutes in a full consultation; 
 
P13 “It depends because if their inhaler technique is quite good it probably only takes 
about ten minutes but it can take up to about twenty minutes, half an hour.” 
 
Customers that requested a full consultation within one particular pharmacy were 
asked to make an appointment at a later date that was convenient to them;  
 
P12 “We arrange the time that’s suitable for them and my colleague makes sure that she 
can go through it with them.” 
 
Pharmacies that were based near to offices often found that it was in fact easier for 
these workers to return for an appointment at a later time, as they had little time during 
their lunch break;  
 
P13 “Or often because a lot of people are office workers etc round here they often prefer 
to come back so then we’ll make an appointment in our diary for when they want to 
come back.” 
 
Other pharmacies did not operate an appointment system and would offer 
consultations there and then. As pharmacies became more confident in delivering the 
service, they often varied the content and timings of the service. Pharmacies that had 
tried running an appointment system often found that customers were reluctant to 
return at a later time;   
 
P14 “I think from the beginning we set it out quite formally, sticking to this pro-forma and 
obviously as we’ve gone along we’ve found that doesn’t really work. Particularly in a 
store like this where patients are going to just pop in, I’m not running an appointment 
system.” 
 
Other pharmacies varied their practice depending on how busy they were. If it was 
convenient for both them and the customer then they would try and offer a 
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consultation there and then. This was often limited however depending on whether 
they were the sole pharmacist on duty at the time;  
 
P16 “It has been very useful, the idea that there is someone who can give information to 
the customer straightaway as they’re standing there, they don’t have to make an 
appointment. The thing that can be a problem is that the majority of the time we do 
only have one pharmacist in the dispensary. It can be quite tricky to be able to spend 
the time especially when you’re busy. Even just a few minutes with a customer can be 
quite tricky in which case we do have the opportunity to ask them to call back at a 
later time if it’s not convenient.” 
 
7.2.1.6 Personnel delivering the asthma service  
The pharmacists that were involved with the original design and set up of the service 
also appeared to take the main lead for the running of the service within the individual 
pharmacies. These pharmacists took responsibility for updating other colleagues 
within the pharmacies on a regular basis;   
 
P17 “I’m not the lead pharmacist so we’ve got one lady that does most of it, she’s not here 
today, so the rest of us are supporting her in that.” 
 
All of the participating pharmacies had tried to involve the whole of the pharmacy 
team in the delivery of the asthma service;  
 
P15 “The whole team – another pharmacist, all the dispensers, the pre-reg. The 
healthcare staff has also been briefed.” 
 
The extent of their involvement however varied between individual pharmacies. Some 
pharmacists had encouraged dispensary staff to be involved with the initial 
introduction of the service, and provide informal advice;  
 
P13 “Well they’re involved in broaching the customers, but also the three trained 
dispensers have been involved in giving out the informal advice, we’ve encouraged 
that. The actual full, appointment consultation that’s done by the pharmacist but 
otherwise the dispensers to get involved with the informal discussions with the 
patients, or we’re trying to get them to be involved.” 
 
Within this particular pharmacy, the pharmacist would always carry out any full 
consultations themselves;  
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P13 “If there’s any sort of intervention I always counsel the patient on it as apposed to a 
dispenser or whatever and we just try and fill the form in straight away so it gets sent 
to the GP.” 
 
Pharmacists could see the benefits of using dispensary staff to carry out elements of 
the service particularly when pharmacist resource was tight;  
 
P12 “The dispensers are very good at it. Actually sometimes they’re the ones who have 
really the time to start the chat with them because sometimes if you only have one 
pharmacist or two in store you’re very busy with checking and maybe phone calls and 
maybe counter queries things like this so actually they’re the ones who normally start 
the chat.” 
 
Three of the pharmacies had pre-registration graduates at the time of the initiative, and 
had actively encouraged them to be involved with the service from the start; 
 
P16 “Well he’s been involved in this from the start and he’s really keen. He’s been coming 
along to our asthma meetings as well.” 
 
Healthcare staff within one of the pharmacies had been particularly proactive with the 
asthma service, more so than the dispensary staff;  
 
P17 “Yeah the counter staff, we were just talking about it this morning and they were 
asking what sort of advice they could give so I was telling them the sort of things that 
they could advice people and then they can refer them onto us if that not adequate for 
the patient. So there’s a bit of a gap, I haven’t seen the dispensers or pharmacy 
assistants doing much but then we’re quite a busy dispensary so they’re quite busy 
anyway but the counter staff and the pharmacists are certainly doing a bit.” 
 
The pharmacists within this pharmacy were keeping the staff enthusiastic and 
motivated about the service by ensuring that they were kept informed of progress and 
updates at weekly team meetings;  
 
P17 “But we’re talking to them at least weekly about it in the briefing meeting to keep it 
fresh and on the boil.” 
 
One of the pharmacists questioned was also a store manager. Although they were 
extremely positive and pleased with the delivery of the service within their pharmacy, 
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they also commented that this was because they had made it a priority which could 
change depending on other business needs;  
 
P14 “My dispensers. They’re pretty good at explaining inhaler technique and going 
through the questions but again it’s being driven by me and if I’m more interested in 
what crackers I’ve got on the shelf then well…” 
 
7.2.1.7 Type of asthma advice provided 
The majority of advice that pharmacists discussed with customers was mainly around 
medication use, and in particular, inaccurate, or over use of reliever inhalers;  
 
P13 “The main ones are using steroid inhalers when required, we get quite a lot of 
prescriptions for that. And again using the reliever ones on a regular basis.” 
 
One pharmacist felt that this was because customers did not understand the importance 
of using them correctly, and no-one had taken the time to explain this to them in the 
past; 
 
P16 “The main thing is the steroid preventer inhalers that they’re just not using them. 
They don’t understand the importance of them because they just see the word steroid 
and no-one’s actually in the past sat down and explained to them how they work and 
what they’re doing to them long term. So they’re very under used whereas the blue 
inhalers are over used.” 
 
Some people had not been using their inhalers at all which had caused significant 
problems with their asthma;  
 
P17 “They have been doing things wrong, they haven’t been using their inhalers properly 
or they just haven’t been using them at all so they were in need of advice so that was 
useful.” 
 
One pharmacist had actually found that the majority of problems had been due to 
medication dosage and frequency rather than inhaler technique; 
 
P17 “It hasn’t actually been inhaler technique it’s been more dose frequency and using 
brown preventers regularly instead of when they feel like it, so more dosage and 
frequency than actual inhaler technique.” 
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Pharmacists were finding that customers did not know simple advice like rinsing their 
mouth out after using a steroid inhaler, or the correct way of cleaning a spacer device; 
 
P15 “Really information like rinse your mouth out after a steroid inhaler, that sort of little 
tips. If you use a spacer don’t wipe it dry because it creates static. Those are the sort 
of things where they go ‘oh, I didn’t know that.’” 
 
One pharmacy actually found that the majority of customers within their locality were 
already receiving good asthma advice from their local clinics;  
 
P16 The majority of people it’s just checking they know how to use their inhalers and a 
few do have problems but most of the people we’re actually getting I’m finding are 
having attention from the asthma nurse, they are attending clinics.” 
 
During the cough and cold season, pharmacists were receiving a lot of queries from 
people with asthma around concurrent OTC medication use, and therapies to help 
prevent symptoms getting worse;  
 
P14 “Different types of devices, particularly in the last month or so controlling their 
symptoms while they’ve got a cold, we can give them quite a lot of advice on dosages 
and other over the counter medicines that can help enough for them not to be ending 
up with a chest infection. In what order to use their inhalers. I think that would be 
mainly it.” 
 
Very few of the pharmacists received specific requests on lifestyle advice, although 
some pharmacists would proactively ask this topic as part of the full consultation 
process; 
 
P13 “Then at the end go through any lifestyle issues, you know whether they do a lot of 
walking, exercise, even diet, etc. Just general lifestyle advice and counselling advice 
on their inhalers – rinsing mouth that kind of thing.” 
 
Pharmacists would also discuss with customers whether their asthma was restricting 
them from carrying out any of their normal routine or activities;  
 
P12 “…..so normally we just ask them about their medication, if it’s working, if their 
asthma is keeping them from doing normal things, just routine things.” 
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The pharmacists stated that they felt confident in referring people through to their GP 
if appropriate;  
 
P16 “That’s an important thing to stress I think, that we would be referring people with 
the patients’ consent if we felt there was an underlying problem.” 
 
Within the customer interviews, six of the respondents were asked what advice they 
had spoken to the pharmacist about during their last interaction, the same time that 
they were also recruited for the interviews. Many of the conversations were related to 
asthma symptoms and medication;  
 
C25 “Yes, I think it was if she could ask a few questions for a questionnaire, did I mind 
that? Not at all. Did I have any questions that she could help with? I’m sure she 
offered to help. Very nice lady…….. I think about the use of the inhaler and also she 
gave me an empty one to see how I inhaled, to see if I was doing it correctly…… I 
remember telling her that when I have a cold I take more Becotide® and the 
Ventolin®, I just increased it. And she asked how often I used them and things like 
that…… She asked me if I’d been to the local asthma clinic and also I know they do a 
reading if you blow out, it’s been a while since I did that but that’s about it.” 
 
Following the conversation with the pharmacist, one respondent also recalled being 
offered the opportunity to speak to an asthma nurse who was working on the premises 
at the time;  
 
C33 “They asked me how long I’d had it for, if I knew the proper way to use the 
medication, things like did I know I had to rip one out after using it.  They offered, 
they said they had an asthma nurse on the premises and was I interested in talking to 
her about it.” 
 
For two of the respondents, the interaction with the pharmacist had not been advice 
related, but purely to recruit them for research.  
 
C27 “No it was just about taking part in a survey. I think it was because I wasn’t actually 
picking up my own prescription.” 
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7.2.1.8 Factors affecting service delivery as identified by the pharmacists 
delivering the asthma service  
Within the interviews, pharmacists participating in the asthma service commented on 
any factors they believed had affected the delivery of the asthma service. All of the 
pharmacists stated pharmacy resource as a factor affecting service delivery. For two of 
the pharmacists in particular, being the sole pharmacist on duty had restricted the 
number and length of consultations they were able to deliver;   
 
P13 “It’s quite difficult because generally when I work I’m the only pharmacist here.” 
 
P16 “The only thing that can be a problem is that, the majority of the time, we do only 
have one pharmacist in the dispensary. It can be quite tricky to be able to spend the 
time especially when you’re busy.” 
 
Throughout the interviews, many of the pharmacists commented on the various 
demands on their time, which did not always allow them the luxury of spending time 
with individual customers;  
 
P16 “It can be the tricky thing in-store because when you’re the only pharmacist in 
dispensary, you’re supervising the healthcare counter and people are calling out 
‘pharmacy’ to you so you have to acknowledge them which means that as you’re 
talking to someone they can see that you’re being distracted continually which doesn’t 
look good and you forget where you’ve got to in the conversation.” 
 
It became apparent that the time of the year that the service had been implemented was 
particularly bad as it was the busiest trading time for the pharmacies. Priorities were 
mainly focused on Christmas sales, which made it particularly difficult for the 
pharmacists to concentrate on asthma services; 
 
P14 “I think particularly the time of the year we’ve been doing it, in the run up to 
Christmas, I wouldn’t say it gives me a conflict of interests but it’s difficult to focus on 
two totally different things at the same time so I’m sure I could have made more 
interventions.” 
 
Lack of customer time was also seen as a factor that affected service delivery, which 
was particularly apparent if the pharmacy was located in commuter and office areas;  
 
P12 “They say they’re interested but they haven’t got the time…It’s also that the store is in 
a commuter place so there’s lots of people working here but then they live somewhere 
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else so when they come to us for their prescription they come in their lunch break they 
maybe collect them after work, they go home and that’s it.” 
 
One pharmacist whose second language was English found it particularly difficult to 
communicate with customers on a personal level. This was not just a language barrier, 
but difficulty understanding the body language signs of individuals;  
 
P12 “I mean I was able to speak English when I came but to treat people it’s a little 
difficult to understand not only the language, the different accents and the slang but 
also it’s a cultural difference so sometimes you find it difficult to see what the mood 
they’re in, the kind of problems they have, what they’re expecting from you…so I think 
that’s the difficult bit.” 
 
Only one pharmacist thought that the pharmacy environment caused problems for 
them in service delivery and this was due to a lack of space within the dispensary area; 
 
P13 “I think primarily people in our area see us as a major dispensing area – we could do 
other kinds of things but then it’s just finding the space to do it as there isn’t really 
room to turn around in here.” 
 
 
7.2.2 Discussion of the results  
Within this section of the chapter I have presented the results from the delivery of the 
asthma service to understand the various factors affecting service delivery. The service 
itself was designed and implemented locally by a group of pharmacists. There was a 
feeling amongst participants that they had the opportunity to provide input and 
participate in the project, in particular through the regular meetings that were held 
throughout the period of the project. The pharmacists appeared enthusiastic and 
motivated towards the service, and this was demonstrated through their commitment 
to the project throughout the time period. This level of commitment and ownership of 
the project could have been influenced by the fact that these pharmacists designed the 
service themselves, and were keen to prove its success. In effect they owned the 
project locally, and felt a professional responsibility and pride in delivering the service 
successfully. The regular meetings appeared to work well and provided an opportunity 
to share best practices and learnings between the different pharmacies.     
 
Like the service, the training was designed and organised locally. Many of the 
pharmacists leading the service had already completed, or were undertaking clinical 
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diplomas. Despite having this knowledge, many of the lead pharmacists undertook 
additional training on asthma prior to the service training. These pharmacists 
identified additional clinical modules on asthma, or distance learning training 
packages that they could undertake to feel more knowledgeable on asthma. The 
training course was designed to meet local needs and involved both the pharmacists 
and pharmacy staff. The asthma brief intervention materials were used as pre reading 
before the course, whilst the course itself involved hands on experience and 
operational guidance. This additional training and hands on experience appeared to 
give the pharmacists and their staff the confidence they needed to be able to deliver 
the service. A review of the literature relating to evidence of community pharmacies 
involvement in health development concluded that training was a key component in 
changing pharmacists behaviour during health promotion programmes [166]. The 
literature concluded that training increased the pharmacists involvement in 
opportunistic health promotion, and resulted in longer consultations between 
pharmacists and customers.  
 
Pharmacists and their teams spent lots of time and effort promoting the service locally, 
to try and increase awareness and encourage uptake into the service. This marketing 
activity was well received by schools and shopping centres, many of whom displayed 
the posters and leaflets. Despite this activity, the pharmacists were disappointed in the 
low numbers of people coming to the pharmacy as a result of seeing a poster or leaflet. 
The poor response from the marketing activity could be due to the effectiveness of the 
posters and leaflets, or the mechanisms that were used to promote the service, neither 
of which was measured within this study. By targeting schools and shopping centres 
the pharmacists hoped to make people aware of the service. The marketing activity 
may have been successful in doing this, but it was not successful in converting people 
into accessing the service.  
 
All of the pharmacists involved in the project had spent time going out to their local 
GP practices to make them aware of the service. The feedback from practices was 
generally positive, with many discussing referral criteria with the pharmacists. The 
asthma service was used as a way to help build links and strengthen the relationship 
with the GPs, with many interested in the link through to GP contracts and local 
targets. The service seemed to work well as a facilitator in building local relationships, 
particularly when it was advantageous to the parties concerned. There was some 
variation in the response from GP practices, with a few GPs and nurses showing no 
interest in the service at all. This was particularly evident with the reaction of some 
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nurses and the pharmacists perception of the threat they posed to their role. Although 
a couple of the pharmacists experienced hostility from local nurses, others formed 
close working relationships with their local asthma nurse. In these sites, the nurse and 
pharmacist worked together to help people with asthma locally to improve control of 
their condition. Despite all the communication and positive links made with local 
healthcare professionals, pharmacists received very few referrals from their local GP 
practices. It is unclear whether healthcare professionals referred people through to the 
service or not, as this was not measured in this study. If local healthcare professionals 
had referred people to the service, they may have decided themselves that they did not 
want to access it. The pharmacists themselves felt comfortable referring customers 
through to the local GP or asthma nurse if they deemed it appropriate. Whether 
customers acted on this advice was not measured as part of this study. 
 
Despite all of the external activity to raise the awareness of the service and encourage 
uptake, the majority of people appeared to have heard about the service whilst in the 
pharmacy. Most pharmacists recruited customers to the service by asking them 
questions on symptom control when handing out prescriptions. Only a small sample of 
pharmacists were actively targeting people presenting at the pharmacy for OTC 
products. Those that did this found it worked well as a recruitment method. Customers 
purchasing cough and cold products were presenting with symptoms at the time, and 
as such, pharmacists found them much more receptive to the service. Some 
pharmacists may have felt more comfortable recruiting people to the service when 
presenting with a prescription, than they did with people purchasing OTC products. 
Pharmacists working in a busy dispensing pharmacy may have had limited 
opportunity to target people OTC, and could have left this task to the pharmacy staff. 
The overall impact of in store recruitment methods appears to have been far more 
effective at increasing the uptake of the service compared to other external activities. 
 
In order to keep the service simple for pharmacists, they were not asked to record the 
number of interventions they were delivering. During the interviews however, they 
were asked to provide an estimate of the type and frequency of service they were 
offering. There was a huge variability in the service that was provided, with many 
pharmacists delivering brief interventions daily, and the full service only a couple of 
times a week. The length of the consultations varied, whether it was a brief 
intervention or the full service. The pharmacists would adapt the service based on how 
busy they were at the time of the interaction and how responsive the customer was.  
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Although the pharmacists used the same core structure for the service, they also varied 
the content depending on local needs. The questions on symptom control were used by 
many of the pharmacists as an initial prompt to identify poor symptom control, 
although the pharmacists would often not ask all the questions, but use a combination 
of one or two, or their own variance on them. If short of time, pharmacists found 
themselves discussing simple things like inhaler technique, whereas if more time was 
available then they would go through the structured questionnaire. Many pharmacists 
often found customers preferred to have these brief or mini interventions rather than 
the full consultations. It is unclear who ultimately drove the type, length and content 
of the consultation; demands on the pharmacists time, the customers needs, or a 
combination of both. As the pharmacists had the confidence to adapt the service to 
meet local needs, it enabled them to offer their services to more customers. If they had 
stuck with the formal structure of the full consultation then many customers would not 
have had the benefit of the opportunistic advice that the pharmacists were able to 
offer.  
 
Pharmacists appeared to be providing advice in a very informal manner, as many 
utilised the time and space they had available to them at the time. This resulted in the 
majority of the brief interventions occurring over the counter, or even on the shop 
floor. The pharmacists found that the majority of customers were more receptive to 
advice that was offered there and then, as apposed to trying to get them to call back for 
an appointment at a later date or time. Some pharmacists did try and operate an 
appointment system, and those that did, found reluctance from customers to return. 
Appointments that were made at the request of the customer after receiving brief 
advice and returning for a full consultation appeared to work the best. Customers 
appeared to be less enthusiastic about appointments that were pharmacist led, and that 
were made because of lack of resource available at the time. There seemed to be an 
overall reluctance to book appointments with the pharmacist, as this was not 
something that customers had had to do with the pharmacist in the past. One of the 
key strengths of community pharmacy has always been the ability for the general 
public to be able to access health advice from the pharmacist without an appointment. 
A shift to appointment based services could require an enormous change in the general 
publics perception of role of the pharmacist compared to other healthcare 
professionals, and a behaviour change for customers when accessing services.        
 
It is not surprising that the pharmacists involved in the set up of the service took the 
lead within their individual pharmacies. Some of these pharmacists were able to 
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delegate some of the operational aspects of managing the service to other members of 
the team, and where pharmacies had pre-registration graduates; they were often the 
key person in the pharmacy helping to manage the project. Pharmacists that had 
delegated some of the responsibility of the day to day management of the project often 
found that they were able to manage the overall project more effectively, and tended 
to be more active in the service activities. Having a lead person responsible for 
delivery of the service within each pharmacy appears to have worked well for this 
service.    
 
Pharmacists that involved all members of the pharmacy team in delivery of the 
services appeared to be far more active than those that did not. There were variations 
to what extent other staff were involved, but pharmacists tended to engage them in 
helping to identify people with poor symptom control, and where appropriate, to offer 
brief advice. Pharmacists who had involved pre-registration graduates tended to find 
that they had more time available and so were very active in service delivery. The 
involvement of the pharmacy team in initiatives like this appeared to be very 
motivational, although the pharmacists found it important to keep them regularly 
updated to keep the service active. The involvement of pharmacy staff in service 
delivery provided greater opportunities to make the service more widely available to 
customers. Pharmacy staff were able to target customers opportunistically when they 
presented at the pharmacy counter to purchase OTC medicines, or for their 
prescriptions. It was more cost effective to use pharmacy staff for certain elements of 
the service delivery, allowing the pharmacist to become more involved when 
appropriate.  
 
The influence of the store manager on the priorities and focus of the pharmacy team 
was extremely important. As pointed out by the store manager involved in the project, 
unless the service was on their agenda then it would be unlikely to get focus within the 
pharmacy. Individual pharmacists could be extremely keen to deliver services, but 
unless the support of the manager was acquired they could be fighting an up hill battle. 
The impact of the time of year could have affected the delivery of the service as much 
of the store focus was on Christmas sales. Although the busiest time of the year, it was 
also an opportunity to target the many customers entering the store. Pharmacists who 
are also store managers, particularly in single store pharmacies, may have a conflict of 
interest when it comes to delivering professional services over business priorities.  
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The majority of asthma advice appeared to be around inaccurate, over or under use of 
medication, with problems being identified with dosage and frequency, as well as 
inhaler use. There was a feeling amongst the pharmacists that this was due to 
customers not understanding the importance of medication use, with many customers 
not previously having had the opportunity to talk to a healthcare professional about 
medication issues. The provision of simple advice linked to asthma medication use, or 
concurrent OTC products were well received. Very few requests were made for 
lifestyle advice, although pharmacists would often bring this up in conversation with 
the customer. Customers appear to have felt at ease speaking to pharmacists about 
medication use, but were not as used to, or possibly felt uncomfortable in talking 
about advice that they would not normally get from the pharmacist.  
 
All the pharmacists interviewed commented on pharmacist resource as a factor that 
affected delivery of the service. Those working in single pharmacy environments were 
felt to be at a disadvantage in service delivery. Even though resource was raised as an 
issue by all pharmacists during the interviews, the majority had managed to work 
around this for the service by involving other members of the pharmacy team, or by 
offering the asthma brief interventions. If resource had been made available, it is 
unclear whether the pharmacists would have delivered more of the brief interventions 
or full consultations. Linked to the resource issue, the pharmacists also believed that 
the constant demands on their time (including requests by customers and staffs), was 
an issue that affected the delivery of the service. Better trained support staff would 
help to reduce the number of requests coming through by both customers and staff, 
and enable the pharmacists to utilise their time more effectively.  
 
The lack of customer time was felt to be a factor that affected service delivery, 
particularly when people were shopping in their lunch hours when their time was very 
limited. This was found to be particularly problematic in commuter towns, which 
could help to explain the demand for the informal brief interventions over the full 
consultations. The pharmacy environment was mentioned by one pharmacist which 
they felt could have put people off the service. It is unclear whether the pharmacist 
themselves felt uncomfortable not having a private consultation area to conduct the 
service, or whether it was the individual customers.  
 
The language barrier was discussed by one pharmacist as a factor that could have 
affected delivery of the service. This could be linked to the pharmacists confidence in 
 238 
using the English language to deliver the service, or the customers being unable to 
understand what the pharmacist was saying.  
 
7.2.3 Summary of section two 
The asthma service was designed and implemented by a group of pharmacists within 
their locality, and was based around identifying people with asthma that would benefit 
from a consultation with the pharmacist on inhaler technique, medication use and 
general lifestyle advice. The service was successful in being implemented, with the 
pharmacists taking ownership of the project locally. Many of the pharmacy team were 
involved in helping to identify customers with uncontrolled asthma. Pharmacists had 
the confidence to adapt the content and length of service locally according to local 
business or customer needs, and would often carry out asthma brief interventions 
rather than the full consultations. The local flexibility allowed the pharmacists to offer 
their services to a greater number of customers.  
 
From these results presented within this section, I have identified a number of factors 
that appeared to have influenced the delivery of this service, some helping to facilitate, 
and others acting as barriers. Those factors affecting the delivery of the asthma service 
are summarised within Table 55. The external marketing used for this project did not 
result in facilitating the uptake of the service, nor did the communication with local 
healthcare professionals and expected referrals, and as such are not included in the 
factors affecting service delivery identified within this section.    
 
Table 55: Summary of the experiential factors affecting delivery of the asthma service 
(Please note that this table is presented over two pages) 
 Facilitators  Barriers 
Customer need 
̇ Ability to adapt service to 
customer need 
̇ Advice that is pharmacists 
area of expertise (e.g. 
medicines related) 
̇ Advice that is not perceived 
to be in pharmacists area of 
expertise 
Pharmacist 
attitude 
̇ Commitment to service 
̇ Enthusiastic 
̇ Confidence to adapt service 
 
Implementation 
of the service 
̇ Local ownership and 
delivery of the service 
̇ Service lead in each 
pharmacy 
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 Facilitators  Barriers 
Training 
̇ Opportunity for additional 
training 
̇ Language barriers 
Pharmacy 
communication 
̇ Regular communication 
with team (central and 
local) 
̇ Opportunities to share best 
practice and learnings  
 
Recruitment 
̇ In store recruitment 
̇ Targeting uncontrolled 
people with asthma  
 
Service structure 
(asthma service) 
̇ Flexibility in service 
delivery 
̇ Simple service to deliver 
̇ Ad hoc consultations and 
advice 
̇ Appointments available at 
the customers request 
̇ Appointments led at the 
pharmacists request 
Management 
support 
̇ Management support of the 
service 
̇ Lack of management 
support and prioritisation of 
other activities 
Time  
̇ Lack of customer time 
̇ Lack of pharmacist time 
̇ Demands on pharmacist 
time 
Staff resource 
̇ Adequate staff resource 
available (pharmacists and 
support staff)  
̇ Involvement of all 
pharmacy staff 
̇ Effective use of pharmacy 
team 
̇ Inadequate resource 
available (pharmacists and 
support staff) 
̇ Single pharmacists stores  
Pharmacy 
environment 
 
̇ Pharmacy located in 
commuter towns (potential 
link to customer time 
available) 
 
The last section of this chapter goes on to present the recommendations that customers 
and pharmacists believed would help to improve future service delivery.  
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SECTION THREE 
 
7.3  Potential facilitators for service delivery identified by 
pharmacists and customers  
The previous two sections within this chapter have looked at the factors affecting the 
delivery of the brief intervention and asthma service. This section goes on to explore 
the recommendations made by the pharmacists and customers for future service 
delivery. These recommendations can also be classified as potential facilitators for 
service delivery. Data is provided from the pharmacist and customer interviews, and 
the results presented explore the implementation of the service, staffing, the pharmacy 
environment, awareness of the service, service delivery, advice on asthma, and advice 
on other condition areas.  
 
 
7.3.1 Results 
7.3.1.1 Implementation of the service 
Within the interviews, two of the pharmacists commented about the need for training 
for initiatives such as the brief intervention. Although both of these pharmacists liked 
the information they received, one pharmacist thought that it would have been more 
effective if they had the chance to attend a training day, rather than just read the 
materials themselves; 
 
P4 “The intervention idea is a good one but I think that when we’re dealing with specific 
ailments such as asthma we might need some more training. You know stuff on the 
different medications available and a reminder on the symptoms and things that could 
improve them. Reading leaflets isn’t always a good way to learn and feel confident in 
what you’re telling customers. I reckon if we had a half day training in the area that 
we would feel more confident and it might make us ask more people if they would like 
some advice. The lifestyle advice I gave out is excellent but some of it I could have 
done with a chat through with someone before I offered it. I ended up picking out the 
things that I already knew and how I could talk about if they asked any difficult 
questions.” 
 
The second pharmacist was late receiving the initial briefing pack, but thought that it 
would be better if the materials were available for all the pharmacy staff to get 
involved;  
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P11 “…I think that it would have been a good idea to put some sort of asthma training 
pack in there, purely just for if you’re doing something like this it’s good the whole 
team getting involved in doing it…..” 
 
7.3.1.2 Staffing 
Many of the pharmacists commented that they enjoyed initiatives such as the brief 
intervention which allowed them to get closer to their customers as long as they had 
the time and resource to do it properly; 
 
P1 “Other than that like I said I reckon all pharmacists would welcome the opportunity 
to get more involved with customers – as long as we have the time and manpower to 
be able to provide this added service.” 
 
They believed that they were offering a better service to their customers, but needed to 
ensure that they had the time to deliver it; 
 
P5 “We’re offering a better service and we just need to ensure that we have the time to 
do it.” 
 
Some pharmacists felt that pharmacy managers could plan time for the pharmacists to 
be able to deliver interventions such as this; 
 
P2 “I enjoy it, it’s just simply the time and level of opportunity to offer it that’s the key 
issue. And I’m sure that we can sort that internally at management level.” 
 
Early communication about initiatives such as this would help to ensure that 
pharmacies had enough time to plan any additional resources required;  
 
P6 “…..as long as details of such initiatives are sent through early enough with all the 
information that we might need so that we can work out if we have enough time and 
resources to take part.” 
 
Although pharmacists recognised that they did not need to spend a lot of time with 
customers to deliver the brief intervention, one pharmacist thought that it might be 
better to manage pharmacist time and resource by having allocated slots of time when 
people with asthma could come and talk to the pharmacist; 
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P11 “…if you’ve got the time to do it, it’s not a massive amount of time that you’re going 
to be spending with people, it’s just having the organisation and people knowing when 
you’re there. You could almost have times when people came in to see you.” 
 
Pharmacists were constantly being interrupted during the course of a normal day, 
many of which they felt were unnecessary queries. By reducing the level of 
interruptions by pharmacy staff, one pharmacist thought that this would help to 
increase the level of time they had to spend with individual customers;  
 
P10 “Oh, lots of ways, we could have more staff here, that would be nice. We could have 
less interruptions. We’re always being interrupted, some are reasonable queries that 
we would need to deal with but a lot aren’t.” 
 
Only two pharmacists participating within the asthma service had recommendations to 
make regarding pharmacist resource and future service delivery. Both pharmacists 
believed that extra resource was required in the pharmacy to carry on delivering 
interventions like this, although they were aware that funding of this would be an 
issue; 
 
P15 “I think well maybe not a lot more but when the company works out how much 
manpower we need in the dispensary that’s all got to be taken into account and of 
course it’s all to do with funding and if there’s no funding…its not an easy issue.” 
 
They believed that extra pharmacist resource would allow them to take customers into 
a private consultation area so that they could conduct a full intervention with them; 
 
P16 “I think if we are going to carry on with interventions like this we do need to have 
more pharmacists in store so you can take someone away from the actual dispensary 
area itself, sit them down and just completely talk to them as you would do in a 
surgery.” 
 
A number of the pharmacists who thought that asthma interventions would be better 
with additional pharmacy resource, believed that this could be fulfilled by having 
more support staff, rather than extra pharmacists.  
 
P2 “We just need to be able to have the time to do it and that could mean more staff on 
the counter I guess. We would get used to offering it as part of the job and it would 
become accepted into the routine.” 
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Pharmacists saw the benefits of developing roles such as checking technicians, as they 
would free some of the pharmacists time to enable them to spend more time with 
individual customers;  
 
P5 “I’d like to see that we have cover available to support us when we’re providing the 
intervention service. A dispenser is adequately trained to check prescriptions and 
research suggests that non-pharmacist checkers check more thoroughly and at the 
end of the day they can free us up and might allow us to spend more time talking to 
the customers and offering them some advice.” 
 
Many of the pharmacists believed that this kind of intervention would work better if 
all the support staff were involved, particularly in pharmacies with a busy dispensary 
business. They believed that it was important to keep everyone informed and 
motivated on an ongoing basis in order to keep the service active;  
 
P14 “I think it will work better in a store where it’s busier dispensing and you’ve got a 
dispensing team, lots of dispensers and everyone can get on board. It needs everyone 
on board to keep it going basically.” 
 
One pharmacist had suffered problems within their pharmacy, due to the dispensing 
team having the service as a lower priority compared to them. They felt that future 
interventions could be helped by involving other staff more, such as dispensers, and 
having this kind of service higher on the list of store priorities; 
 
P13 “And the dispensers….I think when you’re working in quite a busy dispensary they 
feel they should just be doing that and anything else is low on their priorities. 
Whereas to someone like me it’s probably very high on my priority and on the days 
when I work I’m sort of telling them…….” 
 
One pharmacist felt that it was important to get pre registration graduates and newly 
qualified pharmacists involved with this kind of initiative. They also thought that 
training packs could be developed for counter staff so that pharmacists could utilise 
them to identify and approach people with asthma on their behalf; 
 
P11 “…..purely just for if you’re doing something like this it’s good the whole team getting 
involved in doing it and I think especially for pre-reg’s or newly qualified pharmacists 
and also counter staff being aware of what’s actually happening, some kind of 
training pack would be good to show them and talk to them about it and explain these 
are reasons why people can not be using their inhalers right or their asthma’s can be 
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getting worse which with their normal pilot highlight to them, the other staff, to be 
able to pick out people and say maybe that person needs some help or that person 
needs to be able to talk to you about it, and almost start the conversation off for you 
before you actually get there, especially if you’re going to be checking a script.” 
 
7.3.1.3 Pharmacy environment  
In total, four pharmacists thought that interventions like the asthma services would be 
better if pharmacies had private consultation areas. Of these pharmacists making the 
comments, two had been delivering the brief intervention and two the full asthma 
service. These pharmacists believed that some customers would not want to talk to 
them whilst surrounded by other people, and would feel more comfortable in a private 
area; 
 
P5 “It would be a good idea if we could invite customers into the screened off Pro-
Change™ boothsq so that we have somewhere quiet to talk to them about their 
medications and symptoms. Some people wouldn’t be prepared I reckon to talk about 
themselves while waiting in the queue.” 
 
Pharmacists also felt that it was important to have consultations with customers where 
they could talk privately with them, without being interrupted by other staff and 
customers; 
 
P16 “But the important thing we have to do is we’ve got to have the surroundings where 
we can give undivided attention to the customers as a doctor or nurse would be able 
to do. Somewhere that’s quite private and that we’re not being distracted by 
customers.” 
 
Designated consultation areas would help improve customer awareness for the service, 
and could be used not only for asthma, but also other health promotional activities; 
 
P13 “I think it could be probably carried out in a more…I know some of the larger stores 
have a designated area, you know a proper consultation area. I think if people see 
that there….if we could have had our machine out and various things out that would 
have drawn a lot more attention from our customers……” 
 
                                                 
q Pro-Change was a computer based smoking cessation programme delivered by Boots 
during 1999 - 2000  
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Within the customer interviews, three respondents also suggested that the service 
could be improved by having a separate area or counter for advice. Respondents felt 
that many customers would feel uncomfortable about receiving or asking for advice 
from the pharmacist at the main pharmacy counter in case this held up the queue. One 
respondent suggested that the separate counter be called a well-being counter’ or 
‘health advice counter’;  
 
C1 Boots have a separate counter for everything anyway.” 
 
In addition to a separate area for advice, one respondent also felt that customers 
should be able to approach a designated member of staff for advice; 
 
C20 “Maybe if there were separate compartments in the pharmacy that you could go and 
get information off one specific member of staff who just deals with that, then yes 
maybe, but otherwise I wouldn’t really ask.” 
 
Another respondent thought that the area for advice should be made larger, as the one 
they had access to within their local Boots pharmacy was extremely small and always 
crowded. They also suggested that the advice giving area should be well sign posted 
so that people would be aware that they could access advice from the pharmacist; 
 
C26 “Probably the lighting. It’s not particularly accessible: it’s not a lone counter, it’s a 
round semi-circle of a counter and it gets quite crowded in there at times and the 
actual area of it, because it’s such an important, integral part of Boots I think it could 
be made larger. The XXXX one is nothing like as good. It wants to be a little bit more 
accessible and some notices up saying ‘Come and see us, we can answer a lot of 
medical questions’. I think a lot of the older generation does but the younger 
generation I don’t think they’d know - they’d go and sit in a doctor’s surgery for 
hours instead.” 
 
7.3.1.4 Customer awareness of the service 
Within the customer interviews, three of the respondents who had participated within 
the brief intervention believed that the branding of the service could be improved by 
calling it an advice service or simply over the counter advice. One respondent who 
had participated within the asthma service also thought that instead of calling the 
service this, it should be termed a support service, as it was supplementing the 
advice from GPs; 
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C28 “An intervention is quite a confrontational kind of word and you know pharmacists 
aren’t doctors and whatever. I think it should be some sort of support. Like care in the 
community sort of thing isn’t it, it’s offering additional support.” 
 
Many of the pharmacists participating within the brief intervention activity felt that 
having posters and leaflets would help raise awareness of the service, and would 
encourage customers to ask about the service, rather than just relying on the 
pharmacist or staff to approach them directly; 
 
P1 “I think it would be really good if we could have some posters for the next waves, or 
some leaflets that customers could pick up letting them know about the service. That 
way they could ask for some information and advice without us only being able to 
offer it if we spot an opportunity.” 
 
Having these kinds of materials would help to improve access to the service, rather 
than pharmacists just being able to offer advice to customers during quieter times;  
 
P2 “I think it would be a good idea if we could have posters or signs on the counter 
advertising the service then at least customers could ask for it, even when we’re busy. 
That way everyone could have access to it and not just those that come in when we’re 
quiet.” 
 
One pharmacist also thought that it would be good to have contact cards so that 
pharmacists and staff could hand these to customers to make an appointment at a later 
date; 
 
P8 “I think part of it might be regarding patient awareness that the service is available. 
But then it’s very difficult with respect to the advertisement of professional services 
and that then comes into the code of ethics for pharmacists and that can be quite 
difficult. But it’s trying to make the patient aware so that if for example its my day off 
or I’m on holiday when they come in that they are still aware of the service so that 
they can make contact or make an appointment for an appropriate time. It may well 
be that it’s just something simple like having little cards with the pharmacists name 
and number on. Not so much saying ‘asthma expert’ but just saying do you need help 
and advice regarding your condition, your local contact is…Just something like that.” 
 
One pharmacist had independently designed posters to advertise the service, and had 
also photocopied the lifestyle advice for customers to take away with them following 
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the discussion with the pharmacist. Future interventions, they thought, should provide 
the pharmacist with flowcharts to describe the process to customers.  
 
Pharmacists thought that interventions like this should be an ongoing thing, with 
general awareness of the public being raised that this advice was available in 
pharmacies. It was felt by two pharmacists that future services would need advertising 
outside of the pharmacy environment to try and encourage people to come into the 
pharmacy for advice. Show material in GP practices and messages on repeat 
prescriptions were some of the suggestions raised; 
 
P11 “Then make people aware you’re actually doing it as appose to the first time they 
know about it they see it or come into the store, you know in the surgeries, putting 
show material up, the GP’s actually putting it on the repeat slips to say that if you 
need any advice on inhaler techniques then pop into Boots.” 
 
Many of the customers also suggested ways they thought that the service could be 
improved by raising awareness of the service. They believed that the service needed to 
be promoted better in the pharmacy, so that customers had the option to take up the 
advice if they wished to. Customers could be made aware of the service via labelling 
on products, posters and information next to the pharmacy counter; 
 
C19 “I would probably say the best thing to do is have it at the pharmacy desk because we 
go there for our medication, it might be have posters or as they hand over your 
Ventolin® to say ‘did you know’ or maybe hand over a leaflet or talk you through 
something, I think that would be best.” 
 
Putting leaflets into prescription bags was also thought to be a good way of raising 
awareness of the service by one respondent;  
 
C34 “I suppose when handing out prescription have leaflets in the bag with the items, to 
make people aware these services are available so if people do want to know more 
they can go and ask.” 
 
Boots dental and optician departments were seen as well signposted within the store, 
with dynamic signage. Respondents felt that this was not the same for the dispensary 
area and that the signage needed to be more dynamic, and clearly sign post the 
services available;  
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C26 “Well they do have notices up but they could be slightly more dynamic……. There are 
small notices there saying we can pick your prescriptions up from the chemists or the 
doctors or things like that but I don’t remember seeing anything about offering 
advice. There again, it’s general knowledge because you can always go and see a 
pharmacist. But you see so many people, I hate to say it, aren’t very educated in doing 
things like that. I would but a lot of people just think, oh it’s just the chemist and go 
and pick their pills up or their aspirins.  It needs to be…You see in the Woking Boots 
they’ve got a very good dental department, it’s all lit up and ‘Come and see us’ and 
opticians in there as well. The dispensary is very big but it probably could be a bit 
more dynamic.” 
 
Boots was seen as a company that took a soft approach to advertising and promotions 
generally compared to other competitors;  
 
C28 “One thing about Boots is they’re very softly, softly in all their promotions and 
everything compared to others. I mean I can’t think of the last time I saw a Boots 
advert on TV whereas some of the other pharmacies use TV and I don’t think Boots 
do, maybe they don’t need to because of the turnover and the sales but I think in terms 
of awareness that might be useful.” 
 
One respondent felt that as well as advertising the service on till receipts, it would be 
good to have a tip of the week, or month to encourage repeat users of the service;  
 
C13 “I think it’s a great idea especially if they could so some kind of leaflet or tip of the 
week or month perhaps. It might make you visit the counter to see what this month’s 
tip is. Or perhaps they could put it on your receipt if you buy a related product like 
they do on bus tickets.” 
 
The advantage cardr was also seen as a useful avenue to raise awareness of the service, 
in particular through the associated health and beauty magazines; 
 
C22 “I have a Boots advantage card and if they put an article in the Boots magazine, I do 
leaf through that. That would reach more people then….” 
 
One respondent also suggested using the website as a tool to advertise the service; 
 
                                                 
r Loyalty card available at Boots  
s Boots magazine which is sent to high spending advantage card users  
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C34 “Obviously there’s website advertising, I don’t know how many people go on Boots 
website or whatever.” 
 
Within the pharmacies delivering the asthma service, two pharmacists thought that 
improvements could be made to the service by working more closely with local 
healthcare professionals. One of the pharmacists thought that the initial 
communication that they sent to the local GPs could be improved by making it more 
personalised, instead of the standard letter the team had come up with;  
 
P17 “The letters that we had something like Dear Health Professional on them which I 
find a bit cheesy. We should have had a facility to put Dear Dr Smith or whatever 
on.” 
 
The second pharmacist felt that working more closely with the asthma nurses, and 
getting them to come into the pharmacy might help improve future activity. 
 
Within the brief intervention pharmacies, one pharmacist also had some good ideas 
that if they had known more about the service in advance, they would have liked to 
have implemented. These were mainly focused around taking the opportunity to work 
closely with the local GPs and asthma nurses, and appeared to be based around an 
extended service such as the asthma service; 
 
P11 “Also give GP referral slips to GP’s so if they want to refer people to us to talk to 
people about inhaler technique and that kind of thing as appose to taking up their 
time or the nurses time…” 
 
P11 “Then obviously, speak to the asthma clinics to see who is actually running them and 
what type of advice they’re given so you’re not giving conflicting advice….” 
 
7.3.1.5 Service delivery 
Very few of the pharmacists had any recommendations to make on the service 
materials that were used within the brief intervention and asthma service. Of the three 
that commented on the brief intervention materials, one pharmacist thought that the 
intervention could have been improved by making it slightly more structured, with 
perhaps the use of a questionnaire. They also thought that future materials should 
distinguish between asthma and COPD. When questioned about what else they would 
have liked for the intervention, one pharmacist suggested that sample inhalers would 
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have been good. They had proactively approached companies for them as a result of 
the intervention, but had generally found them quite difficult to get hold of; 
 
P10  “Samples of inhalers that we found quite difficult to get out of some manufacturers. 
Did get some eventually, but it did take a while to get them, and that was some things 
that you really need if you’re going to do any kind of meaningful discussion with a 
patient with a new inhaler.” 
 
One of the other pharmacists was late in receiving the initial communication, and felt 
that the service could have been improved by better communication of these 
interventions and services beforehand so that pharmacists knew what to expect; 
 
P11 “It wasn’t like this is something that Boots are doing, and that kind of stuff, and I 
know you’ve got to trial things, but a bit more thought in it really.” 
 
Only one of the pharmacists involved within the asthma service had recommendations 
to make regarding the service materials, and felt that future interventions would be 
better if paperwork was kept to a minimum, and the intervention itself was kept very 
simple. The same pharmacist also thought that it would be better to send pharmacies a 
complete kit at the start of the service with all the materials that they needed rather 
than as separate deliveries. This was because the pharmacies were often inundated 
with deliveries of materials, and found that things could quite easily get lost as a 
result;  
 
P14 “They could almost do with setting up a kit and that’s what you need for each store 
and send it out.” 
 
Some of the respondents participating within the customer interviews felt that the 
asthma service could be improved by having information leaflets available for both 
adults and children that could be given out when people pick their prescriptions up. 
The information could contain advice relevant to people with asthma at that time of 
the year, such as tips to help you through the winter. One particular respondent felt 
that current literature seemed to be aimed entirely at children; 
 
C22 “Leaflets I’ve seen before are quite informative but always aimed at children. They’re 
never aimed at adults, and the thing is, yes, fair enough, a child needs to know how to 
take their inhaler but I’m 25 and I’m not going to ask a crocodile. Maybe literature 
aimed at adults with some advice with regard to help through winter, vitamins, herbal 
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tablets to help boost immune systems and other things to do to reduce your chance of 
getting chest infections, all that kind of thing.” 
 
Advice on alternative medication and things that could be used in conjunction with 
inhalers were also of interest to some respondents. They felt that advice on leaflets and 
posters should be made available to customers near the pharmacy area; 
 
C34 “I don’t know, like I said, perhaps put out some leaflets offering alternatives or advice 
for things to be used in conjunction with inhalers.  It all depends, I personally 
wouldn’t mind being approached, if I was to walk in to the pharmacy and there was a 
poster there or leaflets there then certainly I would look at them and if someone 
wanted to approach me on the subject then yes, I’d be amenable to that, that’s not a 
problem.”   
 
Respondents felt that it was important for customers to pick up some of the 
information themselves as they could be doing this for a friend or family member with 
asthma, rather than themselves; 
 
C25 “I think on the counter because then it will remind people and they can bring it up, for 
maybe they don’t need it for themselves, maybe a relative and things like that it can 
always help.” 
 
One respondent felt that people did not always pick up or read information leaflets in 
the pharmacy, and thought that it would be more effective to send information through 
the post via targeted leaflet drops. This information should be kept very simple, so that 
customers would spend the time to read it, and not immediately place it in the bin; 
 
C24 “Can’t think of anything, unless they did information drops to asthma sufferers, these 
leaflets that are in the store, lot of people probably wouldn’t pick up the leaflet and 
take the time to read it, so could send through a newsletter or something, with bits of 
information to do with symptoms or something. Something quick and easy to read, get 
through the letterbox and not something that you’d want to chuck in the bin, but 
actually sit down and spend the time to read it. I’m a blood donor and they do a 
similar thing when they actually send through a magazine regularly and it keeps you 
up to date on things about good things to do with giving blood, etc, but it’s quite 
interesting and you then feel part of a special group. I know asthma is slightly 
different but you’d still feel part, that there are other people out there going through 
similar things to you.” 
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Although the majority of respondents wanted additional written information available, 
one respondent felt that verbal advice for them would always be more favourable as 
they were more likely to listen and take the information in; 
 
C19 “I think verbal advice would be best because I think written things don’t get read 
properly. I’m terrible for scan reading, and at least I picked the leaflet up, but I think 
if someone’s talking to you, you have to pay more attention don’t you, otherwise it’s 
rude.” 
 
Having recently acquired access to the internet, one respondent stated that they would 
prefer access to advice and prescription services via this avenue;   
 
C24 “I’m just in the process at the moment of having a PC installed and if there was 
something that could be given through Boots pharmacy web address or do something 
where you could get information on the screen and then have it sent directly to you or 
something, general information, but you’d still have to physically go to the store and 
get your prescription, you can’t get it posted out to you which would be quite nice 
sometimes.” 
 
A couple of the pharmacists participating within the asthma service thought that the 
service could be improved if they were able to conduct interventions there and then, 
rather than asking people to make an appointment at a later time; 
 
P16 “I think the best thing about it would be if we were in a situation where we were able 
to give them the advice and do everything there and then. You know rather than ask 
them to come back which is rather like a doctor or a nurse appointment.” 
 
In total, three of the customers participating within the brief intervention activity felt 
that any future services and simple request for advice should be available from the 
pharmacist on an ad hoc basis, and should just be a case of speaking to the pharmacist 
when you go into the pharmacy; 
 
C24 “I think maybe as I pick product it might come into my head, that I might want to ask 
about such and such. I don’t think I’d want to have a proper sit down formal thing 
with the pharmacist. I think because everyone is so stuck for time these times you want 
to be able to just come in, ask the question and then it’s done. Don’t like the idea of 
actually booking something and going in and sitting down.” 
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There was a recognition amongst a couple of the respondents that if they wanted to sit 
down and speak to the pharmacist for anything other than simple advice, then they 
would have to make an appointment depending on how busy the pharmacist was at 
that time; 
 
C19 “I think for me it would be better on an ad hoc basis, I mean I could understand if you 
wanted to have a long conversation that you would probably be right having an 
appointment but if I was in town and just wanted to speak to you about this quick 
thing that would be nice but would obviously depend on how busy they are.” 
 
7.3.1.6 Advice on asthma 
The majority of respondents within the customer interviews had suggestions to make 
on the type of advice that Boots should be offering to people with asthma. Of these, 
many thought that Boots should offer both general advice on asthma and advice on the 
latest news and developments. They would not see this as a personally tailored service 
but as an outlet for information on asthma more generally;   
 
C22 “I know they have to make money out of things but if they know something on lifestyle 
like you need to eat more of this vegetable or whatever else, but there’s always the 
latest research and you never hear about it until it’s on the news.” 
 
Many of the respondents also wanted to be able to access advice from the pharmacist 
about the avoidance of triggers and other issues they did not feel was appropriate to 
speak to their GP about;  
 
C19 “I don’t know really, I guess a lot of mine is triggered by allergies and I’ve noticed 
something new I might be able to go and talk to them about it and do you think it’s 
this or is it just a bad day, that’s often quite interesting. Or I would be quite interested 
if there are other things I should avoid such as food items or I wouldn’t necessarily 
have to go and see a GP about that.” 
 
Advising on inhaler type, frequency and use was important to some of the respondents 
questioned; 
 
C11 “My granddaughter has something called a spacer its like a big plastic balloon you 
put one end in your mouth and you put the puffer in the other press it down and breath 
it in. When Melanie put me on the green puffer she showed me how to use it. I showed 
her what Holly did and she said I didn’t need to do that all you have to do is breath in 
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and out three times. And that is something Boots needs to do. Because there’s no use 
in taking something if you’re not taking it properly.” 
 
In particular, one of these respondents thought that Boots should offer this type of 
service to people with asthma who were newly diagnosed; 
 
C23 “I seem to remember when I first had asthma they gave me different inhalers but that 
was the doctor more than the chemist. It wasn’t Boots who said if you have that one 
that’s easier for a child, although maybe they could suggest that to someone.” 
 
A couple of the respondents thought that the Boots asthma service should include a 
monitoring aspect, including discussing their peak flow, asthma symptoms, and advice 
on inhaler use. This was particularly attractive to one respondent who had difficulty 
getting access to her own GP;  
 
C24 “Maybe about my peak flow and how I’m feeling and maybe feel that what I’m using 
hasn’t been effective as I’m getting worse, or is there a reason for it, which obviously 
you could ask the doctor if you can get an appointment but if its anything like my 
doctor’s it’s quite hard work and they have this new policy that you can’t pre book 
your appointment if you want one within 48 hours of phoning.”  
 
The role of Boots was seen as filtering through information which would ultimately 
increase control of asthma and reduce symptoms;  
 
C13 “Just simple day to day tips I guess. Things that might make you feel better just by 
making little changes to your life.” 
 
Respondents felt that the most important thing was for Boots to have pharmacists 
available to answer questions as and when they had them; 
 
C12 “I guess just stuff that might help you feel a bit better. The main thing I guess is being 
there to answer your questions when you have them.” 
 
One respondent even suggested that this could be done via a computer terminal or help 
point within the pharmacy; 
 
C13 “Perhaps they could have a help point or something or a computer in the store that 
you could type questions into.” 
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Advice on alternative treatments or medications was important to one respondent, who 
felt that they would like to be able to access this information from Boots;  
 
C34 “I don’t know, like I said, perhaps put out some leaflets offering alternatives or advice 
for things to be used in conjunction with inhalers.”   
 
One respondent just wanted to be able to access the dispensary service as quickly as 
possible with no advice being offered by the pharmacist; 
 
C25 “No I can’t really, it’s just the way it is. I just head on in there when needed. Nothing 
I’m sat here thinking I could really do with knowing about this or if they included that 
I’d be over the moon. Probably just purely a service I’m looking for, the quicker I’m 
away from the till the better.” 
 
7.3.1.7 Service delivery in other condition areas 
Only four of the pharmacists commented on other condition areas that they thought 
this intervention could be extended to, of which all felt that it could be extended to 
most other condition areas.  Following the asthma initiative, one of the pharmacists 
had already started delivering brief interventions for customers with diabetes;  
 
P15 “It can extend to everything really, all the major diseases like heart disease, people 
with high blood pressure. All the major things like diabetes.” 
 
Pharmacists felt that people with conditions that affected their everyday life, or those 
that had constant medication issues might find this kind of service more beneficial 
than others; 
 
P2 “I think people would appreciate advice if they have a constant medication issue. Like 
someone with diabetes or rheumatoid conditions – things that affect their everyday 
life and where they take regular medication.” 
 
Dermatology was also seen as a key area that pharmacists felt they could offer 
extended advice in that would be useful to both the patient and the NHS, through a 
reduction in waste medicine; 
 
P10 “Yes, dermatology certainly. We do a lot with people coming in with creams and 
ointments, they haven’t got a clue what to use, where and when and how to use it 
appropriately and that’s quite a big loss to be honest to the NHS as they’re not using 
the stuff properly so it’s not worth prescribing it in the first place or they go on to 
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using much stronger products earlier than they need to. Diabetes and cardiovascular, 
anti cholesterol drugs.” 
 
Within the customer interviews, five of the respondents mentioned other condition 
areas in which they thought Boots should offer extended advice services. The majority 
of respondents mentioned advice services that could be applied to asthma related 
conditions such as hayfever, allergies and eczema. Other conditions mentioned 
specific to individuals included irritable bowel syndrome and epilepsy; 
 
C25 “Well, I also have hayfever and it’s one of these things that people just take for 
granted and live through but at the time when your eyes are scratching… Because the 
first year when I got it I just got the pills and it was helping my nose but it wasn’t 
helping my eyes and a couple of years later I saw a doctor again and he said, have 
this extra stuff as well and the difference it made: it stopped me wanting to scratch my 
eyes out. So if there was the same sort of information given out about hayfever and 
other allergies people would maybe pick up more information.” 
 
One respondent felt that the Boots advice service was best suited to conditions that 
may not seem important enough to “waste time with your doctor, particularly if there is a 
four week wait” (C4). 
 
Another respondent thought that people with conditions that affected them on a daily 
basis should be able to access good lifestyle advice from the pharmacist; 
 
C19 “I guess other things that people have to do on a daily basis, I can’t think of anything 
off the top of my head, people with eczema or epilepsy or something, they’re all 
triggered by things, you know you have to go to the doctor for your prescription but 
for lifestyle advice I don’t see why it couldn’t come over the counter from a chemists.” 
 
Other respondents felt that simple measurements such as cholesterol should be 
available from places such as Boots;  
 
C28 “Especially with things like cholesterol because most people don’t get their 
cholesterol checked regularly unless they’re with some kind of private health thing 
like BUPA, or Well Man clinic through work which costs a fortune. I think it should 
be some sort or caring for you kind of thing or sort of guiding you through because 
there are so many things you can get at the counter it all gets a bit out of control.” 
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7.3.2 Discussion of the results  
Within the last section of this chapter I have presented the recommendations from 
pharmacists and customers regarding future delivery of both the brief intervention and 
asthma service. These recommendations are described as potential facilitators due to 
the fact that pharmacists and customers interviewed believed that these 
recommendations would help to meet a customer need for the service, and / or help 
facilitate better delivery of the service.  
 
The overall feedback on the initial content and level of information provided as part of 
the brief intervention in asthma was good, but some pharmacists commented on the 
need for additional training. They felt that the option to attend a training day, or 
discuss the service with their colleagues would have better equipped them with the 
skills to provide the service. Pharmacists have different needs and training 
requirements to help them feel confident in service delivery. A literature review by 
Anderson et al. [166] found that studies investigating the effect of training concluded 
that it was a key component in changing pharmacists behaviour and resulted in longer 
consultations with customers and increased opportunities for healthcare professional 
involvement. Due to the simplicity of the brief intervention, it was communicated via 
a briefing document rather than a formal training package. Whilst not wanting to over 
complicate the service itself, future delivery should consider signposting to additional 
training or information sources that pharmacists can undertake if they require. The 
standard training or briefing documents should help meet the needs of the majority, 
and the additional training help meet the needs of those requiring it. The briefing 
materials for the brief intervention were distributed solely to pharmacists, with the 
guidance and expectation that they would communicate the information to their 
pharmacy staff. As the pharmacy staff had a huge role to play in identifying customers 
for the service and offering brief advice, future communications should be directed at 
both pharmacists and their teams.     
 
Many of the pharmacists thought that time and resource was a factor in the delivery of 
the intervention. They believed that early communication of the intervention to both 
pharmacists and the management team would have helped with the planning of 
resource, and the involvement of management would ensure that this was seen as a 
priority. The brief intervention was designed to be simple to deliver and provide the 
pharmacists with the opportunity to deliver opportunistic interventions when people 
with asthma presented at the pharmacy. The pharmacists need for additional time and 
resource should not have been a factor in the delivery of this intervention, as it was 
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brief advice that should have taken the pharmacists a couple of minutes to deliver as 
part of their normal routine. The need for additional resource for this service reflects 
the lack of spare capacity within the pharmacists role, as also found in a study by 
Savage [140]. Within the more detailed asthma service, the pharmacists commented 
on the need to have additional pharmacist resource when they were delivering the full 
consultation and were away from the pharmacy area. Whilst pharmacists participating 
in the asthma service did not comment on the need for additional resource whilst 
delivering the brief interventions over the counter, they did request resource for those 
that required their time to deliver full consultations and which took them away from 
the pharmacy area. The subsequent interim guidance issued by the RPSGB allows the 
continued operation of the pharmacy whilst the pharmacist is not immediately 
available due to other professional activities [36]. Whilst not withstanding the need for 
additional resource for services that require longer time with the pharmacist, the need 
for additional resource for simple interventions raises questions regarding the 
deliverability of more complex services within the current pharmacy environment. 
Some pharmacists felt that they could have managed their time more effectively and 
made customers aware of allocated times when they were able to offer advice. This 
limits the accessibility of pharmacist advice by restricting the times that it is available, 
and reduces the benefits to customers being able to access ad hoc advice on request 
from the pharmacist. Other pharmacists thought that the constant demands on their 
time could have been better managed by involving all the pharmacy staff in service 
delivery, and by having better trained support staff. This would help reduce the 
number of interruptions and queries they received, allowing them to provide more 
opportunistic advice and services. Checking technicians were seen as particularly 
important in helping to free up some of their time, allowing them to provide a better 
service to customers.   
 
Very few of the pharmacists interviewed mentioned the need for consultation space to 
deliver the services, and of those that did, they tended to be the pharmacists delivering 
the more in depth service. Those pharmacists that did mention access to consultation 
space did so within the context of having it available if required by the customer. 
Similarly, a recommendation that emerged from the customer interviews was an area 
within the pharmacy for advice that was well signposted. It appears that pharmacists 
and customers did not feel uncomfortable discussing advice within the pharmacy area, 
but both parties would have liked access to space or an area to use if they wanted to. 
Customers in particular were looking for an area of the pharmacy that was clearly 
signposted where they could access advice as required. The lack of need for 
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consultation space for the brief intervention could be due to the simplistic nature and 
the opportunity to provide opportunistic advice. Stipulating that consultation space is 
required for the service may add too much formality to this simple service. The use of 
consultation space for services could be driven by the needs of the customer, the 
pharmacist, or the type of service offered, none of which were investigated as part of 
this study. Customer need should not be assumed, but require the pharmacist to check 
and manage necessary expectations.  
 
Both pharmacists and customers thought that the branding of the service should be 
clear and say exactly what the service was all about. The wording of the service was 
important as customers were very clear about the type of advice they expected from 
community pharmacists to support, and not compete against advice they would expect 
to receive from their GP. Inappropriate wording of the service could lead to customers 
misunderstanding the type of advice they would receive and therefore be put off by the 
service. There is a need to manage the transition of customers expectations towards 
receiving more detailed advice from the pharmacist over a period of time.  
 
As well as the branding of the service, respondents felt that there needed to be more 
awareness of services such as these to improve customer awareness and demand for 
the service. Posters and leaflets on display would allow customers to pick up 
information of their own accord. Advertising through the Boots Advantage card, 
boots.com website and magazines would improve awareness and offer people the 
opportunity to proactively approach the pharmacist about the service. Advertising of 
pharmacy services was something that Boots was seen as being particularly poor at in 
the past, compared to some of its competitors such as Lloyds. Pharmacists also felt 
that more could be done to raise the awareness of services through the local GPs. 
Building local relationships through communication of the service and referral 
guidelines were felt necessary to encourage collaborative working amongst the local 
healthcare professionals.  
 
There was a mixture of pharmacists that wanted to see the intervention more 
structured, and those that liked it unstructured so that it allowed greater flexibility in 
delivery. There was agreement that services needed to be simple, and paperwork kept 
to a minimum. Some pharmacists expressed the desire for additional support materials 
such as placebo inhalers to enable them to deliver a better service. In effect, what they 
were asking for was the asthma service that was designed and delivered by the local 
pharmacists. It appears that some of the pharmacists delivering the brief intervention 
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naturally extended the service to the full asthma service as and when required by 
customers, and those delivering the asthma service condensed it to the brief 
intervention when required. The solution going forward was a service that combined 
the best of both, something that allowed the pharmacists to be flexible in service 
delivery depending on customer or business needs.  
 
Individual pharmacies within Boots receive a tremendous amount of post and stock on 
a daily basis. Occasionally, the post does not reach its intended destination. 
Recommendations from the pharmacists were to have the service communication sent 
to individual pharmacies via a number of media, including the traditional paper 
method, alongside the intranet. For service materials, the pharmacists recommended 
that this be sent to pharmacies packaged in one box to avoid any smaller components 
getting lost within the post or elsewhere within the store.   
 
Customers wanted to be able to access advice via several different medium, including 
leaflets, internet, and verbal advice from the pharmacist. Leaflets on display in the 
pharmacy area would allow for people to take the information away with them, to read 
themselves, or to pass on to a family or friend member. Both pharmacists and 
customers thought that advice should be available from the pharmacist on the spot, 
rather than having to make an appointment for a later date. One of the main 
advantages of pharmacists advice was the accessibility. Having to make an 
appointment to access brief advice was seen as removing this advantage. Despite this, 
those customers who chose to request additional support and help from the pharmacist 
in a more detailed consultation accepted the fact that they would be required to return 
at a mutually convenient time. 
 
Customers wanted to access general advice from the pharmacist, and in particular, 
advice that they would not necessarily go to their GP about. This varied between 
individuals depending on the type of service and support that they were currently 
receiving from their GP practice. Those who were well supported wanted advice on 
the latest news and developments in asthma, whilst those with little support wanted 
help with the general management and monitoring of their condition. Access to top 
tips, alternative treatments, and new developments were of interest to most 
respondents in an attempt to seek out better treatments or new techniques that would 
help to improve their asthma. Future services need to be flexible enough to allow the 
pharmacist to recognise the different needs of the individual customers and offer the 
appropriate level and content of advice.  
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When asked about other conditions that the brief intervention could be extended to, 
many of the pharmacists felt that similar services could be delivered for most 
condition areas, but that it would be particularly beneficial to those conditions that 
affected everyday life or had constant medication issues. Customers mentioned 
condition areas that were mostly of personal relevance to them as people with asthma, 
including hayfever, allergies, and eczema. Advice and support on conditions that 
affected people on a daily basis was also seen to be of particular benefit. Customers 
were clear that the advice and support they wanted from pharmacists was on 
conditions or ailments that they did not want to bother their GP with. Although the 
type of advice customers would seek from the pharmacist and from their GP is 
discussed in an earlier chapter, the definition of what conditions customers would 
class as suitable to discuss is not covered within this thesis. Explicit consent may be 
needed for future services, which is a new concept for pharmacists who have always 
assumed implied consent for services to date. Future research should consider what 
the definition of suitable services and conditions is, and whether it is changing over 
time with the introduction of the new pharmacy contract and pharmacists involvement 
in the direct delivery of consumer facing NHS services.  
 
 
7.3.3 Summary of section three 
A number of potential facilitators have been identified based on the recommendations 
of both pharmacists and customers for future service delivery. These potential 
facilitators are summarised in Table 56.   
 
Table 56: Summary of the potential facilitators identified by pharmacists and customers  
(Please note that this table is presented over two pages) 
 Facilitators 
Customer need 
̇ Services aimed at conditions that affect people on daily basis 
̇ Services that deliver advice and support that people would not 
want to bother their GP with 
Training 
̇ Opportunity for additional training 
̇ Information aimed at pharmacy staff and pharmacists  
Pharmacy 
communication 
̇ Early communication of service to pharmacists and managers to 
enable better planning 
̇ Communication via a number of medium 
̇ Service materials delivered in one box prior to service 
commencing (to avoid items going missing) 
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 Facilitators 
Awareness of service 
̇ Clearly signposted area or member of staff to go to for advice 
̇ Simple branding that explains clearly what the service is 
̇ In store support materials to make people aware of the service 
and give people the opportunity to ask for advice  
̇ Advertising outside of the pharmacy to make people aware of 
the service and help create customer demand 
Type of asthma 
information 
̇ Advice available in different formats (verbal and written) 
̇ Information leaflets aimed at different target groups, and 
covering wide range of topics  
̇ Information easy to access by individual, for example picking 
up leaflet in pharmacy 
̇ Rotation of themes and advice to keep advice relevant and 
service sustainable 
Service structure 
̇ Flexibility of service delivery (level and content) 
̇ Simple interventions but opportunity to deliver more in depth 
service when required  
̇ Guidance on additional materials if required 
̇ Minimal paperwork associated with service 
̇ Ad hoc advice available to customers on request 
̇ Longer consultations available if required by the customer 
Time ̇ Allocated time to deliver services 
Staff resource 
̇ Planning of resource to support service 
̇ Additional resource (pharmacists and support staff) 
̇ Better trained support staff 
̇ Involvement of all pharmacy staff in service delivery 
Remuneration ̇ Funding for time and resource 
Pharmacy environment ̇ Option to take customer to private consultation area 
Healthcare professional 
relationships 
̇ Communication with GPs to help build links and working 
relationship 
̇ Working with local asthma nurses  
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7.4  Summary of chapter VII: Facilitators and barriers 
affecting delivery of the asthma services  
This chapter of my thesis has presented the data following the implementation of the 
two asthma services used in this study in an attempt to identify experiential and 
potential facilitators and barriers affecting service delivery.  
 
Both the brief intervention in asthma and the more in depth asthma service were 
successfully implemented and delivered. Pharmacists delivering both services were 
flexible in responding to customer and business needs, and would often condense or 
extend the service as appropriate. Some pharmacists delivering the brief intervention 
would extend this to a version of the asthma service, and pharmacists delivering the 
asthma service would often condense it and deliver the brief intervention.     
 
Potential factors affecting delivery that have been identified from the results presented 
within this chapter can be grouped under the following headings: customer need, 
public attitude, pharmacist attitude, implementation of the service, training, pharmacy 
communication, awareness of the service, recruitment to the service, type of asthma 
information, service structure, pharmacist confidence in service delivery, management 
support, time, staff resource, remuneration, pharmacy environment, and healthcare 
professional relationships. Details of the individual facilitators and barriers are listed 
in Table 57. Where similar themes have been identified within previous literature, this 
has also been identified.   
 
All the factors identified from this chapter will be discussed in more detail in chapter 
nine, where final conclusions will be drawn. The next chapter of this thesis details the 
last set of results looking at the benefits of service delivery to the customers, 
pharmacists and service provider.   
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Table 57: Summary of the facilitators and barriers affecting delivery of both asthma services 
(Please note that this table is presented over five pages) 
 Facilitators Barriers 
Customer need 
̇ Perceived usefulness of advice 
̇ Advice that is in the pharmacists area of expertise (e.g. 
medication related) 
̇ Ability of service to help identify potential customers, and 
recognising potential need for advice   
̇ Ability to adapt service to customer need 
̇ Services aimed at conditions that affect people on daily basis 
̇ Services that deliver advice and support that people would not 
want to bother their GP with 
̇ Perception that do not need advice  
̇ Advice that is not in the pharmacists perceived area of expertise  
Public attitude 
 ̇ Poor level of confidence in pharmacist advice 
̇ Level of authority of pharmacist advice compared to other 
healthcare professionals 
[3, 7, 16, 18, 21, 26, 32] 
Pharmacist attitude 
̇ Commitment to service 
̇ Enthusiastic 
[5, 17-19, 30-32] 
̇ Poor attitude towards role expectations 
̇ Limitations of role    
[1, 5, 16, 29, 32] 
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 Facilitators Barriers 
Implementation of the 
service 
̇ Simple structure that is easy to follow  
̇ Ability to adapt and extend service locally 
̇ Local ownership and involvement in service delivery and design 
̇ Service lead in each pharmacy 
[11] 
 
Training 
̇ Opportunity for additional training 
̇ Information aimed at pharmacy staff and pharmacists 
[1, 3, 4, 11-13, 16, 18, 20, 23-26] 
̇ Language barriers where English is not the first language 
 
[8, 29] 
Pharmacy communication 
̇ Early communication of service to pharmacists and managers to 
enable better planning 
̇ Communication via a number of media 
̇ Service materials delivered in one box prior to service 
commencing (to avoid items going missing)
 
 
̇ Regular communication with team (central and local) 
̇ Opportunities to share best practice and learnings  
[10, 16, 22] 
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 Facilitators Barriers 
Awareness of service 
̇ Simple branding that explains clearly what the service is about 
̇ In store support materials to make people aware of the service and 
give people the opportunity to ask for advice 
̇ Advertising outside of the pharmacy to make people aware of the 
service and help create customer demand 
[1, 11, 16] 
 
Recruitment 
̇ Captive audience available, e.g. when dispensing prescriptions 
̇ High volume target customers visiting pharmacy 
̇ In store recruitment 
̇ Targeting uncontrolled people with asthma  
̇ Clearly signposted area or member of staff to go to for advice 
[6] 
̇ Patients not easily identifiable  
̇ Less opportunity to identify patients, particularly in non contract 
pharmacies  
 
 
[16, 24] 
Type of asthma 
information 
̇ Content relevant for time of year 
̇ Advice available in different formats (verbal and written)  
̇ Information leaflets aimed at different target groups, and covering 
wide range of topics 
̇ Information easy to access by individual, for example picking up 
leaflet in pharmacy 
̇ Rotation of themes and advice to keep advice relevant and service 
sustainable 
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 Facilitators Barriers 
Service structure 
̇ Simple interventions but opportunity to deliver more in depth 
service when required  
̇ Flexibility in service delivery (content and length of intervention) 
̇ Good fit with other initiatives and activities 
̇ Regular and updated communications 
̇ Opportunity to improve awareness of symptom control 
̇ Providing opportunity to access healthcare professional advice  
̇ Ad hoc consultations and advice 
̇ Appointments available at the customers request 
̇ Guidance on additional materials if required 
̇ Minimal paperwork associated with service 
̇ Intervention too simple so not perceived as a service 
̇ Appointments led at the pharmacists request 
Pharmacist confidence in 
service delivery 
̇ Confidence to deliver and adapt service to meet customer and 
business needs  
 
[9, 19, 30] 
̇ Lack of confidence and comfort in using particular questions and 
providing advice that is not related to medicines (outside comfort 
zone) 
[5, 8, 19, 25] 
Management support 
̇ Management supportive of the service 
[1, 10, 12, 19, 22, 23] 
̇ Lack of management support and prioritisation of other activities 
[1] 
Time 
̇ Allocated time to deliver services 
 
 
[2, 13, 23] 
̇ Lack of pharmacist time 
̇ Pharmacy workload and demands on pharmacist time 
̇ Lack of customer time 
[1-3, 7, 8, 12, 14-16, 20, 21, 23, 25-27, 29] 
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 Facilitators Barriers 
Staff resource 
̇ Involvement of all pharmacy support staff in service delivery 
̇ Effective use of pharmacy team 
̇ Adequate staff resource available (pharmacists and support staff)  
̇ Planning of resource to support service 
̇ Better trained support staff 
[1-3, 10-13, 16, 18, 20, 22-24, 26] 
̇ Inadequate resource available (pharmacists and support staff) 
̇ Single pharmacists stores  
 
 
 
[7, 18, 23-26, 28] 
Remuneration 
̇ Funding for time and resource 
[3, 6, 11, 13, 16, 22, 32] 
 
Pharmacy environment 
̇ Service sited in large and small size pharmacies, and edge of town 
locations (potential link to resource and how busy the pharmacy 
is) 
̇ Accessibility of pharmacist  
̇ Private consultation area available 
 
[1, 3, 4, 6, 13, 16, 18, 22, 26] 
̇ Pharmacies located in commuter towns (potential link to customer 
time available) 
̇ Services sited in middle size pharmacies and health centre 
locations (potential link to resource and how busy the pharmacy is) 
̇ Non contract pharmacies (less opportunity to target customers) 
̇ Busy pharmacies (customers waiting) 
[2] 
Healthcare professional 
relationships 
̇ Communication with GPs to help build links and working 
relationships 
̇ Working with local asthma nurses 
[3, 5, 11, 13, 16, 18, 19, 24, 32] 
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CHAPTER VIII 
Motivators of service delivery 
 
8.0  Introduction to the chapter 
Previous studies that have investigated the motivators for service delivery have tended 
to do so from the perspective of the pharmacist [14, 16, 22, 28]. Little thought has 
been given to the motivations of service users and providers in delivering pharmacy 
services. To get a true picture of what would motivate customers to access services 
from community pharmacies, it is important to understand what benefits they would 
get. Likewise, to deliver the services, you have to understand what motivates 
pharmacists. Similarly, how the service provider benefits in delivering these services 
should also be considered. An understanding of the benefits to each of the 
stakeholders concerned will allow me to consider those factors acting as motivators 
that are affecting service delivery in community pharmacy. 
 
This chapter of my thesis provides the results from the interview data looking at the 
benefits of service delivery to the pharmacists, customers, and Boots as the service 
provider. The benefits to the service provider are presented from the views of 
customers and pharmacists, and not from the management board of Boots. Anecdotal 
financial data is briefly discussed in this chapter, but not provided in any detail due to 
the commercial sensitivity of these data. The commercial reasons for developing and 
delivering services such as these is discussed in more detail in chapter nine, including 
my views as Service Development Manager at Boots. 
 
 
8.1 Results 
8.1.1 Benefits to pharmacists  
Within the pharmacist interviews, respondents were asked what benefits they thought 
would come from offering this kind of service. In total, six of the pharmacists believed 
that this service helped to raise awareness of the role of the pharmacist, and in turn the 
type of services that a pharmacist could offer;  
 
P15 “They probably will think that we give advice and we are there if they have questions 
to ask so they might very well come back to us next time when they have a 
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prescription or they have a problem so it raises awareness of what a pharmacist can 
do for health.” 
 
Many of the pharmacists commented that doing this intervention was good for the 
image of pharmacy, and would help people realise that pharmacists were available for 
advice, and not just to sell products;  
 
P1 “It would be good for the image of the store as people might see how caring we are 
and that we’re not just here to sell them products” 
 
The brief intervention was seen as something that would help to change the way that 
people used pharmacies, in particular for Boots in making them the preferred 
pharmacy provider for asthma care; 
 
P1 “You feel like you are helping move things forward and change the way that 
customers treat you and Boots in general.” 
 
P8 “Hopefully for Boots it would make us perceived to be the experts with respect to 
asthma care in comparison perhaps to other pharmacies.” 
 
Using services such as this to help raise the awareness of the pharmacists expertise 
and role in advice giving was seen as the right way forward, and something that would 
be good for both pharmacists and Boots in the long term; 
 
P11 “And I think if you had a constant stream of like the intervention thing , and people 
knew that it was something that Boots just did then that would be much better off for 
us, and for patients and doctors because they’d be aware of it.” 
 
P5  “I have no hesitation in that this will only be good for us in the long term.” 
 
This was particularly important as many of the pharmacists recognised that their role 
was no longer just about dispensing medication;  
 
P2 “I love the whole idea of intervention and getting closer to our customers. It’s 
definitely the way forward for Boots to go on the pharmacy counter. It’s all about 
more service and adding value these days and that also applies to us now.” 
 
Pharmacy needed to move with the times and have a role in helping people to look 
after their own health; 
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P11 “…It’s just nice to see that they’re starting to do things that can be really important 
and I think there are so many avenues that you can go down and get more people into 
store, but also to help people with their own health because it’s so important 
nowadays with the fact that GPs are that busy and people are looking to look after 
their own health that the more good quality information you can give them to help 
look after themselves the better….” 
 
Offering good quality services that were beneficial to customers was seen as an 
essential element that was required to help get people to come back to the pharmacy 
for repeat services;  
 
P8 “Sometimes it’s the patient perception – they’re confident with the standard of advice, 
they’re confident with the dispensing and hopefully they’re happy with the standard of 
service and that is vital because we need people to come back through the doors time 
after time.” 
 
During the interviews, five of the pharmacists commented on how they enjoyed 
performing the service, and how good it made them feel to be part of this kind of 
initiative;  
 
P4 “I like talking to customers and I felt confident with the fact that it was a legitimate 
trial and could end up helping people improve their lives. That kind of stuff always 
makes you feel good.” 
 
This was particularly true for one pharmacist who worked in a non dispensing 
pharmacy;   
 
P1  “It made me feel good too and I really enjoyed it – it made it feel like I was working in 
a dispensing store.” 
 
Interactions like this with customers made all the staff feel more involved in 
delivering a better service for customers, and as such, helped to improve job 
satisfaction; 
 
P2 “At the end of the day it keeps me and my staff interested and more involved.” 
 
The service was professionally rewarding for pharmacists, and many used this as an 
opportunity to undertake personal professional development; 
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P8 “It was something that we really enjoyed and certainly from a professional point of 
view I learnt a lot as I was going through and revising the CPPE package made me 
aware of things that perhaps I’d forgotten. So generally it was a very useful set up.” 
 
Five of the pharmacists thought that some of the benefits of this service were around 
reducing pressure on GPs and targeting those people that could not get access to their 
GP services. Most asthma clinics locally were vastly overbooked, and services like 
this were seen as helping to improve access for those people that just needed someone 
to talk too occasionally, and offer them advice when they might not want to bother 
their GPs. The asthma service had also helped to revive a PCT intervention scheme in 
one pharmacy, not just for asthma, but also for other condition areas;   
 
P13 “At the moment in this PCT we do have standard intervention forms that we’re using 
and before this asthma campaign the forms weren’t really being used, I think they 
were being perceived as quite a rude way of talking to GPs because they are for non-
urgent referrals really. But this asthma campaign has sort of brought to light with, 
especially with the other pharmacists but also with the surgeries they’re all aware of 
these forms and they’ve all reacted to them quite positively. I think it was perceived 
that if they got one of these in the post it was you know why didn’t they ring us or 
whatever but the whole point is that it’s non urgent. The intervention forms have 
been….and we’re using them for everything now not just asthma.”  
 
 
8.1.2 Customer benefits 
Of the pharmacists questioned about benefits of delivering services like this in 
community pharmacy, five thought that improved access to healthcare professionals 
was of benefit to the customer. Providing healthcare professional advice during 
lunchtimes, evenings, and the weekends without an appointment was seen as an 
important element to help improve accessibility; 
 
P16 “I think just the fact that there is someone on the high street who’s there to actually 
give them advice, its ready advice there and then at the time of their prescription and 
they don’t necessarily have to make an appointment. A lot of people are quite glad of 
it because if they’re working full time they can’t get asthma nurse appointments and a 
lot of their employers aren’t very happy about them taking time off unless they’re 
actually, as they see it, ill.” 
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Pharmacists believed that it was important for customers to feel like they had someone 
to talk to about their asthma, particularly when they did not feel that it was appropriate 
to bother their GP; 
 
P1 “I think people just need someone to talk to occasionally and offer them some advice 
when otherwise they would never consider bothering their GPs. We are all so 
conscious these days of wasting their time so people just ignore their symptoms and 
think they can sort it by buying OTC remedies but it is not always that 
straightforward.” 
 
Services such as the brief intervention were seen to help improve access to advice as 
the pharmacists were proactively prompting customers by asking the RCP questions 
when they presented at the pharmacy with a prescription, or to purchase OTC 
medications;  
 
P9 “I think it’s really good because patients don’t always ask for advice so when you 
prompt them or ask if they have any problems or questions it gives them opportunity 
to mention anything.” 
 
Pharmacists reported that customers seemed to like the fact that somebody had taken 
the time and interest to talk to them about their asthma. Very often the pharmacists 
would find that customers were not aware of basic facts and inhaler techniques with 
their asthma;  
 
P16 “I think just the fact that someone genuinely seems to have time and is interested in 
asking them about their asthma because it’s surprising what they come out with when 
they’re speaking to you. Often they don’t know basic things and they’re quite happy 
that someone is there and interested and can maybe give them some ideas that could 
help them.” 
 
The pharmacists commented on groups of people that they found had particularly 
benefited from the service. Overall, pharmacists thought that newly diagnosed people 
with asthma would benefit the most from services such as the brief intervention;  
 
P5 “You just don’t know how many people were first time users and at the end of the day 
they are the ones who would have been most suitable to talk to……I see the whole 
intervention thing being for first time users of their medication – that’s why I try and 
ask them that question whenever I can. That’s when people need the advice and you 
need to make sure they know how to use it and how it might make them feel.” 
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Parents with young children were also seen as a target group that would benefit from 
this service; 
 
P8 “But sometimes for newer people who were using them (inhalers) or very often 
parents with young children who hadn’t any experience of any form of chronic 
obstructive airways disease they actually found this useful because they were able to 
learn a little bit as well.” 
 
Mothers of teenagers and partners of people with asthma appeared very grateful for 
any additional information and advice from the pharmacist, as these were the people 
who often witnessed worsening of asthma symptoms or attacks; 
 
P10 “…..they are quite grateful for some information because they’re the ones who might 
see someone perhaps have an attack or struggling and not know what to do….” 
 
Younger people seemed to be more receptive to the brief intervention and willing to 
talk to the pharmacists compared to the older generation;  
 
P16 “I find that the younger people tend to be more interested and they’re the ones who 
will co-operate if I ask them if I can just ask a few questions. They tend to be the ones 
who are more responsive to questioning, a lot of the older people will be ‘no maybe 
the next time we’ll answer your questions but not today.’ I think they’re just a bit 
frightened and don’t know what you’re going to ask them, or ask them to do. But 
younger people or young mums especially are quite keen on it. I think they’re our 
biggest market.” 
 
Pharmacists reported that the elderly population were less receptive in discussing their 
asthma with the pharmacist, and in particular in checking their inhaler technique. 
Pharmacists believed that this was because they had been dealing with their asthma 
and using their medication for a number of years and as such, did not feel they needed 
any additional help or advice; 
 
P13 “I have had mainly the elderly people who aren’t so keen on wanting us to check their 
inhaler techniques etc. I mean they’re probably the worst because, but no they just 
feel that they’ve used it for long enough and they don’t want to be re-trained or 
whatever on it.” 
 
As part of the customer interviews, respondents were asked who they thought would 
benefit the most from receiving additional advice on asthma from the pharmacist.  One 
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respondent thought that the key areas in which pharmacists offering advice could 
greatly benefit people with asthma would be to help undiagnosed asthma sufferers 
realise they might have asthma, and to raise the awareness of different medications 
and the benefits of each. The latter area was seen as the pharmacists expertise, and 
would provide them with information that they did not access elsewhere. Other 
respondents thought that younger people, parents of young children, and the elderly 
would find access to this advice particularly useful;  
 
C10 “Well I think that if you initiate the conversation and I think that the young and the 
elderly really need the advice because it comes on later in life.” 
 
Respondents that had lived with asthma for a number of years did not see the service 
as something that would benefit them personally. People that were newly diagnosed, 
the young or the old, were seen as those that would benefit the most as they would not 
be used to using devices like inhalers;  
 
C22 “For me because I’ve had asthma so long I probably wouldn’t take it up, but for 
people who haven’t had it before, my grandfather was diagnosed late, he was given 
inhalers when he was in his late 60’s, he wasn’t sure how to use them and everything 
else. The doctor explained that for older people and younger people not used to using 
things like that I think maybe that service would be very useful. For my grandfather I 
know it would have been very useful to him.” 
 
People who had little knowledge of their condition and who would not proactively 
seek out advice for themselves were seen as ideal target groups that would benefit 
from this service by two respondents. One of these respondents in particular though 
that this advice service would be ideally suited to those of more limited intellect 
(C2). 
 
Overall the pharmacists thought that customers seemed pleased with the service and 
advice that they had received, and in particular liked the fact that they took an interest 
in their asthma; 
 
P1 “I would say overall they were pleased with the advice that I gave them and the fact 
that I took an interest in them and appeared to be trying to help them.” 
 
Most people welcomed the advice on medication and lifestyle tips, and even learnt a 
thing or two along the way;   
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P8 “I think for some people it was ‘Ooh I didn’t know that, that’s very useful’” 
 
Some customers had been extremely happy to spend the time with the pharmacist, as 
their own GP had not had the time to explain the importance of using their medication 
correctly;  
 
P16 “I think they’re very positive. I have had a lot of customers who’ve said ‘Oh what a 
good idea’ and they’re quite happy to tell you about it. It’s surprising when you 
actually question people, how few people actually use their inhalers as they should do 
because they don’t really understand what they’re for and a lot of customers will then 
turn round and say to ‘well you know the doctor hasn’t got any time, he just told me to 
use them’. But they don’t really have an understanding of the importance and when to 
use them and in what order. That’s the main thing. So it is useful, I think the 
customers are quite glad that someone is there and available.” 
 
The advice from the pharmacist was a useful refresher to some people with asthma; 
 
P10 “If you start to talk to someone about it and you’ve got time then they’re quite happy 
to take more advice even if they’ve had it before. They say ‘oh yes, they said that to 
me in the clinic’ but they’d forgotten it, it’s a refresher for them…” 
 
Pharmacists also received a positive reception from customers who knew all they 
needed to know about their asthma, as during the interactions they were reassured that 
they knew the latest information and were not missing anything new; 
 
P15 “I think they are quite glad that you tell them something that they didn’t know and 
even if they know everything they are still very happy that we approach them and tell 
them to make sure that they know.” 
 
Respondents within the customer interviews were asked to give some general 
feedback on the pharmacist following the brief intervention.  All seventeen 
respondents that were questioned were extremely positive about their interaction with 
the pharmacist and the manner in which the intervention was conducted. Respondents 
were put at ease by the pharmacists approach, which was seen as friendly, 
enthusiastic, and non-threatening;  
 
C1 It wasn’t the Spanish inquisition, you weren’t forced to answer.” 
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One respondent commented that the pharmacist was very knowledgeable and used 
simple language during the interaction, regularly checking their understanding. They 
encouraged them to come back if they had any further questions, even bringing their 
inhalers with them for further guidance if they needed it. Respondents especially 
valued the fact that the pharmacist had made time for them, sending other customers 
to a colleague and also talking quietly and discreetly. Other respondents also 
commented that they liked the fact that the pharmacist had made time to talk to them;  
 
C13 “He was very friendly and he actually seemed to have time to talk to me which was 
good.” 
 
Respondents felt that the pharmacists were personally trying to help them to achieve 
better control with their asthma;  
 
C12 “Well they seemed quite helpful and like they were trying to help me and really see if 
they could help me.” 
 
C25 “She gave the impression of being very helpful and concerned that I was inhaling 
properly.” 
 
One respondent had a feel-good factor after the brief intervention, as it was so rare 
for them to be asked about their condition and have the chance to talk about it. 
Another respondent was grateful for the opportunity to discuss inhaler technique; 
 
C25 “Yeah, it gives you the impression that they’re interested in whether you’re doing it 
correctly. Because originally I hadn’t got proper instructions from the first doctor, 
I’m grateful for any proper instructions afterwards.” 
 
The pharmacist was seen as knowledgeable in this subject area, and respondents were 
confident in the advice they received;  
 
C16 “She was most helpful……..I’m OK about taking advice from pharmacists, she 
seemed to know what she was talking about.” 
 
C17 “Very confident she knows what she is talking about, she will advise what is 
personally best for me.” 
 
Where pharmacists had spent time with customers and given them specific lifestyle 
advice to reduce their symptoms, customers had appeared very thankful; 
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P1 “I explained to her that she could cut down on dust and bed mites by doing this and 
she seemed really pleased to listen and even thanked me afterward.” 
 
Pharmacists had discussed simple lifestyle advice with customers such as avoiding 
triggers which had helped a number of customers improve their symptom control; 
 
P4 “She seemed pleased with that idea and added that she would now tell her husband 
that he had to cut it (the grass) as it would improve her condition.” 
 
Some of the customers that the pharmacists had spoken to returned to the pharmacy to 
let them know how they were doing as a result of acting on the advice they had 
received; 
 
P4 “The lady who I recommended hoovering her mattress has already been in to see me 
and told me that she sneezes less when she wakes up in the morning. She is now 
hoovering her mattress a few times a week.” 
 
Some of the customers actually thanked the pharmacists for taking the time and 
interest in them; 
 
P11 “…there have been one or two people who have actually thanked me and said ‘nice to 
see you taking an interest’ which is nice because obviously it means that nobody has 
been bothered to take an interest before.” 
 
As part of the customer interviews, respondents were asked whether they had found 
the advice they had received from the pharmacist during the brief intervention useful. 
Many respondents seemed to find the practical information on how to use and look 
after inhalers very useful. Information such as cleaning spacers and rinsing the mouth 
out after steroid inhaler use had not been previously mentioned to many of the 
respondents. Even those respondents who had been indifferent to the brief intervention 
found that they had learnt something new that they did not know before. Pharmacists 
had also reinforced a lot of information that respondents had previously received from 
other healthcare professionals;  
 
C13 “He just reinforced a few ideas that I had. I told him that I sometimes get chesty if I 
was cleaning and he basically suggested that I get my husband to do the hoovering. I 
thought it was a great idea but I haven’t managed it as yet. But I’ll keep on the 
pressure.” 
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Respondents appeared confident in the advice they received from the pharmacist; 
 
C16 “Its about the service, they give you advice if they can, they’re not doctors, but the 
advice was very good they do know what they’re talking about.” 
 
Although positive about the advice they received, one respondent commented that 
they would not want to be offered the advice all the time, but have access to it as and 
when they needed it; 
 
C13 “Well I don’t think I would want it all the time as sometimes I’m in a rush but it might 
be good if you knew it was there if you needed it.” 
 
Only one of the respondents questioned was disinterested and detached from their 
condition, and as a result, the brief intervention failed to have an impact on them.   
 
Customers that were interviewed following the asthma service were also questioned 
on whether they had found the advice they received from the pharmacist useful. All 
those that responded found the advice they had received useful;  
 
C25 “Yes actually, I did want to check because when I inhale I make a sort of sucking in 
noise and my sister, who’s recently become asthmatic, doesn’t and she says I’m doing 
it wrong. But it turns out I’m doing it right and she’s doing it wrong.” 
 
The majority of respondents from the asthma service also found the practical 
information about cleaning inhalers and spacers the most useful advice;  
 
C31 “Overall the help is really good. She was telling me about cleaning the equipment as 
well - useful. That’s a good things to know.” 
 
One respondent had received advice from the pharmacist on a number of occasions, 
and felt that the pharmacist worked closely with their GP to help them improve their 
asthma control;  
 
C29 Yes, I was very reluctant to use the second inhaler and I remember he said on one 
occasion “why don’t you use it just before you’re coming here”, as Boots is up a hill 
and that was one of the more, and I’m reading from my repeat, “XXXX in 
consultation with my GP suggested I use the Volumatic® spacer to assist in making 
the treatment more effective and again on my birthday believe it or not, more 
judicious use of the Ventolin®, so he has over the period.  It’s sort of general 
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encouragement.  When he first took me in he did the blower thing, the strength of 
breath which they do, this machine that measures the strength of the puff and I was 
dead, and so that lead on to the Volumatic® and we go from there.” 
 
A couple of the respondents felt that the use of questions by the pharmacist had helped 
them during the interaction and was very thorough; 
 
C33 “Think the questions asked “Is it under good management” and “would you like to 
see anyone else” is pretty thorough.” 
 
One particular respondent was used to this line of questioning by pharmacists within 
their home country, and so perceived it as normal for pharmacists to ask questions 
about their condition; 
 
C33 “I find a lot of places in Australia where I’m from, they ask you those questions all the 
time, so I’m pretty used to it, they ask you how your asthma is, some medications you 
have to rinse your mouth out because you can get thrush, so every time back home 
they reinforce that. And a lot of places have more of an expert you can see if you need 
to.  Pretty normal yeah” 
 
Respondents within the customer interviews were asked whether the brief intervention 
had made a difference to their asthma symptoms. Of the six respondents who 
answered, three had acted upon the advice and seen an improvement in their level of 
symptom control. These respondents had found the information they had received very 
useful and informative, in particular the practical advice on cleaning inhalers.  Though 
positive about the intervention, the remaining three respondents had not learnt 
anything new about their condition. As a result, the intervention had not made any 
difference to their symptoms or the degree of control they had over their condition; 
 
C18 “No because it’s something I can control. I’ve had it for 43 years now.” 
 
Only two of the respondents within the asthma service customer interviews were 
questioned on the impact of the advice from the pharmacist. Both respondents had 
acted upon the advice that had been given to them by the pharmacist and had noticed 
an improvement in their asthma control as a result. One of these respondents had also 
visited their GP to request a change in medication; 
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C28 “So after going into Boots I went to the doctors to say look I’m really going through 
these Ventolin® inhalers quite quickly so they’ve changed my medication so I now 
have the brown one, I think it’s Becotide® something like that, which is more 
preventative.” 
 
Respondents who participated in the asthma audits were asked each of the RCP three 
questions as a measure of their symptom control, the results of which are shown in 
Table 58. Participants were taken from the general pharmacy population within Boots 
pharmacies participating in the local asthma service during audits one and two. The 
first audit was conducted prior to the asthma service commencing, and the second was 
completed during delivery of the asthma service. 
 
Table 58: Response to RCP questions within the asthma audits  
Percentage 
distribution 
RCP question 
 
Audit 
one (A1) 
Audit 
two (A2) 
Yes 27.7 18.4 
q1 
Have you had difficulty sleeping because of your asthma 
symptoms? (A1 n=119, A2 n=114) No 72.3 81.6 
Yes 23.1 17.9 
q2 
Has your asthma interfered with your usual activities such 
as housework, work or school? (A1 n=117 , A2 n=112 ) No 76.9 82.1 
Yes 62.2 38.1 
q3 
Have you had your usual asthma symptoms, such as 
coughing, wheezing, tight chest, or feeling breathless 
during the day? (A1 n= 119, A2 n=113) 
No 37.8 61.9 
 
 
8.1.3 Benefits to the service provider (Boots) 
8.1.3.1 Customer views  
Within the customer interviews, eighteen of the respondents were asked what they 
thought about Boots offering this kind of service. All of the respondents felt that it was 
a good thing for Boots to be doing, as long as the pharmacists had the latest 
information and facts;  
 
C10 “I think it’s a good idea as long as they have the expertise and they have the facts to 
back them up.” 
 
One respondent felt that it was appropriate for Boots to offer this kind of service, but 
did not think that it would offer massive benefits to their customers. This particular 
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respondent was in the minority, as all other questioned felt that these types of services 
would be beneficial; 
 
C13 “Oh definitely, we’re all looking for more information these days and at the end of the 
day it’s all about getting the best service.” 
 
Respondents stated that they liked the ease of access to advice within the Boots 
pharmacy;  
 
C14 “Well it’s a good idea. At the end of the day you know if you can talk to someone like 
that it’s sort of – it puts your mind at rest.” 
 
A couple of the respondents liked the fact that they could access this type of advice 
from Boots as they would rather go to a pharmacist for advice than bother their GP for 
the information; 
 
C19 That would be nice, more convenient to me than going to the doctors.” 
 
One respondent commented on the type of queries that nurses and GPs currently 
received, and how it was appropriate for many of these to go directly to the 
pharmacist. As such, services like the brief intervention were seen as a good thing for 
Boots to be involved with; 
 
C11 “My daughter’s a nurse practitioner and the things that people go to her with I think 
what the hell are they playing at why don’t they go and ask at the chemist and they’re 
doing that at the doctors a lot of them. I think it’s a good idea that Boots are doing 
that.” 
 
Many of the respondents believed that Boots was well placed to offer this kind of 
service to people with asthma, as it fitted with the general concept of them trying to 
help their customers; 
 
C18 “Very helpful and do whatever they can as far as I’m concerned.” 
 
Some respondents felt that Boots was taking an extra interest in them; 
 
C25 “I thought it was nice of them to put on an extra little bit. I know people like to collect 
statistics and such like but it wasn’t intrusive or anything so you felt, well they’re 
taking an interest in their customers.” 
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Whilst others felt that services like this gave Boots extra credibility and trust; 
 
C28 Well I think it gives you an extra trust in them, it gives it a kind of credibility.” 
 
To one respondent, Boots was seen as the pharmacy that would be the first to deliver 
services like this before anyone else; 
 
C34 “I think it’s a good thing, I mean they’re the largest pharmacy in the country anyway, 
if anyone is going to do it, then Boots should start it.” 
 
When asked whether Boots offering this type of advice would make a difference 
between Boots and its competitors, one respondent thought that it would help to move 
the others along anyway; 
 
C11 “Well the competitors could do it as well it would probably gee them up a bit.” 
 
As part of the customer interviews, respondents were asked what they thought about 
getting this type of advice from Boots. Some of the respondents felt that they would 
not want to be offered advice unless they had asked for it, because the times they went 
into the pharmacy they just wanted to collect their prescriptions and go. They did 
however, want the reassurance that the advice would be available for when they 
needed to access it;  
 
C26 “I would certainly use it if I needed to. Because I’m reasonably in control of mine it 
probably wouldn’t be very often but it would be jolly useful to know it was there yes.” 
 
Other respondents stated that they would like to be approached with this type of 
advice from the pharmacist as they felt that they did not know enough about their 
condition. They felt they could listen to the advice, but then would not have to act 
upon it unless they wanted to. Although in favour of this, one particular respondent 
could see why some people might not like it; 
 
C34 “Some people have a problem being approached by other people, I wouldn’t, if 
someone wanted to offer advice to me I’d listen.  I don’t have to take their advice, but 
I can certainly understand some people might have a problem, but I wouldn’t.  That 
would be fine to come to me with advice.” 
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A couple of the respondents stated that one of the advantages of getting advice from 
Boots would be the ease of accessibility to a healthcare professional. One respondent 
felt that it would be a good idea to access this advice at Boots and felt that it could 
replace their visits to the asthma nurse which they experienced as highly inconvenient 
and generally not very useful or up to date; 
 
C19 “Well that’s great because it’s very difficult to get an appointment at my doctors. I 
think its most doctors. It’s very busy, lots of people moving out of London to Woking I 
think they just over subscribe, but that would be great because often I don’t think I 
need to see a doctor but a medically trained person might be able to point me in the 
right direction.” 
 
The main perceived advantage of the Boots offering was that it would be up to date, 
and respondents expected it to include day to day management advice and news about 
the latest developments on the market;  
 
C22 “I’d be quite happy as long as it wasn’t repeat, repeat, repeat. If it was new 
information or updated then I’d definitely be interested in it, but not if not new.” 
 
Many respondents had heard a lot of the same information before, and as such were 
only interested in the new developments in asthma. They did not like being dependent 
on medication and were always looking for new developments that would help to 
reduce their dependency on medication and improve their lives;  
 
C4  The only time I look for more information is if there’s something in the news – and it 
usually seems like its new and different, but it isn’t.”  
 
Within the customer interviews, ten respondents were asked about whether this kind 
of service would make them visit Boots more frequently. Over half of the respondents 
said that Boots offering this kind of service would make them go to Boots more 
frequently, compared to other providers;  
 
C13 “Yeah, it’s a really good idea and it would definitely make you go there more often I 
think. Well I certainly would.” 
 
One respondent felt that by making people feel more welcome with services like this, 
Boots were likely to sell more medicines as more people would go to them for advice 
and purchases;  
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C29 “They might sell more medicines to start with, but by the same token commercially if 
you make somebody welcome then you’re more likely to go to them for advice and 
make a purchase.” 
 
Three of the respondents valued services like this from Boots, and would recommend 
it to others; 
 
C31 Would recommend it to other people, yes its very good.” 
 
C17 I recommend Boots to others often anyway, as it’s so good.” 
 
Although one respondent was happy with the service, they would always prefer advice 
from GPs or nurses;  
 
C32 “I am quite happy with the service and would recommend it to other people, but advice 
from doctors or nurses is much better, really in the know.” 
 
A total of three of the respondents would not visit Boots more frequently as a result of 
this service. Although two of these respondents welcomed this service, they were 
already frequent visitors to Boots, so services such as this would not change their 
frequency of visit. For the remaining respondent, they would continue to use Boots to 
collect prescriptions only, and use their own initiative to keep themselves educated on 
asthma management. 
 
8.1.3.2 Financial benefits  
Prescription data for asthma items were collected throughout the brief intervention and 
asthma service. Although detailed results cannot be disclosed due to the commercial 
sensitivity of the data, the following information is available. The brief intervention 
activity halted Boots decline in market share in asthma and resulted in a small share 
increase. Incremental items were estimated in the range of 34,000 to 78,000. 
Dispensing data for the eight pharmacies participating in the asthma service showed a 
24% increase in asthma prescription volume, resulting in 9,000 incremental dispensing 
items. There was also a change in the type of medication dispensed, as these 
pharmacies showed a slight increase in devices, combinations and preventer inhalers 
dispensed, and a decrease in relievers as a percentage of the total asthma volume. 
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8.2 Discussion of the results  
Within this chapter I have presented the benefits of delivering the asthma services 
from the perspective of the pharmacist, customer and service provider. A discussion of 
the benefits of service delivery will help me to understand the motivations of 
pharmacists participating in the service, customers accessing the service, and Boots in 
providing the service. Unless each of these groups of individuals are motivated to 
provide, deliver, and access the service then the service itself will not be successful.  
 
The pharmacists felt that services such as these helped to raise the awareness of the 
role of the pharmacist and the type of services they could provide. It was seen to be 
good for the image of pharmacy, not just for Boots, but also for pharmacy in general. 
There was recognition amongst the pharmacists that they could no longer just dispense 
medicines and the remit of their role was expanding to deliver more services. Offering 
interventions such as the asthma service was felt to help encourage people to extend 
the use of pharmacies for advice and support.      
 
Delivering the asthma services helped to improve the job satisfaction of not only the 
pharmacist, but also the pharmacy staff. Pharmacists were motivated by the fact that 
they were helping to improve peoples lives, and this was particularly evident with 
pharmacists working in non NHS contract pharmacies. Pharmacists stated that 
services such as these helped to make them feel like they were still performing the job 
of a pharmacist, and not that of a general sales assistant. An opportunity could exist to 
utilise the skills of pharmacists sited in non NHS contract stores, to allow them to 
deliver more services of this nature. Extended services like asthma could also go in the 
favour of pharmacy contractors when local PCOs are considering whether an NHS 
contract should be awarded or not. 
 
Pharmacists felt that delivering services helped to reduce the pressure on GPs and 
provided them with an opportunity to work more closely with them. Although the 
benefits to GPs and PCOs are not discussed here, this does need considering when 
delivering NHS services. GPs can be very target driven, and are likely to be more 
cooperative if they can see the benefits for their patients and their practices. Benefits 
of services such as these could include reducing the pressure on their workload, and 
having access to data that helps to meet their targets within the GMS contract. The 
benefits to PCOs in commissioning services through community pharmacy could 
include patient accessibility, value for money and increased service capacity.  
 287 
Customers highlighted the benefits of the accessibility of the pharmacist, the 
convenience of the pharmacy locations, and the immediate access to a healthcare 
professional without an appointment. As pharmacists continue to take on additional 
roles and responsibilities, the accessibility of their advice could be of most benefit to 
those working full time and unable to access conventional GP services. This is 
particular true in light of the new GP contract [59] where GPs are able to opt out of 
out of hours provision, and as a consequence, no longer deliver services on evenings 
and weekends. There was a strong feeling that customers did not want to waste GP 
time with minor queries, particularly if they could access advice elsewhere. This 
appeared to be a strong motivator for accessing pharmacist time over the GPs.    
 
Some of the customers felt that the use of questions by pharmacists helped provide 
them with the opportunity to talk to the pharmacist, when they might otherwise not 
have done so. Other customers felt that they did not want to be hassled with advice, 
and would just prefer to know that they could access help and support as and when 
they needed it. Clearly the benefits for individuals differ. It is important to be able to 
help people to identify if they have a problem with their condition, but at the same 
time not impose advice onto them. There was a positive response from those 
customers who felt that the pharmacist was taking time and interest in them to help 
them to improve the management of their condition. Many of the respondents 
questioned did not get the opportunity to discuss their asthma with their GP when first 
diagnosed and seemed grateful for the chance to do so. With so much pressure on 
GPs time, they felt that they were unable, or ready to ask all the necessary questions 
when first diagnosed with asthma. Asthma services were seen to be particularly 
beneficial to newly diagnosed, parents of young children, and partners of people with 
asthma. Support and advice were highlighted for both people with asthma, and their 
friends and family who often observed asthma attacks. Customers who had been using 
inhalers for a number of years were less responsive to the service, although new 
developments in asthma were still of great interest. Despite the knowledge of those 
that had asthma for a number of years, the majority of respondents in both services 
had learnt something new as a result of the interaction. Many benefited from simple 
advice, and the pharmacists were surprised at the lack of knowledge on basic 
techniques. Those respondents that had not received basic instructions on inhaler 
technique and management were extremely motivated and supportive of the 
pharmacist services as a result. Respondents that had acted on the advice had noticed 
an improvement in their symptom control. The service had helped to build 
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relationships locally with customers, with some customers going back into the 
pharmacy to update the pharmacist on their progress.  
 
Within the second asthma audit, those responding yes to the RCP questions on 
symptom control were lower than in the first audit, which was particularly apparent 
within question three. Although no direct conclusions can be made, this could be as a 
result of the increase in activity locally to help to improve awareness of asthma and its 
management.       
 
The asthma services were provided at a cost to Boots, and as such the motivations for 
the company doing this need to be considered. Motivators for services commissioned 
by the DH, local PCOs or GPs, would be different to those discussed here and are not 
covered within this chapter. The views within this chapter are provided by the 
pharmacists and customers interviewed. Further discussion and commercial 
implications of the wider benefits to service commissioners and providers is discussed 
within chapter nine.  
 
Delivering extended services was seen as a good thing for Boots to get involved with, 
and something that gave the company extra credibility and trust. Customers felt that 
Boots were taking extra interest in them, something that is seen as key to the company 
brand. It was also expected for Boots to lead the way with services, which other 
pharmacy retailers would then follow suit into providing similar services.  
 
As well as increasing the trust in the brand within Boots, driving footfall into stores is 
another important motivator when assessing the viability of services. Over half of the 
respondents questioned stated that services like the asthma ones would make them go 
to Boots pharmacies more often, and there was a strong feeling that they would also 
recommend the services to others. This provides a strong motivator for Boots 
involvement in services. Both the brief intervention and asthma service increased the 
volume of asthma medication dispensed during the service activity. It is not surprising 
that the asthma service increased the volume of asthma prescriptions dispensed more 
so than the brief intervention, particularly given the increased support locally and 
length of consultation. What is unclear is whether the increase in volume was due to 
new customers bringing prescriptions into the pharmacy, or existing customers 
bringing in more prescriptions. Due to the level of data collected I was unable to 
distinguish between new and existing customers.  
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Alongside the increase in volume of asthma medication dispensed, there was also a 
change in the ratio of type of medication dispensed. During the asthma service activity 
there was a shift towards more combination and preventer inhalers, and asthma 
devices being dispensed, and a decrease in the ratio of reliever inhalers dispensed. 
Although the data cannot be directly linked with individuals participating in the 
asthma service, this could be as a result of the delivery of the asthma services within 
that locality. An increase in combination inhalers, relievers, and devices would imply 
that people with asthma within that locality were having more control of their asthma 
by using the appropriate type of medication.  
 
 
8.3 Summary of chapter VIII: Motivators of service delivery 
This chapter of my thesis has looked at the benefits, or motivators of service delivery 
to the pharmacist, customer, and service provider. It is important to understand the 
benefits of service delivery to each of the stakeholders concerned in order to recognise 
those factors which may be affecting service delivery.  
 
For both asthma services, clear benefits were identified for all the stakeholders 
concerned. For pharmacists, this was primarily around the enjoyment of delivering 
services and the job satisfaction it provided. The opportunity to build relationships 
with both customers and other healthcare professionals was also seen as important, as 
was raising the awareness of the extended role of the community pharmacist. 
Customers benefited from the accessibility of this type of advice, and were interested 
in new developments for the treatment and management of asthma. Information 
needed to be up to date, and personalised to the individuals needs. Particular groups of 
individuals, such as newly diagnosed, were seen as being more motivated for 
accessing these types of services. To service providers such as Boots, the delivery 
enhanced the public image of the company, driving footfall into the pharmacies. 
Business benefits are important for the sustainability of services, and this was 
demonstrated within both asthma services.  
 
A summary of the potential motivators identified within this chapter are detailed in 
Table 59. Where similar themes have been identified within previous literature, this 
has also been identified. 
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Table 59: Potential motivators of service delivery 
Stakeholder Factors Motivators 
Public image of 
pharmacy 
̇ Raised public awareness of the role of the 
pharmacist 
[16, 28] 
Pharmacist role 
̇ Extension of the pharmacist role 
[16] 
Job satisfaction 
̇ Professional satisfaction 
̇ Helping to improve peoples health 
[14, 22, 28] 
Pharmacist 
Relationship 
building 
̇ Enhanced relationships with customers, GPs, and 
PCOs 
Access to advice 
̇ No appointment necessary 
̇ Convenience of pharmacy locations  
̇ Availability when required 
̇ Offered by pharmacist to customers (push model), 
AND available to customers when required (pull 
model) 
̇ Alternative healthcare professional resource to 
avoid wasting GPs time with minor queries 
Type of advice 
̇ Personalised advice useful to individuals  
̇ New information, medication, and techniques  
̇  Impact of advice (improvement in symptom 
control) 
Target groups 
̇ Member of target group who may be more 
motivated and responsive to advice (for example; 
newly diagnosed, parents with young children, 
mothers with teenagers, partners of people with 
asthma, less experienced inhaler users) 
Customer 
Relationship 
building 
̇ Pharmacists expressing an interest, and taking the 
time to talk to customers about their condition 
Image 
̇ Enhanced credibility and trust  
̇ Leading the market 
̇ Recommendations to friends and family Service provider 
(Boots) 
Business 
̇ Increase in prescription business 
̇ Increase in frequency of customer visits 
 
All of the factors identified within chapters five, six, and seven, along with those 
above, will be discussed in more detail within the next chapter. 
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CHAPTER IX 
Factors affecting service delivery within 
community pharmacy 
 
9.0 Introduction to the chapter 
The final chapter of my thesis begins by providing a summary of this study and 
general research findings presented throughout this thesis. I then go on to discuss the 
factors affecting service delivery that have been identified as part of this study, 
including recommendations for future service models. The chapter then goes on to 
reflect on the methods used within this study and discuss the limitations of the results. 
The final conclusions are then presented along with questions for future research that 
have been identified through the course of this study. 
 
 
9.1  Review of the thesis  
The review of the literature was split into two parts, the first exploring the 
development of the health services strategy in England and how this has opened up a 
number of opportunities for community pharmacy. The Government is committed to 
providing a health service that is based around the needs of the patient, and has 
focused on providing prevention programmes that help to keep people healthy, making 
healthcare more accessible, and reducing health inequalities. New providers are 
required to help deliver the NHS vision, and in particular, the importance of the role of 
the community pharmacist has been emphasised. Despite the number of opportunities 
available for community pharmacy, the implementation and delivery of NHS and 
private services is proving difficult and slower than expected. The second part of the 
literature review provided an overview of the facilitators [1-6, 9-13, 16-20, 22-28, 30-
32], barriers [1-5, 7, 8, 12, 14-16, 18-21, 23-32] and motivators [14, 16, 22, 28] 
affecting service delivery within community pharmacy which have been identified 
from the literature. These factors included; customer need and demand, public 
attitudes towards the pharmacist, pharmacist characteristics and attitude, training, 
communication, awareness of the service, recruitment to the service, operational 
aspects of service delivery, pharmacist confidence in service delivery, support for the 
service, time available, staff resource, remuneration for the service, pharmacy 
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environment, healthcare professional relationships, evidence of the value of the 
service, and the external environment. The review concluded that there is a need to 
understand more about the various factors affecting delivery of services in community 
pharmacy, and ways to overcome barriers and enhance facilitators and motivators. 
This would enable service providers and commissioners to identify key obstacles that 
would hinder service development and delivery, and focus on primary facilitators and 
motivators that would enhance them. 
 
The overall aim of this study was to investigate factors affecting service delivery 
within a national pharmacy chain, from the perspective of pharmacists and consumers, 
using asthma services as an example. Data were collected to explore the current 
environment and opportunities available to pharmacy, the factors affecting service 
delivery, and to identify recommendations for future service models. The impact of 
the design and route of service implementation were studied through two different 
types of asthma services. The brief intervention in asthma was designed centrally 
and implemented nationally throughout Boots, whilst the asthma service was 
designed and implemented locally by a group of pharmacists. The principles behind 
action research were used during this study for the implementation and delivery of 
both services. A triangulation of qualitative and quantitative methods were used 
throughout this study, including an omnibus survey, audits, mystery customer 
research, customer and pharmacist interviews, and a review of the dispensing data.  
 
The publics current utilisation of community pharmacies and the pharmacists role in 
services was explored. A high proportion of respondents visited the pharmacy on a 
regular basis to purchase general toiletries, or for medication purchases or queries. 
Three quarters of respondents regularly used one pharmacy, with a quarter choosing to 
use a combination of providers. Reasons cited for the choice of provider included 
loyalty, convenience, and the quality of staff and service. Those that had spoken to the 
pharmacist for advice in the past rated the quality of this advice highly.  
 
Pharmacists were seen as an accessible healthcare resource and the benefits of 
receiving advice from them included not having to make an appointment and the 
speed of access. There was some confusion over the exact role of the pharmacist due 
to the wide range of general requests that they dealt with. The pharmacists role was 
felt to be limited as they were unable to change any medication directly, which often 
resulted in a referral back to the GP. The role of the pharmacist was seen as someone 
who could advise on minor ailments and medication  but for anything more serious 
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would require referral to a GP. Despite the enthusiasm for change and the hope that 
the pharmacy contract brought, there was still huge frustration amongst the 
pharmacists regarding the lack of progress and opportunities for service delivery to 
date.  
 
Asthma was chosen as a condition area to focus on for this study. Many people with 
asthma still have a relatively poor knowledge of their condition and its management. 
To some, there was a fear of finding out more information about their asthma, but to 
others they simply believed that they know enough already. Use of medication was 
poor, with many customers not always picking up all of the medication that their GPs 
had prescribed. There was a high use of reliever medication, and an under use of 
preventer inhalers. The majority of people still experienced regular symptom 
occurrence as a result of their asthma, and readily accepted the restrictions that it 
placed on their lifestyle.  
 
People with asthma need to be able to access up to date and reliable information on 
their condition through a number of media, including the regular reinforcement of key 
messages by all healthcare professionals. Most people appeared to be responsive to 
new information that could help to improve symptom control, or reduce medication 
use. The expectations of people with asthma need to be raised so that the majority aim 
to be relatively symptom free, with few or no restrictions on their life. People with 
asthma need to have a better understanding of how to control their condition, 
including management strategies and the use of medication.  
 
There are opportunities for community pharmacists to help identify people with poor 
control of their asthma through the use of simple questions. Pharmacists can act as an 
information source for people wanting general advice on asthma, or can proactively 
target customers when they are in the pharmacy. There is also a need to help people to 
understand and manage their condition better by helping them to recognise triggers for 
their asthma, identify strategies for managing symptoms, and improve understanding 
and confidence with medication. Although this study uses asthma as an example, the 
concept around customer need and demand for such services is not unique to this 
condition, and as such could be applied to other condition areas.  
 
The brief intervention in asthma was a service that was designed to be very simple to 
deliver and through the dissemination strategy, pharmacists were encouraged to take 
local ownership and adapt the service delivery to meet local requirements. This 
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service was successful in being implemented and delivered, as shown in the high 
delivery rates over the four month mystery customer assessment period. Regular 
communications to the pharmacists appeared to have kept the project alive and 
sustainable over a longer period of time. Many pharmacists seem to have disseminated 
the information to their healthcare staff who were then able to offer opportunistic 
interventions themselves. As the service was very simple, pharmacists and staff were 
able to integrate it into their everyday practice and use elements of the intervention as 
they deemed appropriate. 
 
The asthma service was designed and implemented by a group of pharmacists within 
their locality and was based around identifying people with asthma that would benefit 
from a consultation with the pharmacist on inhaler technique, medication use and 
general lifestyle advice. The service was successful in being implemented, and the 
pharmacists took ownership of the project locally. Many of the pharmacy team were 
involved in helping to identify customers with uncontrolled asthma. Pharmacists had 
the confidence to adapt the content and length of the service locally according to local 
business or customer needs, and would often carry out asthma brief interventions 
rather than the full consultations. The local flexibility allowed the pharmacists to offer 
their services to a greater number of customers.  
 
For both asthma services, clear benefits were identified for all the stakeholders 
concerned. For pharmacists, this was primarily around the enjoyment of delivering 
services and the job satisfaction it provided. The opportunity to build relationships 
with both customers and other healthcare professionals was also seen as important, as 
was raising the awareness of the extended role of the pharmacist. Customers benefited 
from the accessibility of this type of advice, and were interested in new developments 
for the treatment and management of asthma. Information needed to be up to date, and 
personalised to the individuals needs. Particular groups of individuals, such as newly 
diagnosed, were seen as being more motivated for accessing these types of services. 
To service providers such as Boots, the delivery enhanced the public image of the 
company, driving footfall into the pharmacies. Business benefits are important for the 
sustainability of services, and were demonstrated within both asthma services.  
 
This large scale study has used a triangulation of data to investigate the factors 
affecting service delivery within community pharmacy, and includes the collection of 
data from the pharmacists delivering the service, the views of customers accessing the 
service, and the operational delivery of the service. Although previous literature has 
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investigated some of the factors affecting service delivery, this is the first large scale 
study within the UK that has investigated the barriers, facilitators and motivators 
relating to the market opportunity, the role of the pharmacist within services, and the 
implementation and delivery of a locally and nationally led service. The findings from 
this study have already provided valuable insights and learnings that have been 
utilised within Boots itself as part of the development of new services. 
 
 
9.2 Discussion of the factors affecting service delivery in 
community pharmacy 
This study has investigated the factors affecting service delivery in community 
pharmacy by looking at the current utilisation of community pharmacies, the 
pharmacists role in service, the opportunities for delivering services in asthma, the 
factors affecting delivery of services themselves, and the benefits of service delivery. 
The barriers and facilitators identified throughout this study can be grouped under 
similar themes and are associated with the following factors: current pharmacy 
utilisation, customer need and demand, attitudes of customers and pharmacists, 
implementation of the service, training, pharmacy communication, awareness of the 
service, recruitment to the service, the type of advice available, the service structure, 
the pharmacist confidence in service delivery, management support, time, staff 
resource, remuneration, pharmacy environment, healthcare professional relationships 
and the external environment. Details of the individual facilitators and barriers are 
provided in Table 60. Where these factors are presented in a positive light they are 
seen as facilitators, and when presented in a negative light, barriers. Where the 
individual factors have already been identified within previous studies, this is 
indicated within the table.  
 
The benefits of service delivery to the pharmacist, customer and service provider have 
been investigated within this study, and are referred to as motivators. Those 
motivators that have been identified for the pharmacist included the opportunity to 
deliver an extended role, to improve the public image of pharmacy, increased job 
satisfaction, and relationship building. Customer motivators were based on the 
accessibility of advice, type of advice, membership of a particular target group, and 
the opportunity to build relationships with a healthcare professional. The motivators to 
the service provider were based on the image of the company, and the business 
benefits and return on investment. Details of the individual motivators are provided 
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within Table 61. Where the individual motivators have already been identified within 
previous studies, this is indicated within the tables. 
 
This is the first large scale study of its kind to look at all the factors involved from the 
perspective of both customers and pharmacists, and many of the facilitators and 
barriers identified extend beyond those provided within the current literature. In 
addition, the service implementation methods, the type of advice, and the service 
structure have not been recognised as factors affecting service delivery within 
previous studies. The motivators identified within the previous studies have been from 
the perspective of pharmacists only. This study has looked at the perspective of not 
only pharmacists, but also the motivators to customers and the service provider.  
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Table 60: Summary of the facilitators and barriers identified throughout the study (*Factors identified as experiential facilitators and barriers) 
(Please note that this table is presented over seven pages) 
 Facilitators Barriers 
Current 
pharmacy 
utilisation  
̇ High frequency of visit to pharmacy for general purchases 
̇ Use of different types of pharmacies for different services  
̇ Wider audience for dissemination of advice (patient, partner, parent) 
̇ Good use of pharmacy for general purchases  
̇ Good use of pharmacy for medication related queries [6]  
̇ Previous good experience of pharmacist advice 
̇ Poor frequency of visit to pharmacy for health related reasons 
̇ Poor loyalty to one pharmacy  requirement for access to centralised 
medication records [3, 7, 8, 14, 18, 21]  
̇ Poor use of pharmacy for general health 
̇ Expectations when in pharmacy depending on shopping mode for health 
or general purchases, and receptiveness for advice 
̇ Poor use of pharmacy for general health queries  
̇ Previous poor experience of pharmacist advice 
Market 
opportunity 
(customer need 
and demand) 
̇ Perceived usefulness of advice* 
̇ Ability of service to help identify potential customers, and recognising 
potential need for advice*  
̇ Ability to adapt service to customer need* 
̇ Customer need for service, including; poor knowledge, poor use of 
medication, poor management of condition, poor quality of life 
̇ Services aimed at conditions that affect people on daily basis [1, 11, 20]  
̇ Services that deliver advice and support that people would not want to 
bother their GP with 
̇ Demand for service, including interest in accessing additional 
information, and interest in improving management of condition [16]  
̇ Perception that do not need advice*  
̇ Advice that is not in pharmacists perceived area of expertise* 
̇ No customer need for service, good control and management of 
condition 
̇ No demand for the service, or interest in improving condition [1, 8, 14, 
16]  
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Facilitators Barriers 
Public attitude 
̇ Accessibility (speed of access and no appointment required) 
̇ Customer receptiveness to advice when in pharmacy 
̇ Pharmacists seen as knowledgeable and respectful 
̇ Confidence in pharmacist advice and ability to refer as appropriate 
̇ Alternative source of advice to GP (GP time valuable, previous poor 
experience, speed of access) 
̇ Customers interested in accessing services and advice on particular 
condition area from the pharmacist 
̇ Advice that is in the pharmacists area of expertise (e.g. medication 
related)* 
 
General: [3, 12, 17, 18, 23, 30, 32] 
̇ Unclear role of pharmacist because of breadth of requests for advice, 
and no records made  
̇ Poor confidence in advice from staff 
̇ Limitations of pharmacist advice (referral, lack of commitment, inability 
to prescribe) 
̇ Poor expectations of pharmacists role [3, 7, 16, 18, 21, 26, 32]  
̇ Poor level of confidence in pharmacists advice* 
̇ Level of authority of pharmacists advice compared to other healthcare 
professionals* 
̇ Customers not willing to access services and advice on particular 
condition area from the pharmacist 
Pharmacist 
attitude  
̇ Services that are incorporated as part of day job 
̇ Expectation that pharmacists core role includes services and advice 
̇ Commitment to service* [5, 17-19, 30, 32]  
̇ Enthusiastic* [30]  
̇ Expectation that pharmacists role should be dispensing only  and 
advice should be given by GP 
̇ Frustration of pharmacists  
̇ Resentment of pharmacists towards nurses 
̇ Poor attitude towards role expectations* [1, 5, 16, 29, 32]  
̇ Limitations of role*    
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 Facilitators Barriers 
Service 
implementation 
̇ Simple structure that is easy to follow*  
̇ Ability to adapt and extend service locally* 
̇ Local ownership and involvement in service delivery and design* 
̇ Service lead in each pharmacy* 
 
Training 
̇ Opportunity for additional training* 
̇ Information aimed at pharmacy staff and pharmacists 
General: [1, 3, 4, 11-13, 16, 18, 20, 23-26] 
̇ Language barriers where English is not the first language* [8, 29]  
Pharmacy 
communication 
̇ Regular communication with team (central and local)* [10, 16, 22]  
̇ Opportunities to share best practice and learnings*  
̇ Early communication of service to pharmacists and managers to enable 
better planning 
̇ Communication via a number of media 
̇ Service materials delivered in one box prior to service commencing (to 
avoid items going missing) 
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 Facilitators Barriers 
Awareness of 
service  
̇ Pharmacists able to identify customers easily that require help or 
support 
̇ Clearly signposted area or member of staff to go to for advice 
̇ Simple branding that explains clearly what the service is about 
̇ In store support materials to make people aware of the service and give 
people the opportunity to ask for advice 
̇ Advertising outside of the pharmacy to make people aware of the 
service and help create customer demand [1, 11, 16]  
 
Recruitment 
̇ Captive audience available, e.g. when dispensing prescriptions* 
̇ High volume target customers visiting pharmacy [6]  
̇ In store recruitment* 
̇ Targeting uncontrolled people with asthma*  
̇ Customers not easily identifiable*  
̇ Less opportunity to identify customers, particularly in non NHS contract 
pharmacies* [16, 24]  
Type of advice  
̇ Content relevant for time of year* 
̇ Information easy to access by individual, for example picking up leaflet 
in pharmacy* 
̇ Advice available in different formats (verbal and written) 
̇ Information leaflets aimed at different target groups, and covering wide 
range of topics 
̇ Rotation of themes and advice to keep advice relevant and service 
sustainable 
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Facilitators Barriers 
  
Service 
structure  
̇ Ad hoc consultations and advice* 
̇ Appointments available at the customers request* 
̇ Simple interventions but opportunity to deliver more in depth service 
when required*  
̇ Flexibility in service delivery (content and length of intervention)* 
̇ Good fit with other initiatives and activities* 
̇ Regular and updated communications* 
̇ Opportunity to improve awareness of symptom control* 
̇ Providing opportunity to access healthcare professional advice*  
̇ Guidance on additional materials if required 
̇ Minimal paperwork associated with service 
̇ Services that provide opportunity to talk (proactive) 
̇ Focus on key services   
̇ Appointments led at the pharmacists request* 
̇ Intervention too simple so not perceived as a service* 
Pharmacist 
confidence in 
service delivery 
̇ Confidence to deliver and adapt service to meet customer and business 
needs* 
̇ Staff incentives to encourage participation in services 
̇ Experience in delivering services [16, 17, 19, 24]  
̇ Customers willing to listen 
̇ Pharmacist confidence in service delivery [9, 19, 30]  
̇ Good preparation prior to service delivery 
̇ Lack of confidence and comfort in using particular questions and 
providing advice that is not related to medicines (outside comfort zone)* 
[5, 8, 19, 25]  
̇ Lack of customer contact  
̇ Lack of confidence in services 
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 Facilitators Barriers 
Management 
support 
̇ Management supportive of the service* [1, 10, 12, 19, 22, 23]  ̇ Lack of management support and prioritisation of other activities* [1]  
Time 
̇ Allocated time to deliver services [2, 13, 23]  ̇ Lack of pharmacist time* [2, 3, 7, 8, 12, 14-16, 20, 23, 25-27, 29]  
̇ Pharmacy workload and demands on pharmacist time* [1, 21]  
̇ Lack of customer time* [26]  
̇ Constant demands competing for pharmacist time 
Staff resource 
̇ Involvement of all pharmacy support staff in service delivery* 
̇ Effective use of pharmacy team* [2, 12, 13, 20, 22-24]  
̇ Adequate staff resource available (pharmacists and support staff)* [1, 3, 
16, 26]  
̇ Planning of resource to support service 
̇ Better trained support staff 
̇ Inadequate resource available (pharmacists and support staff)* [7, 18, 
23-26, 28]  
̇ Single pharmacists stores* 
Remuneration  ̇ Funding for time and resource [3, 6, 11, 13, 16, 22, 32]   
Pharmacy 
environment  
̇ Service sited in large and small size pharmacies, and edge of town 
locations (potential link to resource and how busy the pharmacy is)* 
̇ Accessibility of pharmacist* [18, 20]  
̇ Private consultation area available [1, 3, 13, 18, 26]  
̇ Pharmacies located in commuter towns (potential link to customer time 
available)* 
̇ Services sited in middle size pharmacies and health centre locations 
(potential link to resource and how busy the pharmacy is)* 
̇ Non contract pharmacies (less opportunity to target customers)* 
̇ Busy pharmacies (customers waiting)* [2]  
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 Facilitators Barriers 
Healthcare 
professional 
relationships  
̇ Communication with GPs to help build links and working relationships 
[3, 5, 11, 13, 16, 18, 19, 24, 32]  
̇ Working with local asthma nurses 
̇ Underutilisation of pharmacists by GPs [3, 7, 8, 14-16, 18, 19, 21, 23, 
25-27, 29, 32]  
External 
environment 
̇ Opportunities within new pharmacy contract [5, 32]  ̇ Lack of opportunities to deliver extended service 
̇ Delay in timing of new pharmacy contract 
̇ Decisions by professional organisations and companies 
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Table 61: Summary of the motivators identified throughout the study  
Stakeholder Factor Motivators 
Opportunity 
to deliver 
extended 
role 
̇ Enthusiasm for involvement in services and trials by 
pharmacists and staff 
̇ Personal development 
̇ Adding professionalism to the role 
̇ Extension of the pharmacists role 
General: [16, 22]   
Public 
image of 
pharmacy 
̇ Raised public awareness of the role of the pharmacist [16, 
28]  
Job 
satisfaction 
̇ Professional satisfaction 
̇ Helping to improve peoples health  
General: [14, 22, 28] 
Ph
ar
m
a
ci
st
 
Relationship 
building 
̇ Enhanced relationships with customers, GPs, and PCOs 
Access to 
advice 
̇ No appointment necessary 
̇ Convenience of pharmacy locations  
̇ Availability when required 
̇ Offered by pharmacist to customers (push model), AND 
available to customers when required (pull model) 
̇ Alternative healthcare professional resource to avoid 
wasting GPs time with minor queries 
Type of 
advice 
̇ Personalised advice useful to individuals  
̇ New information, medication, and techniques  
̇  Impact of advice (improvement in symptom control) 
Target 
groups 
̇ Member of target group who may be more motivated and 
responsive to advice (for example; newly diagnosed, 
parents with young children, mothers with teenagers, 
partners of people with asthma, less experienced inhaler 
users) 
C
us
to
m
er
 
Relationship 
building 
̇ Pharmacists expressing an interest, and taking the time to 
talk to customers about their condition 
Image 
̇ Enhanced credibility and trust  
̇ Leading the market 
̇ Recommendations to friends and family 
Se
rv
ic
e 
pr
ov
id
er
 
(B
oo
ts)
 
Business 
̇ Increase in prescription business 
̇ Increase in frequency of customer visits 
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One of the benefits of using action research is the opportunity to learn from the study 
as it progresses. Both the services studied throughout this thesis have already been 
rolled out across Boots pharmacies. The success of the brief intervention in asthma led 
to subsequent brief interventions in other topic areas being implemented during 
2004/05. To keep the staff and customers interested, the themes were rotated every 
two months, and included brief interventions for smoking cessation, hypertension, 
blood pressure, arthritis, diabetes, and obesity. Pharmacists were sent communication 
packs on the initiatives which included continuing professional development for 
themselves and other members of the healthcare team, and information leaflets for 
customers. All information was designed alongside the appropriate patient 
organisation to include the latest information and research available and was timed to 
fit with key events. Since the implementation of the new pharmacy contract [37], this 
service has now evolved to fulfil the contractual requirements linked to the promotion 
of healthy lifestyles and prescription linked interventions. In addition to this, the local 
asthma service is also in the process of being rolled out across Boots pharmacies. This 
service has evolved to link with the advanced service requirements within the new 
pharmacy contract for MURs.  
 
The learnings from this study have also influenced the design, implementation and 
delivery of other pharmacy services within Boots. The most successful of these is the 
Chlamydia screening and treatment service that is being delivered by all 216 Boots 
pharmacies in London on behalf of the NHS. An application of the learnings from this 
study led to the success of winning this two year contract with the DH. This service 
was designed to take advantage of the current pharmacy utilisation by the target age 
group and to meet an unmet customer need. The service was planned so that it was not 
only simple for pharmacists and pharmacy staff to deliver, but also simple for 
customers to access. Where possible, the barriers to testing have been removed. The 
distribution of vouchers near to general products that the target age group purchase, 
and outside of the pharmacy, enable greater awareness of the service, and provide 
customers with the opportunity to access the service with minimal embarrassment  
without having to say the word Chlamydia! Results are communicated to customers 
via their chosen route, with the option of text, phone or letter. Positive patients and 
their partners are able to return to any Boots pharmacy in London to access treatment. 
Paperwork has been kept to a minimum within the pharmacy, with the majority of 
information recorded at the laboratory performing the testing. The pharmacists and 
staff involved in the service are enthusiastic and feel that they are making a difference 
to peoples health by providing the service. Each area has a service lead who co-
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ordinates any external activity and local training. The management team support the 
pharmacies and regularly monitor activity levels and feedback on progress. Each 
pharmacy is automatically remunerated for any service activity, and is targeted on 
services sales. Pharmacies located near to train, bus and tube stations perform 
extremely well at the service, due to the anonymity offered within these types of 
environments. The pharmacies work closely with other local healthcare professionals 
and providers to offer referrals into the Boots service, and from Boots into more 
extensive screening services. The service has proved highly successful with 
consumers, with over 18,000 kits issued within the first six months. It has also proved 
successful to Boots as a service provider, with the decision taken to roll out a national 
private Chlamydia service in over 1300 Boots pharmacies from October 2006.  
 
Based on the factors identified throughout this study, and the learnings applied in 
subsequent services, a number of recommendations for service design, implementation 
and delivery have been made below. Consideration of these factors may help to 
improve the sustainability and scalability of future pharmacy led services.  
 
a) Current pharmacy utilisation 
Some NHS services, such as MURs, require the customer to be registered at an 
individual pharmacy for a period of time before they are eligible for that service. 
Other services can be accessed by any member of the public presenting at any 
pharmacy. Customers may prefer to use different pharmacies for different purposes, as 
not every pharmacy offers the same services. Access to patient medication records 
will help to facilitate the use of multiple pharmacies for various services. When 
designing the service, consideration needs to be placed on how the general public 
currently uses an individual pharmacy, and the service should build on these core 
strengths. For example, pharmacies dispensing high volumes of prescriptions in local 
communities are likely to have a high proportion of people with long term conditions 
and should target services to that group. In contrast, services for sexual health may be 
better operating in pharmacies where there are less regular prescription customers and 
more general purchases. Before designing and implementing services, there is a need 
to recognise the current customer base and usage of the pharmacy. It is far easier to 
target services at existing customers, than it is to recruit new customers to the 
pharmacy.  
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b) Market opportunity (customer need and demand) 
For a service to be successful there has to be both a customer need and demand for 
that service. Customer demand should not be assumed, as customers may not 
recognise that they need help, or they may not actually want help. The use of simple 
questions can help customers to recognise the fact that their condition is uncontrolled. 
The service itself should meet an unmet need for something that is currently not 
provided, or something that is not currently accessible to all.  Services should be 
aimed at people that have conditions that affect their daily life, or for advice and 
support that they do not want to bother their GP with. There needs to be a reason why 
customers would want to access new services, or services from alternative providers.  
 
c) Public attitude 
The pharmacy profession needs to work together to improve the publics attitude and 
use of community pharmacies, so that they are seen as a member of the primary 
healthcare team. Pharmacy services should play on the core strengths of the 
profession, namely the accessibility and convenience of access to healthcare 
professional advice. The deregulation of medicines from prescription only to 
pharmacy status, and the introduction of independent prescribing will provide 
pharmacists with the opportunity to have greater authority and involvement in patient 
care. It will also provide increased convenience to customers accessing pharmacy 
services as they will not have to return to their GP for medication. As the number of 
services pharmacists provides increases, and the number of customers experiencing 
these services increases, then hopefully the confidence in pharmacist advice will also 
improve. The word of mouth from friends and family has a positive influence on 
perception and access of services and products.   
 
d) Pharmacist attitude 
There are a number of pharmacists that are not interested in delivering services, but 
these tend to be in the minority. The majority of pharmacists and healthcare staff are 
extremely positive and enthusiastic about delivering an extended role. Identifying 
local leads that are particularly enthusiastic and driven can help to motivate other 
pharmacists and staff delivering the service. They can also be used as a local expert 
and point of reference for other pharmacists. Services that utilise their expertise help 
to improve job satisfaction and professional reward. Creating a positive attitude 
towards a service helps the pharmacist and staff to overcome any barriers for 
delivering the service, as they will often come up with potential solutions themselves. 
Although barriers are still identified, these pharmacists are more likely to ask for help 
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to overcome any problems, rather than letting the barriers overcome the service. 
Although most of the barriers can be aided by external intervention, pharmacist 
themselves still need to be proactive in seeking opportunities to extend their role, and 
should not rely on everything being done for them.  
 
e) Implementation of the service  
Having different services operating in pharmacies using different service 
specifications can be difficult to manage within large organisations. The key is to 
provide some standardisation and tools for pharmacies to adapt and use at a local 
level. This encourages local ownership of the service, and allows flexibility in service 
delivery. Services that are too rigid in nature do not allow for any local variation or 
flexibility for the pharmacists and staff to vary depending on local customer or 
business needs. The use of service leads to co-ordinate and manage the 
implementation and delivery of the service encourages local responsibility and 
ownership.  
 
f) Training 
Training helps to improve the confidence of pharmacists and staff. The training should 
not be too onerous, but should meet the requirements and standards for professional 
service delivery. Training should be standard, with the signposting to other materials if 
the trainee requires. Guidance and experience of practice consultations provide a 
forum for feedback to improve confidence on service delivery. Training should be 
available to all staff involved in the service delivery. Briefings should also be made 
available to other staff working within the pharmacy so that they are able to signpost 
customers as appropriate. This is particularly true for services that may be of a 
sensitive nature and that need to be handled discreetly.     
 
g) Pharmacy communication 
Pharmacies are often bombarded with mail, both from external and internal sources. 
Communication on the services should be clearly signposted, and available via a 
number of media to improve the awareness by pharmacy staff. This should include 
briefings at pharmacist meetings before the service is implemented to help raise the 
awareness and enthusiasm for the service. Initial service packs should arrive within 
the pharmacies in one package that includes everything required to operate that 
service. Regular communications to the pharmacists and the managers monitoring the 
service help to keep the focus and interest in the service on an ongoing basis.  
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h) Awareness and recruitment to the service 
Marketing activity outside of the pharmacy can be used to create awareness, but 
materials within the pharmacy and recruitment by pharmacy staff are critical to aid 
conversion to the service. The use of marketing can sometimes help to create a 
customer demand for the service, and drive footfall into the pharmacy environment. 
Working with patient organisations around key dates and initiatives can help to drive 
the public awareness of certain problem areas. Although the marketing was not 
effective for the asthma service, it has been shown to work in driving demand for the 
Chlamydia service. Once within the pharmacy, customers need to be clearly 
signposted to where they can access the service. This can be via signage materials 
inside the pharmacy, or pharmacy staff proactively recruiting people to the service. 
Services targeted at prescription customers should be located in pharmacies that have 
a high proportion of the target group visiting the pharmacy as this is an ideal 
opportunity for staff to recruit customers to the service. The use of simple questions, 
as in the asthma services, can help to identify people who have a condition which is 
uncontrolled, or who may be in an at risk group. Services targeted at non prescription 
customers should find other ways to recruit customers to the service. For example, 
messages and vouchers can be placed near to products that the target group buy, or via 
targeting groups of customers through routes such as the Boots Advantage card kiosk. 
The use of vouchers provides a tool to direct people to the pharmacy counter to ask 
about the service. 
 
i) Type of advice 
The advice available should be up to date, and provide the latest news and information 
for that particular condition or ailment. Rotating the advice, and keeping the content 
relevant for that time of year helps to keep customers interested in the service and 
support available. Advice should be available via a number of media, including the 
internet, as well as verbal and written information leaflets. Working with key patient 
organisations also helps to add credibility to the advice provided, and offers referral 
channels for customers wanting additional help and support. The depth of advice 
available should be flexible, to enable brief or detailed advice depending on customer 
need and time available.  
 
j) Service structure 
The service should be simple so that it is easy for pharmacists and staff to deliver, and 
is easy for the customer to understand. The use of toolkits enables the pharmacist to be 
flexible in service delivery, and adapt the length of consultation and the content 
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depending on the customer or business need. This worked particularly well with the 
delivery of the brief intervention and the asthma service, as this resulted in the two 
distinct services merging into one asthma service, with variable content and timing of 
delivery. The service should meet a customer need and have clear consumer messages. 
Keeping paperwork to a minimum is essential to encourage delivery by pharmacists 
and staff. If data does need to be recorded, then the use of alternative ways should be 
investigated. This could include recording data in alternative settings, or the use of till 
based systems. For example, the Chlamydia service relies on staff recording age on 
the tills when handing out the kits to customers. Customer details for the service are 
then recorded at the laboratory where data is entered onto the database.  
 
Linking the service to other initiatives provides clear messages and focus for 
pharmacy teams. Designing the service to operate as an extension of activity that 
pharmacists are already delivering makes the service even easier to operate. It is also 
important to involve all members of the pharmacy team in service delivery as 
appropriate, allowing the service to be more scaleable. Pharmacy staff can be used to 
identify customers for the service, or provide brief opportunistic interventions or 
elements of the service over the counter. Customers are used to accessing immediate 
advice by the pharmacists, and this should be available at all times. Where the 
pharmacist is too busy to offer advice or services, they should still aim to offer brief 
advice, and provide the customer with the opportunity to return at a convenient time. 
Where possible, appointments should be made at the request of the customer. To keep 
services sustainable, they should evolve over time to fit with other initiatives, or 
service requirements. Both asthma services have done just that, and have evolved to 
meet the pharmacy contract requirements of prescription linked interventions and 
MURs.  
 
k) Pharmacist confidence in service delivery 
The more experience a pharmacist has in delivering services, the more confident they 
tend to feel. The use of training and forums to practice consultations can help to 
improve this confidence. Local colleagues and experts in service delivery can also act 
as role models and provide examples of best practice. Linking a service to an activity 
that the pharmacist is already undertaking helps to make it easier to deliver. This was 
the case for the Chlamydia screening service which was linked to the routine activity 
of selling a product.  
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l) Management support 
Management support of services provides clear focus and accountabilities for service 
delivery by pharmacy staff. If the management team are not aware of a service, or if it 
is not on their priority list, then no matter how much enthusiasm individual members 
of the team may have the service delivery will be hampered by other priorities and 
initiatives. Briefings to area and regional teams before the initiative can help to raise 
the profile and support for the service. Internal stakeholder management can help to 
make the service a business priority and provide clear targets and accountability for 
pharmacy staff and the management teams.  Providing regular feedback on 
performance helps to keep the service sustainable.  
 
m) Time and staff resource 
Time and staff resource are linked together as having the appropriate resources in 
place, frees up time for service delivery. The type of resource required very much 
depends on the service being delivered. For example, if the pharmacist is required to 
deliver all elements of the service that is time intensive, then a second pharmacist may 
be required during times of service delivery. If the service requires brief or 
opportunistic advice by the pharmacist then this could be managed by a single 
pharmacist by having the appropriate support staff in place. The greater use of 
accuracy checking technicians will help to release pharmacists time from some of the 
traditional dispensing roles, which in turn would then enable greater contact with 
customers. Services that utilise other members of the pharmacy team enable greater 
opportunity for delivery during the normal working day. Flexibility in the content and 
length of service delivery will also enable pharmacists and staff to respond to 
customer and business needs.  
 
n) Remuneration 
Although the brief intervention and asthma services were free to the customers (as the 
service was paid for by Boots centrally), funding for time and resource were still 
presented as a potential factor affecting service delivery. Remuneration for service 
implementation and delivery will vary between individual services, pharmacy 
organisations, and local commissioners. Organisations like Boots may choose to fund 
services that offer benefits to the business such as increased loyalty, prescription or 
product purchases. Private services that offer benefits to the public may attract 
customer funding for services, particularly those that offer access to services that are 
not currently provided by the NHS. Services that offer benefits to the NHS such as the 
prevention of long term complications, hospital admissions, reduced wastage of 
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medicines, or freeing up GP time may attract NHS funding. Due to the current 
financial constrictions of the NHS, any new services delivered by pharmacists would 
have to fit with key priorities and local targets. To obtain NHS funding the services 
would have to improve patient care by providing increased capacity or accessibility in 
a cost effective manner. Relying on NHS remuneration for services could hamper the 
development of the extended role of the pharmacist due to the cash flow restrictions 
and problems currently experienced by PCOs. Pharmacists should look at alternative 
means of funding service delivery, such as commercial organisations, DH initiatives, 
and insurance providers. Although remuneration has also been highlighted as a factor 
within many of the studies identified within the literature [3-8, 11-16, 20, 22, 23, 25-
30, 32], this can not be the only factor at play as MURs are remunerated nationally 
within the new pharmacy contract [37], yet problems with service delivery still exist 
[77].  
 
o) Pharmacy environment 
As already discussed, the type of pharmacy best suited to services may vary depending 
on the type of service being considered and the target group of customer. Services 
targeted at prescription customers may not be particularly successful in pharmacies 
without NHS contracts. Likewise, services targeted at young people who are not high 
prescription users may not be successful in high volume dispensing pharmacies 
located near to health centres. Services that require anonymity may be better placed in 
pharmacies with a high volume of commuter traffic, whilst services that build local 
relationships may be better located in pharmacies serving static populations. The 
location and type of pharmacy the population serves should be a primary consideration 
for the target group the service is aimed at. The resource in the pharmacy should be 
dependent on the current volume of workload and the additional work that the new 
service presents. Consultation space should be available for pharmacists and 
customers to utilise, but should not always be presumed as an absolute requirement for 
service delivery. The use of consultation space in some services may be more off 
putting for certain groups of customers.  
 
p) Healthcare professional relationships 
Pharmacists should alert any stakeholders that need to be aware of the service, 
including local healthcare professionals who may interact with the target group. This 
could include building relationships with local GP practices or other local service 
providers. The relationship with other healthcare professionals is important to present 
a coherent approach to individual patients. Referral into and out of services may be 
 313 
two way, with local practices referring patients to the pharmacy services, and 
pharmacists referring patients to the GP using agreed guidelines. For example, for the 
Chlamydia service pharmacists are able to refer positive patients wanting further 
testing for other sexually transmitted infections to local NHS clinics. Before visiting 
local healthcare professionals, it is important to determine how the pharmacy service 
will benefit their patients and themselves as key stakeholders. The service may help to 
free up some of their time to focus on other activities, or may help them to deliver 
local targets.   
 
q) External environment  
It is important for pharmacists to be aware of the external environment and 
opportunities that can help them deliver an extended role. Local service innovators 
should be aware of PCO local development plans and key priorities, and in particular, 
areas which are not currently being achieved. On a national scale, it is important to 
align services with key DH targets or customer needs. Services can be designed to 
customer, NHS and / or business needs and priorities. The remuneration for the 
service may vary depending on the key beneficiaries and funding sources available.  
 
r) Benefits and motivators of service delivery 
For services to be delivered, whether private or NHS, there have to be clear benefits to 
all the stakeholders concerned. At the heart of the service, the customer has to see 
some advantage to using the service in community pharmacies. This could be a new 
service that is meeting an unmet need, or a service that provides increased 
convenience, accessibility, or benefits to the individuals concerned. If the NHS is 
commissioning the service, they would expect to see a cost effective service that 
provides the customers with improved care, prevention of long term complications, a 
reduction in hospital admissions, medicines wastage, or GP time. The service would 
also need to fit with local priorities and targets. For a pharmacy organisation to deliver 
a service there would need to be clear financial benefits. Community pharmacies are 
privately owned business that operate NHS services, and provide private services and 
products to consumers in a competitive market. Although individual pharmacists may 
deliver the services because of increased job satisfaction and care to customers, the 
management team would need to see benefits to their individual pharmacies. This can 
be met by targeting management teams on service delivery and crediting individual 
pharmacies for service delivery.   
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These recommendations have been based on the factors identified throughout this 
study, and the learnings applied in subsequent services. Consideration of these factors 
during service design, implementation and delivery may help to improve the 
sustainability and scalability of future pharmacy led services.  
 
 
9.3  Reflections on the study and limitations of the results  
The asthma services studied within my thesis were developed and implemented by 
myself as part of my development role within Boots, and were used as an example to 
study service implementation and delivery within community pharmacy. Although 
developed for commercial reasons, these services provided an ideal example to study 
as part of my PhD. The data collection methods that I have used within this study have 
been chosen with both research and commercial interests in mind. Whilst the research 
has been undertaken utilising resources available to me within my job at Boots, all 
analysis of the data presented within this study has been conducted by myself as a 
researcher conducting a PhD and independently outside of the work environment. 
Although there was a potential conflict of interest in delivering both commercial and 
research objectives concurrently, I do not believe that this has affected the outcomes 
of the data. An understanding of the factors affecting service delivery is critical to 
organisations such as Boots, as well to the wider pharmacy and academic community. 
My role as service development manager in Boots has enabled me to design, 
implement and control all elements of the services being studied. This is something 
that I would have been unable to do if I was not in charge of service development, 
particularly if I was not employed by a pharmacy organisation and was investigating 
this purely from a research perspective. My personal development from undertaking a 
research study and the learnings I have gained has also enhanced my work 
performance. As such, I believe that investigating the factors affecting service delivery 
from both a research and commercial perspective has enhanced the study and enabled 
me to fully understand the bigger picture.    
 
During the initial stages of my PhD I focused on the effect of the implementation 
route on the success of a service, but broadened this as my PhD progressed to include 
all factors affecting service delivery. Whilst the collection of data from several sources 
has enabled me to analyse the data to fit with the change in focus, it was not originally 
designed to do so. Additional questions may have prompted further factors to be 
identified within this study. Although I have been able to add the commercial and 
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business perspective into this study, it may have been useful to interview other 
stakeholders and commissioners to add to this perspective.  
 
This study was designed to look at the factors affecting service delivery in community 
pharmacies, using asthma services as an example. As such, the methods of data 
collection were not designed to measure patient outcomes following the interventions. 
Although anecdotal feedback was gained from customers and pharmacists, no 
evidence was collected to evaluate whether the interventions with the pharmacist 
resulted in beneficial health outcomes. For the NHS to commission services of this 
nature additional data would need to have been collected to measure the health 
benefits of delivering these types of asthma services. These could include improved 
adherence to medication (resulting in a reduction in medicine wastage), and 
improvement in symptom control (leading to a reduction in hospital admissions and 
prevention of long term complications). The most rigorous methods to collect these 
types of data are often in the form of randomised controlled studies.      
 
The dispensing data was collected and monitored throughout the brief intervention and 
asthma service in order to assess the financial benefits to Boots. Due to the fact that 
the brief intervention was implemented within all Boots pharmacies, no control data 
were available. As such, the differences between the asthma dispensing data for Boots 
were tracked against the total asthma market within the UK. Although no other asthma 
activity was undertaken within Boots at the time of this study, no direct correlation 
can be made between the rise in market share and the brief intervention activity due to 
the absence of control data. Although control pharmacies were used to compare the 
dispensing data from the pharmacies conducting the asthma service, these controls had 
also been conducting the brief intervention. Ideally, pharmacies conducting no asthma 
activity would have been used as controls.   
 
Research agencies were used to conduct the omnibus survey, and perform the 
interviews with both customers and pharmacists, providing anonymity to the 
interviewee. Due to the semi structured nature of the interviews, there was variability 
on the content of the data collected between individual respondents, which was also 
increased by the use of interviewers from a research agency. Each interviewer probed 
the respondents to varying degrees, on different questions. The likelihood of this may 
have been reduced by the use of a more structured questionnaire, but would have 
resulted in less rich data. Bias may also exist within the interviews as the issues raised 
may be a reflection of the interviewees pressing concerns at the time of data 
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collection.  The use of a research agency to collect the data also resulted in the 
transcripts within quarter one being transcribed manually, which may have 
compromised the comprehensiveness of the data collected, as being preoccupied with 
transcribing, the interviewer is less able to pick up and develop issues as they are 
raised by the respondent. Whilst the use of research agencies allowed for large 
volumes of data to be collected, they may have resulted in less comprehensiveness of 
the data.  
 
The use of existing data collection methods allowed me to collect data from several 
sources, but did present constraints as to the type of information that could be 
collected. Mystery customers were used for data collection within the company on a 
monthly basis, and as such, operated within certain guidelines. The design of the 
asthma scenario and collection of data was limited within these existing constraints. 
For example, mystery customers did not carry out the pharmacy scenario if there were 
more than four customers present at the pharmacy counter at the time of assessment. 
This restriction was one of the pre set parameters, so that the mystery customers did 
not disrupt the pharmacy counter any further during busier times. If these data had 
been collected, they would have provided a more accurate snapshot of the advice 
given during busier times. As a result, the factors identified from the mystery 
customer data will not provide a true representation of all the factors affecting service 
delivery when the pharmacy is busy. The use of a triangulation of data methods will 
have helped to reduce the limitations presented from using this method of data 
collection and the constraints it presented.  
 
Within each quarter, ten pharmacists were selected to recruit customers to research. 
Although there are advantages in the use of pharmacists and staff to recruit customers 
to research, this is extra work for them, and bias may exist in their recruitment 
method. Staff may have varied recruitment depending on the perceived customer 
response, and how busy the pharmacy was at the time. Individuals who chose to 
participate in the first place are often self selecting, and their comments may not be 
applicable to the wider population. The pharmacies were initially selected for 
customer recruitment to research based on a variety of formats and geographical 
locations. Due to recruitment problems within the pharmacy, the quota for the quarter 
one interviews were not reached, and led to additional selection criteria being used 
over the subsequent months. Despite the additional criteria for selecting the 
pharmacies to recruit customers to research, the overall response was extremely 
disappointing. This led to a small number of sites recruiting a limited number of 
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customers to interview. Previous studies have shown that more community 
pharmacists want to be involved in research [167, 168], but that a number of barriers 
exist [168, 169], namely cultural and professional barriers, and practical and financial 
barriers. It is unclear from the research whether the pharmacists themselves did not 
attempt to recruit customers, or whether the customers themselves were not interested. 
Feedback from the pharmacists involved suggested that it was the latter reason, 
although no data was collected from customers to substantiate these findings. The 
pharmacists may not have had the chance to undertake the recruitment exercise, and 
may have felt uncomfortable saying this to company representatives. The limited 
number of pharmacy sites recruiting customers to research led to a smaller sample of 
customers recruited. Because of the smaller sample size to select from, this will have 
resulted in less randomisation of the customers selected for interview. Further 
problems were experienced with this recruitment methodology, as pharmacists did not 
always recruit customers to the research following an intervention in asthma. This was 
mentioned by a handful of customers within the interviews. This data has still been 
included within the results, as these customers provided valuable feedback on 
pharmacy utilisation and services.  
 
As customers were recruited to interview whilst visiting Boots pharmacies, this may 
have resulted in less generalisability of the results regarding general pharmacy use. 
This was important however in order to obtain feedback on the asthma services. 
Despite this flaw in the recruitment methodology, a number of the customers 
interviewed regularly used other pharmacy providers. Bias may also exist in the 
content of the pharmacists interviews as although they were feeding back through a 
third party, the data was ultimately for the company that employed them As a result, 
they may not have been as honest as they would have been if reporting back to an 
external source.  
 
Whilst the results were collected from the delivery of asthma services within one 
organisation, experienced by pharmacists working in that organisation, and customers 
visiting pharmacies within that chain, many of the factors affecting service delivery 
should still be applicable to services for other condition areas, and delivery within 
other pharmacy environments. The recommendations suggested within this study have 
already proved successful within other condition areas, but have not been tested within 
other pharmacy settings.  
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9.4 Final conclusions 
This study has investigated the factors affecting service delivery in community 
pharmacy within the UK, using asthma services as an example. The barriers and 
facilitators identified throughout this study can be grouped under similar themes and 
are associated with the following factors: current pharmacy utilisation, customer need 
and demand, attitudes of customers and pharmacists, implementation of the service, 
training, pharmacy communication, awareness of the service, recruitment to the 
service, the type of advice available, the service structure, the pharmacist confidence 
in service delivery, management support, time, staff resource, remuneration, pharmacy 
environment, healthcare professional relationships and the external environment. 
Where these factors are presented in a positive light they are seen as facilitators, and 
when presented in a negative light, barriers.  
 
The benefits of service delivery to the pharmacist, customer and service provider are 
referred to as motivators within this study. Those motivators that have been identified 
for the pharmacist included the opportunity to deliver an extended role, to improve the 
public image of pharmacy, increase job satisfaction, and relationship building. 
Customer motivators were based on the accessibility of advice, type of advice, 
membership of a particular target group, and the opportunity to build relationships 
with a healthcare professional. The motivators to the service provider were based on 
the image of the company, and the business benefits and return on investment.  
 
Based on the factors identified throughout this study, and the learnings applied in 
subsequent services, a number of recommendations for service design, implementation 
and delivery have been made below. Consideration of the following questions during 
service design, implementation and delivery may help to improve the sustainability 
and scalability of future pharmacy led services.  
 
a) What is the current customer base and usage of the pharmacy? 
b) What is the customer need?  
c) Is there a customer demand for the service? 
d) Do customers want to access the service from community pharmacies? Or is a 
change in consumer attitude required? 
e) Do pharmacy teams want to deliver the service? How are you going to motivate 
and create a positive attitude? 
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f) How will the service implementation process create local ownership and 
responsibility for the service? 
g) What training will be provided to help pharmacists and support staff deliver the 
service?  
h) What briefings are planned to brief other members of team not involved in service 
delivery? 
i) What communication will be provided to pharmacists, support staff, and 
management teams prior to service implementation, during implementation and 
during delivery? 
j) Who is the target customer?  
k) How will customers be recruited to the service?  
l) What activities are planned to drive awareness of the service and to convert people 
into accessing the service? 
m) What advice will be provided and in what format? 
n) How will the service be structured? Is it simple to deliver? Does it offer flexibility 
in service delivery? 
o) What will be done to help improve pharmacists confidence in service delivery? 
p) How will the management team be engaged to ensure the service is seen as a 
priority?  
q) What resources are required to deliver the service? Is this a restructure of current 
resource, or is new resource required? 
r) How will the service be funded and by whom?  
s) How will the service be measured and monitored? 
t) What type of environment is required to deliver the service? 
u) Who are the stakeholders that need to be aware of the service?  
v) How will local healthcare professionals and other providers be engaged in the 
service? 
w) How does the service fit with NHS or business priorities?  
x) What are the benefits of delivery of the service to all stakeholders (customer, 
pharmacist delivering the service, commissioners, service provider)?  
y) Can each of the stakeholders clearly see the benefits during service delivery? 
 
This is the first large scale study of its kind to look at all the factors involved from the 
perspective of both customers and pharmacists, and many of the facilitators and 
barriers identified extend beyond those provided within the current literature. In 
addition, the service implementation methods, the type of advice, and the service 
structure have not been recognised as factors affecting service delivery within 
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previous studies. The motivators identified within the previous studies have been from 
the perspective of pharmacists only. This study has looked at the perspective of not 
only pharmacists, but also the motivators to customers and the service provider. Based 
on all the factors identified throughout this study, a number of recommendations have 
been made for future service delivery. 
 
 
9.5  Future research questions 
My research into the factors affecting service delivery in community pharmacy has 
highlighted a number of areas that warrant further investigation on this matter. A list 
of future research questions are detailed below: 
 
1. People with uncontrolled asthma often purchase cough products to help alleviate 
symptoms. As such, are people presenting at the pharmacy counter to purchase 
OTC products more likely to be less in control of their asthma?  Can the same be 
said for other condition areas? Should pharmacists be targeting more people OTC 
for opportunistic advice and services? Do pharmacists feel as comfortable 
recruiting customers to services when they are in the pharmacy purchasing OTC 
products, compared to when they present with a prescription? What is the role of 
the pharmacy counter staff in helping with this process?  
 
2. There are mixed attitudes between pharmacists about their extended role in 
services. Do these attitudes vary by age, gender or employment status (multiple 
versus independent)? 
 
3. The timings of consultations vary between customers, individual pharmacists 
delivering the service, and the service itself. Who drives the length of 
consultations between customers and pharmacists? Is it the customer? Or the 
pharmacist?  
 
4. Many community pharmacists are now delivering multiple services within their 
pharmacy. Are the factors affecting service delivery different between pharmacies 
offering single or multiple services? Are they different between different types of 
services? How will they operate in the pharmacy? Who will be in charge of co-
ordination of diaries and time management?  
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5. Multiple factors have been identified within this study as affecting service 
delivery. What is the importance of each factor? Are some rated more highly than 
others, or do they have an equal impact? What are the main barriers that need to 
be overcome, or facilitators that need to be in place to tip the balance towards 
service delivery? 
 
6. The general public is used to accessing pharmacy advice and services without an 
appointment. With the move to deliver more in depth services this is not always 
possible, and many pharmacists now have to operate appointment based systems. 
How do customers feel about this? Is it acceptable to the public to make 
appointments for community pharmacist services? Is it taking away the unique 
selling point of community pharmacists? 
 
7. The pharmacist is a valuable but expensive resource. Are they the best people to 
deliver services? Is it better to use a mixture of the healthcare team to be able to 
provide a cost effective service that utilises pharmacists expertise appropriately? 
Is it acceptable to customers to receive elements of services by other members of 
the team? Do they notice any difference? If this happened, how would it affect the 
patients perception of what a pharmacist does? 
 
8. Pharmacists are starting to get more involved in helping people manage their long 
term conditions. This involves advice, as well as monitoring and testing services. 
Does the general public like receiving in depth advice on long term conditions 
from community pharmacists? Or do they prefer brief advice? How confident are 
they in the pharmacists advice? Does this differ between condition areas? Explicit 
consent may be needed for some services in the future  is this a new concept for 
pharmacists that have lived with implied consent for services up until now? Is the 
perception of the pharmacists role in long term conditions changing as a result of 
the new pharmacy contract?  
 
9. The traditional use of the community pharmacist for advice has mainly related to 
medication queries or minor ailments, with very little advice sought on general 
health. The Government and pharmacy profession are attempting to change this 
and increase the publics use of the pharmacist for general health enquiries. Are 
there barriers in place to customers accepting this? Do they trust the pharmacists 
advice? Does this vary by age or condition area? Or is it related to payment of 
services and goods? 
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10. The majority of community pharmacies already have, or are in the process of 
implementing consultation space into their premises. The new pharmacy contract 
requires the need for such space before pharmacists can deliver advanced services. 
It is not appropriate to conduct all services in this space. Some customers may feel 
more relaxed having confidential conversations on the shop floor, as apposed to in 
a defined consultation area. This has been found to be particularly true for the 
Chlamydia screening service that Boots is operating in London on behalf of the 
NHS. Who defines the need to use the consultation space? Is it the pharmacist, 
customer or the service? 
 
11. The public use pharmacies to buy general products as well as medical purchases. 
This is particularly true for some of the large multiple pharmacy chains and 
supermarkets. Is there an opportunity to target customers for health advice and 
services whilst they are in the pharmacies shopping for non medical products? 
How receptive are customers to receiving health messages and advice when they 
are in this shopping mode?  
 
12. Pharmacists often refer patients through to GPs or nurses if they think it is 
appropriate. Do patients follow this advice and book a subsequent appointment at 
the GP practice? Similarly, if GPs refer patients to a pharmacist led service do 
they follow this advice and act on the referral? 
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APPENDIX A 
Brief intervention information pack 
 
TAKE CONTROL OF ASTHMA 
Attached:   
Summary asthma management guidelines [BTS / SIGN] 
Fact sheet 
 
FAO The pharmacist 
 
Dear colleague 
 
Boots is working with the National Asthma Campaign to help make the lives of people 
living with asthma easier.  We are helping people with asthma understand their 
condition so that they can achieve a better quality of life; and we are raising money 
which will help fund vital National Asthma Campaign research into the causes and 
ultimately a cure, for asthma. Pin badges will be on sale from 7 April 2003; and your 
store will be briefed on the fund-raising activities via a separate communication.  In 
addition, your store will be sent a document on charity guidelines. 
 
Pharmacists and healthcare staff have a key role to play in this partnership.  Research 
undertaken by Boots shows that people with asthma want more lifestyle information 
that will make a real difference to managing their condition. 
 
The accompanying guidelines outline a brief intervention that you could make which 
will help patients identify whether their symptoms are well controlled.  These can 
provide an opportunity, if appropriate, to provide additional lifestyle advice.  
 
This briefing pack also includes a fact sheet on appropriate seasonal advice regarding 
hayfever, for a person with asthma. We will be sending you updated advice and 
information on a quarterly basis, enabling us to keep you informed of how the 
campaign activity is going and highlighting other opportunities for you to get 
involved.  
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We have also included a summary of the updated BTS / SIGN guidelines on the 
management of asthma in this pack, providing the latest advice and evidence on 
asthma management. [British Thoracic Society / Scottish Intercollegiate Guidelines 
Network] 
 
Alongside this activity, we will also be looking at running a number of trials to study 
the effect of different types of pharmacist intervention on patient outcomes. This will 
provide learnings in the management of long term medical conditions that will help 
shape the role of the pharmacist in the future. 
 
I hope that you find this a professionally rewarding campaign that will demonstrate 
our commitment to healthcare. If you have any queries or comments, please feel free 
to contact Tracey Thornley on 0115 949 2186.  
 
Yours sincerely 
 
Steve Churton 
Assistant Pharmacy Superintendent     March 2003 
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PHARMACY GUIDELINES 
 
Introduction 
There are over 5.1 million people in the UK currently receiving treatment for asthma, 
with an estimated 8 million people who have been diagnosed with asthma at some 
point in their lives. Asthma is estimated to cost the NHS over £850m per year, and the 
number of new cases is continually rising with GPs in the UK seeing over 18,000 first 
or new cases per week. 
 
Asthma is not well controlled with over 74% of people affected by symptoms, often 
resulting in severe restrictions on lifestyle. Boots is working with the National Asthma 
Campaign to help make the lives of people living with asthma easier. We are helping 
people with asthma understand their condition so that they can achieve a better quality 
of life; and we are raising money which will help fund vital National Asthma 
Campaign research into the causes and ultimately a cure, for asthma.  
 
As pharmacists, you have a unique opportunity to interact with the customer in 
helping them to understand and manage their asthma better. This opportunity may 
arise when speaking to customers who come in to store to collect prescriptions or to 
purchase OTC products to relieve their symptoms. As a result of the campaign activity 
you may also notice an increase in the number of people presenting at the Pharmacy to 
speak to you about their asthma in general.  
 
This briefing pack outlines the most up to date information for asthma management, 
and we hope that you find it a useful aid to deal with any queries that you might have.  
 
Brief intervention 
To help identify people whose asthma is poorly controlled and to help build a picture 
of their overall wellbeing, you may wish to use one or all of the following three 
questions, recommended by the Royal College of Physicians: 
x Have you had difficulty sleeping because of your asthma symptoms (including 
cough)? 
x Have you had your usual asthma symptoms during the day (cough, wheeze, chest 
tightness or breathlessness)? 
x Has your asthma interfered with your usual activities (e.g. housework, work, 
school, etc)? 
 326 
If appropriate, you may want to consider giving the respondents some advice from the 
attached fact sheet. 
 
Continuing Professional Development 
As a healthcare professional and easily accessible to all patients, you can make a 
difference to the quality of life of patients with asthma. To enable you to fulfil this 
role, use the CPD cycle found on StoreNet, to identify the gaps in your knowledge.  
Once you have identified your learning needs, use the information supplied in this 
pack to support your Continuing Professional Development. You may wish to record 
this learning as evidence of your CPD. 
 
Lifestyle advice  
Boots conducted some research last summer, which showed that people with asthma 
want more lifestyle information that will make a real difference to managing their 
condition. We are going to be providing you with quarterly fact sheets with seasonal 
advice that is relevant to people with asthma at that particular time of year. This also 
provides us with an opportunity to update you on the success of the campaign and to 
keep you posted on fundraising activities locally. 
 
This quarters theme is about hayfever and asthma, due to the season and occurrence 
of these conditions within families who are allergy prone. We hope that you find the 
attached lifestyle facts both interesting and useful. 
 
Customer Advice and Information Leaflet 
An updated information leaflet will be sent through to stores in April to help support 
this campaign. The content of this leaflet will based around advice to help customers 
take control and manage their asthma, hayfever and eczema. It can be used as a tool to 
help support the advice that is given by the pharmacy team.  
 
Guidelines on the Management of Asthma [BTS / SIGN] 
The guidelines for asthma management in the UK have recently been updated. We 
have incorporated a summary document of this latest advice and research within this 
pack, to help you when communicating with customers.  
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Next Steps 
If you have any questions or queries regarding the campaign activity or intervention, 
then you can contact Tracey Thornley via EBC on corporate destination, or by 
telephone on 0115 949 2186. 
 
We will be evaluating the outcomes of this partnership and campaign with the 
National Asthma Campaign, and any resulting activity that it may drive in the 
pharmacy. As such, we would appreciate you contacting us with any examples where 
the brief intervention has had a positive outcome for patients. 
 
Dont forget to look out for further quarterly updates including the latest fact sheets. 
 
Further Reading 
Useful websites: 
www.asthma.org.uk  - National Asthma Campaign 
www.sign.ac.uk  - The Scottish Intercollegiate Guidelines Network from which you 
can download and print the British Guidelines on the Management of Asthma 
www.asthmaweb.net   Requires registration which is free and it also provides you 
with access to The Respiratory College (www.therespiratorycollege.com) with further 
links to respiratory sites and journals 
www.lunguk.org - British Lung Foundation 
www.brit-thoracic.org.uk - British Thoracic Society 
www.allergyfoundation.com  - Allergy UK 
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APPENDIX B 
Asthma service questionnaire for 
pharmacist consultations 
 
Good morning / afternoon, I was wondering if I could ask you a few questions about 
your asthma. It will take about five to ten minutes and any information you give me is 
strictly confidential. 
1. Gender M / F  Approximate age____________ 
2. Patients initials ________________ 
3. Where did you hear about this service? __________________________________ 
4. Could you tell me what your doctor or nurse has prescribed for you for your 
asthma and how often you should take it? 
If no  Follow up 
If yes -  
Medication Frequency Variation from Rx 
   
   
   
   
   
 
5. Do you use the above medication as prescribed? (record in variation column) 
6. If not, are there any reasons why? 
 
 
 
7. Have you experienced any of the following in the last week? 
 Yes No 
Have you had difficulty sleeping because of your asthma symptoms?   
Have you had your usual asthma symptoms, such as coughing, wheezing, 
tight chest or feeling breathless during the day? 
  
Has your asthma interfered with your usual activities such as housework, 
work or school? 
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8. How often do you take your reliever? 
More than once a day  
Once a day  
More than once a week  
Once a week  
Less than once a week  
 
9. When did you last have an asthma review with your doctor / nurse? ___________ 
10. Do you have any concerns about your treatment or inhaler technique? 
 
 
 
11. Have you been advised to rinse your mouth out after using your preventer? Y / N 
12. Do you use a peak flow meter? Y / N 
13. Have you been given any other practical advice? Y / N 
14. PCS offered? Y / N / NA 
15. If you smoke have you considered stopping? Y / N / NA 
16. Do you have any other questions? 
 
 
 
17. Referral required? Y / N (If yes, summarise reason below) 
 
 
 
18. If referral required  Permission gained?  
N - Advise to contact GP 
Y  See below & gain signature 
Name: D.O.B. 
Address: 
Patient Signature: 
Dr: Surgery: 
 
19. Is patient on medilink? 
N  No further action 
Y  Make dated note on record of interview 
 
Thank you for your time, please dont hesitate to contact me if you have any queries
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APPENDIX C 
Omnibus survey questionnaire 
 
Q1a Have you or anyone in your immediate family i.e. your partner or child/ren, 
been diagnosed with any of the following conditions? 
READ OUT AND ROTATE 
Asthma     Yes / No 
Diabetes    Yes / No 
Hypertension i.e high blood pressure Yes / No 
High cholesterol    Yes / No 
Osteoporosis i.e. brittle bones   Yes / No 
 
If "No" to all, then close.  If "Yes" to any, then ask for each. 
 
Q1b You mention [iteration mentioned from above].  It is yourself, your partner 
or your children who suffer with [iteration mentioned from above].   
Yourself 
Partner 
Child/ren 
 
NOTES FOR INTERVIEWER 
x If the respondent has two or more children that suffer from the same condition 
please confirm that the following questions will be asked in relation to the child 
suffering worst with the condition.  
x The following questions are linked from Q1b. The order of priority going into Q2 
is as follows: 
1. Yourself  Asthma 
2. Yourself  Anything else (first mention) 
3. Partner / child  Asthma 
4. Partner / child  Anything else (first mention) 
 
I would now like to talk to you about your/your child's/your partners [iteration 
taken from Q1b using the order above] 
 
 331 
Q2 How knowledgeable would you say you/they are about your/your child's/their 
[iteration taken from above]? 
Very knowledgeable 
Quite knowledgeable 
Neither knowledgeable nor un-knowledgeable 
Not very knowledgeable 
Not at all knowledgeable 
Dont know 
 
Q3a Do you/they take any medication for your/their [iteration taken from 
above]? 
Yes  regularly 
Yes  only when have symptoms 
No 
Dont know 
 
Answer Q3b if "Yes" at Q3a Otherwise, go to Q4 
 
Q3b Do you/they use your/their medication as often as advised by the doctor? 
Yes, all the time 
Yes, most of the time 
Sometimes 
Rarely 
Never 
Dont know 
 
Ask all 
 
Q4 How frequently do you/they experience symptoms of your/their [iteration 
mentioned from Q1b] that effect your/their life, by which I mean you cannot do 
things you normally would do? 
Everyday 
Several times a week 
Weekly 
Once every 2 weeks 
Once every 3 weeks  
Monthly 
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Less often 
Dont know 
 
Q5 Have you/they asked the pharmacist for advice related to your/your 
child's/their [iteration mentioned from Q1b] in the last 6 months? 
Yes 
No 
Dont know 
 
Answer Q6 if "Yes" at Q5 Otherwise, go to Q8 
 
Q6 What was this concerning? Anything else? DO NOT PROMPT 
Lifestyle advice e.g. diet, smoking, fitness 
Medication  
Products  
Services  
Symptoms 
Other (specify) 
 
Q7 On a scale of 1 to 5 where 1 is very poor and 5 is excellent, how would 
you/they rate the quality of information you/they were given by the pharmacist? 
1 
2 
3 
4 
5 
Dont know 
 
Ask All  
 
Q8 Which of the following stores or chemists, would you say you/they collect 
your/their prescription from most often?  
Asda 
Boots 
Co-op  
Lloyds 
Moss 
 333 
Safeway 
Sainsbury's 
Superdrug 
Tesco 
Other local chemist chain 
Other shop/store 
Doctors surgery 
Independent chemist (by this I mean not part of a chain)  
I got my prescription delivered by the store  
 
Q9 Do you or your partner have a Boots advantage Card?  
Yes  
No 
Dont know 
 
CLOSE 
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APPENDIX D 
Asthma audit questionnaire 
 
Introduction: Say “Good morning / afternoon / evening. I was wondering if I could 
ask you a few questions about your asthma. It will take around five minutes.” 
 
1. Indicate gender of respondent 
Male 
Female. 
 
2. Use best estimate for age: 
Under 18.. 
18-44.... 
45-64 
65 and over.. 
 
3. Ask: Do you know what your doctor / asthma nurse has prescribed for you in 
terms of frequency of taking which medication? 
Can accurately say whats on the prescription = yes. 
Doesnt know / not sure = no..... 
 
4. Ask: Do you pick up all the medication on your prescription? 
Picks up all medication = yes. 
Only picks up some e.g. only picks up relievers but leaves preventers = no.. 
 
5. Ask: Do you take your medication as often as prescribed by the Doctor? 
Yes, all the time 
Yes, most of the time... 
Sometimes 
Rarely 
Never 
 
6. Ask: How many times do you take your reliever medication? 
More than once a day 
Once a day. 
More than once a week. 
Once a week. 
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Less than once a week. 
 
7. Ask the patient whether they have experienced any of the following within the last 
week: 
 Yes No 
Have you had difficulty sleeping because of your asthma symptoms?   
Have you had your usual asthma symptoms, such as coughing, wheezing, 
tight chest or feeling breathless during the day? 
  
Has your asthma interfered with your usual activities such as housework, 
work or school? 
  
 
Close “Thank you – that’s all. Thank you for taking part in this survey.” 
 
During the second audit the following set of questions were also asked; 
 
8. Ask: Have you spoken to a Boots pharmacist about your asthma in the last three 
months? 
Yes (complete questions 9, 10 and 11).. 
No (finish and close)... 
 
9. If yes, ask what was the advice about? 
Lifestyle advice 
Medication .... 
Products.. 
Services 
Symptoms 
Other (specify) 
 
10. On a scale of one to five, ask how useful did they find the information that the 
pharmacist gave them (one is not very useful, five very useful) 
 
11. Ask: How they found out about the additional pharmacist advice? 
In store 
Referral from GP.... 
Referral from A N other 
Poster / leaflet outside of store 
Family / friend 
Other 
 
Close “Thank you – that’s all. Thank you for taking part in this survey.” 
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APPENDIX E 
Mystery customer research questionnaire 
 
E. DISPENSING 
ACTION: Join the queue for the dispensary and follow the guide below based on 
how long you queue for, if you are acknowledged &how well the queues are 
managed; 
 
1. If you queue for 2 minutes and receive no acknowledgement then answer E1a as 
code 1 & answer E2 & E3  and move to the next section 
2. If you are acknowledged within 2 minutes then queue for another 2 minutes.  If by 
this time you are not served then answer E1a as code 2, answer E2 & E3 and 
move to the next section 
3. If you are acknowledged within 2 minutes and are served after  a further 2 
minutes then answer E1a as code 3 and complete the ‘quick question’ enquiry  
(below) 
4. If served within 2 minutes then answer E1a as code 4 and complete the standard 
enquiry (below)  
 
Standard enquiry 
You want to enquire about your brother/sister who has asthma. It is coming up to the 
hayfever season and his/her asthma is getting worse. You do not feel that he/she 
controls his/her asthma very well as he/she is always running out of his/her blue 
inhaler. Ask whether or not you can get replacement inhalers directly from the 
pharmacist rather than having to go to the doctor for a prescription.  
If asked, your brother/sister seems to suffer from wheezing symptoms quite regularly 
which is leading you to believe that they are not controlling it well. The pharmacist 
may ask about the brown inhaler  say that your brother/sister does not use this very 
much and has not had it replaced for months. 
N.B. The blue inhaler is for relief of symptoms and the brown inhaler is for 
prevention. 
 
Quick question enquiry 
You are enquiring on behalf of a member of your family who has a number of 
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prescriptions every month and you just want to know how much it costs to get a pre-
payment certificate.   
 
Please answer all questions based on the response given apart from E9 & E10 
 
E1a What happened at the Pharmacy counter?  SINGLE CODE 
x I was not acknowledged within 2 minutes    
[complete E2 and E3 and then move to next section] 
x I was acknowledged within 2 minutes but still did not get  
served within a further 2 minutes     
[complete E2 and E3 and then move to next section] 
x I was acknowledged within 2 minutes and served  
within a further 2 minutes      
[complete the quick question enquiry] 
x I was served within 2 minutes     
[complete standard enquiry as normal] 
  
E2 Where there any signs of the queue being managed?  SINGLE CODE 
 [i.e. extra staff being called to help or extra tills being opened] 
x Yes    100 
x No    0 
x N/A  there was no queue R 
    MAX = 100 
  
E3 Which option best describes how you were acknowledged?  SINGLE 
CODE 
x Even when they are busy serving other customers, staff are aware of what is 
going on around them.  They smile and make eye contact with me and say 
something if appropriate      100 
x Staff are aware of what is going on around them and make an effort to 
acknowledge waiting customers      70 
x Staff appear to be aware of what is going on around them, although they do 
not acknowledge waiting customers     30 
x Staff appear oblivious as to what is going on around them.  They can only 
focus on one thing at a time and are not even aware that other customers are 
waiting         0 
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MAX = 100 
 
E4 Which option best describes how you were greeted?  SINGLE CODE 
x As soon as they see me, staff make eye contact, smile,    greet me in a warm 
and natural way and say something appropriate     110 
x Staff make eye contact and greet me in a genuine way   when I am close 77 
x Staff greet me but it is in a mechanical way which makes me feel they are just 
going through the motions      33 
x Staff do not greet me or acknowledge me even when I am close  0 
MAX = 110 
 
ACTION: If you are not initially served by the pharmacist, ask if you can speak 
to someone from the dispensary. It is not essential that you are served by the 
pharmacist but you must request to speak to someone from the dispensary. 
 
E5 Were you served by a pharmacist?   SINGLE CODE 
x Yes 
x No  
x Not clear  
 
ACTION: If you conducted the quick question enquiry please code E6 & E7 based 
on how the member of staff dealt with your query re: pre payment certificate 
 
E6 Which option best describes how well the member of staff established 
your needs? SINGLE CODE 
x The member of staff asks relevant questions in an open and friendly way to 
ensure she fully establishes my needs      110 
x The member of staff asks relevant questions in an open and friendly way and 
establishes most of my needs      77 
x The member of staff does not really ask sufficient questions to establish my 
needs          33 
x The member of staff does not ask any questions or attempt to establish my 
needs         0 
MAX = 110 
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E7 Which option best describes how well the member of staff recommended 
a product? SINGLE CODE 
x The member of staff is very knowledgeable about the product area. She 
explains how the products will benefit me and recommends a suitable 
product(s). She offers information on related products and services 90 
x The member of staff knows the area well. She is able to make a 
recommendation and explains how the product will benefit me. She does not 
mention related products and services      63 
x The member of staff has some knowledge of the products but is not very 
confident.  She is not comfortable recommending a product and does not fully 
explain product benefits       27 
x The member of staff is unable to help me. She has limited product knowledge 
of the area        0 
MAX = 90 
  
E8 What were you offered as a solution/given as a cost? SINGLE CODE 
 Write in  
 ___________________________________ 
 
Please answer E8a if you conducted the standard enquiry
 
E8a Please indicate whether the member of staff did any of the following (code 
all that apply)?  MULTI CODE    
x Give lifestyle advice (Please detail below)  
x Ask if your brother/sister has difficulty sleeping 
x Ask if your brother/sister is suffering from any symptoms affecting their day 
to day activities 
x Ask if your brother/sister is suffering any usual asthma symptoms during the 
day 
x N/A  asking quick question enquiry  
  
E9 Did the member of staff recommend any other products or services e.g. the 
Repeat Prescription Collection Service?  SINGLE CODE    
x Yes     100 
x No     0 
x N/A  asking quick question enquiry R 
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MAX = 100 
 
E10 Which option best describes your experience at the Dispensary counter in 
terms of integrity? SINGLE CODE 
x I really feel like I can trust the staff. They try to recommend or give me advice 
on the product which is right for me, whether or not it is a Boots brand and 
whether or not they make a sale      100 
x I am quite confident that the advice given or the product recommended is right 
for me         70 
x I feel as if the staff are obliged to promote or sell certain products or their own 
brand (e.g. Boots brands) even though they may not be quite right for me 30 
x I feel like the staff just want me to buy a specific product regardless of what I 
need or want        0 
x N/A  asking quick question enquiry     R 
MAX = 100 
 
ACTION: Thank the pharmacist and explain that you will talk it through with 
your brother / sister / member of family before making a decision  
 
E11 Which option best describes the parting you received? SINGLE CODE 
x Staff thank me and say goodbye in a warm and friendly way. They say 
something extra thats appropriate to me. They maintain eye contact and I 
have all of their attention until I am ready to leave   110 
x Staff thank me and say goodbye in a warm and friendly way. I have all of their 
attention until I am ready to leave     77 
x Staff thank me or say goodbye but it might sound rather mechanical. I might 
feel a bit rushed        33 
x Staff finish serving me and do not say goodbye or thank you. They move 
quickly on to the next customer      0 
MAX = 110 
 
E12 Please write comments about your experience in this scenario 
 ________________________________________ 
 ________________________________________ 
 ________________________________________ 
 ________________________________________ 
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APPENDIX F 
Customer interview questionnaire 
 
Introduction 
Inform respondents that we are conducting the survey on behalf of Boots and that their 
feedback is invaluable in the development of products and services provided by them.  
Inform them of the MRS Code of Conduct and confidentiality and that all of the 
information will remain anonymous and confidential and that they will never be 
referred to in person.  They should also advise us of any questions that they would 
prefer not to answer. 
 
As a background to the interview inform them that the overall objective of the 
research is to help Boots evaluate the success of the added value asthma services and 
in the development of the pharmacy offering. 
 
x Explore socio-demographics  
x Any other family members with asthma? Who? 
x Can I just check, have you or anyone in your immediate family i.e. partner / 
children, been diagnosed with any of the following conditions in addition to 
asthma - diabetes, hypertension, high cholesterol, osteoporosis? 
x If yes to any of the above - who is it that suffers? 
 
Respondent/Asthma Sufferer Background 
x Invite respondents to spontaneously describe their condition in order to develop a 
customer profile and to build a rapport with them during the interview. 
x How long have they suffered form their condition? 
x What asthma symptoms do they have?  
x How frequently do they experience symptoms that effect their life e.g. cannot do 
things that they normally do?  
 Everyday 
Several times a week 
Weekly 
Once every 2 weeks 
Once every 3 weeks 
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Monthly 
Less Often 
x What affects / triggers their asthma? 
x Does their asthma get worse at certain times of the day? Year? 
x Do other members of their family suffer from asthma? Who? 
x Explore how they deal with their asthma  do they visit their GP and if so how 
frequently?  If not, why not?   
x How do they deal with their asthma? (medication, avoidance triggers, other) 
x Do they visit their GP or Nurse for regular asthma reviews? If not, why? 
x Do you take any medication for your asthma? 
Yes - regularly 
Yes - only when have symptoms 
No 
Dont know 
x If yes, what medication are they on for their asthma? Explore preventer inhaler 
(brown), reliever (blue) or tablets. 
x Do they know what their medication is for? 
x Do they use their medication regularly as advised / prescribed by Doctor?  
Yes, all of the time 
Yes, most of the time 
Sometimes 
Rarely 
Never 
x Do they use any additional OTC remedies to help relieve their asthma symptoms? 
x Explore how knowledgeable they feel about their condition  
Very / Quite Knowledgeable 
Neither knowledgeable nor unknowledgeable 
Not very / Not at all knowledgeable 
x How they have achieved this? 
x Do they seek information on how they can alleviate their symptoms and if so 
where / what etc.? 
x Do they continually seek more information / advice / helpful hints etc. on how 
they can improve their condition?  If yes, are their certain periods if the year when 
this occurs e.g. summer & hayfever etc.? 
x How in control of their condition do they feel and would they like to improve this? 
If yes, what can they think of / suggest as to how they could achieve this? 
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Pharmacists 
x In this section seek to evaluate their current usage of pharmacists both in general 
term and in relation to their asthma condition. 
x How often do they visit pharmacy stores? 
x Which pharmacist do they use? 
Asda, Boots, Co-op, Lloyds, Moss, Safeway, Sainsburys, Superdrug, Tesco, Other 
local chemist chain, Other shop/store, Doctors surgery, Independent Chemist (not 
part of a chain), prescription delivered (record multiples if applicable) 
x How do they use their pharmacist  simply to collect prescriptions, advice etc.? 
x Thinking of their asthma in particular, have they approached their pharmacist for 
advice in the last 6 months? 
Yes 
No 
Dont know 
x If yes, what was this concerning? 
x Anything else? (Do not prompt) 
Lifestyle advice e.g. diet, smoking, fitness 
Medication 
Products 
Services 
Symptoms 
Other (specify) 
x How helpful do they feel they were?  
x On a scale of 1-5 where 1 is very poor and 5 is excellent, how would you / they 
rate the quality of information you / they were given? 
x What type of advice? What was it concerning? 
 
Boots Asthma Intervention 
x How often do they visit Boots stores? Is it for general purchases? Or 
prescriptions? 
x Do they or their partner hold an advantage card? Yes/No 
x If not already discussed explore where Boots fits into their asthma management 
x Why did they initially enter Boots on this visit e.g. asthma specific  prescription 
collection, advice, media campaign, links with national Asthma Campaign, 
browsing, usual store etc. ? 
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x I understand that you recently visited Boots and spoke to the Pharmacist about 
your condition  invite respondents to describe how this occurred and what they 
spoke to the Pharmacist about 
x How did the intervention occur  did they ask for advice or was it prompted by the 
pharmacist? 
x How did the conversation with the pharmacist make them feel?  
x Explore initially how they felt about this advice and how this makes them feel 
about Boots  this will enable us to fully evaluate the consumer experience 
x Explore in detail their conversation with the pharmacist  what information did 
they receive and how useful do they feel this was? 
x Have they acted or intending to act on this advice? 
x How do they feel about receiving lifestyle / product advice from a Boots 
pharmacist and how valuable do they feel this service is? 
x Would the intervention service encourage them to visit Boots pharmacy more 
often  probe and explore? 
x Thinking of the advice they have received, what other information/areas do they 
think would be useful to them and other customers?  This can include asthma and 
any other conditions that they think relevant e.g. Osteoporosis, CHD etc. 
x Would they like to see an extension in more asthma services delivered by their 
pharmacist? Or more services around other chronic conditions? 
 
Service Offering 
x Explore how they felt the pharmacist dealt with them as customers and how they 
provided the advice, referring to specific symptoms and advice offered, and tone 
& language  clarity etc. 
x How confident did they feel about the advice provided  were they already aware 
of the suggestions made 
x What difference do they feel this will make to their everyday lives? 
 
Post Intervention Service 
x Now that they have received the advice, has it made any difference to their 
condition/symptoms and if so how?  Have they seen any improvements in their 
health or do they expect to in the future? 
Quality of life 
Symptom control 
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x Have they changed the products they use or anything else in relation to their 
asthma? 
x Do they feel more / less in control of their condition? 
x How much do they feel in control of their condition? Has the intervention 
improved them taking their medicines? 
x Would they recommend this pharmacy advice to anyone else? 
x Throughout the interview listen as to how they describe the intervention  do they 
call it a service, knowledge transfer, advice etc.?  If not already covered, explore 
fully how they consider it in their view. 
x How do they relate the intervention service to that provided by their GPs?  
Explore whether or not they would visit their GP more / less as a result This 
relates to how much self control and management they have. 
 
Boots and NAC 
x Evaluate their awareness of the link between Boots and the National Asthma 
Campaign (NAC) and if aware encourage them to explain  
x What have they seen leaflets, press articles, Boots magazine, pin badges etc.? 
x How valuable do they feel this link is and the benefits to Boots customers? 
x How do they think consumers should be made aware of the intervention offer? 
 
Summary and Conclusion 
x Invite respondents to provide their overall views and comments about the 
intervention service that they have received and invite them to discuss how they 
feel about this in relation to the Boots brand and offering and in relation to 
pharmacists 
x What suggestions could be made to the offering  thinking of asthma and other 
conditions? 
x Would you like to talk to a healthcare professional in more detail about your 
asthma? 
Provide them with NAC helpline, pharmacist or GP contact details 
 
Thank & Close 
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APPENDIX G 
Pharmacist interview questionnaire v1 
 
Introduction 
Inform respondents that we are conducting the survey as part of the Asthma 
Intervention pilot study that is going on in Boots stores across the country for a year.  
Highlight the fact that their feedback is invaluable in the development of products and 
services offered by Boots.  Inform them of the MRS Code of Conduct and 
confidentiality and that all of the information will remain anonymous and confidential 
and that they will never be referred to in person. They should also advise us of any 
questions that they would prefer not to answer. 
 
As a background to the interview inform them that the overall objective of the 
research is to help Boots evaluate the success of the added value asthma services and 
in the development of the pharmacy offering. 
 
Background 
x Age, gender of Pharmacist etc. 
x How long have you worked for Boots? How long have you been based at this 
store? How many stores have you worked at in the last 12 months? 
x How much interaction or advice did you give to a person with asthma prior to this 
intervention? 
x Do they personally know anyone who suffers from asthma? Who? How do they 
deal with it? 
 
Asthma Intervention – Pharmacist Opinions 
As an introduction to the Asthma intervention discussion, invite Pharmacists to 
spontaneously tell you what they understand of the offer and their thoughts and 
comments so far in relation to the trial, customer feedback etc. This will provide us 
with a real understanding from their point of view in relation to customers etc.  
Where necessary/applicable probe on the following: 
x What do they think of the idea of providing customers with advice/info on 
relieving their asthma symptoms? 
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x Have they been able to offer the service so far and how easy / difficult have they 
found this? If difficult, why? 
x Have they used the three questions as outlined on the brief sent out informing 
them of the trial? E.g. difficulty sleeping, asthma interfering with usual activities 
etc. 
x What do they think of the idea behind the brief intervention  e.g. more 
involvement for opportunistic brief interventions for Pharmacists in conditions 
such as asthma? 
x How do they normally interact with customers? How often do customers ask them 
for advice and what conditions do they commonly relate to?  
x How much time do they normally spend with customers? Does this vary? Is there 
a range? Do they feel more comfortable having a brief intervention that is semi 
structured, or not? 
x Invite them to explain how they see themselves e.g. Pharmacist only, advisor, 
councillor etc.  Do different types of customer treat them differently  e.g. have 
more confidence in them? 
 
Asthma Intervention – In Practice 
Explore the Pharmacists reactions to the intervention service in real situations e.g. 
when dealing with customers: 
x How frequently have you conducted the intervention since the trial began? 
Approximately how many times do you get the opportunity daily / weekly? 
x How do you feel about speaking to customers about their asthma and then offering 
them advice on their condition? 
x Explore whether or not they feel their role has changed when offering this advice 
 and how this makes them feel e.g. increased job satisfaction, helping customers, 
increased job load? 
x How long is the average intervention / conversation taking? Do you have enough 
time and how has this impacted on workload? 
x Who in their department is providing the service  themselves, pharmacy staff 
etc.? 
x Have they briefed the rest of the pharmacy team? 
x What is the feedback from the rest of their team? 
x Invite the pharmacist to describe a recent example of the intervention being 
offered to a customer e.g. prompt for conversation, symptoms, recommendations / 
advice given etc. 
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x What have been the most common issues raised by customers that you have been 
able to help them with? 
x And what advice have you been giving  is it from the list supplied by Boots in 
the Asthma pack? What are their thoughts on the advice they have been provided 
with  have they any suggestions on additional info / sources etc? 
x Have they been using the three questions from the RCP? What type of lifestyle 
advice have they been giving? 
x What are their thoughts on the advice they are receiving from head office? What 
themes do you think should appear? When? 
x Where have they seen information about the campaign internally? (Options could 
include: briefing pack, pharmacy first, ideas for life, intranet, focus, health and 
beauty) 
x Which advice do they feel is most readily accepted by customers and how have 
they reacted when you have provided this? 
x What are their own personal thoughts on the campaign e.g. Percy and Penny 
Puffer fish pin badges etc. 
x What are their thoughts on having National Asthma Campaign as the charity of 
choice? Do they think that we should be linking pharmacy healthcare campaigns 
with charity of choice in the future? 
x What effect do they think the offer/service will have on the Boots brand, increased 
customer footfall etc.? 
 
Customer Feedback 
x What has been the initial reaction from customers when you have offered them 
advice and information? What feedback have you had from customers? 
x How satisfied do you think they have been with the advice?  
x Explore the issues that customers have raised with Pharmacists  have you been 
able to advise them on all queries so far? 
x If not, would more training help in this area  any suggestions at this stage how 
Boots can improve the offering? 
x What are the most common symptoms / conditions that they have talked to you 
about?  
x Have any customers returned for more advice and / or have they any feedback so 
far e.g. improved customer wellbeing etc.? 
x Were any customers aware of the new campaign?  If yes did they mention their 
source e.g. NAC website, press, stores etc.? 
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Future Intervention 
x Thinking of the brief asthma intervention trial, what other conditions do you 
believe this would work well with?  
x What else do you think you / Boots could do in relation to this service? E.g. fuller 
intervention etc.? 
x What are your thoughts on offering a similar service for e.g. Osteoporosis, CHD 
etc.? Any other suggestions? 
x If you had the freedom, how would you offer an intervention offer? Explore any 
suggestions here  and listen for potential barriers etc. 
x Do they think there are any barriers? 
 
Thank & Close 
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APPENDIX H 
Pharmacist interview questionnaire v2 
 
Introduction 
Thank you for agreeing to take part in the customer research recruitment process for 
the asthma brief intervention. The customer and pharmacist research is very valuable 
to us as we aim to use this as a feedback mechanism, and provide useful insights into 
other programmes going forward. Unfortunately we were not as successful as we 
hoped to be in recruiting customers into the research programme, and we understand 
this to be for a variety of reasons. We are very interested in collecting the feedback 
from the pharmacists involved to capture the experiences and learnings, so that we can 
amend the process for recruitment in quarter two. We would really appreciate you 
helping us by spending 15 minutes talking to the interviewer and answering the 
following questions. 
 
Explain that the interviewer is independent of Boots. 
 
Questions 
x Name 
x Store Number 
x Do you use the asthma brief intervention? If not, why not? 
x Do you ask the RCP 3 questions? Give lifestyle advice? 
x How frequently would you say you do this? 
x Approximately how many people did you approach in store during this time 
period? 
x How many people do you think you could have approached but didnt? 
x How many people did you recruit into research? 
x Over how many weeks? 
x How did you approach customers? [OTC purchase, Prescription, Advice] 
x Thinking about all the people you spoke to about this research, what would you 
say their overall response was? [positive, negative, surprised] 
x On a scale of 1 (easy)  5 (difficult), how easy would you say it was to recruit 
customers into the research programme 
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x Did you have any problems with recruiting? 
x If so, what were they? [Explore operational and customer issues] 
x Are there any recommendations that you would make for future recruitment 
purposes? What are they? 
x Would you be willing to take part in studies like this in the future? 
x On a scale of 1-5, how confident do you feel in approaching customers for 
recruitment? [self efficacy] 
x On a scale of 1-5, how confident do you feel in being able to deliver an extended 
role for pharmacists? What, if anything, needs to change? [self efficacy] 
x What pharmacy services have you taken part in the past? 
x Gender 
x Age 
x Position in store 
x Is this the store where you are usually based? 
x How many years is it since you qualified as a pharmacist? 
x Where did you do your pre registration training [hospital, community or 
industry]? 
x Have you ever worked in hospital pharmacy? 
x Do you have a Post Graduate Diploma, MSc, etc? 
 
Thank & Close 
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APPENDIX I 
Abbreviations 
 
AD  All Data 
AIM  Aerosol Inhalation Monitor 
AS  Asthma Service 
B  Baseline data 
BI  Brief Intervention 
BTC  Boots The Chemists 
CE  Continuing Education 
CHD  Coronary Heart Disease 
COPD  Chronic Obstructive Pulmonary Disease 
CP  Consistent Positive data 
CPPE  Centre for Pharmacy Postgraduate Education  
CPS  Cognitive Pharmacy Services 
CS  Cognitive Services 
DH  Department of Health 
EPS  Electronic Prescription Service 
FI  Full Intervention  
GMS  General Medical Services 
GP  General Practitioner 
IT  Information Technology 
LEP  Leading Edge Practitioner  
LPS  Local Pharmaceutical Services 
MUR  Medicines Use Review 
NAC  National Asthma Campaign 
NHS  National Health Service 
NPA  National Pharmaceutical Association 
NSF  National Service Frameworks 
OFT  Office of Fair Trading 
OTC  Over The Counter 
PC  Pharmaceutical Care 
PCCP  Pharmaceutical Care Certificate Programme 
PCO  Primary Care Organisation 
PCT  Primary Care Trust 
 353 
PDP  Professional Development Pharmacist 
PGD  Patient Group Directive 
PIPC  Pharmacists Implementation of Pharmaceutical Care 
POM   Prescription Only Medicine 
PPA  Prescription Pricing Authority 
PSNC  Pharmaceutical Services Negotiating Committee 
Q  Quarter (one to four) 
QOF  Quality and Outcomes Framework 
RCP  Royal College of Physicians  
RPSGB  Royal Pharmaceutical Society of Great Britain 
SPSS  Statistical Package for Social Sciences  
UK  United Kingdom 
USA  United States of America 
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